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Abstract 
The aims of the work presented in this thesis were two-fold: [i) to investigate whether 
domestic dogs are important reservoir hosts of AQ in a L. [Viannia]-endemic area 
where domestic transmission to humans has been reported [Part 1]; and [ii] to identify 
the shortcomings of currently practiced leishmaniasis dog control programmes and to 
evaluate whether topical insecticides could be used to control canine leishmaniasis 
[Part 2]. 
There is a growing belief that dogs [Canis familiaris] are peridomestic reservoirs of 
American cutaneous leishmaniasis [AQ] , as numerous studies have reported high AQ 
infection rates in dogs. The work described here is the first longitudinal study of AQ in 
dogs, and was carried out in 18 Leishmania [Viannia] -endemic villages of the 
Department of Hutmuco, Peru. Over three years [1997-1999] a total 1104 dogs were 
surveyed, 104 of which prospectively. A polymerase chain reaction [PCR)] protocol to 
identify L. [Viannia] parasites in dogs was developed [Chapter 2], and, together with 
serology [ELI SA. and I FAT], used to calculate prevalence and incidence of disease 
[Chapter 4]. The data was used to estimate the basic reproduction number [Ro] 
[Chapter 4] of canine AQ and to demonstrate a correlation between canine and 
human AQ incidences in the study villages [Chapter 5]. Several findings presented in 
Chapters 2-5 suggest that dogs are reservoir hosts of [peri-]domestic L. [Viannia] 
transmission in Huanuco, Peru. Rrst, whereas the prevalence (3.8%) and incidence of 
clinical disease [4.2%] are low, the prevalence [25.6%] and incidence [29.0% per year] 
of L. [Viannia] infection in dogs is comparatively high. Second, the average duration of 
infection [2.2. years] can be as long as the mean life expectancy of an infected dog [2.5 
years]. Third, L. [Viannia] parasites in dogs do not remain localised at the site of 
inoculation but are able to disseminate to both viscera and mucosa. Fourth, the 
detection of L. [Viannia] parasites by PCR in the blood of a high proportion of both 
symptomatic [32%] and asymptomatic [7.5%] dogs suggests that infected dogs are 
potentially infectious to sandfly vectors. Rfth, after controlling for inter-village 
differences in transmission rates, household dog ownership was shown to be a 
significant risk factor for human ACL. The results presented here show that if dogs were 
the main AQ reservoir host and if L. [Viannia] transmission were homogeneous, a dog 
control strategy (e.g. culling, insecticide-treated dog collars) in the study villages in 
Huanuco would be very feasible and effective, because the control effort [i.e. coverage] 
to reduce Ro<1 would be comparatively small [as low as 47%]. 
Domestic dogs are established reservoir hosts of ZVL caused by L. infantum. Hence, one 
of the approaches to reduce the incidence of human ZVL is to target infected dogs. The 
findings of a comparative study testing topical insecticides and applications to protect 
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dogs from sandfly bites are presented in Chapter 7. It was shown that whilst 
permethrin and fenthion pour-on lotions had a more immediate effect on sandfly biting 
rates and mortality, deltamehtrin-impregnated collars [DMq had a more prolonged 
protective effect, with the survival rate of bloodfed sandflies reduced by up to 86% after 
two months of deltamethrin collar application. I n the work described in Chapter 8 the 
effectiveness of DMC to control canine ZVL was tested in a matched cluster intervention 
trial. Possible constraints associated with a community-wide implementation of a dog 
collar ZVL control strategy were also investigated using mathematical modelling. 
Although ZVL incidence was 32% lower in collared as compared to uncollared dogs after 
five months collar application, the difference was not significant. However, DMC did 
significantly reduce the odds (by 50%) of dogs increasing their anti-Leishmania antibody 
titre. Whether topical insecticides such as DMC will be effective as leishmaniasis control 
tools will depend on several factors. Rrstly, the strategy will be most effective in those 
endemic areas where domestic dogs are the main ZVL reservoir and the epidemiological 
significance of wild reservoirs or stray dogs contributing to ZVL transmission is 
negligible. Secondly, in order to achieve a significant epidemiological impact on ZVL 
transmission, high dog collar coverage rates are essential. This will not only require the 
rapid replacement of lost collars, but also the collaring of new dogs recruited into the 
population; where population turnover rates are high, maintaining high coverage rates 
will be a greater logistic challenge, which invariably applies to dog populations in 
tropical, ZVL-endemic countries. Ultimately, the decision to replace the dog culling 
strategy with community-wide application of DMC will depend on [i] the relative cost of 
the interventions; and [ii] the practical applicability of DMC in the field [e.g. the 
willingness of the community to apply DMC and the efficiency with which they replace 
collars which have detached]. Clearly, the implementation of DMC on dogs is more likely 
to have the consent of the population at risk than the highly unpopular dog culling 
policy that continues to be practised in some ZVL-endemic countries. 
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Preface 
Think again. A query made in March 1999. 
Dear Dr LO, 
I work with Douglas Barker in Cambridge and do some F{R on clinical specimens from 
patients with suspected leishmaniasis. Although we usually use kDNA primers, we also 
try other primers described in the literature ego ribosomal, repetitive nuclear sequence, 
mini-exon, etc. 
From reading your papers published in Transactions and JCM in the last couple of years, 
you appear to favour the small subunit ribosomal primers developed by Van Eys et al. I 
also use these primers and have found them reliable and not prone to amplify the host 
DNA non-specificically. 
I hope you do not mind, but I would like to ask you a couple of questions about your 
PCR: 
1. Why do you not increase the sensitivity of the procedure by Southern blotting and 
hybridisation? 
2. Do you repeat the F{R reaction with the same or different primers to confirm that 
a positive is really positive and a negative samples remains negative? 
really would appreciate your answers as, although F{R is valuable, at times it 
frustrates me so. 
Yours sincerely, Dr BL 
The reply a couple of weeks later. 
Dear Dr BL, 
On behalf of Dr LO who is absent for a while, I will answer the questions in your E-mail. 
1. We found our F{R in practice sensitive enough and Southern Blotting did hardly 
improve the number of positive cases. Moreover, apart from the extra labour, cost 
and time, it mainly led to false positive reactions. 
2. I n general never repeat a successful experiment. I n our hands, one F{R proved to 
be suffiCiently reliable. However, we run at least 1 negative control per 5 F{R 
samples. We repeat all tests if one of the negative controls appeared to be 
positive. 
If you pass the stage of frustration about F{R, I am sure you will get bored. I am still 
puzzling what is worse. 
Regards 
DrGS 
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CHAPTER 1: 
General Introduction. 
The leishmaniases are a group of zoonotic diseases transmitted to humans 
and anim als by the bite of phlebotom ine sandflies. I n term s of global burden 
of disease, the leishmaniases are currently the third most important vector-
borne disease [after malaria and Iym phatic filariasis], being responsible 
annually for an estim ated 1.81 million Disability Adj usted Life-Years [DAl Ys] 
and 57,000 deaths (574). The world-wide annual incidence is estim ated at 
1.5-2 million clinical cases per year, with 12 million people currently infected 
and more than 350 million at risk of infection. 
Over the past 20 to 30 years there has been a dramatic increase in the 
number of reported human leishmaniasis cases, a trend that shows no signs 
of abating. Although partly due to better diagnOSis and notification of 
leishmaniasis cases, this trend is probably due to [i] the adaptation of the 
transm ission cycle to the peridom estic habitat because of urbanisation and 
deforestation (378, 563, 575); [ii] the failure of vector and reservoir control 
campaigns (32); [iii] the em ergence of Leishmania as an opportunistic 
infection in HI V-infected people (20, 169); and [iv] the increasing evidence 
of circulating, drug- resistant parasite strains (131, 525) . 
Despite the multiple aetiologies [for review see Ref. (298)], the New World 
leishmaniases can be divided into two broad categories: so-called American 
zoonotic visceral and American zoonotic cutaneous leishmaniasis [AVl and 
ACl respectively]. The latter includes localised cutaneous leishm aniasis 
[lCl] , mucocutaneous leishm aniasis [MCl] and diffuse cutaneous 
leishmaniasis [Del]. 
Throughout the Am ericas, AVl is exclusively caused by Leishmania 
[Leishmania] infantum. It has been isolated in: Argentina, Bolivia, Brazil, 
Colom bia, Costa Rica, Ecuador, EI Salvador, Guadeloupe, Guatem ala, 
Honduras, Martinique, Mexico, Nicaragua, Paraguay, Surinam e, United States 
and Venezuela. I n contrast, ACl is caused by several Leishmania spp., 
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including L. braziliensis, which is the most widespread Leishmania spp. in the 
New World and also accounts for most cases of ACL. I t has been isolated in 
Argentina, Belize, Bolivia, Brazil, Colom bia, Costa Rica, Ecuador, French 
Guiana, Guatemala, Honduras, Mexico, Panama, Paraguay, Peru and 
Venezuela [for review see Refs. (148,227,229,298)]. Over the following 
sections the clinical presentation, disease pathogenesis, immunology, 
treatment and prevention of the leishmaniases will be discussed, in particular 
with reference to L. [Vianniaj spp. and L. infantum, as those are the 
leishmaniae of interest in this thesis. 
1.1. The American leishmaniases: clinical presentation, 
disease pathogenesis and immunology. 
Clinical presentation. L. [Vianniaj may cause single or multiple primary 
lesions [for review see Ref. (565)] [Plate 1 A, 1 B, 1 D, 2A, 2B and 2E], 
which may be more severe [Plate 1 B] and long-lasting than lesions caused 
by other Leishmania spp. (246). lym phat ic spread and involvem ent of Iym ph 
glands are frequent (51, 52), and there is a variable tendency for lesions to 
self-cure [up to 75% of infections, e. g. (122, 123, 240, 266, 348, 475)]. 
Spontaneous healing usually results in a life-long protection from disease, 
which mayor may not be restricted to the same Leishmania sp. (374, 375), 
and protection is mediated by the host's cellular immunity [see below]. In 
order to maintain a memory immunity response dependent on continuous 
antigen presentation, life-long protection against reinfection may involve the 
persistence of live parasites (2). Thus, recurrence [due to exogeneous 
reinfection or endogeneous reactivation of persistent infections] may occur 
(158, 319, 492) [Plate 1 C and 1 E], and som e patients develop a second 
cutaneous lesion at a different site after their prim ary lesion has healed. 
Multiple [i. e. infections with the sam e Leishmania strain (132)] or mixed 
infections [i.e. infections with a different Leishmania strain or species (489, 
509)] have also been reported. 
Though MCl can be caused by L. [Vianniaj panamensis (411, 490), L. 
[Vianniaj guyanensis (488) and L. [Leishmaniaj amazonensis (53, 483), it is 
15 
most commonly associated with L. [Viannia] braziliensis (148). Mucosal 
involvem ent is the most serious com plication in L. braziliensis infections and 
can lead to disfiguring and life-threatening MCl [also called 'Espundia'] in up 
to 25% of L. braziliensis infections (172, 173). MCl is characterised by the 
ability of the parasite to m etastasise to mucous tissues by Iym phatic or 
haemotogenous dissemination [for review see Refs. (345, 565)]. The disease 
typically begins with nasal inflammation and stuffiness, followed by ulceration 
of the nasal mucosa and perforation of the septum. In som e cases the lips, 
cheeks, soft palate, pharynx or larynx are involved as well [Plate 1 F, 1 G and 
20]. Tissue destruction is thought to be due to a hyperergic im m une 
response. MCl never heals spontaneously, is very difficult to treat (65, 206, 
346, 347, 462), and secondary bacterial infections are frequent and may be 
fatal (345). 
Aim ost all cases of AVl are caused by L. infantum. I n contrast to L. [Vianniaj 
spp., L. infantum rarely remains localised in the skin in chronic infections and 
will migrate to the viscera, i. e. spleen, bone m arrow and liver. Com m on 
clinical AVl symptoms include abdominal swelling, fever, malaise, emaciation 
and diarrhoea, symptoms that tend to be associated with 
hepatosplenom egaly, pancytopenia, hypergam m aglobulinaem ia and 
hypoalbuminaemia (265, 423). If left untreated, AVl is fatal due to the 
hyperplasia that leads to liver and renal failure (265, 423). Recent 
observations, however, indicate that infection with L. infantum and other 
visceralising Leishmania spp. remain subclinical in up to 85% of infected 
individuals, producing com paratively mild oligosym ptom atic disease that may 
spontaneously resolve (37, 40, 41, 269, 307). I t also has becom e clear that 
sandfly saliva may modulate the course of infection of L. infantum and, 
hence, pathology of disease [see below]. Studies in Central America have 
shown that different concentrations of maxidilan, a salivary enzyme of the 
vector Lutzom yia longipalpis, may determ ine whether a L. infantum infection 
rem ains localised and cutaneous, or dissem inates causing classical kala-azar 
(61, 304, 305, 568). 
Disease pathogenesis and immunology. The establishment of the 
primary Leishmania infection is dependent on host susceptibility [e.g. genetic 
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susceptibility (9, 72-74, 306, 506), acquired im m unosuppression (20) and 
malnutrition (179, 569)], parasite virulence [e. g. parasite st rain (230, 279, 
590) and species (456)] and dose and/ or route of inoculation (577, 590). 
Evolution of infection and disease is, on the other hand, dependent on a 
com plex set of interactions including signalling properties of the epiderm is 
(377, 528, 529) and the cell- mediated immune response (76, 519). 
Over the past years it also has becom e clear that sandfly saliva may be 
crucial in establishment of infection and disease pathogenesis. Since the 
pioneering study by Titus and Ribeiro (535) demonstrated that the course of 
Leishmania infection in m ice is significantly enhanced by co-inoculated 
sandfly salivary gland extract, there have a been a series of studies 
confirm ing and extending this finding. These studies show that [i] sandfly 
saliva increases parasite burden, lesion size and persistence following co-
inoculation with L. major (59, 364, 386, 533), L. amazonensis (533), and L. 
braziliensis (70, 105, 484); [ii] sandfly saliva is vasodilatory and enhances 
erythema [due to the maxadilan peptide in the sandfly vector Lu. /ongipa/pis] 
(313, 314, 444, 458); and [iii] intraspecific variation in saliva com ponents 
determ ines clinical response to L. infantum [cutaneous as opposed to 
visceral] (568). 
The im m unological basis for these findings is not fully understood, but it 
appears that proteins in saliva can shift the adaptive im m une response from 
a Th1 to Th2 cell-mediated immune response [e.g. by increasing the 
production of interleukin [I L] -4 (59, 364) and I L-6 (516), or by inhibiting 
tumor necrosis factor [TNF]-a (516), interferon [IFN]-y (364), IL-12 (364) 
and nitric oxide production (248, 282, 562)]. Immunomodulation may be 
mediated by action on the pituitary adenylate cyclase-activator polypeptide 
[PACAP] type 1 receptor (516), or by inhibiting protein phosphatase 1/2A 
(282, 562). More recently, it has been shown that pre-exposure to sandfly 
saliva [i.e. with salivary gland sonicate [SGS] (59) or by natural sandfly bites 
(60)] cancels any enhancing effect from subsequent co-inoculation of SGS 
with L. major. Pre-exposure with SGS [twice at 2 week intervals] causes: 
1 ~O-fold reduction in parasite load, up to 5-fold reduction in lesion width, an 
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increase in delayed type hypersensitivity response [i. e. an influx of 
mononuclear phagocytes and eosinophils] and a reduction in I L-4 production 
(59, 60). The effect seem s to be mediated by anti-saliva antibodies, as pre-
incubation of SGS with anti-SGS antibodies has been shown to neutralise the 
ability of SGS to enhance the severity of L. major infections in na"ive hosts in 
the same way as did pre-exposure to SGS [e.g. by reducing Il-4] (59). If 
this phenom en on acts under natural conditions, it may play a role in 
explaining variation in host susceptibility to lCl and MCl with age -- as 
observed in epidemiological surveys of people in ACl-endemic areas (148). 
Despite significant differences between the various experim ental models and 
hum ans in their im m une response upon infection with Leishmania spp. [for 
review see Refs. (271, 366), several com m on features have been identified: 
[i] disease resolution is mediated by the cell- mediated immune response, not 
the humoral response; [ii] primary activation of T-cell subsets [mainly CD4+] 
is im portant for the developm ent of Th 1 and Th2 responses and subsequent 
course of infection; and [iii] there is strong evidence for a correlation 
between activation of different T-cell subsets and severity of disease. 
Resolution of infection and protection against reinfection is regulated by the 
expansion of Leishmania-specific Th 1 type CD4+ T helper cells secreting 
interferon [I FN] y, interleu kin [I l] 2 and tum or necrosis factor [TNF] ~ via 
Ca2 + and protein kinase C [PKC] -m ediated signalling pathways (58, 109, 
208, 410), which will activate macrophages to kill intracellular amastigotes 
through oxidative and nonoxidative mechanism s (76, 519). I l12 facilitates 
Th1 responses by stim ulating the differentiation of naive [ThO] cells into Th1 
cells and by serving as co-stim ulus required for maxim um IFNy secretion by 
antigen-activated Th1 cells and natural killer cells [NK] (496). Moreover, IL 12 
by itself is required for NK activation (495, 503). 
In contrast, susceptibility to Leishmania infections is regulated by the 
expansion of Th2 type CD4+ cells that secrete IL4, IL5, IL6 and IL 10, but not 
IFNy or IL2, in response to leishmanial antigens (127). IL4 and IL 10 suppress 
the developm ent of murine Th 1 responses (254, 280), and deactivation of 
macrophages occurs actively through intracellular parasites [e.g. 
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lipophosphoglycan (541)], or indirectly through inhibitory cytokines [e.g. I L4 
(267) and transforming growth factor [TGF] ~ (54, 55)] and other molecules 
[e.g. prostaglandin E2 (26) and m axidilan (314)]. I n hum ans with VL, I L 10 
rather than I L4 is responsible for the suppression of the Th 1 response (268, 
270). 
However, key data exists that cannot be explained in terms of Th1 [i.e. 
resolution/ resistance] and Th2 [i. e. susceptibility] T cell subsets only (18). 
For exam pie, adm inistration of I L4 [which is thought of regulating the Th2 
response] reduced both lesion size and parasitaem ia in L. major-infected 
BALB/C m ice, and rendered animals resistant to infection (103). This 
outcom e cou Id be explained by the ability of I L4 to synergistically act with 
IFNy to activate macrophages to kill L. major amastigotes (78). Similarly, the 
transfer of IFNy-producing, L. major-specific Th1 cells can exacerbate 
cutaneous leishmaniasis in some circumstances (534). These studies suggest 
that factors accounting for resistant and susceptible parasites have yet to be 
identified. 
Several studies now have indicated that antigen-presenting Langerhans cells 
play an im portant role upon Leishmania infection (377, 528): after parasite 
phagocytosis, Langerhans cells migrate from the site of infection to the 
draining lymph node, and activate antigen-specific T-cell subsets (75). 
Activated T-cells migrate via the blood into the lesion where infected 
macrophages and Langerhans cells that remained in the dermis regulate their 
effector activity by several mechanisms including cytokine secretion. 
Langerhans cell differentiation is stimulated by granulocyte-macrophage 
colony stimulating factor [GM-CSF] and TNFa (107), but inhibited by IL10 
(183,331). Incidentally, both GM-CSF and TNFa are also known to activate 
macrophages to kill intracellular Leishmania amastigotes (267). 
There is also som e evidence that CD8+ cells may play an im portant function 
in the host im m une response, either by stim ulating I FNy secretion and 
activation of m acrophages (390), or by a cytotoxic effect of CD8+ cells upon 
parasitised macrophages (68, 127, 137,268,316,354). 
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Epidemiological data from patient surveys appear to confirm the lh1/lh2 
dichotomy shown in experimental animal models. Briefly, La... patients, who 
present limited and ulcerated skin lesions, represent the 'healing form' of the 
disease, i.e. they display a positive proliferative response to leishmanial 
antigens: the delayed-type hypersensitivity response [Dn-I, as measured by 
the Montenegro skin test] is positive, with induration size correlated to lesion 
size and occasionally lesion number (29, 147, 573). Patient with recurrent 
infections have a weaker DTH than patients with sub-clinical infections (83), 
as do patients with relapses when compared to those with reinfections (492). 
This em phasizes the role of a Th2-type response in chronic infections. There 
is som e evidence that cytokine profiles vary with tim e during the course of 
infection: significant levels of I FNy are produced upon leishmanial antigen 
presentation, but during the early phase of infection [< 60 days] I FNy 
production may be down- regulated, and high levels of I L1 0 may account for 
a transient period of high parasite multiplication (461) (459). There is no 
evidence, however, that patients with low I FNy production are at risk of 
developing larger lesions or parasite dissem ination. I n fact, patients with 
lower I FNy may have a better response to therapy with pentavalent 
antimonials (459). They also tend to produce significant levels of I FNy, and a 
lim ited proportion of patients also produce I l5, though in lower am ounts 
than for DCl and MCl patients. DCl patients display predom inantly a Th2-
type cytokine response, i. e. DCl patients have a com plete anergy to 
leishmanial antigen, with a negative DTH response and lymphocytes non-
responsive to leishmanial antigen. DCl patients have low levels of I FNy and 
I l12, but significant serum levels of I l4, I l5 and TNFa. MCl patients display 
a mixture between Th1 and Th2-type cytokine responses [with high levels of 
I l2, I l4, I l5 and TNFa] which could explain non- resolution of disease, as the 
Th2-type response tends to dom inate when both type of responses are 
activated (431, 435). MCl patients tend to have a larger DTH than lCl 
patients, with comparatively high serum levels of IFNy and IL2, as well as IL5 
and TNFa. Up to date, there are no immunological markers that may help to 
identify those lCl patients who are at risk of developing MCL. Indeed, 
studies showing differences in the im m une response to different parasite 
strains or species are scarce. For exam pie, the DTH response to leishmanial 
is greater in L. braziliensis-infected patients than in L. panamensis-infected 
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patients, even after adjusting for time of evolution and lesion type [Le. LCL 
or MeL] (491). 
1.2. The American leishmaniases: treatment and prevention. 
Treatment. The detection and treatment of active cases currently represents 
the only leishmaniasis control strategy. Although the biochemical basis for 
their effectiveness remains unknown (330), the mainstay of anti-Ieishmanial 
therapy are still pentavalent antimonials [i.e. sodium stibogluconate 
[Pentostam] and meglumine antimoniate [Glucantime]], at a dosage of 
20m g/ kg/ day for 20-28 days. Am photericin B [Fungizone] is the second line 
drug of choice if patients are unresponsive to antimonials, at a recommended 
dosage of 1 m g/ kg/ day for 20-40 days. The drugs are typically adm inistered 
intram uscularly, although in areas where MCl is rare, intralesional 
inocu lat ion is becom ing m ore regular [Llanos- Cuentas, personal 
communication]. I n all leishm aniasis-endem ic countries, the official policy is 
to provide free treatment to all patients. This is often not feasible in practice 
as drugs may be in limited supply in the highly dispersed rural hamlets where 
ACl or AVl are prevalent. The demand for anti-Ieishmanial drugs during the 
1980s am ongst jungle migrants from Cusco, Peru, who were at particularly 
high risk of MCl, led remarkably to the formation of self-help patient 
associations. These successfully lobbied for improvements in drug availability 
and provided a health education service that encouraged patients to seek 
early treatment (241, 581). In endemic areas, such as in the departments of 
la Paz and Beni, Bolivia (160), early diagnosis and treatm ent of patients was 
greatly facilitated by non- governm ental organizations, usually funded by 
international aid. 
In Venezuela, control policy differs radically from the other countries latin 
Am erican countries, as the majority of all lCl patients treated by the MOH 
each year since 1989 have been provided with im m unotherapy [i.e. a 
com bination of heat- killed Leishmania prom astigotes and viable BCG] , rather 
than antimonials; and currently [i.e. in 1999] im m unotherapy is applied to 
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about 83% of all la... patients in Venezuela. Although trials with la.. patients 
in Miranda, Venezuela (119), showed that im m unotherapy was as effective 
as standard chem otherapy [as well as being cheaper and with fewer and less 
severe side effects], no sim ilar trial has been carried out elsewhere; and it 
rem ains uncertain whether im m unotherapy would be suitable in populations 
at greater risk of MCL. 
The main problems in treating ACl and AVl are that [i] clinical diagnosis can 
be difficult [e.g. skin lesions with aetiologies other than ACl are frequent, 
such as tuberculosis, leprosy, and skin carcinom as [Plate 1 H, 2 F and 21]] 
(185) as m ore reliable diagnostic tools are rarely available in rural health 
posts; and [ii] antim onials and am photericin B can have serious side effects 
[e.g. myalgia, pancreatitis, musculoskeletal pains, renal failure, peripheral 
neuropathy, hepato -and cardiotoxicity] (64), and are relatively ineffective 
against MCl (190, 205, 206, 320, 344, 346), especially in the latter stages. 
Drugs and medical attention due to the side-effects make courses of 
treatm ent expensive, and there is an increasing num ber of reports on 
patients non-responsive to the drugs either due to the emergence of drug-
resistant parasite strains (231-233, 330, 413) or to im m unosuppression [as 
is the case in HIV-infected patients] (20). Also, there are doubts whether -
despite clinical cure- available treatments clear the parasites at all (158, 244, 
245, 498, 499), which in turn wou Id lead to persistent infections and explain 
the frequency of relapses reported in several studies (245, 319, 492, 566, 
573). The ability of Leishmania to persist in the host despite containment or 
adequate im m une response has im plications for im m unocom prom ised 
persons: as is the case for AVl [for review see Refs. (20, 21)], ACl becomes 
an increasing problem in HI V- infected patients in endem ic regions, notably 
Brazil (81, 124, 138-140, 159, 198,332, 358, 383, 398, 471), French Guiana 
(393), Mexico (448), Peru (180) and Venezuela (256, 257), with some 
studies suggesting that lCUHIV co-infected patients are more at risk of 
developing MCl than lCl patients (20, 21). 
Finally, the invasiveness of the standard procedure, i.e. a lengthy course of 
intramuscular inoculations, means that a significant proportion of patients fail 
22 
to complete their full course of treament. Hence, most research has focused 
on the development of alternative dosage schedules or treatments [e.g. 
pentamidine, allopurinol, dapsone, mefloquine, miltefosine] , including 
immunotherapy (39, 119, 392), thermotherapy (27, 315, 395) and 
phytotherapy (7, 141, 154, 214, 283, 552). Although the possibility of 
vaccination as method of leishmaniasis control has been extensively studied 
[for review see Ref. (249)], no safe and effective ACl or AVl vaccines are 
currently available and are unlikely for some time. 
Despite the number of clinical trials that have tested different dosages, 
schedules, and drugs against leishmaniasis, comparisons between studies are 
difficult. Firstly, ACl is characterised by a tendency of lesions to self-cure, 
which can be as high as 75% (240). Failure to include either negative 
[placebo] or positive [recom m ended standard treatm ent, i.e. pentavalent 
antimonials] control in the studies (190,291,412,521,522) makes the 
interpretation of an effect of either differences in drug, dosage or schedule 
impossible. This is of particular importance in studies that have used small 
numbers of patients to evaluate treatment response. Secondly, infecting 
parasite species and strains are likely to vary in their sensitivities to drugs, 
and cure rates of ACl patients with moderate [lCl] or severe disease [MCl] 
are very different (320). Healing rates also depend on host factors, such as 
localisation and chronicity of lesions, underlying illness or concom itant 
infection, and acquired resistance to Leishmania infection. Thirdly, 
com parisons between studies are also difficult because the studies vary in 
experim ental protocol [e. g. st udy design, duration of follow- up] and in 
particular in their definition of 'clinical cure'. Thus, whereas in one study 
clinical cure is defined as 'when lesions had > 80% re-epithelialised by the 
first follow-up at 1.5 months' (240), other studies define it as 'complete re-
epithelialisation of all lesions at the end of treatment and no reactivation or 
mucosal involvement during the follow-up' (412). 
Le ish man iasis prevention. The principal leishm an iasis prevent ion strategy 
available is house spraying with residual insecticides (13, 145, 149, 189, 
284, 310, 336, 407), which is practiced infrequently and arbitrarily according 
to available funds and local political pressures. Anecdotal evidence suggested 
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that residual insecticide spraying of houses is effective against endophilic and 
endophagic sandfly vectors [e.g. La.. incidence in Peru dropped dramatically 
during malaria and bartonellosis house spraying campaigns (144, 263)]. 
Recently, a random ized control trial in the Peruvian Andes conclusively 
showed that renewed 6-month spraying inside walls and ceilings with 
lambda-cyhalothrin reduced ACL incidence by 81 % [95% C.I. 20- 95] (145). 
As for other vector-borne diseases, the long-term sustainability of a house-
spraying leishm aniasis control program me, whatever its efficacy, must be 
questioned. 
In the absence of a vaccine, alternative control strategies are being explored. 
Firstly, anum ber of mostly small-scale trials have been carried out to test 
the effectiveness of insecticide- im pregnated bed nets (16, 166, 408), 
curtains (16, 166, 408) or clothes (497, 523). Secondly, environmental 
management (187, 531) combined with the spraying of the peridomestic 
environm ent and sandfly resting sites with insecticides (111, 426, 450) has 
also been studied. Thirdly, the possibility to control sandfly vectors with 
repellents (12, 44, 94, 118, 130, 497) or biological control agents [e.g. 
Bacillus thuringiensis (151) or Beauveria bassiana (454, 567)] has also been 
investigated. 
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1.3. Study objectives. 
Current thesis is divided into two parts, both of which investigate and discuss 
the epidemiology and control of zoonotic canine leishmaniasis. 
Because several studies have reported high ACL infection rates in dogs there 
is a growing belief that domestic dogs are ACL reservoir hosts. The 
Introduction in Part 1 will review current evidence to incriminate dogs as 
ACL reservoir hosts. Chapters 2 to 5 will present the findings of a 
prospective epidem iological study on canine ACL in the Department of 
Huanuco, Peru, a L. [Vianniaj-endemic area that has been well described in 
terms of vector ecology and human disease. 
Dom estic dogs are established reservoir hosts of L. infantum. Hence, one of 
the approaches to reduce human ZVL has been to cull infected dogs. This 
strategy has failed to produce the expected reduction in human disease, and 
the reasons why this has been the case will be discussed in the 
Introduction in Part 2 of this thesis. Chapter 6 will assess the potential 
usefulness of a rapid diagnostic test in canine leishmaniasis mass-screening 
surveys. Findings will then be presented on studies testing the efficacy of 
topical insecticides to protect dogs from both sandfly bites [Chapter 7] and 
disease [Chapter 8]. 
Thus, the aims of this thesis were two- fold: 
1. To investigate whether dom estic dogs are im portant reservoir 
hosts of ACL in a L. [Vianniaj-endemic area where domestic 
transmission to humans has been reported [Part 1]. 
2. To identify the shortcom ings of currently practiced leishm aniasis 
dog control program m es and to evaluate whether topical 
insecticides could be used to control canine leishm aniasis [Part 
2]. 
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Specific objectives were: 
A. To test whether a polym erase chain reaction [PCR] -based 
diagnosis to detect L. [Vianniaj spp. infection in dogs could be 
used as a m ass-screening tool in epidem iological or control 
studies [Chapter 2]; 
B. To describe clin ically, parasitologically and im m unologically the 
course of L. [Vianniaj infection in naturally infected [Chapters 3 
and 4]; 
c. To test whether dog abundance or dog ownership is an ACL risk 
factor for human populations in endemic villages [Chapter 5]; 
D. To evaluate the utility of an immunochromatographic dipstick 
test to detect L. infantum infection in dogs [in com parison with 
ELISA and peR] as a tool of improving the success of current dog 
culling strategies [Chapter 6]; 
E. To com pare the effect of different topical insecticides and 
applications for protecting dogs from sandfly vector bites 
[ Chapter 7]; 
F. To test the effectiveness of insecticide-impregnated dog collars 
to reduce the incidence of canine leishmaniasis in a community-
based intervention trial [Chapter 8]. 
26 
PART 1 
a-IAPTERS 2 - 5 
AMERI CAN aJTANEOUS 
LB SHMANI ASI SIN DOMES II C 
DOGS AND THB R ROLE OF 
RESERVOI RS OF HUMAN 
DISEASE 
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Introduction 
Canids [e.g. the crab-eating fox Cerdocyon thous] , and especially dogs 
[Canis fam iliaris] , are the peridom estic reservoir hosts of zoonotic visceral 
leishmaniasis [ZVL] caused by L. infantum (126,298,299) [see also Part 2]. 
Because transm ission of ACL is increasingly evident in the dom estic 
environm ent, and because several studies have reported high infection rates 
of ACL in dogs, there is a growing belief that they are also reservoir hosts for 
ACL. I f dogs are reservoir hosts of ACL, dog cont rol may be a feasible 
intervention strategy, as it is for the control of ZVL in humans [see Chapters 
6-8]. Over the following pages, the current evidence to incrim inate dogs as 
ACL reservoir hosts will be critically reviewed. 
Originally associated with forested areas (298, 301), the transm ission cycle 
of ACL has now adapted to the domestic environment due to deforestation 
and urbanisation (225, 378, 563). The transition from sylvatic to dom estic 
transmission cycle was further encouraged by the lack of a specific 
leishmaniasis control strategy, and the discontinuation of intervention 
campaigns designed for other vector-borne diseases, e.g. malaria (144, 
263). Dom estic transm ission of L. braziliensis has now been dem onstrated in 
Argentina [probably by Lu. [Nyssomyia] intermedia] (476-479), Bolivia [by 
Lu. [verrucarum group] nuneztovan] (308), Brazil [by Lu. [N.] whitmani or 
Lu. [N.] intermedia] (156, 449), Peru [probably by Lu. [Helcocyrtomyia] 
tejada/] [Davies CR et al., unpublished data], Venezuela and Colom bia [by 
species in the Lu. verrucarum group, e.g. Lu. young/] (15, 501). Domestic 
transm ission of L. panam ensis has been dem onstrated in Ecuador, Colom bia, 
Panama and Costa Rica [generally by Lu. [N.] trapidoi or Lu. [LutzomyiaJ 
gomez/] (114, 264, 382, 389, 588, 589) and L. peruviana is transm itted 
dom estically in Peru [generally by Lu. [H.] peruensis or Lu. [H.] 
ayacuchensis] (146, 561). 
Natural Leishmania infect ions have been det ected in a range of non- human 
hosts, principally marsupials, rodents, edentates and carnivores. However, so 
far only reservoir hosts for L. infantum [Canis fam iliaris, Cerdocyon thous 
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and Didelphis marsupiaJis], L. amazonensis [Proechimys spp.], L. guyanensis 
[Choloepus didactylusj and L. panamensis [Ch. hoffmaml have been fully 
incriminated (33, 229). 
Since the historical accounts in the first half of the past century (93, 204, 
218, 362, 363, 369, 424, 425, 468), an increasing number of studies have 
reported ACL infection in dogs, although many failed to confirm the 
identification of any Leishmania parasites. I n particular, the status of dogs as 
reservoir hosts of L. peruviana -often reported as conclusive (281, 338, 422, 
565)- has been uncertain for decades as Herrer's pioneering studies failed to 
isolate or characterise any parasites (259, 260). Only recently has L. 
peruviana been isolated and characterised from dogs (322, 400). 
Circumstantial evidence that dogs might act as reservoir hosts for ACL comes 
from two observations: [i] Leishmania strains isolated sym patrically from 
dogs and humans are indistinguishable; and [ii] the risk of ACL infection in 
dogs is correlated with the risk of ACL in humans. 
Ta ble 1.1. lists studies that have isolated and identified Leishmania 
parasites from ACL-infected dogs, the geographic distribution of which is 
shown in Figure 1_1. As for human ACL, L. braziliensis seems to be the most 
widespread Leishmania sp. causing ACL in dogs in the New World, and 
accounts for most canine ACL infections with confirmed aetiology. It has been 
isolated and identified from dogs in Argentina, Bolivia, Brazil, Colombia, Peru 
and Venezuela. Several other members of the L. [Vianniaj subgenus have 
been isolated from dogs: L. panamensis in Colombia, Costa Rica, Ecuador, and 
Panama; L. peruviana in Peru; and L. colombiensis in Venezuela. L. 
panamensislL. guyanensis, L. braziliensislL. peruviana and L. guyanensislL. 
colombiensis hybrids have been isolated in Ecuador, Peru, and Venezuela, 
respectively. Other isolates likely to be L. [Vianniaj spp., but which remain to 
be identified to species have been reported in Brazil, Peru, and Venezuela. In 
the Leishmania subgenus, L. mexicana has been identified in Ecuador, 
Guatemala, Mexico, and United States; and L. pifanoi in Ecuador. 
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Figure 1.1. Distribution of American cutaneous leishmaniasis in Canis familiaris . 
o Le.(Viannia) spp. 
• Le. (v.) braziliensis 
• Le.(V.) peruviana 
• Le. (V.) panamensis 
Le. (v.) guyanensis 
• Le(V.) colombiensis 
• Le.(L.) mexicana 
Le.(V.) lainsoni 
• Le.(V.) guyanensisiLe. (v.) braziliensis hybrids 
Le. (V.) peruvian aiLe. (V.) braziliensis hybrids 
• 
• 
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Table 1.1. American cutaneous leishmaniasis in dogs: identified isolates. 
Country Parasite species Identification method Reference 
Bolivia 
Alto Beni LV spp. 1 ? (309) 
Brazil 
various~§ LB8 MO (226) 
Amazonas~ LVspp.1 C,H (394) 
Bahia LB9 C, H, ISO, MO, X (56) 
Bahia~ LB3 C, H, ISO, MO, X (133) 
Bahia LB 13 ISO,MO (470) 
Ceara~ LB 1 ISO (550) 
Ceara~ LB2 DNA, ISO (551) 
Ceara~ LB 1 C, ISO, MO (549) 
Ceara~ LB2 C, DNA, ISO (548) 
Ceara LB5 C (155) 
Espirito Santo LB27 C, H, MO (191 ) 
Espirito Santo LB4 ISO,MO (192) 
Espirito Santo LB 7 C, H, MO (504) 
Espirito Santo LB4 C,H,MO (504) 
Minas Gerais LV spp. 11 C,H (170) 
Minas Gerais LV spp. ? 3 C,H (360) 
Minas Gerais~ LB5 ISO (337) 
Minas Gerais LB4 C, H, ISO (135) 
Minas Gerais LB5 C, ISO? (255) 
Minas Gerais~ LVspp.?1 ? (361) 
Minas Gerais LVspp.1 ? (417) 
Minas Gerais~ LV spp. 1 PCR (420) 
Minas Gerais LV spp. 3 PCR (216) 
Parana~ LB3 C, H,MO (325) 
Parana LB5 ISO (104) 
Pernambuco LV spp. 12 PCR (86) 
Rio de Janeiro~ LB4 ISO, ISOEL, RF (326) 
Rio de Janeiro LB? ISO, MO, RF (128) 
Rio de Janeiro LB8 C,MO (409) 
Rio de Janeiro~ LB28 C,H,MO (432) 
Rio de Janeiro~ LB2 C, H, ISO, MO, X (6) 
Rio de Janeiro LB4 C, H, ISO, MO (5) 
Rio de Janeiro LV spp. ? C,H (45) 
Rio de Janeiro LV spp. 1 DNA (399) 
Rio de Janeiro LV spp. 5 C,H (487) 
Rio de Janeiro LB 12 C, ISO, RF (46) 
Rio de Janeiro LB 1 ? (272) 
Sao Paulo LB2 ISO, MO (586) 
Sao Paulo LA PCR (536) 
Colombia 
various~ LB 3 ISO (120) 
Valle del Cauca~ LP 1 ISO (120) 
Ecuador 
Azuay LPIF 2 C, ISO (252) 
Azuay LM 1 C, ISO, MO (253) 
Esmeraldas LP/LG C, ISO (43) 
Pichincha LP 1 C, ISO (262) 
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Table 1.1. A?"eri~a.n c~taneous leishmaniasis in dogs: 
Identified Isolates (continued). 
Country Parasite species Identification method Reference 
Panama 
Central Panama LP 9 C, H, ISO (167) 
Peru 
Ancash LV spp. 3 C, ISO, PCR (322) 
Huanuco LPR 1, LB/LPR 10 C, ISO, PCR (400) 
Lima LV spp. 2 C, ISO, PCR (322) 
United States of A. 
Oklahoma LM 1 ISO (292) 
Venezuela 
-~ LV spp. 3 DNA, PCR (245) 
Cojedes LV spp. 3 C,H,X (3) 
Cojedes LB 2 C, H, ISO, MO (5) 
Lara LV spp. 9 C,H (80) 
Lara~ LB/LG 12 ISO (134) 
Nueva Esparta LC 1 ISO (161 ) 
Vale Hondo~§ LB 1 MO (226) 
NOTE. The studies reporting canine ACL of known etiology are listed by country and state. 
Unless otherwise stated (~,"¢-), studies were carried on random dog samples. Also given are 
methods of parasite isolation and identification, and parasite species (number of Leishmania 
isolates identified). Abbreviations are C: culture; DNA: DNA probes; H: hamster inoculation; ISO: 
isoenzyme electrophoresis; ISOEL: isoelectric focusing; LA: L. amazonensis; LB: L. braziliensis; 
LB/LG: L. braziliensislL. guyanensis hybrid; LB/LPR: L. braziliensislL. peruviana hybrid; LC: L. 
colombiensis; LG: L. guyanensis; LM: L. mexicana; LP: L. panamensis; LP/LG: L. panamensislL. 
guyanensis hybrid; LPR: L. peruviana; LPIF: L. pifanoi; LV: L. (Viannia) spp.; MO: monoclonal 
antibodies; PCR: polymerase chain reaction; RF: restriction enzyme electrophoresis; X: 
xenodiagnosis. ~, characterization and identification of parasite isolates only; "¢-, non-random dog 
sample, i.e. dogs with cutaneous lesions and/or scars; §, sample was part of a larger study 
assessing the distribution of Leishmania spp. in the New World. Out of 227 isolates identified as 
L. braziliensis by monoclonal antibodies, 53 came from dogs, mainly from suburban areas of 
Brazil. 
Of course, the identification of parasites from dogs does not distinguish 
whether dogs are accidental or reservoir hosts. Sim ilarly, the reported 
coincidence between households with ACL patients and the presence of 
infected dogs (192) reflects the fact that humans and dogs are likely to be 
exposed in the sam e way to the sandfly vector, but is not evidence for dogs 
being a reservoir of disease. Furthermore, most of the studies reporting ACL 
infections in dogs fail to report comparable data on the Leishmania infection 
rates of other animals found in the domestic environment [see Chapter 5]. 
For exam pie, L braziliensis has been isolated or detected in cats [Felis 
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domesticus] (419), equines [Equus cabal/us and Equus asinus] (3, 4, 49, 79, 
195), rodents [e.g. Akodon arviculoides and Oryzomys spp.], and opossums 
[Didelphis marsupialis] (228); and both L. panamensis and L. peruviana have 
been isolated from opossum s and rodents [e. g. Heterom ys desmarestianus, 
Akodon sp. and Phylottis andinum] (229). 
Direct evidence for a reservoir role for dogs depends on the m easurem ent of 
three param eters, which together determ ine the probability that a dom estic 
dog population plays a significant role in ACL epidem iology (286): [i] the 
prevalence of ACL infections in dogs; [ii] the biting rate of sandfly vectors on 
dogs; and [iii] the infectiousness of ACL-infected dogs to sandfly vectors. 
Each of these param eters is exam ined below. But in general, the reported 
measurements of prevalence are difficult to interpret, measurements of dog 
biting rate and dog infectiousness are scant, and the threshold values 
required for all three param eters in order to incrim inate dogs as ACL 
reservoir hosts need to be determined by mathematical modelling. 
Measurements of prevalence. Isolation and identification of parasites 
provides a conclusive [i.e. there are no 'false positives'], but insensitive test 
for Leishmania infection in dogs, [i.e. there are many 'false negatives'], and 
m easurem ents of prevalence typically depend on less specific diagnostic 
tools. These include clinical diagnosis [the detection of characteristic lesions 
or scars], parasitological diagnosis [usually by microscopic inspection of 
impression smears from lesions], and immunological diagnosis [detection of 
a serological or cell-m ediated im m une response]. Difficulties associated with 
each diagnostic test are discussed in Chapter 2. 
Table 1.2. lists reported studies that provide estimates of the prevalence of 
ACL in dogs surveyed in different endemic areas (453). These estimates 
depend on the diagnostic test used, and the studies are divided accordingly. 
A small number of studies have used more than one diagnostic test, 
therefore appearing m ore than once in the table, and perm it direct 
com parisons of the 'sensitivity' [note: the studies listed in Table 1.2. give 
ACL prevalence; strictly speaking the sensitivity can not be estimated as a 
diagnostic gold standard does not exist] of the diagnostic tests used. For 
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example, in eight out of nine direct comparisons the enzyme-linked 
immunosorbent assay [ELI SA] appeared to be m ore sensitive than the 
im m unofluorescence ant ibody test [I FAT] . I ndirect com parisons of 
'sensitivity' can also be made by comparing the results for all reported 
surveys in Table 1.2. For example, the proportion of dogs with clinical 
symptoms ranges from nil to 0.409 [amongst the 47 surveys reported] with 
a median of 0.082 [SE±0.017]. In contrast, the median proportion of dogs 
with a positive parasitological diagnosis is only 0.049± 0.024 [n= 19; range: 
0-0.364] by microscopic detection of amastigotes in impression smears or 
aspirates, or 0.072± 0.037 [n= 5; range: 0-0.197] by using the polym erase 
chain reaction directly on skin sam pies. Reported seroprevalences tend to be 
highest using ELI SA, with a median of 0.167± 0.043 [n= 16; range: 0.063-
0.589], compared to median of 0.080±0.027 [n=37; range: 0-0.636], and 
0.000 [n= 3] using I FAT or the com plem ent fixation test [CF], respectively. 
The only study to use the direct agglutination tests [OAT] for diagnosing ACL 
in dogs recorded a prevalence of 0.382. The median reported prevalence 
using the Montenegro skin test [MST] is 0.286±0.066 [n= 18; range: 0-
0.856]. 
However, these reported estimates of ACL prevalence in dog populations 
[Table 1.2.] must be treated with caution because many are based on non-
random [e.g. clinically positive] sam piing of dog populations (309, 325, 359, 
361, 394, 420, 432, 588), mainly designed to provide parasite isolates for 
species identification and characterisation (120, 133, 134, 162, 170, 226, 
245,337,470,548-551 ). 
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Table 1.2. American cutaneous leishmaniasis in dogs: reported infection rates. 
Prevalence 
Clinical diagnosis 
0.409 (9/22)LV 
0.375 (18/48) 
0.375 (18/48)LV 
0.322 (165/513)LV 
0.320 (8/25) 
0.315 (85/270) 
0.308 (8/26) 
0.300 (15/50)LV 
0.283 (17/60)LV 
0.259 (21/81) 
0.250 (4/16) 
0.247 (46/186) 
0.208 (33/15~LV 
0.195 (8/41)L 
0.159 (7/44) 
0.152 (5/33) 
0.143(5/35) 
0.140 (6/43)LV 
0.133 (13/98) 
0.130 (7/54)lV 
0.127 (7/55)LB 
0.125 (7/56) 
0.111 (73/659)LB,LPR,LB/LPR 
0.082 (52/631 )LV 
0.078 (8/103) 
0.076 (27/355)LV 
0.067 (2/30) 
0.066 (6/91) 
0.062 (7/113) 
0.058 (2/34)lP 
0.057 (5/88) 
0.047 (7/148)LV 
0.045 (6/132) 
0.045 (5/112) 
0.043 (1/23) 
0.042 (9/214)LV 
0.041 (12/293)LV 
0.033 (11/333)LP 
0.031 (8/261) 
0.029 (2/70) 
0.023 (5/215) 
0.010 (7/697) 
0.002 (1/643)LV 
0.000 (0/310) 
0.000 (0/139) 
0.000 (0/65)lPIF 
0.000 (0/5)lM? 
O. 082:tO. 017 (median~S.E.) 
[n=47; range:O-OA09j 
Country 
Lara (VZL) 
Rio de Janeiro (BR) 
Lima (PR) 
Lima (PR) 
Rio de Janeiro (BR) 
Rio de Janeiro 
Espirito Santo (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Espirito Santo (BR) 
Rio de Janeiro (BR) 
Espirito Santo (BR) 
Espirito Santo (BR) 
Parana (BR) 
Amazonas (BR) 
Cojedes (VZL) 
Bahia (BR) 
Espirito Santo (BR) 
Rio de Janeiro (BR) 
Espirito Santo (BR) 
Huanuco (PR) 
Minas Gerais (BR) 
Cojedes (VZL) 
Espirito Santo (BR) 
Sao Paulo (BR) 
Minas Gerais (BR) 
Minas Gerais (BR) 
Pichincha (ECR) 
Minas Gerais (BR) 
Minas Gerais (BR) 
Parana (BR) 
Para (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Lima (PR) 
Central Panama (PAN) 
Rio de Janeiro (BR) 
Amazonas (BR) 
Rio de Janeiro (BR) 
Minas Gerais (BR) 
Ancash (PR) 
Rio de Janeiro (BR) 
Pernambuco (BR) 
Azuay (ECR) 
Trepoda (DOM) 
Reference 
(80) 
(355) 
(259) 
(259) 
(409) 
(46) 
(504) 
(399) 
(47) 
(5) 
(500) 
(191 ) 
(45) 
(196) 
(504) 
(30) 
(25) 
(3) 
(57) 
(194) 
(272) 
(192) 
¥ 
(417) 
(5) 
(170) 
(586) 
(527) 
(418) 
(167) 
(255) 
(216) 
(510) 
(486) 
(396) 
(487) 
(259) 
(262) 
(335) 
(242) 
(48) 
(135) 
§ 
(334) 
(88) 
(252) 
(277) 
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Table 1.2. American cutaneous leishmaniasis in dogs: reported infection rates. 
Prevalence 
Parasite detection 
(i) PCR 
0.197 (12/61)LV 
0.119 (8/67)LV 
0.072 (7/97)LV 
0.000 (0/72)LV 
0.000 (0/39)LV 
0.072:tO.037 (median::tS.E.) 
[n=5; range: 0-0. 197J 
(ii) Biopsy smears 
0.364 (8/22)LV 
0.291 (45/158)LV 
0.173 (54/312) 
0.172 (32/186) 
0.163 (8/49) 
0.125 (8/64 )LP 
0.125 (7/56) 
0.067 (2/30)LM 
0.057 (5/88) 
0.049 (2/41 )LV 
0.047 (7/148)LV 
0.034 (1/29)LV 
0.032 (3/93) 
0.030 (24/800)LV 
0.000 (0/35) 
0.000 (0/33)LV 
0.000 (0/23) 
0.000 (0/12)LV 
0.000 (0/10)LV 
0.049:tO.024 (median::tS.E.) 
[n=19; range: 0-0.364J 
(iii) Histolog~ 
0.043 (1/23) V? 
Serology 
(i) CF 
0.000 (0/697) 
0.000 (0/355)LV 
0.000 (0/170)LV? 
0.000 (median) 
[n=3J 
(ii) DAT 
0.382 (13/34)LP 
Country 
Pernambuco (BR) 
Ancash (PR) 
Lima (PR) 
Piura (PR) 
Lima (PR) 
Lara (VZL) 
Lima (PR) 
Espirito Santo (BR) 
Espirito Santo (BR) 
Espirito Santo (BR) 
Central Panama (PAN) 
Espirito Santo (BR) 
Azuay (ECR) 
Minas Gerais (BR) 
Piura (PR) 
Minas Gerais (BR) 
Lima (PR) 
Bahia (BR) 
Minas Gerais (BR) 
Amazonas (BR) 
Ancash (PR) 
Rio de Janeiro (BR) 
Lima (PR) 
Lima (PR) 
Rio de Janeiro (BR) 
Minas Gerais (BR) 
Minas Gerais (BR) 
Minas Gerais (BR) 
Pichincha (ECR) 
Reference 
(86) 
(322) 
(322) 
(322) 
(322) 
(80) 
(322) 
(193) 
(191 ) 
(193) 
(262) 
(192) 
(253) 
(255) 
§ 
(216) 
§ 
(56) 
(360) 
(25) 
§ 
(396) 
§ 
§ 
(396) 
(135) 
(170) 
(82) 
(167) 
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Table 1.2. American cutaneous leishmaniasis in dogs: reported infection rates. 
Prevalence 
(iii) ELISA 
0.589 (1 0/17)LM 
0.550 (11/20)LP,LG 
0.412 (40/97) 
0.390 (62/159}LV 
0.328 (19/58)LM 
0.233 (21/90)LV 
0.216 (11/51)LV 
0.180 (35/194)LV 
0.153 (11172} 
0.147 (5/34)LP 
0.141 (26/184)LB 
0.102 (22/215} 
0.080 (8/100}LB 
0.078 (4/55)LB 
0.069 (18/261) 
0.063 (10/159) 
O.167IO.043 (medianrS.E.) 
[n=16; range:O.063IO.589] 
Serology 
(iv) IFAT 
0.636 (21/33) 
0.632 (86/136~ 
0.433 (26/60)L 
0.378 (17/45) 
0.302 (48/159)LV 
0.265 (9/34)LP 
0.260 (13/50)LV 
0.244 (66/270) 
0.229 (11/48) 
0.203 (30/148)LV 
0.188 (3/16) 
0.187 (26/139) 
0.182 (24/132) 
0.182 (27/148) 
0.169 (35/207)LV 
0.119 (37/310) 
0.086 (32/373) 
0.083 (6/72) 
0.080 (7/88) 
0.071 (4/56) 
0.069 (7/102) 
0.048 (5/104 )LB 
0.039 (35/905) 
0.033 (7/215) 
0.032 (20/617)LV 
0.029 (1/35) 
0.026 (10/389) 
0.018 (73/4110) 
0.018 (1/55)LB 
0.014 (10/697) 
0.063 (26/407) 
0.004 (1 /261 ) 
Country 
Chimborazo (ECR) 
Manabi (ECR) 
Para 
Rio de Janeiro (BR) 
Chimborazo (ECR) 
Ancash (PR) 
Ancash(PR) 
Rio de Janeiro (BR) 
Sao Paulo (BR) 
Pichincha (ECR) 
Parana (BR) 
Rio de Janeiro (BR) 
Bahia (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Parana (BR) 
Parana (BR) 
Ceara (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Pichincha (ECR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Minas Gerais (BR) 
Rio de Janeiro (BR) 
Pernambuco (BR) 
Parana (BR) 
Minas Gerais (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Sao Paulo (BR) 
Sao Paulo (BR) 
Sao Paulo (BR) 
Para (BR) 
Bahia (BR) 
Goias (BR) 
Rio de Janeiro (BR) 
Minas Gerais (BR) 
Amazonas (BR) 
Sao Paulo (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Huilla (CO) 
Minas Gerais (BR) 
Rio de Janeiro (BR) 
Reference 
(384) 
(384) 
(486) 
(45) 
(372) 
(243) 
§ 
(487) 
(367) 
(167) 
(104) 
(48) 
(203) 
(272) 
(335) 
(104) 
(30) 
(155) 
(47) 
(50) 
(45) 
(167) 
(399) 
(46) 
(355) 
(216) 
(500) 
(88) 
(510) 
(217) 
(487) 
(334) 
(128) 
(367) 
(215) 
(537) 
(486) 
(203) 
(381 ) 
(48) 
(417) 
(25) 
(275) 
(402) 
(272) 
¥ 
(135) 
(335) 
37 
Table 1.2. American cutaneous leishmaniasis in dogs: reported infection rates. 
Prevalence 
Serology 
(iv) IFAT (continued) 
0.003 (1/327) 
0.000 (0/973) 
0.000 (0/170)LV? 
0.000 (0/77) 
0.000 (0/10) 
0.000 (0/10) 
0.076IO.027 (medianJ:S.E.) 
[n=38; range: 0-0.636J 
MST 
0.856 (83/97) 
0.813 (13/16) 
0.667 (40/60)LV 
0.644 (29/45) 
0.478 (76/15VLV 
0.409 (9/22)L 
0.389 (105/270) 
0.375 (18/48) 
0.307 (27/88) 
0.264 (24191) 
0.200 (10/50)LV 
0.102 (21/205)LV 
0.088 (19/215) 
0.071 (4/56) 
0.043 (1/23) 
0.009 (1/107) 
0.004 (1/261) 
0.000 (0/77) 
0.286IO.066 (medianJ:S.E.) 
[n=12; range: 0-0.667J 
Country 
Goias (BR) 
Sao Paulo (BR) 
Minas Gerais (BR) 
Sao Paulo (BR) 
Distrito Federal (BR) 
Distrito Federal (BR) 
Para 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Lara (VZL) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Minas Gerais (BR) 
Minas Gerais (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Rio de Janeiro (BR) 
Sao Paulo (BR) 
Rio de Janeiro (BR) 
Minas Gerais (BR) 
Rio de Janeiro (BR) 
Sao Paulo (BR) 
Reference 
(340) 
(493) 
(82) 
(537) 
(547) 
(401) 
(486) 
(500) 
(47) 
(50) 
(45) 
(80) 
(46) 
(355) 
(255) 
(527) 
(399) 
(487) 
(48) 
(537) 
(396) 
(418) 
(335) 
(537) 
Table 1.2. NOTE. The studies reporting canine ACL prevalence rates are listed by country and 
state, and diagnostic method used. All studies were carried out on random dog samples in L. 
braziliensis-endemic areas (as determined by other isolate characterization studies). Also are 
given the median±S.E. of all reported studies using a particular diagnostic method, thereby 
allowing indirect comparison of sensitivity between the methods. Abbreviations: BR, Brazil; CF, 
complement fixation test; OAT, direct agglutination test; DOM, Dominican Republic; ECR, 
Ecuador; ELISA, enzyme-linked immunosorbent assay; IFAT, immunofluorescence antibody test; 
LA, L. amazonensis; LB, L. braziliensis; LB/LPR, L. braziliensislL. peruviana hybrid; LG, L. 
guyanensis; LM, L. mexicana; LP, L. panamensis; LPR, L. peruviana; LPIF, L. pifanoi; LV: L. 
(Viannia) spp.; MST, Montenegro skin test; PAN, Panama; PCR, polymerase chain reaction; PR, 
Peru, VZL, Venezuela. ¥ Nicholls, unpublished. 
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The biting rate of sandfly vectors on dogs. There appear to be no studies 
that directly measure the biting rate of ACL vectors on dogs. However, the 
relative attractiveness of dogs has been measured for a number of ACL 
vectors, such as Lu. whitmani (101). The proportion of blood meals taken 
from dogs [the dog blood index] has been measured for some populations of 
ACL sandfly vectors, such as Lu. peruensis (404). This index, usually 
estim ated by the detection of dog antigens [by ELI SA or the precipitin test] 
in wild-caught, bloodfed sandflies (404), will depend on the relative 
abundance of dogs [in com parison with other potential bloodm eal sources], 
sandfly host preferences, and the accessibility of dogs to sandflies (380, 388, 
404, 443). Accessibility is determ ined by factors such as sandfly dispersal 
(10,17,387, 442), and dog ecology. This may explain why, for example, 
ZVL prevalence has been found to be higher in 'hunting' than in 
'urbani dom estic' dogs (126, 587). Finally, the probability of collecting a 
sandfly with dog blood will additionally depend on the location of the trap, 
and, hence, an objective measurement of the dog blood index of a sandfly 
population is therefore rarely attainable (11). 
The infectiousness of dogs to sandflies. Although it is axiomatic that 
ACL-infected dogs can only be reservoir hosts if they are infectious to 
sandflies, none of the studies listed in Tables 1.1. and 1.2. measured this 
parameter. Only two small xenodiagnosis studies have been reported and 
they are outlined in detail in Chapter 5. However, no generalisations can be 
made from these two studies, because a low number of replicates was used 
and because sandflies were fed artificially on active ACL lesions. Also, the L. 
braziliensis infection rate of flies fed on dogs was less than the one reported 
for flies feeding on human ACL patients or opposums [Chapter 5]. 
The course of ACL infection in dogs. The studies reviewed here imply that 
dogs are readily infected with ACL, but -as opposed to canine ZVL (1, 96- 99, 
115,177,178,290,352,353,427,429,439-441, 513, 553}-little is known 
about the clinical, parasitological and im m unological course of canine ACL 
infections [see Chapter 3]. Combined with xenodiagnosis studies, this 
information could identify correlates of infectiousness, enabling putative dog 
control programs to maximise their effectiveness by focusing on those dogs 
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that are infectious (176) [see Chapter 6 and 8]. The course of infection will 
also determine the potential reservoir role of dogs; i.e. the role will be 
maxim ised if infectiousness is relatively perm anent, rather than if ACL 
infected dogs tend to recover from infection and infectiousness. If 
infectiousness is transient, dogs will act as reservoirs only if there is a 
sufficient recruitment rate of susceptible dogs into the population. This rate 
in turn will depend on dog demography and on the rate at which infected 
dogs recover their susceptibility upon healing. 
Excluding studies where the infecting parasite was not identified (350), 
descript ions of the course of L. braziliensis infect ion in dogs com e from on Iy 
four experimental studies (135,212,213, 434). In the first study (135), 
lesions developed in 3/4 inoculated dogs after 4, 7 or 8 months, and 
seroconversion occurred within 2-4 months after appearance of lesions [i.e. 
giving a serological pre-patent period of 8-11 months]; the fourth dog 
seroconverted within four months but clinical symptoms [a mucosal ulcer] 
were not detected for another 12 months. I n the second study (434), 3/6 
inoculated dogs developed nodules by 22 days, and 5/6 had ulcerated lesions 
two months post- inocu lation; 6/6 seroconverted by day 36 and 5/6 had a 
positive MST response five months post-inoculation. I n the third study (212), 
all 10 inoculated dogs had a positive MST response within four months post-
inoculation. In the last study (213), 18/24 inoculated dogs seroconverted 
within four months post-inoculation and all developed lesions. These results 
should be treated with caution, as there is considerable variation between 
the studies protocol, sam pie sizes were sm all, and the im m une response to 
parasite inoculation may differ from the response to natural infections. 
However, they are within the sam e range of pre-patent periods [3-25 
months] reported for dogs infected with L. infantum (1, 96-99, 177, 178, 
352,353,427,429,439-441). 
The only information on the natural serorecovery rates of dogs infected with 
ACL com es from a single field study that showed that 3/14 L. braziliensis-
infected dogs healed spontaneously 2-3 months after parasite demonstration, 
with com plete clin ical and serorecovery (432) [Ch apte r 4]. However, lesions 
and positive I FAT reappeared in all three dogs during the 11 months follow-
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up. I t has been suggested that dog immunity to Aa... is dependent on host 
genetic susceptibility as is the case for humans, because some dog breeds 
seem to differ in their response to infection (513, 517). The proportion and 
epidemiological significance of Aa...-resistant dogs in natural populations is 
unclear, and it remains to be established whether they may be infectious to 
the sandfly vector. Other factors likely to affect a dog's immune response 
include host malnutrition (179), and parasite variation [i.e. strain or species] 
(279, 456). For exam pie, the course of L. braziliensis infection in dogs can be 
compared with the results of three reported studies on experimental 
infections of dogs with L. peruviana (260, 322, 351): L. peruviana infections 
seem to be more benign than L. braziliensis infections, frequently causing 
asym ptom atic infections, with parasitological and clinical pre-patent periods 
of at least 2 and 2.5 months, respectively. There appear to be no reported 
studies on the im m unological or parasitological course of L. panamensis 
infection in dogs, but positive parasite diagnosis of naturally infected dogs 
are typically associated with clinical symptoms, e.g. ulcers or depigmentation 
(262). Lesions caused by L. panamensis can persist for at least 45 months, 
although self- healing within 7 or 11 months has also been observed (262). 
Dogs as risk factors for ACL. Finally, the most convincing evidence for 
incrim inating dogs as reservoir hosts of ACL should come from studies 
demonstrating that either dog ownership or dog abundance are risk factors 
for ACL in humans. The epidemiological evidence to date is inconsistent as 
two case-control studies of ACL in dom estic transm ission settings have 
shown a positive association between dog ownership and human ACL in 
Argentina and Costa Rica, but no association was detected in two other 
studies in Argentina and Peru [outlined in detail in Chapter 5]. Direct 
incrim inatory evidence would also come from a dog control trial. Were dogs 
reservoirs of ACL, dog control programs should be effective in reducing not 
only canine incidence but human incidence as well. However, so far there is 
no evidence that targeting dogs with ACL is effective. 
Over the next four chapters, findings of a prospective study investigating the 
epidemiology of canine ACL in a well- studied area of human ACL transmission 
will be presented. Specifically, the merits of PCR as a mass-screening tool [as 
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compared to clinical and serological diagnosis] in epidemiological studies will 
be tested and discussed [Chapter 2]. The findings presented in Chapter 2 
are then placed into an epidemiological context in Chapter 3 and 4, where 
the data will be used to describe the course of infection and disease of ACL in 
dogs. The findings will also be used to discuss their meaning for human 
disease transm ission in terms of ACL prevention and control. Using data 
available on human ACL and dog ownership patterns, we also investigated 
whether dogs represent a significant risk factor for human ACL [Chapter 5]. 
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CHAPTER 2: 
The use of the polymerase chain reaction [PCR] as a 
diagnostic tool in mass-screening surveys to detect 
Leishmania [Viannia] spp. infection in domestic dogs [Canis 
familiaris]. 
Abstract 
Several studies have suggested that the PCR could be used in 
epidemiological mass-screening surveys to detect Leishmania [Viannia] 
spp. infection in human and animal hosts. Dogs from a L. braziliensis 
and L. peruviana-endemic area were screened for Aa... infection using 
established PCR-based and ELI SA protocols. PCR detected L. [Viannia] 
infection in a total 90/1066 [8.4%] dogs: 32/368 [8.7%], 65/769 
[8.5%] and 7/42 [16.7%] were PCR positive on whole blood, buffy coat 
and bone marrow aspirates, respectively. ELI SA detected infection in 
221/1059 [20.9%] of tested dogs. The high prevalence of L. [Viannia] 
parasites detected by PCR in blood of both asymptomatic [7.5%] and 
symptomatic [32%] dogs provides further circumstantial evidence for 
their suspected role as reservoir hosts of Aa..., and suggests that 
haematogenous dissemination of parasites may be a more common 
pathological phenomenon than previously acknowledged. However, the 
low sensitivity of PCR [as compared to ELISA] indicates that PCR 
cannot be used for mass-screening in Aa... epidemiological studies. 
Unless more sensitive PCR protocols were to be developed, its use will 
probably be restricted to diagnosis of active [canine and human] cases 
and to the parasitological monitoring of patients after chemotherapy. 
Bronwen Lambson, Richard Reithinger, Clive R. Davies and Douglas C. 
Barker [1999] PCR diagnostics to identify reservoir dogs. 
Bull. Trop. Med. Internat. Health 7, 3. 
Richard Reithinger, Bronwen E. Lambson, Douglas C. Barker and Clive 
R. Davies [2000] Use of PCR to detect Leishmania [Viannia] spp. in dog 
blood and bone marrow. J. Clin. Microbiol. 38,748-751. 
Richard Reithinger and Clive R. Davies [2002] American cutaneous 
leishmaniasis in domestic dogs: an example of the use of the 
polymerase chain reaction for mass-screening in epidemiological 
studies. Trans. R. Soc. Trop. Med. Hyg. 96 (Supplement 1), 123-126. 
Richard Reithinger, Juan Canales Espinoza, Orin Courtenay and Clive R. 
Davies [2003] The evaluation of the polymerise chain reaction (PCR) as 
a diagnostic mass-screening tool to detect Leishmania (Viannia) spp. In 
domestic dogs (Canis familiaris). J. Clin. Microbiol. 41, 1486-1493. 
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2.1. Introduction. 
I n order to carry out epidem iological surveys to consider putative canine 
leishmaniasis control strategies, sensitive and specific tests for identifying 
ACL-infected dogs are paramount. Serological tests are the standard tools for 
identifying Leishmania-infected dogs during epidem iological mass-screening 
surveys, because clinical and parasitological diagnoses [eg. biopsy sm ears, 
parasite culture] are characteristically insensitive, and because ACL infections 
in dogs are frequently asymptomatic [Part 1: I ntroduction]. However, 
difficulties associated with the interpretation of cross- sectional seroprevalence 
data are that [i] serology is prone to non-specific cross-reactions ['false 
positives', e.g. to Trypanosoma cruzi or L. infantum infection (112, 113, 
556)]; [ii] there may be a delay between infection and seroconversion (177, 
178,439, 440); [iii] a fraction of infected dogs may never seroconvert [e.g. 
due to innate resistance] (178, 437); and [iv] seroconversion may not be 
permanent [e.g. due to development of humoral or cell-mediated immune 
response] (178). Thus, sensitivity and/ or specificity of serological tests with 
respect to infection can vary quite considerably, and may underestimate true 
prevalence and incidence of disease, and hence the scale of the control 
problem. 
It has been suggested that PCR-based methods for Leishmania diagnosis 
may provide the best gold standard for determ ining the presence and 
identity of leishmanial infections not only when diagnosing active cases, but 
also for monitoring parasitological cure of patients after chemotherapy and 
as a mass-screening tool to detect Leishmania infections in vertebrate hosts 
or sandfly vectors (421, 511). Various PCR protocols have been reported for 
the detection of ACL- causing Leishmania in humans using either purified DNA 
[from cult u red parasites (152, 153)] or clinical specim ens [including lesion 
and scar biopsies (36, 62, 153, 251, 327, 328, 371, 433, 447, 465, 485, 
498,499,515, 583), or blood (164,184,244,245, 430)] and have 
consistently proven to be more sensitive than other diagnostic methods, 
including in vitro culture of biopsies, biopsy sm ears and ham ster inoculation 
[Table 2.1.]. However, at present only one large study has been reported 
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where PeR was used as a diagnostic mass-screening tool to detect Aa.... in 
humans or putative animal reservoirs (322). L. [Viannia] parasites were 
detected in skin aspirates or biopsies from 15/276 [5.4%] dogs, 4/153 
[2.6%] Akodon spp., 2/72 [2.8%] Didelphis albiventris, 1/499 [0.2%] 
Phyllotis andinum, 0/178 Mus musculus, 0/8 Oryzomys spp. and 018 Rattus 
rattus. A second diagnostic test for com parative data on infection rates was 
not carried out, and hence no conclusions about the PCR assay's sensitivity 
and specificity can be made. 
I n the work presented in this chapter the utility of peR as a diagnostic m ass-
screening tool in epidem iological studies was evaluated. Specifically, the 
sensitivity and specificity of established PCR protocols on canine blood and 
bone m arrow were com pared to an ELI SA for detecting L. [Vianniaj spp. 
infection in dogs. 
2.2. Materials & Methods. 
Sample population and dog sampling. Dogs came from 18 villages in the 
Departm ent of Huanuco, a L. braziliensis and L. peruviana-endem ic area in 
Peru [10°00' S, 76°15' W] [Map 1 and Plates 3A-H]. Dogs were surveyed 
between April to November 1997, June to September 1998 and between April 
to June 1999 either by house-to-house visits or in the village-square during 
rabies vaccination cam paigns carried out by the local Ministry of Health [see 
Chapter 4 for description of the study site]. None of the dogs belonged to a 
recognisable breed and all were guard or hunting dogs. I nterviews with 
owners were carried out to provide inform ation about the num ber of dogs 
kept, their age and residence tim e in the valley. The dem ography of the 
canine study population and canine ACL epidem iology will be addressed in 
the following chapter [Chapter 4]. 
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Table ~.1. Published studies using peR to detect 
American cutaneous leishmaniasis in humans. 
Disease PCR primers * PCR Culture BMS HIS MST Serology Ref. 
CllV 
CllV 
CllV 
CllV,lMEX 
ClLV 
CllV 
Cl 
CUDCllv 
ClLV,LMEX 
CllV 
CllV,lMEX 
Cl LV,LMEX 
Cl 
Cl 
ClLV,LMEX 
ClLV 
CllV 
CllV 
Cl1v 
CllV 
Cl 
CllG 
CllV 
CllV 
MCllV 
MClLV 
MCllv 
MClLV 
MCllv 
Total 
CL 
Total MCL 
4 
4 
2 
1 
5 
4 
4 
1,4 
5 
3 
2,6 
4 
5 
2,4 
7 
5 
2 
2, 5 
2 
2 
5 
2 
2 
4 
4 
4 
5 
4 
14/18LB 
15/24lB 
14/19lB 
226/233lB 
58/60LB 
18/25 
14/24 
11/17LB 
20/24LB,SC 
19/19lB 
20/32LB 
18/26lB 
21/30lB 
23/35LB 
9/23lB 
13/13LB,SC,LA 
178/184LB 
12/14 
53/99 
10/26LB 
21/40 
35/35 
193/255LB 
20/44lB 
10/12LB 
7/9LB 
2/2LB 
24/34LB 
30/36lB 
1035/1319 
(78%) 
73/93 
(78%) 
13/18 
7/20 
11/19 
100/233 
14/25 
8/13 
1/24 
9/9 
9/26 
10/23 
11/12 
86/144 
21/26 
56/115 
35/35 
141/255 
10/44 
5/12 
2/4 
5/17 
542/1041 
(52%) 
12/33 
(36%) 
12118 
0/24 
5/19 
147/233 
10/24 
13/16 
8/13 
16/24 
9/17 
6/30 
22135 
4/24 
7/13 
76/176 
18/37 
35/35 
119/255 
2/44 
4/13 
16/18 
2/8 15/17 
233/233 
6/25 
7/19 20/20 
5/23 3/5 
65/175 184/184 
14/14 
7/30 
26/26 
76/92 
35/35 
11/11 
24/24 
509/1037 85/250 622/644 
(49%) (34%) (97%) 
11/34 
(32%) 
7/30 
(23%) 
35/35 
(100%) 
9/13 
2/24 
26/26 
6/6 
37/63 
(59%) 
6/6 
(100%) 
(327) 
(327) 
(153) 
(465) 
(538) 
(100) 
(250) 
(542) 
(62) 
(498) 
(251) 
(258) 
(455) 
(343) 
(36) 
(357) 
(433) 
(485) 
(464) 
(150) 
(447) 
(469) 
(572) 
(572) 
(327) 
(327) 
(542) 
(433) 
(433) 
NOTE. BMS, lesion biopsy smear; CL, cutaneous leishmaniasis; DCL, diffuse cutaneous 
leishmaniasis; HIS, histology; LA, lesion aspirate; LB, lesion biopsy; LG, Leishmania guyanensis, 
LMEX, L. mexicana; LV, L. (Viannia) spp.; MCL, mucocutaneous leishmaniasis; MST, 
Montenegro skin test; SC, scar biopsy. *PCR primers. 1, 13A1B Leishmania spp.-specific primers 
(463); 2, B1/2, L. (Viannia) spp.-specific primers (152); 3, LB3C, LM3A, LC3L, LV5A (251); 4, 
MP1 UMP3H, L. (Viannia) spp.-specific primers (327); 5, OCT120: Leishmania spp. primers (197); 
6, M1/2 L. mexicana-specific primers (184); 7, V1/2, 11/2, P1/2, G1/2 and B1/2 (357). 
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Dogs were examined for clinical signs of ACL, i.e. cutaneous lesions or scars 
[Plate 4~ H]. I mpression smears were made of dermal scrapings and! or 
lesion biopsies from dogs with active cutaneous lesions, GI Bv1SA-stained and 
examined microscopically [light microscope, oil immersion, x100 objective] 
for Leishmania amastigotes. Blood, 2-10ml was taken from a total 1104 
[1997: 553; 1998: 289; 1999: 262] dogs by venepuncture and aliquoted into 
sterile, EDTA-coated 10m I polypropylene tubes [Plate 4A]. The sam pies 
were processed 4-1 Ohrs after collection, one of the aliquots was centrifuged 
at 800g for 20min and the buffy coat layer removed and stored at -20°C [i.e. 
buffy coat sample, BCS]; the second blood aliquot [2-3ml] was mixed with 
an equal volume of 6M guanidine HCI/O.2M EDTA [pHB.O] and stored at 4°C 
[i.e. guanidine/blood Iysates, GBL] (34, 35, 91, 92, 27B, 57B, 579). Bone 
m arrow was aspirated from the iliac crest from a subset of dogs [n= 46] 
using a mixture of m edetom idine [Dom itor®, Sm ithKline Beecham, UK] and 
ketam ine hydrochloride [Vetalar®, Parke- Davis Veterinary, UK] as 
anaesthetic, and stored at -20° C [i.e. bone m arrow sam pies, BMS] [Plate 
48]. BCS, GBL and BMS were all prepared in 1997, as at that particular 
stage a PCR protocol for L. [Viannia] detection in dogs had to be developed 
which, amongst others, tested whether PCR sensitivity was associated with 
sam pie origin [i. e. either blood or bone m arrow] or DNA ext raction protocol 
[see below]. In 1998 and 1999, only BCS were prepared from dogs. 
DNA extraction. Sensitivity titration assay. Choice of DNA extraction 
protocol and primers to be used for mass-screening of field samples was 
based on a series of sensitivity titration assays [STA]. One hundred-fold 
dilutions of 108 water-lysed L. braziliensis [MHOMI BAl751 M2903] were added 
to 2001-1 1 aliquots of guanidine dog blood lysate from a single dog, yielding a 
concentration range from 0.01-106 parasites per spiked sam pie. Water was 
added to a separate aliquot for a negative control. DNA was extracted 
according to standard protocols using either phenoll chloroform [PC], 
Chelex100® resin [Biorad, UK] or DNeasy® DNA extraction kit [Qiagen, UK]. 
GBL were heated for 10m in in boiling water to denature the concatenated 
minicircle DNA molecules which constitute most of the Leishmania kinetoplast 
DNA [kDNA] network, and allowed to cool to room tem perature. After one PC 
extraction, DNA was back-extracted with TE [10mM Tris-HCI, 1mM EDTA, 
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pHS.O] , then chloroform extracted and ethanol-precipitated, resuspended in 
50~1 TE, and stored at 4°C. Chelex and DNeasy DNA extractions were carried 
out according to Walsh et al. (564) and the manufacturer's protocol, 
respectively. To increase DNA yield of the Chelex extracted samples, 300~1 of 
the extract's supernatant was ethanol-precipitated and re-suspended in 30~1 
TE. 
Field samples. BCS and BMS were mixed with an equal volume of DNA 
extraction buffer [10mM TrisHCI pH8.0, 0.1M EOTA pH8.0, 0.5% SOS], 
proteinase K was added to a final concentration of 50~g/ m I, and sam pies 
were incubated for 5hrs at 50° C. Aliquots, 200~1 of GBL, BCS and BMS were 
taken and DNA was PC extracted as before. 
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Box 1. Primers used in the PCR assays. 
B1/B2. Primers ~re s.pecific for all Leishmania (Viannia) spp. 
k~~~ but L. lamson!. Amplification yields a full-sized kDNA 
mlnlclrcle (750bp) (152). 
B1: 5'-GGG GTT GGT GTA ATA TAG TGG-3' 
B2: 5' -CTA An GTG CAC GGG GGA GG-3' 
B3: 5'-TTG AAC GGG GTT TCT GTA TG-3' 
MP1 UMP3H. Primers are specific for L. (Viannia) spp. kDNA. 
Amplification yields a 75bp fragment (327). 
MP1L: 5'-TAC TCC CCG ACA TGC CTC TG-3' 
MP3H: 5'-GAA CGG GGT TTC TGT ATG C-3' 
R221/R332. Primers are specific for all Leishmania spp. small 
subunit ribosomal RNA genomic DNA. Amplification yields a 
603bp fragment (546). 
R221: 5'-GGT TCC TTT CCT GAT TTA CG-3' 
R332: 5' -GGC CGG TAA AGG CCG AAT AG-3' 
Min11 B/Min22. Primers are specific for L. (Viannia) spp. 
subtelomeric DNA. Amplification yields a 491 bp fragment (207). 
Min11 B: 5'-GGA TCG CTG GGA ACA ATC-3' 
Min22: 5'-CAT GAA TGG CTT TCG ITT CAG-3' 
P03/P05. Primers amplify acidic ribosomal phosphoprotein 
genomic DNA. Amplification yields a 469bp fragment (474). 
P03: 5'-GGA GAA GGG GGA GAT GTT-3' 
P05: 5'-TCA TTG TGG GAG CAG ACA-3' 
Polymerase chain reaction [PCR]. Sensitivity titration assay (STA). 
Spiked sam pies and the original culture water-lysate dilutions were am plified 
using four different PCR assays [3 replicates], each one using a different set 
of prim er pairs: B1 f B2, MP1 U MP3H, Min 11 Bf Min22 and R221 f R332 [Box 1]. 
Briefly, 11-11 [2-5ng] of DNA was amplified on a Biometra Thermocycler 
[Biometra, UK] in a total reaction volume of 251-11 overlayed with 301-1 1 of 
mineral oil [Sigma, UK]. Table 2.2. summarises reaction conditions. 
Amplification products were analysed by electrophoresis on 1.5% agarose 
gels in 1 xTAE [40m M Tris, 40m M acetic acid, 1 m M EDTA, pH 8.3] buffer 
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PCR Product 
Reaction Mixture 
PCR Buffer 
dNTP 
Primer 
T aq polymerase 
Cycles 
Initial Denaturation 
Initial Annealing 
Extension 
Denaturation 
Annealing 
No. cycles 
Final extension 
Hybridisation 
Probe 
Sensitivity of PCRt 
Gel electrophoresis 
(i) Pure culture 
(ii) PC 
(iii) DNeasy 
(iv) Chelex100 resin 
(v) Chelexlethanol 
Hybridisation 
(i) Pure culture 
(ii) PC 
(iii) DNeasy 
(iv) Chelex100 resin 
(v) Chelexlethanol 
Table 2.2. PCR-hybridisation reaction conditions. 
81/82 
whole kDNA 
minicircle (750bp) 
10mM TrisHCI 
(pHB.3) 
50mM KCI 
1.5mM MgCI2 
0.01 % gelatin 
0.2mM each 
50pmol 
1 U 
95°C/6min 
64.5°C/2min 
72°C/1min 
95°C/30sec 
60.5°C/1 min 
35 
72°CI10min 
B3 oligonucleo-
tide end labelling 
(l2_p) 
0.1 
O.B 
1.9 
0.001* 
O.OOB 
0.00019* 
6.7 X 104 
M1UM3HL 
kDNA minicircle 
fragment (75bp) 
10mM TrisHCI 
(pHB.3) 
50mM KCI 
2.0mM MgCI2 
0.01 % gelatin 
0.2mM each 
50pmol 
1 U 
94°C/3min 
54°C/2min 
72°C/1min 
95°C/1min 
54°C/2min 
35 
72°C/10min 
Positive control 
random primer 
(a32_p) 
105 
BOOO 
1.9 x 104 
103 
BO 
190 
Min 11 IMin22 
subtelomeric 
repeat (491 bp) 
10mM TrisHCI 
(pHB.3) 
50mM KCI 
1.5mM MgCI2 
0.01 % gelatin 
0.2mM each 
50pmol 
0.5 U 
95°C/30sec 
5rC/45sec 
72°C/1min 
95°C/30sec 
5rC/45sec 
35 
72°C/10min 
Positive control 
random primer 
(a32_p) 
0.001* 
O.OOB 
0.019 
0.001* 
O.OOB 
0.00019* 
6.7 X 104 
R2211R332 
ribosomal DNA 
repeat (603bp) 
10mM TrisHCI 
(pHB.3) 
50mM KCI 
1.5mM MgCI2 
0.01 % gelatin 
0.2mM each 
50pmol 
0.5 U 
95°C/5min 
60°C/30sec 
72°C/30sec 
95°C/30sec 
60°C/30sec 
35 
72°C/10min 
Positive control 
random primer 
(a32_p) 
10 
O.B 
1.9 
6.7 X 104 
0.1 
O.B 
0.019 
6.7 X 104 
P031P05 
genomic DNA 
repeat (469bp) 
10mM TrisHCI 
(pHB.3) 
50mM KCI 
1.5mM MgCI2 
0.01 % gelatin 
0.2mM each 
45pmol 
1 U 
95°C/5min 
55°C/30sec 
72°C/30sec 
93°C/30sec 
55°C/30sec 
34 
72°C/10min 
NA 
+ 
+ 
+ 
NA 
NA 
NA 
NA 
NA 
NOTE. PCR and hybridisation were carried out as described in Materials & Methods. t, sensitivity of 
the PCR STA is given as the minimum number of parasites in the PCR sample required for 
successful amplification; *, most dilute sample tested for the assay; -, no amplification product see on 
the gel; + amplification product seen on the gel; NA, does not apply; PC, phenol/chloroform 
extraction. 
(482). To evaluate sam pie degradation or PCR inhibition, sam pie DNA was 
also am plified for a canine housekeeping gene, acidic ribosom al 
phosphoprotein fragment, using P03/P05 primers [Box1]. When samples did 
not yield amplification, they were extracted again, until positive amplification 
was obtained [Plate 5 B]. Each am plification cycle included negative [no 
DNA, DNA from uninfected dog] and positive [water-Iysates of cultures 
obtained from Huanuco dog isolates] controls. PCR-grade H20 was used 
throughout. To avoid cross-contamination, separate areas were used for DNA 
extraction, peR sample preparation and amplification. 
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Hybridisation. Agarose gels were processed according to standard 
procedures, i.e. in denaturation [1.5M NaCI, 0.5M NaOH] and neutralisation 
[1.5M NaCI, 1M Tris, pH7.4] buffer for 20min each, Southern blotted onto a 
nylon m em brane [Boehringer Mannheim, UK], and DNA was fixed to the 
m em brane by UV-crosslinking (482). Mem branes were prehybridised at 42° C 
and hybridised with either a [a32P]-dATP or [y32p]-ATP-labelled probe for 8-
12hrs [Table 2.2.], then washed at 42°C or 65°C for 2x15min in 
2xSSC/0.1 % SOS and in 0.1 xSSC/0.1 % SOS, before being exposed for 
autoradiography 36hrs and 72hrs at -70°C (482). 
Field samples. Based on the results of the STA, all field samples were 
am plified using a P03/ P05 [Plate 5 B] and B1 / B2 prim er pairs. Hybridisation 
was carried out as described above using a [y32p]-ATP-labelled B3 
oligonucleotide primer probe [Box 1]. 
Enzyme-linked im m unosorbent antibody tests [ELI SA]. Log-phased L. 
braziliensis prom astigotes [MHOM/ BRl76/ M2903] were harvested at a 
concentration of ca. 1x107 cells/ml, centrifuged at 5000rpm, washed [x3] in 
PBS [0.14M NaCI, 1.5mM KH2P04, 8mM Na2HP04.12H20, 2.7mM KCI, pH7.2] 
and frozen at -20°C. Cells were then freeze/thawed [x3] and sonicated for 
15m in at 250Am p in a Soniprep sonicator [Soniprep, UK]. Antigen [10 5 
prom astigotes/well] was added to polysterene m icrotitre plates 
[Immunolon® 2, Thermo LabSystems, UK] in 100~1 of carbonate coating 
buffer [15m M Na2C03, 35m M NaHC03, 3m M NaN3, pH9.6] and incubated 
overnight at 4°C. Plates were washed [x3] with PBS and blocked with 
1 OO~I/well 2% m ilk powder in coating buffer for two hours at 37° C. They 
then were washed [x3] with PBS, and serum samples were added at 1/100, 
1/400 and 1/800 dilutions in 1 OO~I incubation buffer [PBS/0.05% 
Tween20+ 2% m ilk powder], and again incubated for two hours at 37° C. 
After washing [x6] with PBS/0.05% Tween20, peroxidase-conjugated, 
affinity-purified rabbit anti-dog IgG [Sigma, UK] was added at 1/1500 in 
100~1 incubation buffer, and plates were incubated for two hours at 37°C. 
Plates were washed [x6] with PBS/0.05% Tween20 before 1 OO~I of substrate 
solut ion [0- phenylenediam ine dihydrochloride in phosphate-citrate buffer 
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[55mM citric acid, 50mM Na2HP04.12H20], pH5.5] was added. The reaction 
was stopped with 50 111 2M H2S04 and plates were read at 490nm in an ELI SA 
plate reader. 
ELISA Standardisation. The method used follows Quinnell et a/. (440). 
Briefly, on each plate a positive control serum was titrated two-fold from 
1/20 to 1/327680. The positive control serum was assigned an arbitrary 
number of units/ml, 81920/ml, which was defined as the reciprocal of the 
highest dilution at which absorbance was greater than the mean + 3 s.d. of 
background [i.e. no antibody] wells. Absorbance was calculated as observed 
absorbance minus mean background absorbance. A standard line was fitted 
over t he range 1/80 to 1/81920 to the positive cont rol absorbance values 
using a log-Iogit transformation (440) Absorbances of the three test sera 
dilutions were expressed as log anti-Leishmania antibody units [LAU]/ml 
using the standard line, from which the test sample's geometric mean 
num ber of LAUI m I was calculated. Where the dilution curve for any test 
serum was noticeably non-parallel to the standard, test sera were repeated 
at dilutions of 1/100, 1/720 and 1/4320. 
Negative and positive controls. Three groups of uninfected dog sera were 
used as negative controls for all diagnostic tests. The sera came from [i] 
dogs of various ages and breeds which had attended a veterinary clinic in 
Lim a [Peru; n= 18]; [ii] mongrel dogs from Belem [Brazil; n= 13]; and [iii] 
dogs of various ages and breeds which had attended a veterinary clinic in 
Cam bridge [UK; n= 13]. Though L. Viannia has been isolated from dogs both 
in Peru and Brazil, Lim a and Belem are not L. [Vianniaj - endem ic areas. The 
positive standard control serum as well as 15 other positive control sera 
came from lesion and biopsy smear-positive dogs surveyed in the study. 
52 
2.3. Results. 
PCR sensitivity titration assay. Table 2.2. summarises the sensitivity of 
the PCR assays according to DNA extraction protocol and prim er pairs used. 
Briefly, t he Min 11 BI Min22 prim er pairs were 106 to 108 -fold m ore sensitive 
than the MP1 U MP3H prim er pair, and 102 to 104-fold m ore sensitive than 
both B1 1 B2 and R221 1 R332 prim er pairs in am plifying DNA from culture 
dilutions, PC or DNeasy-extracted samples [Table 2.2.]. None of the Chelex-
only extracted sam pies could be am plified. PCR using PC extracted sam pies 
was 2- and> 104-fold more sensitive than reactions using DNeasy or Chelex-
ethanol extracted sam pies respectively. Hybridisation generally increased the 
assay's sensitivity by 102-fold, but up to 104-fold for DNeasy extracted 
sam pies am plified with the B1 1 B2 prim er pair [Plate 5 A]. All but the Chelex 
only-extracted sam pies were successfully am plified with P031 POS. PC was 
used as the DNA extraction protocol for field sam pies as it was aim ost as 
good as the DNeasy kit in extracting parasite DNA from blood [Table 2.2.], 
but at a significantly lower economic cost. The B1/B2 primer pair was chosen 
for mass-screening because [i] with hybridisation it yielded the greatest 
sensitivity, along with the Min11 B/Min22 primer pair [Table 2.2.]; [ii] it did 
yield fewer PCR product artifacts [unlike Min11 B/Min22 and MP1 UMP3H]; 
and [iii] it has previously been tested on clinical field sam pies [though not 
blood] (153). PC com bined with B1 1 B2 prim ers and B3 probe could detect 
parasitemias of one L [Viannia] parasite/400ul canine blood. 
Field sa m pies: clin ica I d ia 9 nosis. Of surveyed dogs, 21/1104 [1.9%] had 
active cutaneous lesions, and a further 21/1104 [1.9%] had scars and/or 
ulcers. 17/20 [85%] dogs with active lesions were biopsy smear positive. 
Field sam pies: reproducibility of PCR assay. As described in Materials 
and Methods, all samples were tested using a PCR-hybridisation protocol, 
with PCR am plification products being visualised by gel electrophoresis [PCR] 
prior to hybridisat ion to a L. [Vianniaj -specific probe [HYB]. To assess the 
reproducibility of the used PCR-hybridisation protocol, all field samples were 
tested twice; when diagnostic outcom es differed, the sam pies were tested a 
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third time, the diagnostic outcome being definitive. The diagnostic outcome 
was defined as sam pies being either positive by PCR and/ or HYB or negative 
by both PCR and HYB. 
Hence, GBL were classed into four different groups [Plate 5 C and SO]: they 
were [i] PCR+ if an am plification product could be seen on the agarose gel; 
[ii] PCR- if an amplification product could not be seen on the gel; [iii] HY8+ if 
an am plification product hybridised to the B3 probe; and [iv] HYB- if an 
amplification product did not hybridise to the 83 probe. 
BCS and BMS were classed as either positive [PCRHYB+] or negative 
[PCRHYB-] by PCR-hybridisation, as the prior distinction as done for GBL 
could not be made due to the frequency of PCR artifacts [non-specific bands, 
see above]] on the agarose gel [see below and Plate SE and SF]. 
Guanidine blood Iysates [GBL]. A total of 794 PCR assays were carried out on 
368 tested GBL sam pies [Table 2.3.]. 368 GBL sam pies were tested at least 
twice, 310/368 [84%] of the sam pies had the sam e diagnostic outcom es in 
both replicates, 58/368 [16%] of the samples had to be tested a third time 
because the outcom es of the two PCR- hybridisat ion assays differed [Table 
2.3.]. 
353/368 [96%] of GBL were PCR- in two replicates, of which 73 of the 706 
replicate sam pies [10%] were HYB+. Of the 15 GBL that were PCR+ in at 
least one replicate, 7 [47%] were consistently PCR positive with all 14 
sample replicates being HYB+; of the 8 GBL that were inconsistent [i.e. were 
PCR+ in one replicate, PCR- in the other], 15/16 [94%] of the replicates 
were HYB+ [Ta ble 2.3.]. Hence, there is good reason to believe that those 
samples with inconsistent PCR results were true positives. 
288/368 [78%] GBL were consistently HYB-, all of which were PCR-. 22/368 
[6%] GBL were consistently positive, with 21/44 [48%] of the replicate 
samples being PCR+. Of the remaining 58 samples that were inconsistent, 57 
[98%] were PCR- in both replicates. The one exception was PCR-HYB- when 
re-tested [see above]. Of the 57 PCR negative sam pies with inconsistent 
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hybridisation result, only 10 [18% ] were HYB+ when tested a third time 
[whilst remaining FeR-]. Thus, there is some evidence that inconsistent 
hybridisation results can include a proportion of false positives. 
Hybridisation with the B3 probe detected all 22 B1/2 amplification products 
visible by gel electrophoresis [PCR+ HYB+ ], and was positive for a further 
90/772 [12%] GBL where B1/2 am plification products were not visible by gel 
electrophoresis [PCR-HYB+] [Table 2.3.], i.e. hybridisation increased the 
proportion positive by almost five-fold. 
Butfy coat samples [BCS}. A total 769 BCS were tested at least twice by PCR-
hybridisation [Plate 5].701/769 [91%] of the BCS had the same results in 
the first two PCR replicates, with 39/701 [6%] testing PCRHYB+ and 662/701 
[94%] BCS testing PCRHYB-. Of the 68 sam pies that had to be tested a third 
time, 26 [38%] tested PCRHYB+ and 42 [62%] tested PCRHYB-. 
Bone marrow samples [BMS}. A total 42 BMS were tested at least twice by 
PCR-hybridisation [Plate 5].37/42 [88%] of BMS had the same results in 
both replicates, with 5/38 [16%] and 32/38 [84%] testing PCRHYB+ and 
PCRHYB-, respectively. Of the remainder 2 [40%] tested PCRHYB+ and 3 
[60%] PCRHYB- in the third replicate. 
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Table 2.3. Reproducibility of PCR-hybridisation protocol: guanidine blood 
Iysates. 
Second PCR assay 
PCR+/HYB+ 
PCR+/HYB-
PCR-/HYB+ 
PCR-/HYB-
PCR+IHYB+ 
7 
5 
First PCR assay 
PCR+IHYB- PCR-IHYB+ 
2 
PCR-IHYB-
24C 
288 
NOTE. Field samples were amplified with B1/B2 primer pair and products then hybridised with 
[l2P]-labelied B3 probe as described in Material & Methods. a, 4 and 29 samples were PCR-
IH.YB+ and PCR-/~YB- in the third PCR assay, respectively;b, the sample was PCR-/HYB- in the 
third PCR assay; ,6 and 18 samples samples were PCR-/HYB+ and PCR-/HYB- in the third 
PCR assay, respectively; d, samples were only amplified once. 
Com parison of the reproducibility and sensitivity of PCR for GBl, BCS 
and BMS. No difference between the reproducibility [i.e. in the proportion of 
sam pies that were consistent] of the PCR- hybridisat ion protocol on GBL, BCS 
or BMS was observed [Chi square test, Yates-corrected, l=0.72, df=2, 
p= 0.7]. Sam pies were considered PCR- hybridisation positive if out of a 
maximum three replicates, two replicates were PCR+ HYB+ or PCR-HYB+ [for 
GBL sam pies on Iy], or HYB+ [for BCS and BMS]. Addit ionally GBL sam pies 
were considered positive if one replicate was PCR+ HYB+ and one replicate 
PCR-HYB+. Samples were considered PCR-hybridisation negative if out of a 
maxim um of three replicates, two were negative after hybridisation. Using 
the above definitions, 32/368 [8.7%], 65/769 [8.5%] and 7/42 [16.7%] 
were PCR-hybridisation positive on whole blood [GBL], buffy coat [BCS] and 
bone marrow [BMS] [Table 2.4.], respectively. Although there was an 
observed difference in the proportion positive of the PCR-hybridisation 
protocol between GBL, BCS and BMS, this difference was not significant [Chi 
square test, Yates-corrected, x2= 3.35, df= 2, p= 0.19]. When more than one 
sample was assayed from dogs, there were highly significant associations 
between the results: for example, amongst those 42 dogs with bone marrow 
samples, all four positive by GBL [and 4/4 positive by BCS] were also 
positive by BMS. 
56 
Table 2.4. Detection of L. (Viannia) spp. in field dogs using PCR-hybridisation and ELISA. 
Whole blood Buffy coat Bone marrow ELISA (GBL) (BGS) (BMS) 
1997 
Dogs with active lesions 4/11 (36.4%) 3/7 (42.9%) 0/4 (0.0%) 9/10 (90.0%) Dogs with scars 2/5 (40.0%) 2/5 (40.0%) 0/1 (0.0%) 6/8 (75.0%) Dogs without lesions or scars 26/352 (7.4%) 16/209 (7.7%) 7/37 (18.9%) 100/497 (20.1%) 
Dogs BMS taken 4/33 (12.1 %) 4/41 (9.8%) 7/42 (16.7%) 13/39 (33.3%) Dogs BMS not taken 5/38 (13.2%) 6/38 (15.8%) 8/30 (26.7%) Dogs BMS not taken, BCS NO 23/297 (7.7%) 65/282 (23.0%) Dogs BMS not taken, GBL NO 
Dogs BMS not taken, BCS/GBL NO 
11/142 (7.7%) 18/130 (13.8%) 
11/34 (32.4%) 
Total 1997 32/368 (8.7%) 21/221 (9.5%) 7/42 (16.7%) 115/515 (22.3%) 
1998 
Dogs with active lesions 1/8 (12.5%) 6/8 (75.0%) Dogs with scars 3/9 (33.3%) 3/8 (37.5%) 
Dogs without lesions or scars 15/270 (5.6%) 39/268 (14.6%) 
Total 1998 19/287 (6.6%) 48/286 (16.8%) 
1999 
Dogs with active lesions 0/2 0/2 (0.0%) 
Dogs with scars 3/4 (75.0%) 1/4 (25.0%) 
Dogs without lesions or scars 22/255 (8.6%) 57/252 (22.6%) 
Total 1999 25/261 (9.6%) 58/258 (22.5%) 
1997-1999 
Dogs with active lesions 4/11 (36.4%) 4/17 (23.5%) 0/4 (0.0%) 15/20 (75.0%) 
Dogs with scars 2/5 (40%) 8/18 (44.4%) 0/1 (0.0%) 10/20 (50.0%) 
Dogs without lesions or scars 26/352 (7.4%) 53/734 (7.2%) 7/42 (16.7%) 196/1019 (19.2%) 
Total 1997-1999 32/368 (8.5%) 65/769 (8.5%) 7/42 (16.7%) 221/1059 (20.9%) 
NOTE. Field samples were amplified with B1/B2 primer pair and products then hybridised with [l2p]-
labelled B3 probe; the ELISA was carried out as described in Material & Methods using the 4.16 LAU/ml 
cut-off. BCS, buffy coat sample; BMS, bone marrow sample; GBL, guanidine blood lysate; ND, not 
done. 
Field samples: definition of PCR-hybridisation positivity. A dog was 
considered PCR-hybridisation positive when one of the PCR-hybridisation 
assays on either GBL, BCS or BMS was positive [Table 2.4.]. Thus, using 
B1 / B2 prim ers and the B3 probe, the PCR-hybridisation assay detected L. 
[Viannia] parasites in 8.4% [90/1066] of tested dogs, with 32% [13/41] of 
the clinically symptomatic and 7.5% [77/1025] of the clinically asymptomatic 
dogs testing PCR-hybridisation positive [Chi square test, Yates-corrected, 
l=26.8, p<O.001]. 
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Enzyme-linked im unosorbent assay [ELI SA]. Negative controls. The 
mean antibody levels for the three groups of negative controls were 5 584 
[s.d.=3 150] [Lima], 2 602 [s.d.=1 707] [Belem] and 4 803 [s.d.=4 728] 
[Cambridge] units/ml [Figure 2.1.]. Whereas the mean log anti-Leishmania 
antibody units [LAU]/ml of Lima and Belem [ANOVA, F1 ,29= 17.01, p<0.001] 
and Cambridge and Belem [ANOVA, F1 ,24=4.87, p=0.04] dogs was 
significantly different, the mean LAU/ml of Lima and Cambridge dogs was not 
[ANOVA, F1 ,29=1 .58, p=O.22] [Figure 2.1.A inset]. 
Positive controls and symptomatic dogs. The mean antibody levels for 
positive control [i.e lesion biopsy sm ear positive] and scar positive dog sera 
were 1 243 388 [s.d.=3 635 762] units/ml and 154 825 [s.d.=419 317] 
units/ m I, respectively, with the mean LAU/ m I significantly different between 
the two groups [ANOVA, F1,33=7.91, p=O.01] [Figure 2.1.A inset]. 
Total field sam pIes and definition of ELI SA cut- off. A total of 1059 field dogs 
were tested by ELI SA, the frequency distribution of which is represented in 
Figure 2.1.A. Two different methods were used to analyse the data. 
Firstly, the standard definition of positive cut-off [CO], i.e. the mean level of 
antibody units/ml of negative controls + 3 s.d. was used (177, 178, 437, 
440). The mean level of antibody units/ml of all negative controls was 4 472 
[s.d.=3299] units/ml, hence the CO for positivity was 14 369 units/ml [i.e. 
4.16 LAU/ml]. Using this CO, 221/1059 [20.9%] dogs tested positive, 25/40 
[62.5%] symptomatic and 196/1019 [19.2%] asymptomatic dogs [Yates-
corrected Chi square test: x2=36.1 , p<O.001] [Table 2.4.]. 
However, this CO is conservative and it is likely that it will underestimate the 
true proportion of infected dogs (177,178,440). Hence, a second method to 
determ ine the positive CO was used, which took into account that the 
frequency distribution of log antibody units/ml is bimodal. Using maximum 
likelihood, two log-Iognorm al distributions were fitted to the observed data, 
varying mean and standard deviation [Fig u re 2.1 .B.]. Both distributions 
yield cum ulative probability functions, where the positive CO is the point a 
which the distribution intersect [Figure 2.1.B. inset], i.e. at 4.1 log antibody 
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unitsiml. Using this CO, 230/1059 [21.7%] dogs were positive, 25/40 
[62.5%] symptomatic and 205/1019 [20.1 %] asymptomatic dogs. This 
proportion of infected dogs is close to the best estimate of 249 [23.5%] dogs 
predicted by the fit of the log-lognormal distributions [i.e. the area under the 
log-lognormal distribution fitted to the right-hand tail of the ELISA LAU/ml 
distribution]. 
Field samples. PCR-hybridisation and ELISA. Table 2.5. summarises the 
ELISA and PCR-hybridisation results of field samples, negative and positive 
controls, depending on which ELI SA cut-off was used. The frequency 
dist ribut ion of LAU/ m I relat ive PCR- hybridisation positivity is represented in 
Figure 2.2. None of the 44 negative control samples were positive by PCR-
hybridisation or ELI SA [CO 4.16], but 3 [one dog from Lim a and two from 
Cam bridge] dogs were positive using CO 4.1 [Table 2.5.]. Thus, specificity 
of PCR and ELI SAco4.16 was 100%, whereas the specificity of ELI SAco4.1 was 
95%. 5/15 and 13/15 positive control sam pies were positive by PCR and 
ELISA [no matter which CO was used], i.e. sensitivity for PCR and ELISA was 
33% and 87%, respectively [Table 2.5.]. The proportion of sam pies PCR 
positive was shown to be associated with LAU/m I [Linear regression analysis 
after arc-sine transformation of the data, r=0.54, d.f.=50, p<0.001] [Figure 
2.2.A.], the frequency distributions of PCR positive and negative samples is 
shown in Figure 2.2.B. 
Based on the results of both PCR and ELI SA tests dogs were diagnosed as 
positive when they were either positive by PCR or ELiSAco4.16, or both. The 
reason why we decided to choose C04 .16 as the positive cut-off is because of 
the higher specificity when using C04.16. Hence, out of 1022 sam pies that 
were tested by both PCR and ELI SA, 262/1022 [25.6%] were diagnosed as 
positive [Table 2.5.]: 30/39 [76.9%] clinically symptomatic and 232/983 
[23.6%] clinically asymptomatic dogs. 
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Table 2.5. Comparative diagnosis of L. [Viannia] spp. in dog blood. 
Field samples 
Negative Contrals8 
[n=44j Positive Contrals
b 
[n=16j 
Other 
[n= 1 006j 
PCR+ PCR- PCR+ PCR- PCR+ PCR-
- [3] 4 [4] 9 [9] 33 [35] 163 [171] 
44 [41] 1 [1] 2 [2] 52 [50] 758 [750] 
NO~~. a PC~ on n~gativ~ Belem and Ca~bridge controls were carried out on sera, not buffy 
coat, dogs with active leslo.ns that were biopsy smear positive. Of 21 dogs with active lesions 
[see Table 2.4.], 17 were biopsy smear positive, and 16 were tested by both ELISA and PCR. 
Numbers represented are based on ELiSAc04.16 and ELiSAc041 [in brackets]. 
2.4. 0 iscussion. 
In this chapter we assessed the utility of PCR as a diagnostic mass-screening 
tool for epidem iological surveys and com pared its sensitivity and specificity 
to ELISA, a commonly used test to detect L. [Viannia] in dogs. We chose 
ELI SA rather than I FAT as com parative test, because previous studies had 
shown ELI SA to be m ore sensitive and specific than I FAT for detection of ACL 
in dogs [Part 1: Introduction]. 
PCR protocol and sensitivity titration assay. PCR assays rarely justify 
choice of DNA extraction protocol and PCR prim ers (323), but both were 
shown here to im pact significantly on assay sensitivity [an observation that 
was recently confirm ed (294, 296)]. Furtherm ore, most reported STAs have 
been based on either pure Leishmania parasite culture Iysates or on standard 
amounts of background host DNA added to known quantities of parasite DNA 
(152, 207, 327, 546). Both fail to m im ic the situation encountered in the 
field: the concentration of background host and parasite DNA will vary 
considerably with biopsy sam pie, thereby influencing the outcom e of the PCR 
assay, as will other factors related to the host's medical condition [ego 
haematocrit] (116). The present STA demonstrates that DNA from a fraction 
of Leishmania parasite can be amplified by PCR in the presence of host 
canine background DNA, but generally less readily than pure parasite culture 
Iysates [Table 2.2.]. Hybridisation with a 32P-labelled probe usually 
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increased the sensitivity of the assay by 102 to 104-fold [Table 2.2]. 
Contrary to previous reports [Table 2.1.] the M1 UM3HL primer pair 
perform ed rather poorly. Though the target DNA to be am plified was the 
smallest, M1 UM3HL was 104 to 106 less sensitive than other primer pairs 
used. A particular problem associated with using M1 UM3HL was the difficult 
visual separation of am plification product and prim er dim ers on standard 
agarose gels [and subsequently on the probed filters]. Though organic 
solvents are known to persist in DNA extracts and can inhibit the PCR 
reaction, PC extraction was com parable to the DNeasy kit in preparing 
samples for PCR. Commercial DNA extraction kits [ego DNeasy] may have the 
advantage of speed and reduced safety hazard (323), but they are expensive 
when compared to PC extraction, and as shown here no more efficient. 
Quicker and easier DNA extraction techniques using Chelex were not as 
successful [10 3 to 104-fold less sensitive] as the DNeasy kit or PC extraction 
procedures when preparing sam pies for PCR. The reason why none of the 
Chelex only-extracted samples yielded amplification of the target DNA may 
be due to the presence of a PCR inhibitor not removed by the extraction 
method, or remaining Chelex particles. Though ideal for screening large 
numbers of samples, because of the minimal manipulations required and the 
reduced risk of specim en-to- specim en contam inat ion (564), this extract ion 
protocol appears unsuitable for DNA extraction when using clinical specimens 
containing very small numbers of parasites or large numbers of potential PCR 
inhibitors, ego heme. In contrast, L. [Viannia] spp. DNA has been successfully 
extracted from lesion scrapings using Chelex resin (36, 62, 251). The 
advantage of using guanidine HCI is that blood sam pies can be stored at 4°C 
[and possibly at room temperature] (34, 35, 90, 91, 578, 579), which is 
useful in the field where there is often no access to freezers. As for T. cruzi 
(34, 35, 90, 91, 578, 579), Leishmania DNA in guanidine Hel remained 
undegraded for months, and we successfully amplified Leishmania DNA 
originating from samples stored at 4°C for 1 % years [recently it was reported 
that Leishmania DNA in guanidine can be successfully amplified from samples 
stored for up to 3 years (294)]. However, it should be noted that guanidine 
HCI is a salt that could inhibit PCR amplification, so dilutions of extracted 
DNA may be required for successful amplification. 
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peR as a diagnostic mass-screening tool. The classic diagnostic 
techniques for Aa... diagnosis have a number of limitations. Microscopic 
examination of skin scrapings or lesion biopsy touch imprints, though rapid 
and low-cost, has limited sensitivity, particularly in chronic lesions [e.g. MCl] 
(571). Whilst in vitro culture techniques are slightly more sensitive than 
microscopic exam ination of lesion biopsy sm ears or histological sam pies, 
they are labou r- intensive and cost Iy and are susceptible to microbiological 
contam ination. They also are ham pered by the particular growth 
requirements of different Leishmania strains and as some strains grow better 
than others in vitro, the dom inant strains can be inadvertently selected for 
when culturing mixed infections (28). MST detects specific cutaneous 
delayed-type hypersensitivity, but cannot distinguish between active and 
past infections (571). Also, logistical problem s would be associated with its 
application in epidem iological dog surveys [e.g. dogs would have to be 
kennelled or monitored for 48 hours prior reading the MST induration size]. 
peR has been shown to be particularly useful for the diagnosis of L. [Viannia] 
infection, as parasite num bers in clinical sam pies are typically sparse (62, 
153, 244, 245, 433, 498). 
Although a positive PCR was associated with a higher antibody titre [LAU/m I 
[Figure 2.2.], the ELISA test was much more 'sensitive' than PCR in 
detecting Leishmania infection in symptomatic [Chi square test, Yates-
corrected, :l=6.5, p=0.1] and asymptomatic [Chi square test, Yates-
corrected, -l= 58.9, p< 0.001] field dogs. Considering the 100% specificity of 
the ELiSAco4.16 test and the absence of any potential cross-reacting parasites 
in the study area, it is very likely that the 163 ELISA positive but PCR 
negative dogs were true positives [see below]. Based on negative and 
positive control sam pies, the positive predictive value [PPV] for PCR and 
ELiSAco4.16 was 100%, and 81 % for ELiSAco4.1. The negative predictive value 
[NPV] was 80% for PCR and 94% for ELI SA, respectively. I f one estim ates 
the PPV from the PCR GBL replicate data, then the PPV for PCR+ I HYB+ is 
similar, i.e. 95% [out of the 22 PCR assays that were PCR+/HYB+ at least 
once, 21 were diagnosed as positive, Table 2.3.]. However, the PPV for PCR-
IHYB+ is only 31% [out of 80 samples that were PCR-/HYB+ at least once, 
25 were diagnosed as positive]. The reason why this was the case is that for 
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these samples the FeR method was performing at its highest, possible 
sensitivity. Whether future PCR protocols and new PCR primers will be able to 
reduce that false negative rate remains to be established. Replicate results of 
established PCR protocols are rarely reported (295, 439), but are of 
im portance when interpreting epidem iological data, because they show that 
the used diagnostic test is either not reliable [i.e. there is contam ination] or 
perform ing at its highest level of sensitivity. Considering that, in our case, a 
positive PCR result means that a dog is potentially infectious, the lack of 
replicates may have a significant impact on the outcome on dog intervention 
[e.g. culling] campaigns. 
A PCR-based assay on blood is advantageous as samples can be obtained 
less invasively from the patient [human or dog] and are easy to process. We 
also show that the choice of biopsy material does not appear to be as critical 
as for studies using PCR to diagnose hum an ACL patients [skin snips, lesion 
aspirates], as the sensitivity of the PCR on GBL, BCS or BMS was not 
significantly different. Studies using PCR to detect L. infantum in dogs 
reported similar observations to the ones made here, showing that sensitivity 
was higher in clinically symptomatic than asymptomatic dogs (31,67,356, 
451,473,507,518,595). Only in two studies did the sensitivity of PCR vary 
according to biopsy origin (356, 518). The reason why we could not 
demonstrate such an association is probably due to the pathogenesis of 
canine L. [Viannia] infections, with parasites remaining localised at the site of 
infection [see below]. 
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Table 2.6. Use of PCR as a ma~s-screening tool in epidemiological 
studies of ACL. 
Disease Animal Species PCR PCR primers' Parasite isolates 
[NJ Reference 
CLLV Bradypus variegatus 3/7B OCT120 ¥ 
Didelphis marsupialis 0/3B 
CLLV D. marsupialis 1/5ss B1/2 (14) 
Microreus demerarae 2/3 sS 
Microryzomys minutus 1/2 ss 
Melanomys caliginosus 3/14 ss 
Rattus rattus 2/4 ss 
Rhipidomys latimanus 0/4 ss 
Silvilagus braziliensis 1/1 ss 
CLLV Marmosa spp. 1/?SB ? § 
Rattus alexandrinus 1/?SB 
Rattus frugivorus 11?SB 
CLLV Akodon spp. 4/153
sS MP1UMP3H (322) 
Canis familiaris 15/276 sS L peruviana [3] 
D. albiventris 2172 ss L peruviana [1] 
Mus musculus 0/178 
Oryzomys spp. 0/8 
Phyllotis andinum 1/499 L peruviana [2] 
Rattus rattus 0/8 
CLLV Akodon arviculoides 
0/1 B,ss ? 
Akodon cursor 0/2 B,SS 
Nectomys squamipes o. 0/1 B,SS 
O/igoryzomys nigripes 0/21 B,SS 
Oryzmoys raytticeps 0/1 B,SS 
Proechimys iheringi 0/2 B,SS 
Rattus rattus 0/2 B,SS 
Rhipidomys mostaca/is 1/5 B,SS 
CL LV,LMEX Akodon spp. 1/14B [LMEX] L 1/2 L braziliensis [1] (530) 
Conepatus chinga rex 1/2 B [LMEX] 
D. marsupialis 0/12 B 
Microreus cinerea 0/2 B 
O/igoryzomys spp. 2/8
B [LMEX] 
Oryzmoys spp. 0/1 B 
Rhipidomys lencodactylus 0/2B 
NOTE. B, blood; LMEX, L mexicana; LV, L [Viannia} spp.; SB, spleen biopsy; SS, skin snip. *PCR primers. 
B1/2, L [Viannia} spp.-specific primers (152); L1/2: Trypanosomatidae-specific primers; MP1 UMP3H, L 
[Viannia} spp.-specific primers (327); OCT120: Leishmania spp. primers (197); ¥, Pirmez et al., unpublished; 
§, Brandao-Fillho et al., unpublished; ~, Soares et al., unpublished. 
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Olly one large (> 50 tested samples) study has used FeR as a mass-
screening tool in epidemiological studies of AQ and reported lower AQ 
infection rates in dogs than the ones reported here (322). Sim ilarly, other 
small studies using PCR to detect ACL in putative animal reservoirs [Table 
2.6.] failed to observe high ACL infection rates. Incidentally, in all st udies a 
second, com parative diagnostic test such as serology was not carried out. An 
established experimental animal model for L. [Viannia] infection would 
provide som e answers to above questions regarding diagnostic test 
sensitivity and specificity as PCR cou Id be carried out under controlled 
conditions - however, such an experimental model does currently not exist. 
Epidemiological considerations. The high prevalence shown in both 
asym ptom atic and sym ptom atic dogs provides further evidence for their 
suspected role as [peridom est ic] reservoir hosts of ACL [Part 1: 
Introduction]; and the detection of L. [Viannia] DNA in canine blood implies 
that infected dogs should be infectious to bloodfeeding sandfly vectors. 
However, xenodiagnosis studies will be required to prove this. Although L. 
[Viannia] DNA was detected in the blood and bone marrow of a relatively 
high proportion of tested dogs, indicating that metastasis by haematogenous 
dissem ination may be a m ore com m on phenom enon than previously 
acknowledged (19, 570), blood samples from the majority of dogs with active 
[and biopsy smear positive] lesions were PCR negative. This is probably 
because L. [Viannia] parasites are first localised at the site of infection in the 
derm is, with haem atogenous dissem ination occurring after an undefined 
interval [if at all] (570). An interesting observation is the 52 PCR positive but 
ELiSAco4.16 negative asym ptom atic field dogs. Because the PCR was 100% 
specific, it is unlikely that they were false positives. They may have been 
false ELI SA negatives, but considering that their mean level of LAU/m I [i.e. 
3.61] was much lower than the 4.18 log antibody units/ml cut-off this seems 
improbable. One possible explanation is that these dogs represent dogs that 
are innately resistant [e.g. studies on L. infantum in dogs have shown that 
up to 50% of asymptomatic dogs have a anti-Leishmania cellular immune 
response (1, 97, 98, 288, 518)]. Another explanation is that dogs have 
developed cellular immunity after self-cure, as it now becomes increasingly 
evident that persistence of parasites is required to maintain cell-mediated 
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immunity in the long-term (570). Of note is that despite the high prevalence 
of infection only 4% of surveyed dogs had clinical symptoms of ACL, which is 
considerably lower than the figures observed in other studies [Part 1: 
Introduction]. A possible explanation could be that the circulating L. 
[Viannia] parasites are of low virulence [i. e. a sm all proport ion of infect ion 
causes clinical disease] but high pathogenicity [i.e. a high proportion of 
parasite inoculations cause infections] (570); which is characteristic of L. 
peruviana. Surprisingly little known is known about the clinical and 
parasitological course of L. [Vianniaj in dogs [as in humans and other 
m am m alian hosts] and the role of cellular im m unity during infection [Part 1 : 
Introduction]. It also remains to be established whether L. [Vianniaj 
resistant dogs could have an important role in ACl disease transmission. 
Conclusion. This is the first large-scale study to test the feasibility of using 
PCR to detect L. [Vianniaj spp. parasites in host blood and to test whether 
PCR could be used as a diagnostic, mass-screening tool in epidem iological 
studies. As is the case for ZVL (31, 67, 356, 451, 473, 507, 518, 595), PCR 
on blood alone does not appear to be the elusive 'gold standard' for 
diagnosing ACl infections in dogs [or humans]. Unless a more sensitive PCR 
protocol [e. g. PCR- ELI SA] is developed to detect asym ptom atic ACL 
infections, the use of PCR will be restricted to the diagnosis of active cases 
[e.g. hospitals in Europe and elsewhere increasingly rely on PCR for 
Leishmania diagnosis in human patients (71, 89, 515, 583)] and in particular 
MCl cases where common diagnostic tests [e.g. parasite culture, biopsy 
sm ears, histolopathology] are less sensitive [Table 2.1.]. The use of PCR on 
blood will, however, have an im portant epidem iological application in studies 
to monitor the clinical and chemotherapeutic follow-up of patients with ACL 
(164, 245, 498). Detection of dissem inating Leishmania parasites in patient 
blood would indicate that they are at risk of developing mucocutaneous 
lesions, the treatment of which is more complicated than the treatment of 
the single lesions characteristic of ACL (570). Also, PCR com bined with 
specific DNA probing and sequencing should help to identify and characterise 
those strains that are drug resistant and that cause the different clinical 
pathologies associated with ACL. 
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Thus, although there are concerns about the specificity of serological tests 
and although they are unable to distingUish past from present infections, 
they will remain the main diagnostic tool for epidemiological Leishmania 
mass-screening surveys. The main advantages of serological tests are that 
large num bers of sam pies can be processed readily, inexpensively, with 
comparatively low technical expertise required. Significantly, the recent 
identification of specific recom binant Leishmania antigens [e.g. the L. 
donovani and L. infantum-specific rK39, see Chapter 6] suggests that 
serological tests may become more specific in the future. Several studies 
have shown that serological tests based on recom binant antigens [e.g. rK39-
ELI SA] are able to distinguish not only between present and past infections, 
but between sym ptom atic and asym ptom atic infections as well. Surprisingly, 
serological tests based on known L. [Vianniaj spp.-specific recom binant 
antigens (379) have yet to be tested as a diagnostic tool for either active 
cases or in epidemiological surveys. 
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CHAPTER 3: 
Leishmania [Viannia] spp. dissemination and tissue tropism 
in naturally infected dogs [Canis familiaris]. 
Abstract 
Although domestic dogs are suspected reservoir hosts of AD-, 
descriptions of the course of L. [Viannia] spp. infection in dogs are 
scarce and most information on the natural course of L. [Viannia] spp. 
infection is restricted to studies carried out on sloths. The presented 
observations provide the first evidence for L. [Viannia] spp. 
dissemination and tissue tropism in the domestic dog. Using PeR and 
histology, parasites were detected in the conjunctiva and lymph nodes 
of both dogs studied and the detection of parasites in the blood 
indicates that parasite dissemination to those organs may have been 
haematogeneous. Leishmania [Viannia] spp. parasites were additionally 
detected in the lung and ovary of one of the dogs. 
Richard Reithinger, Bronwen E. Lambson, Douglas C. Barker, Helen 
Counihan, Juan Canales Espinoza, Jamintong Sabino Gonzalez, and 
Clive R. Davies. Leishmania [Viannia] spp. dissemination and tissue 
tropism in naturally infected dogs [Canis familiaris]. 
Trans. R. Soc. Trop. Med.Hyg. 96, 76-78. 
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3.1. Introduction. 
I n a minority of ACl infections, L. [Vianniaj parasites dissem inate from the 
prim ary cutaneous lesion to viscera and mucosa, causing MCl [General 
Introduction]. The mechanism s underlying L. [Vianniaj dissem ination and 
tissue tropism are unknown, but it appears that it is dependent upon [i] host 
susceptibility and parasite virulence (73, 306, 506); [ii] persistence of live 
parasites in host tissues (164, 244, 245, 498); and [iii] stim ulation or 
enhancement by trauma (63, 539, 583). Successful detection or isolation of 
L. [Vianniaj parasites from human (84, 164, 244, 245, 349), rodent (86, 
322), sloth (261) and canine (245) [Chapter 2] blood suggests that 
dissemination may be haematogenous. 
Previous reports on the cou rse of L. [Viannia] infection and dissemination are 
almost exclusively from experimental studies using golden hamsters 
[Mesocricetus auratusj or mice [Mus spp.], which are not natural hosts 
(271). Whereas the L. [Vianniaj-hamster model mirrors hum an disease, the 
self- curing, non- disseminating L. [Vianniaj-m ouse model does not (271). 
Hence, it is difficult to draw any conclusions from the m urine studies. Also, 
most mouse and hamster studies have used inoculates containing high 
num bers of parasites, inj ected either intra-venously, -muscularly or -
peritoneally, a protocol which does not m im ic natural infection by sandfly 
bite. The course of natural L. [Vianniaj infections is likely to be affected by 
sandfly saliva whose role in modulating ACl infection [and perhaps 
dissemination] is unclear (70, 106, 174, 317,484) [General Introduction]. 
Descriptions of the course of canine of L. [Vianniaj infection come only from 
a handful of experim ental studies, which exclusively report the macroscopic, 
clinical evolution of infection [Part 1: Introduction]. Information on the 
natural course of canine L. [Vianniaj infection comes from a single study of 
three parasitologically-proven dogs (434), in which L. braziliensis could not 
be detected in spleen, liver or Iym ph nodes [either by in vitro culture, 
Giemsa- stained imprints or histopathology]. 
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Reports on L. [VianniaJ tissue dissemination are almost exclusively restricted 
to studies carried out on sloths. Herrer & Olristensen (261) isolated L. 
panamensis from 56/497 skin, 46/451 spleen, 26/450 liver, 14/382 bone 
marrow, and 4/267 lung biopsies of Cho/eopus hoffmani. Lainson (300) 
reported the isolation of L. guyanensis from viscera [i.e. spleen, liver, lungs] 
and skin from one Choleopus didactylus, from the viscera only of one 
Tamandua tetradactylus and one Dide/phis marsupia/is, and from skin only of 
one Proechimys guyannensis. 
The objective of the study were to determine the extent of L. [VianniaJ 
dissem ination and tissue tropism in two naturally infected dogs which were 
given to the Ministry of Health in Huanuco because the owners wanted the 
dogs to be killed. 
3.2. Materials & Methods. 
Dogs and sampling. Using the polymerase chain reaction [PCR] and 
histology, L. [Viannia} dissemination was investigated in two naturally 
infected dogs, dog 1 [01] cam e from Lim apam pa [906], dog 2 [02] cam e 
from La Esperanza [921] [Map 1 and Chapter 2]. 
Oog 1 [01] was a 2-year-old female mongrel [weight 8.5kg] presenting an 
active cutaneous ulcer [L1] [size: 6x4cm; duration: 4 months] on the snout. 
No other clinico-pathological sym ptom s indicative of ACL were observed. 01 
had a Toxocara canis infection. 
Oog 2 [02] was a 6-year-old female mongrel [weight 11.3kg] presenting two 
active cutaneous lesions [L1 and L2]. L 1 [size: 7x5cm; du ration: 12 months] 
was a mucocutaneous lesion on the snout that had destroyed the septum and 
respiratory cavity [Plate 4H]. 02 was suffering from breathing difficulties 
due to the lesion. L2 [size: 6x3cm, duration: 5 months] was an active 
cutaneous ulcer on the left side of the neck. Other clinical symptoms included 
onychogryphosis, britt Ie and dry hair, conj unct ivit is, and flea- induced 
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dermatitis on the underside of the abdomen. Macroscopic pathological signs 
included hepatosplenomegaly, enlarged right cervical and mandibular lymph 
nodes; enlarged and hemorrhagic mesenteric lymph nodes; and T. canis and 
Espinocerca lupis infection of the oesophagus. 
Blood aliquots [5m I] were taken from the jugular vein following euthanasia 
using sodium pentobarbitone [Euthanol®, MTC Pharm aceuticals, Cam bridge, 
Canada] upon approval of their owners. Blood was processed as previously 
described [Cha pte r 2], and stored as either buffy coat sam pie [BCS] at -
20°C, or guanidine/blood lysate [GBL] at 4°C. The dogs were necropsied and 
tissue sam pies were taken and placed in 1 m I of PBS or 10% form alin for PCR 
and histology respectively. All samples stored in PBS were frozen at -20°C. 
peR and hybridisation. For PCR, DNA from BCS, GBL and biopsies was 
extracted using the DNeasy® extraction kit [Qiagen, Crawley, Great Britain], 
and amplified using three different sets of primers: B1/B2, Min11 B/Min22 
and R221/R332 [Box 1]. Amplification products were hybridised with either a 
[a,32p]-dATP or [y32p]-ATP-labeled probe, before being exposed for 
autoradiography at -70°C [Chapter 2]. 
Enzyme-linked immunosorbent assay [ELISA]. The ELISA was carried 
out as described in Chapter 2, i.e. using L. braziliensis 
[MHOM/ BRl85/ LB300] prom ast igotes as ant igen and peroxidase-conjugated 
IgG as antibody. 
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Table 3.1. peR and histology of different tissue biopsies and blood. 
D1 02 
PCR PCR PCR HIS PCR PCR PCR HIS 
B1/B2 Min11B/22 R221/332 B1/B2 Min11B/22 R221/332 
L1 + + + NO + + + + NA NA NA NA 
L2 
Conjunctiva (left eye) NO NO NO NO + 
Conjunctiva (right eye) + + + + + + + 
Mandibular lymph n. (left) + + + + + 
Mandibular lymph n. (right) 
+ 
+ + + NO NO NO 
Cervical lymph n. (left) 
NO 
Cervical lymph n. (right) 
NO NO NO NO 
+ + NO NO NO NO 
Mammary lymph n. (left) + NO 
Mammary lymph n. (right) + NO 
Maxillary lymph n. (left) + + + NO NO NO NO 
Maxillary lymph n. (right) + NO NO NO NO 
Mesenteric lymph n. + + + + NO NO NO NO 
Popliteal lymph n. (left) NO 
Popliteal lymph n. (right) + + 
Heart NO 
Liver + 
Kidney 
Lung NO NO NO NO + + + 
Spleen NO 
Pancreas 
Ovary NO NO NO NO + + + 
Whole blood (BCS) + + + NO + + + NO 
Guanidine/blood (GBL) + + NO + + + NO 
PCR and histology were carried out as described in Materials and Methods. NOTE. n, node; NA, does 
not apply; ND, not done. For B1/B2, Min11 B/22 and R221/332 PCR primer sequences see Chapter 2. 
Histology. For histological exam ination, biopsy sam pies were processed and 
embedded in paraffin according to standard procedure (42). Sections [2-3J.lm 
thick] were cut on a microtome, stained with haematoxylin and eosin, and 
assessed for histopathological changes or presence of amastigotes. 
3.3. Results. 
Both dogs had high anti-Leishmania log antibody units/ml, with D1 and D2 
having 5.8 and 5.5 log antibody units/m I [the positive cut-off being 4.16 log 
antibody units/ml, Chapter 2], respectively. The results of peR and histology 
with respective biopsies and blood are represented in Table 3.1. Although 
three peR protocols of different sensitivities and specificities were used to 
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maximise parasite detection, on three occasions histology was positive when 
all three FCRs were negative. Parasites were detected in a single lesion on 
both dogs confirming that both had AQ. l2 of D2 was parasitologically 
negative, both by PCR and histology, suggesting that the lesion had a non-
Leishmania aetiology. Most tissue sections from both dogs showed signs of 
advanced fibrosis and marked infiltration of cells, such as lymphocytes, 
m acrophages, polymorphs and fibroblasts; but the abundance of Leishmania 
amastigotes seen was generally low. In 01, most sampled tissues had clear 
evidence of advanced fibrosis. Amastigotes were observed in mandibular, 
cervical, m am mary and mesenteric Iym ph node tissue sections, but not in 
sections from other tissues. In 02, advanced fibrosis was observed, but no 
parasites, in Iym ph node tissue sections. Areas of cellular infiltration were 
seen in lung tissue sections, particularly near larger vessels and airways, 
with small num bers of amastigotes present. Small foci of cellular infiltrate 
were also detected in conjunctiva tissue sections, and the area behind the 
m em brane was inflam ed with am astigotes present. The ovary had marked 
cellular infiltrate, particularly in the connective tissue, with amastigotes seen 
throughout. Liver and spleen biopsies from both dogs were degenerate, 
which may be due to a delay before fixation. 
3.4. Discussion. 
Whereas canine ZVL is a system ic infection and clinical signs are manifold 
(115,290,513), the course of canine ACL infection appears to be analogous 
to human ACL, where parasites remain localised at the dermal site of 
infection, with potential haem atogenous or Iym phatic dissem ination occurring 
after an undefined interval (570). However, as shown in Chapter 2, parasite 
dissem inat ion may not be a rare event as L. [Vianniaj parasites were 
detected by PCR in the blood of 7.5% of asym ptom atic dogs. Clinical 
sym ptoms associated with canine ACL infections are cutaneous ulcers or 
nodules, though not in the frequencies as reported for ZVL, because most 
ACL infections appear to be sub- clinical [Chapter 2]. 
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Observations presented here provide the first evidence for L [Viannia] tissue 
dissemination in the domestic dog. Parasites were detected in the 
conjunctiva and various lymph nodes of both dogs studied, and the detection 
of parasites in the blood indicates that parasite dissemination to those organs 
may have been haem atogenous. Parasites were additionally detected in the 
lung and ovary of 02. 
This is the first report of L. [Viannia] parasites detected in conjunctiva and 
ovary of a vertebrate host, and the first to detect L. [Viannia] parasites in the 
lung of dogs. The detection of parasites in the conj unctiva and lung is 
frequently associated with canine L. infantum infections (115, 290, 513), and 
L. panam ensis parasites have been detected in the lungs of sloths (261). 
Detection of Leishmania parasites in the ovary or testis has been reported in 
natural dog infections caused by L. infantum (513), and the detection of L. 
infantum in dog semen could explain both canine and human cases of 
congenital transmission (77, 157, 181, 182, 222, 324, 365, 368, 373, 403, 
445, 505, 584). Surprisingly, we did not detect parasites in liver or spleen, 
organs that generally are associated with Leishmania infection (570). 
Conclusion. The detection of L. [Viannia] parasites in blood and conjunctiva 
implies that dogs are infectious to sandfly vectors, although confirmation 
requires xenodiagnosis studies. It is also likely that, as for canine ZVL (200, 
513) and ACL in rodents (322) or sloths (261), L. [Viannia] parasites may 
disseminate to an infected dog's skin, thereby enhancing their infectiousness 
to sandfly vectors and their importance as reservoir host for human disease. 
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CHAPTER 4: 
The epidemiology of canine American cutaneous 
leishmaniasis in Huanuco: transmission rates estimated from 
cross- sectional and prospective data. 
Abstract 
A prospective survey to study the epidemiology of American 
cutaneous leishmaniasis [AQ] in domestic dogs was carried out 
in 18 villages in the Department of Huanuco, Peru. Over three 
years 1022 dogs were surveyed, with cumulative village AQ 
prevalence ranging between 0% to 100%. The incidence of L. 
[Viannia] infection was estimated to be 0.285/year [95% G.I. 
0.160-0.410] and 0.291/year [95% G.I. 0.195-0.387] using 
cross-sectional data and data from 108 dogs that were surveyed 
repeatedly over three years, respectively. The recovery rate was 
estimated to be 0.456/year [95% G.I. 0.050-0.862] and 
0.520/year [95% C.I. 0.302-0.738], respectively. The findings 
were used to estimate the basic reproduction number F\J::::: 1.9; 
implications for control are discussed. 
Richard Reithinger, Juan Canales Espinoza, Orin Courtenay and 
aive R. Davies. The transmission dynamics of canine American 
cutaneous leishmaniasis in Huanuco, Peru. Am. J Trap. Med. 
Hyg., in press. 
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4.1. Introduction. 
Although several studies have tried to im plicate dogs as dom estic reservoirs 
of L. [Vianniaj spp. [Part 1: Introduction], it is surprising that the number 
of studies reporting incidence and recovery rates in naturally infected dogs 
are extremely scarce. As shown in Chapter 3, description of the course of L. 
[Viannia] infection are restricted to four experim ental studies, from which it 
is difficult to draw any conclusions due to differences in experimental 
protocol and sm all sam pie size. Also, the course of infection following 
experim ental parasite inoculation is likely to differ from the course of 
infection due to natural infection via sandfly bite. The only information on the 
natural [sero-] recovery rates of dogs infected with L. [Vianniaj parasites 
comes from a couple of field studies. In a small study in Brazil 3/14 L. 
braziliensis-infected dogs were shown to heal spontaneously 2-3 months 
after parasite demonstration, with complete clinical and sero-recovery; 
lesions and positive I FAT results re-appeared in all three dogs during the 11-
month study follow-up (432). Recently, a prospective survey in a L. 
braziliensis-endemic area in Argentina reported yearly incidence rates of 12% 
[6/52] and 19% [10/52] for clinical disease [i. e. appearance of ACL lesions] 
and infection [i.e. as diagnosed by ELI SA], respectively; no inform ation on 
serorecovery rates was reported (341). 
Comparatively vast is the literature on studies trying to describe the 
transm ission dynam ics of canine ZVL. Several cross-sectional and 
prospective studies, mainly in Europe and South America, particularly Brazil, 
have shown that [i] dogs are highly susceptible to L. infantum with high 
infection rates observed throughout the L. infantum-endem ic range (125, 
220) with a basic reproduction num ber [Ra] between 1.06 and 11 (23, 177, 
440, 587); [ii] susceptibility to and persistence of L. infantum infection is 
dependent on host genetic background [e.g. pure breed dogs are more 
susceptible than mongrel dogs (513,517)] and dog ecology [e.g. rural or 
hunting dogs have a higher risk of ZVL infection than urban or pet dogs, 
respectively (126)]; [iii] once infected, dogs tend to rem ain parasitologically 
positive for life and, hence, infectious to the sandfly vector (125). 
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The objectives of the analyses presented here were [i] to describe the 
natural course of L. [Vianniaj infection in dogs parasitologically and 
immunologically estimating both incidence and recovery rates using data 
from both cross-sectional and prospective surveys; and [ii] to assess the 
epidemiological role of dogs in the L [Vianniaj transmission cycle in 
Huanuco, Peru. 
4.2. Materials and Methods. 
Study site. As described in the previous chapter, all surveyed dogs came 
from 18 villages in the Departm ent of Huanuco, Peru [10° 50'S, 76° 1 O'W]: 
Pom acucho [Code 901], Conchum ayo [902], Quechualom a [903], 
Chinobam ba [904], Vilcabam ba [905], Lim apam pa [906], Chullay [907], Coz 
[908], Huancapallac [909], Virroy [914], Cochachinche [915], Parcoy [916], 
Atah uay6n [917], Mauca [918], Cochatam ba [919], EI Rancho [920], La 
Esperanza [921] and San Rafael [922] [M ap 1 in Chapter 2]. All villages lie 
at an altitude of ca. 2000-3500m above sea level, in a mountainous and 
relatively dry area, and each have between 150-650 inhabitants [Plates 3A-
H]. The main econom ic activity is agriculture [the main crops being potatoes 
and maize] and people often own dom estic anim als [guinea pigs, chickens, 
goats, donkeys, dogs and cats]. 
Since 1987, there have been about 500-1000 annual reported ACL cases in 
the Department of Huanuco. A prospective epidemiological study of 2374 
people carried out by UPCH [Universidad Peruana Cayetano Heredia, Lim a, 
Peru] and LSHTM [London School of Hygiene & Tropical Medicine] from 1994 
to 1998 showed that village cumulative ACL prevalence rates [as measured 
by a posit ive response to the Montenegro skin test] range from 10% -56% 
[Davies and Llanos-Cuentas, unpublished]. Though not gender related, risk 
of infection was shown to increase with age, and 23% and 3% of surveyed 
individuals had cutaneous and m ucotaneous lesions or scars, respectively. 
Previous studies carried out by UPCHI LSHTM also showed that [i] there is 
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transmission of AQ in the domestic environment, caused by the bite of Lu. 
[Helcocyrtom yia] tejadai [incrim inated on the grounds of its abundance, 
man-biting habits and the PCR-based detection of L. [Viannia] parasites in 
the gut] [Roncal & Davies, unpublishedj; [ii] households often own one or 
m ore dogs [see Chapter 5]; and [iii] there are ACL infections in dogs, as L 
peruviana [n= 1] and L. braziliensislL. peruviana hybrids [n= 10] were 
isolated from 2% [11/563] of random Iy sam pled dogs (400). There is no L. 
infantum or T. cruzi transmission in the study area. Transmission season of 
ACL is generally after the raining season, from April to November. 
Dog sam piing and diagnosis. Dogs were surveyed either by house-to-
house visits or gathered in the village square during rabies vaccination 
campaigns carried out by the local Ministry of Health. None of the dogs 
belonged to a recognisable breed and all were guard or hunting dogs. 
I nterviews with owners were carried out to provide inform ation about the 
num ber of dogs kept, their age and residence tim e in the valley. In follow- up 
visits, owners were also asked whether previously surveyed dogs were still 
alive or had died. Dogs were surveyed at approximately yearly intervals 
between 1997 and 1999, and ACL was diagnosed clinically, parasitologically 
[PCR] or im m unolog ically [ELI SA] as described before, with dogs diagnosed 
as ACL positive when positive by either PCR or ELI SA, or both ['infection'] 
[ Chapter 2]. 
Data analysis. Cross-sectional surveys. The instantaneous per capita 
conversion [i.e. force of infection, A] and recovery [p] rates were est im ated 
from age-prevalence data where the proportion of animals positive at age a, 
P[al, is given by (576): 
[E1 ] P( a ) = A . ( 1 _ e -{ Mp)a ) (A+ p) 
The equation assumes that [i] A and p are age independent and constant over 
time; [ii] that individuals in the host population are homogeneously exposed; 
[iii] that individuals that are infected becom e instantaneously positive; and 
[iv] that the association between age and prevalence is observed at 
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equilibrium. A. and p can then be estim ated by maxim um likelihood using 
observed age- prevalence data (576). 
Prospective surveys. The instantaneous incidence rate among the susceptible 
dog population was estim ated from the frequency of conversions from a 
negative to a positive PCR or ELI SA diagnosis during the intervals between 
1997, 1998 and 1999 surveys. Both A. and p can be derived from the 
prospective survey data by solving the simultaneous equations (87): 
[E2] 
[E3] 
A-P( c ) = . ( 1 - e -( M p)1 ) 
(A-+ p) 
P( r ) = p . ( 1- e-( Mp)1 ) 
(A-+ p) 
Where P[e] is the proportion of individuals converting from a negative to a 
positive diagnosis in time t, and P[r] is the proportion of individuals 
converting from a positive to a negative diagnosis. 
4.3. Results. 
Dog dem og raphy. During the three years of the study 1114 dogs were 
surveyed, of which 1022 [1997: 481, 1998: 284, 1999: 257] were sampled 
and diagnosed by both ELISA and PCR [Chapter 2].138/1022 [14%] of 
sam pies cam e from dogs that were sam pled m ore than once [see below]. Of 
the 1022 dogs inclu ded in the analyses, 370 [36%] [1997: 161, 1998: 110, 
1999: 99] and 630 [62%] [1997: 303,1998: 171,1999: 156] were female 
and male, respectively; 22 dogs were not sexed [Table 4.1.]. Mean dog age 
during the study period was 30 months [range: 1-180] [1997: 31 months [3-
180], 1998: 29 months [4-120], 1999: 28 months [1-180]]; the age 
frequency distribution is represented in Figure 4.1. The life expectancy [LJ 
of dogs was calculated from the cohort of dogs followed-up between 1997 to 
1999 according to the following equation (125): 
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[E4] t5 = -In(l _ nr+m ). __ 1_2 __ 
Nt (m/nr+m) 
[E5] 
where 8 is the mortality rate per year, nt+m is the number of dogs that died m 
months after time t [i.e. the first time dogs entered the cohort], Nt is the 
total number of dogs at time t, and m the total time in dog-months of cohort 
dogs that died between times t and t+m. Follow-up data was available for 
333 dogs, 122 of which died between any two surveys after a total 2032 
dog-months. The total mortality rate was 0.329/year [95% C.I. 0.227-
0.452]; hence, the life expectancy was 3.04 years [95% C.I. 2.21-3.61, 
range between study valleys: 1.81-5.36]. A higher mortality rate was 
observed in ACL-infected dogs [0.399/year, 95% C.I. 0.301-0.497, n=47] 
than in non-infected dogs [0.298/year, 95% C.I. 0.237-0.357, n=75]; thus, 
the life expectancy of an ACL-infected dog was 2.51 years [95% C.I. 2.01-
3.32], com pared to 3.36 years [95% C.I. 2.80-4.22] for a non-infected dog. 
However, this difference was not significant [Chi-square, Yates-corrected, l 
= 2.35, p=O.13]. 
Cross-sectional data. I n Chapter 2 it was shown that 26% [262/1022] of 
sam pled dogs were infected with L. [Vianniaj, yearly village ACL prevalence 
and cumulative ACL prevalence are shown in Table 4.1. 
For com parative analyses, villages were grouped into five different valleys 
[V]: V1 [901, 902], V2 [903, 904, 905], V3 [906, 909], V4 [907, 908] and 
V5 [914-919] [Map 1]. The proportion of infected dogs was significantly 
different between valleys for the total three year study period [Chi square, 
Yates-corrected, l=20.13, df=17, p<0.001], in 1997 [X2=10.85, df=4, 
p= 0.028] and 1998 [l= 1 0.14, df= 3, p= 0.017], but not in 1999 [x2=3.25, 
df=2, p=O.2]. Though a lower proportion of infected dogs was observed in all 
study villages in 1998 com pared to 1997 or 1999, this difference was not 
significant [x2=3.57, df=2, p=0.17]. In anyone sampling year, prevalence of 
infection was highest in V4 and lowest in V3, with observed cumulative 
prevalence of infection being as high as 0.44±0.07 [proportion infected ± 
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s.e.] [1997] and 0.07±0.03 [1998], respectively. The highest observed 
canine Aa... prevalence observed during the three years of the study was in 
village 908 in 1997, where 21/38 [0.55±0.08] dogs were AQ positive. No 
ACL-infected dogs were found on two occasions only, in villages 909 [in 
1998] and 922 [in 1997] [Table 4.1. and 4.2.]. 
Using maxim um likelihood, the instantaneous incidence ["" ± s.e.] and 
recovery [p ± s.e.] rates were estim ated from the cum ulative ACL prevalence 
data, according to the diagnostic criteria used, i.e. dogs diagnosed as 
positive by PCR, ELISA or both [Table 4.1.,4.2. and Figure 4.2.]. The 
estim ated instantaneous incidence rate for 'infection' [i.e. dogs positive by 
either ELI SA or PCR, or both] ""infection was 0.28S±0.064/year and the recovery 
rate for infection Pinfection was 0.4S6±0.207/year. Best estimates of ""infection and 
pinfection varied between valleys and were as high as 0.83±0.34/year and 
0.97±0.44/year, respectively, in V4 [Table 4.2.]. 
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Table 4.1. Yearly and cumulative ACL prevalence in study villages. 
Study village 901 902 903 904 905 906 907 908 909 
1997 
Number of dogs 43 36 65 30 37 38 14 38 38 [females, males] [14,29] [10,16t [17,48] [12,17)" [12,25] [21,17] [7,7] [21, 17] [13, 25] Mean dog age 28 27 32 27 25 16 17 35 29 [months] [range] [5-84] [5-72] [3-144] [9-120] [5-60] [4-36] [4-72] [3-180] [6-144] PI [infection] 0.23 0.39 0.29 0.33 0.08 0.13 0.14 0.55 0.29 PI [peR] 0.09 0.14 0.09 0.07 0.03 0.11 0.00 0.24 0.08 PI [ELISA] 0.14 0.31 0.25 0.30 0.05 0.05 0.14 0.47 0.24 
1998 
Number of dogs 44 36 38 51 38 28 9 27 13 [females, males] [24,20] [13,22] [14,22)" [17,34] [12, 25]" [14,14] [4,5] [11, 16] [1, 12] Mean dog age 31 26 31 31 31 26 31 29 26 [months] [range] [12-96] [8-72] [12-120] [4-84] [6-120] [4-108] [5-96] [5-96] [5-72] PI [infection] 0.11 0.28 0.24 0.35 0.08 0.11 0.33 0.33 0.00 PI [peR] 0.05 0.17 0.05 0.08 0.05 0.00 0.00 0.07 0.00 
PI [ELISA] 0.07 0.17 0.18 0.29 0.05 0.11 0.33 0.26 0.00 
1999 
Number of dogs 55 48 43 62 49 
[females, males] [25,28t [21, 27] [15,28] [18,44] [20,29] 
Mean dog age 31 30 24 29 28 
[months] [range] [6-72] [6-180] [5-132] [1-96] [4-108] 
PI [infection] 0.35 0.19 0.12 0.31 0.37 
PI [peR] 0.09 0.10 0.02 0.15 0.10 
PI [ELISA] 0.33 0.13 0.09 0.27 0.33 
1997 - 1999 
Number of dogs 142 120 146 143 75 66 23 114 51 
[females, males] [63,77]" [44,66t [46,98)" [47,95)" [24,50)" [35,31] [11, 12] [52,62] [14,37] 
Mean dog age 30 29 29 29 28 20 24 31 29 
[months] [range] [5-96] [5-180] [3-144] [1-120] [5-120] [4-108] [4-96] [3-180] [5-144] 
PI [infection] :r s. e. 0.24±O.07 0.28±O.07 0.23±O.05 0.33±O.09 0.08±0.04 0.12±O.05 0.20±0.11 0.43±O.13 0.30±0.10 
PI [peR]:r s.e. 0.08±0.04 0.13±O.06 0.06±O.03 0.10±0.06 0.04±O.03 0.06±O.04 0.00 0.14±O.06 0.06±O.04 
PI [ELISA] IS.e. 0.19±O.06 0.19±O.07 0.19±O.05 0.29±O.08 0.05±0.04 0.08±O.04 0.22±O.11 0.37±O.08 0.18±O.06 
Study village 914 915 916 917 918 919 920 921 922 
1997 
Number of dogs 14 20 19 11 9 57 4 2 6 
[females, males] [4,10] [5,15] [6,13] [9,2] [8,1] [47,10] [1,3] [2,0] 
Mean dog age 30 26 39 30 46 45 69 
[months] [range] [5-108] [8-60] [6-144] [8-48] [7-180] [5-168] [36-84] 
PI [infection] 0.43 0.31 0.37 0.45 0.11 0.11 0.75 1.00 0.00 
PI [peR] 0.07 0.10 0.11 0.09 0.11 0.07 0.00 1.00 0.00 
PI [ELISA] 0.36 0.20 0.37 0.45 0.11 0.04 0.75 1.00 0.00 
NOTE. The proportion of infected dogs [PI] is tabled according which di~gnostic test ~as 
used [peR or ELISA, or both, i.e. 'infection'], see Chapter 2 for detaIls. PI, proportIon 
infected; a some dogs not sexed. 
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Table 4.2. Yearly and cumulative infection rates in study valleys. 
Study valley 
1997 
Number of dogs 
[females, males] 
Mean dog age 
[months] [range] 
PI [infection] 
PI[PCR] 
PI [ELISA] 
1998 
Number of dogs 
[females, males] 
Mean dog age 
[months] [range] 
PI [infection] 
PI [PCR] 
PI [ELISA] 
1999 
Number of dogs 
[females, males] 
Mean dog age 
[months] [range] 
PI [infection] 
PI [PCR] 
PI [ELISA] 
1997 - 1999 
Number of dogs 
[females, males] 
Mean dog age 
[months] [range] 
PI [infection]:t s.e. 
PI [PCR] :t s.e. 
PI [ELISA] :ts.e. 
A.:t s.d. 
p:ts.d. 
L [years] 
Ro 
V1 
79 
[24,45]" 
27 
[5-84] 
0.30 
0.11 
0.22 
80 
[37,43] 
29 
[8-96] 
019 
0.10 
0.11 
103 
[46,55]" 
30 
[6-180] 
0.27 
0.10 
0.23 
262 
[107,143t 
29 
[5-180] 
0.26±O.05 
0.10±O.03 
0.19±O.04 
0.35±O.12 
0.76±O.22 
5.36 
2.88 
V2 
132 
[41,90]" 
29 
[3-144] 
0.24 
0.07 
0.20 
127 
[43, 81]" 
31 
[4-120] 
0.24 
0.06 
0.19 
105 
[33,72] 
27 
[1-132] 
0.23 
0.10 
0.19 
364 
[117, 243]" 
29 
[1-144] 
0.24±0.04 
0.07±0.02 
0.19±0.03 
0.19±0.04 
0.17±0.05 
3.51 
1.67 
V3 
76 
[34,42] 
22 
[4-144] 
0.21 
0.09 
0.14 
41 
[15,26] 
26 
[4-108] 
0.07 
0.00 
0.07 
117 
[49,68] 
24 
[4-144] 
0.16±O.04 
0.06±O.03 
0.12±O.04 
0.12±O.04 
b 
1.81 
1.22 
V4 
52 
[28,24] 
30 
[3-180] 
0.44 
0.17 
0.38 
36 
[15,21] 
29 
[5-96] 
0.36 
0.06 
0.31 
49 
[20,29] 
28 
[4-108] 
0.37 
0.10 
0.33 
137 
[63,74] 
29 
[3-180] 
0.39±O.07 
0.12±O.04 
0.34±O.07 
0.84±O.34 
0.97±O.44 
1.81 
2.52 
V5 
130 
[79,51] 
38 
[5-180] 
0.24 
0.08 
0.28 
130 
[79,51] 
38 
[5-180] 
0.24±O.04 
0.08±O.02 
0.18±O.03 
b 
b 
Total 
481 
[209,255]" 
31 
3-180] 
0.27 
0.10 
0.22 
284 
[110,171]" 
29 
[4-120] 
0.21 
0.06 
0.17 
257 
[99, 156]" 
28 
[1-180] 
0.27 
0.10 
0.24 
1022 
[418, 582]" 
30 
[1-180] 
0.26±O.02 
0.09±0.01 
0.21±0.02 
0.29±O.04 
0.46±O.06 
3.04 
1.88 
NOTE. Annual incidence [A] and recovery [p] rates for 'infection' were estimated by 
maximum likelihood from cross-sectional data as described in Materials & 
Methods. The basic reproduction number Ro [1 +U A] was estimated using 
incidence rates estimated by maximum likelihood. PI, proportion infected; a 
remaining dogs were not sexed; b could not be estimated. 
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Figure 4.1. Age frequency distribution 
of the sampled dog population. 
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Prospective data. A total of 138 observations were used in the analyses: 
49 dogs were surveyed in 1997 and 1998, 33 dogs in 1998 and 1999, 16 
dogs in 1997 and 1999. Twenty dogs were sam pled at all three tim e points. 
Among the 138 observations, 11/122 [9.0%] converted from a PCR negative 
to a PCR positive result during two surveys, and 8/16 [50%] recovered from 
a PCR positive to a negative result. 20/113 [17.7%] dogs sero-converted 
du ring any two su rveys and 11/25 [44.0%] sero- recovered. Using diagnost ic 
criteria set out in Chapter 2, 23/103 [22.3%] dogs were incident 
Leishmania infect ions du ring any two su rveys, wh ilst 14/35 [40.0%] dogs 
had infections that resolved. Thus, solving equations E2 and E3 [using the 
average time between survey time points] the instantaneous rates of 
conversion and recovery for 'infection' were Ainfection = 0.291/year [95% C.I. 
0.195-0.387] and pinfection = 0.520/year [95% C.I. 0.302-0.738], respectively 
[Table 4.3.]. 
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Figure 4.2. Cumulative age-prevalence of canine ACL infection. 
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NOTE. Cumulative age-prevalence of ACL 
infection in dogs according to diagnostic 
technique: 'infection' [i.e. positive by ELISA or 
PCR, or both] [A], PCR [B], ELISA [C]. Lines 
are the best-fit to the data as estimated by 
maximum likelihood; for estimates of A and p 
see Table 3. Age-prevalence curves 
['infection'] in different survey years [0]. Using 
the incidence and recovery rates calculated 
from the prospective surveys, the cumulative 
age-prevalence was simulated [E] (591). 
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I n order to better understand the dynamics of L [Viannia] transmission in 
dogs, incidence and recovery rates were estimated in a four-compartmental 
model for different status of disease with twelve possible rates defining the 
m ovem ents between pairs of com partm ents. At any tim e point, each dog in 
the cohort can be in one of four states as they may have been either PCR 
negative or positive [PCR-/+] and either ELISA negative or positive [ELlSA-
/+] [Figure 4.2.]. As before, the parameters describing the yearly rates 
were derived using E4 and E5. Whereas no difference was observed between 
the sero-conversion rates of PCR- dogs [i.e. 0.192/year] and in PCR+ dogs 
[i.e. 0.228/year], the parasitological conversion rates of ELI SA- dogs [i.e. 
0.072/year] was half the rate in ELI SA+ dogs [i.e. 0.156/year] [Figure 
4.2.]. The serological recovery rate was higher in PCR- [i.e. 0.642/year] 
than in PCR+ [i.e. 0.384/year] dogs. Sim ilarly, the parasitological recovery 
rate was much higher in ELlSA- [i.e. 1.032/year] than ELlSA+ [i.e. 
0.168/year] dogs. The odds of susceptible [i.e. PCR- ELlSA-] dogs becom ing 
serologically positive was significantly higher than the odds of dogs becoming 
parasitologically positive [OR 3.34, 95% C.I. 1.08-11.02, Yates-corrected, 
:l=4.49, p=0.034], or becoming both serologically and parasitologically 
positive [OR 5.68, 95% C.I. 1.48-25.60, Yates-corrected, '"l=7.37, 
p= 0.007]. Using differential equations derived from the incidence and 
recovery rates in the com partm ental model, the change in the proportion of 
dogs in each of the four states can be sim ulated over very short tim e 
intervals, as at tim e 0, all dogs will be susceptible to infection [PCR- ELlSA-] 
[Figure 4.3.E.]. The simulations show that dog age prevalence and 
sim ulations from the prospective data are rem arkably consistent with the 
rates that were calculated from the cross-sectional data using maxim um 
likelihood [Figure 4.3.A- 4.3.C],. 
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Table 4.3. Epidemiology of L. [Viannia] in dogs: incidence and recovery rates 
estimated from cross-sectional and prospective surveys. 
'Infection,a peR ELISA 
Incidence [/.. ± s.e.] 
Cross-sectional data O.285±O.O64 O.147±O.OO8 O.180±O.O41 
Prospective data O.291±O.O49 O.113±O.O28 O.227±O.O41 
Recovery [p ± s.e.] 
Cross-sectional data O.456±O.207 1.237±1.018 O.288±O.176 
Prospective data O.520±O.111 O.630±-O.181 O.565±O.137 
NOTE. Incidence and recovery rates using cross-sectional data were calculated as described in 
Materials & Methods. a dogs positive by either PCR or ELISA, or both. 
Figure 4.3. Compartmental model of L. [Viannia] transmission in dogs. 
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The basic reproduction number [Rol. The basic reproduction num ber R 
can be estimated, as: 
[E6] L Ra = 1+-
A 
o 
where L is the life expectancy of a dog [3.04 years, 95% C.I. 2.21-3.61] and 
A is the average time for a dog to acquire infection which can be estimated 
from the reciprocal of the force of infection [Le. 1/Ainfection] (440). Using cross-
sectional and prospective data [Table 4.3.] A is estimated to be 3.51 [95% 
C.I. 2.44-6.25] and 3.44 years [95% C.I. 2.58-5.13], respectively. Hence, Ro 
is estimated to be 1.87 and 1.88, respectively. 
4.4. Discussion. 
Epizoology of L. [Viannia] in dogs. This is the first large-scale study to 
describe the epidem iology of ACL in dogs. Considering the extensive 
literature suggesting the incrimination of domestic dogs as ACL reservoir 
hosts, it is surprising that data on the clinical, parasitological and 
im m unological course of L. [Viannia] infection in dogs are scarce. Using both 
cross-sectional and prospective data the ACL incidence and recovery rates in 
the dog population surveyed in Huanuco was estimated. Although there was 
a slight difference in age-prevalence curves observed between years [Figure 
4.2.0.], both cross-sectional and prospective analyses gave similar results 
with incidence and recovery rates estimated to be ;::::0.3/year and ;::::0.5/year, 
respectively [see also Figures 4.2.A. and 4.2.E.]. The reason why estimates 
from cross-sectional and prospective data were slightly different is because 
ACL transm ission is likely to be heterogeneous (582), as shown by the 
different prevalence of infection and incidence rates between study villages, 
valleys and years. This is not surprising because ACL transm ission in 
Huanuco is seasonal, with a peak transm ission season between May and 
August after the yearly rainy season [January-April]. This also may explain 
the som ewhat lower prevalence of infection in 1998, a year of exceptionally 
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low rainfalls [Canales, personal communication]. Other factors that will affect 
L. [VianniaJ transmission rates between villages or valleys are temperature 
and altitude, factors that will influence sandfly vector ecology and, hence, 
vectorial capacity [see also Chapter 5]. 
One major caveat of this study is that currently no diagnostic test exists that 
is able to different iate between L. peruviana and L. braziliensis infect ions , 
both of which are endemic in Huanuco. Of note are the high recovery rates 
[as estimated by both cross-sectional and prospective data] observed in this 
study. A possible explanation for this is that dogs readily develop a cell-
mediated Th1 immune response against L. [Viannia] parasites controlling 
infection [i.e. parasite numbers in the blood drop below the level detectable 
by PCR]. This hypothesis appears to be confirmed, as PCR+ELlSA+ dogs 
sero- recover [i.e. they becom e ELI SA-] at a higher rate than they cure 
parasitologically [i. e. becom ing PCR-] [Fig u re 4.2.]. The high rates of sero-
and parasitological recovery could also be explained if a proportion of 
infections is due to L. peruviana. L. peruviana is known to be very 
pathogenic, i.e. the parasites easily infect dogs, but - unlike L. braziliensis-
infections self-cure and do not cause clinical disease (147, 322). Both cross-
sectional and prospective surveys indicate that L. [Viannia] parasites 
infecting dogs in Huanuco are pathogenic, but not very virulent indicating 
that many infections may have been caused by L. peruviana. The cross-
sectional surveys showed that 3.8% [see Chapter 2] of dogs had clinical 
disease and only one of the dogs with incident infections [i.e. 4.3%] was 
clinically positive. Unfortunately, parasite isolates were not made in this 
study, but a previous study had shown that most of the Leishmania dog 
isolates in the study villages are L. braziliensislL. peruviana hybrids (400). It 
has to be noted that the course of L. braziliensislL. peruviana hybrids in 
either natural hosts or experim ental laboratory anim als is unknown. 
Interest ingly, the highest observed sero- recovery rate [1. 032/year] was in 
those dogs that appeared to have low levels of parasites in their blood [i.e. 
PCR- ELI SA+ dogs]. This again indicates that dogs are able to clear 
Leishmania infections readily [as otherwise a sustained antibody response 
would be observed], underlining the avirulence of Leishmania parasites 
infecting dogs in Huanuco. 
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The observed high recovery rates are in stark contrast to recovery rates 
[:::::0.1 ~O/year] observed in humans living in L. peruviana-endemic areas 
(147), where infections tend to result in life-long im m unity to the parasite. 
This life-long im m unity may be sustained by continuous antigen presentation 
due to persistent parasites (245, 446, 498, 499). The observed recovery 
rates are also in contrast with those observed in L. infantum-endem ic areas , 
where most infections in dogs appear to be life-long with no detectable 
recovery (126, 440). Nevertheless, the recovery rates that were detected in 
L. [VianniaJ- infected dogs mean that infection persists [i.e. 1/p = 2 years] for 
almost the average life-time of an ACL-infected dog [2.5 years]. Thus, should 
a dog become infected at an early age, it will remain infected until death, 
and, hence, potentially infectious to the sandfly vector. 
Implications for ACL control. The reason why canine ACL transm ission 
dynamics at the dog population level are of interest is because it allows the 
quantification [in terms of Ro] of the putative reservoir role of domestic dogs. 
In epidem iological term s, a prim ary reservoir of a zoonosis can be defined as 
a host that is able to maintain the endem ic transm ission of the pathogen in 
the absence of any other host species, i.e. maintain Ro above 1 (24). 
Secondary reservoirs are those host species whose presence significantly 
increases Ro, but who are unable to maintain Ro above 1 in the absence of 
other host species. I n contrast, accidental reservoir hosts play no role in the 
transmission cycle and their presence has no impact on Ro. Hence, were dogs 
primary ACL reservoir hosts, it would be feasible to eradicate domestic 
transm ission by targeting dogs; but if dogs are secondary reservoir hosts, 
targeting dogs would only reduce [i.e. control] ACL. Of course, any dog 
control strategy would be ineffective were dogs accidental hosts of ACL. 
If infected dogs are significantly infectious to sandflies and do playa role in 
the maintenance of L. [Vianniaj transm ission in Hucinuco, they contribute an 
Ro of approximately 1.9 [range between valleys: 1.3-2.5]. This estimate 
com pares well with the Ro for canine ZVL which have been estim ated to be 
1.1, 1.5, 5.9, 11 in Spain (23), Italy (587), Brazil (440) and Malta (177), 
respectively. Future analysis of hum an ACL data will have to determ ine to 
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what extent canine transmission rates contribute to overall Aa.... transmission 
in Huanuco. RJ is probably the best indicator of the disease control problem. 
Because Ro::::1.9 is calculated from the mean incidence, the mean yearly effort 
[Le. coverage] of a dog control intervention [e.g. vaccination, culling or 
application of dog collars] to ensu re the elim ination of L. [Vianniaj spp. 
transmission [Le. to reduce Ro<1] can be estimated: 100[1-1/Ro]=470/o. 
One has to note that Ro does not measure the maximum seasonal potential 
for an outbreak, nor can that quantity be obtained from seasonal or yearly 
incidence rates. Thus, one cannot establish from these data how to prevent a 
dog population to have epidem ic outbreaks of L. [Vianniaj infection. 
Moreover, the Ro that was calculated here did not account for heterogeneous 
L. [Vianniaj transm ission by sandfly vectors, although entom ological and 
epidem iological studies indicate that this is the case in Huanuco; sim ilarly 
different canine ACL prevalence was observed in study villages [Table 4.2.]. 
When including heterogeneity in the distribution of sandfly vectors and hosts 
across endemic areas and using mathematical modelling, it has been shown 
that the Ro may be in fact 2-4 tim es higher than the Ro calculated on the 
assum ption of hom ogeneous transmission (582). Modelling theory predicts 
that 20% of all hosts will account for 80% of the total transm ission [L e. the 
so-called '20/80 rule'], a hypothesis that has recently been confirmed by a 
field study (125) showing that 20% of L. infantum-infected dogs account for 
80% of the transmission to sandfly vectors. Clearly, this has implications for 
a dog control strategy, as in the case of Huanuco Ro could be as high as 7.6 
and, thus, the control effort to eliminate transmission in Huanuco could be as 
high as 87%. The same principle could apply to ACL infections in dogs in 
Huanuco. The life expectancy of dogs in Huanuco was 3.04 years and the 
average tim e for a dog to acquire an infection was 3.4 years. As seen in 
Table 4.2. these figures vary between valleys, but generally appear to 
indicate that most dogs will not becom e infected during their lives. This in 
turn means that those dogs that will become infected will account for most L. 
[Viannia] transm ission to dogs [and hum ans]. I n order to account for 
heterogeneous transm ission in the analyses, correlates of infectiousness will 
have to be known and a diagnostic test detecting highly infectious dogs will 
have to be available, neither of which is the case for either ZVL or ACL. 
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Conclusion. The results presented here show that if dogs are the main ACL 
reservoir host, a dog control strategy in the study villages in Huanuco would 
be very feasible, because the control effort to reduce Ro< 1 would be 
com paratively sm all. Such an intervention should also provide the ultim ate 
proof in the incrim ination of dogs as ACL reservoir hosts, as -if such an 
intervention strategy were successful- it should have a significant 
epidemiologial impact on human ACL transmission. 
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CHAPTER 5: 
Domestic dog ownership: a risk factor for human infection 
with Leishmania [Viannia] spp. 
Abstract 
An epidemiological study has shown that cumulative, village 
prevalence of L. [Viannia] infection in dogs ranges from 8% to 
45% in Huanuco, Peru. Using data from a prospective survey of 
human AQ, it was shown that the risk of human AQ did not 
significantly increase with dog abundance, neither in absolute 
terms [p= 0.659] nor in relation to dog: human ratios [p= 0.213]. 
A significant positive association was observed for risk of human 
ACL and village dog ACL prevalence [p=0.022]. When controlled 
for village dog AQ prevalence, there also was an association 
between the average number of dogs per household and risk of 
AQ [p=0.033]. The results suggest that dogs playa role in the 
[peri-]domestic transmission of L. [Viannia] to humans in 
Huanuco and indicate that a control intervention targeting dogs 
to control human ACL is warranted. 
Richard Reithinger, Juan Canales Espinoza, Alejandro Uanos-
OJentas and Oive R. Davies. Domestic dog ownership: a risk 
factor for human infection with Leishmania [Viannia] spp. Trans. 
R. Soc. Trop. Med. Hyg. 97,141-145. 
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5.1. Introduction. 
As discussed in the General I ntroduction and Chapters 2-4, there is 
growing evidence that domestic dogs are not only reservoir hosts of zoonotic 
visceral leishmaniasis [ZVL] but of ACL as well, because [i] high ACL infection 
rates in dogs are found in ACL endem ic areas across Latin Am erica; [ii] 
Leishmania [Vianniaj strains isolated sympatrically from dogs and humans 
are indistinguishable; and [iii] there is som e reported coincidence between 
households with ACL patients and the presence of infected dogs. However, 
these observations alone are not criteria to incrim inate dogs as ACL reservoir 
hosts, but are merely evidence that hum ans and dogs are likely to be 
exposed in the same way to the sandfly vector. 
Xenodiagnosis studies are the 'golden standard' for reservoir host 
incrim inat ion, but are notoriously cum bersom e to carry out due to the 
requirements of a constant supply of colonised sandflies (125). Only two 
small xenodiagnosis studies have been carried out for L. [Vianniaj-infected 
dogs. I n the first study it was shown that Lu. whitmani becam e infected 
when made to feed on the lesions of 3/9 L. braziliensis-infected dogs, with a 
mean infect ion rate on the three infectious dogs of 2.7% [5/186; range: 1.8-
8.30/0] (557). I n the second study, Lu. m igonei was fed on the lesion of four 
L. braziliensis-infected dogs, with all dogs being infectious for up to two 
months after the appearance of the lesions. Infectiousness was also shown to 
change with tim e, with dogs infectious to 36%, 13%, 14%, 0% and 0% of 
total flies fed on dogs 11, 41, 56, 71 and 86 days after appearance of lesion 
(69). No generalisations can be extrapolated from those results due to the 
low num ber of replicates, and because sandflies were fed artificially on 
lesions. I ndeed, the L. braziliensis infection rate reported for sandflies fed on 
dog lesions is not higher than that reported on humans: 10.4% [10/96] for 
Lu. youngi fed directly on the lesions of eight human patients, all of whom 
were infectious (466). Lu. youngi have also been infected when fed on 3/6 
[asym ptom atic] opossum s, 40-60 days post- inoculation with L. braziliensis, 
with a mean infection rate on the three infectious hosts of 7.3% [4/55] 
(502). 
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These infection rates can be compared with those on ZVL-infected dogs: for 
example, 13/16 naturally L. infantum-infected, seropositive dogs were 
infectious to A1/ebotomus perniciosus fed on the head, with a mean infection 
rate of 37% [149/404] (376). 8t udies on dogs either natu rally or 
experim entally infected with L. infantum have shown that [i] asym ptom atic 
dogs can be infectious to sandflies (22, 125, 238, 376, 558); [ii] dogs 
becom e infectious to sandflies after a median period of about 209 days 
(125); [iii] infectiousness may be associated with high antibody titres (22, 
125) and the num ber of Iym phoid T helper [CD4+] cells (239); and [iv] the 
infectiousness of dogs that have serologically recovered and/or clinically 
healed after treatm ent tends to drop tem porarily until the dogs relapse (22, 
224). Whether any of these features are true for ACL is unknown. 
One of the criteria for incrim inating dogs as ACL reservoir hosts should com e 
from studies demonstrating that either dog abundance or dog ownership are 
risk factors for ACL in hum ans. The epidem iological evidence to date is 
inconsistent. From four case-control studies in areas of domestic ACL 
transm ission, a positive association between dog ownership and human ACL 
was identified in two studies [with odds rat ios [OR] of 2.9 [95% C.I. 1.4-6.1] 
and 2.9 [1.0-8.1] in Argentina (186) and Costa Rica (467), respectively], but 
no association [and a negative trend] was detected in two other studies in 
Argentina [OR=0.50 [0.2-1.6]] (585) and Peru [OR=0.77 [0.5 - 1.2]] (321). 
Furthermore, using multivariate regression analysis, a cohort study of ACL 
incidence in Peru identified a slight negative association between village dog 
abundance and ACL incidence in humans after controlling for inter-village 
variation in sandfly vector abundance (146). 
The objectives of the analyses presented here were to determine whether 
either village dog abundance, the dog: human ratio or dog ownership could 
explain the variation in the cumulative ACL prevalence amongst the human 
population within and between villages of the Department of Huanuco, Peru. 
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5.2. Materials and Methods. 
Human data set and project description. Data on human demography 
and cum ulative ACL prevalence were obtained from an epidem iological study 
carried out by LSHTM and UPCH in 14 of the 18 study villages of Huanuco 
included in the canine survey [Davies and Llanos-Cuentas, unpublished, see 
also Map 1 in Chapter 2], and will be briefly outlined below. In 1994 
[villages 901 to 909] and 1996 [villages 914 to 918] the houses of each 
study village were surveyed and mapped. The houses were given a unique 
code number and demographic as well as clinical information was collected 
on each household member by questioning (143). All villages were visited at 
3- mont h intervals between 1994 [villages 901- 909] or 1996 [villages 914-
918] and 1998 to record changes in demographic and clinical data. MST were 
applied at yearly intervals to a subset of individuals between 1996 and 1998 
to record im m unological and parasitological changes in Leishmania infection 
status; these data were included in all risk analyses [see below]. The MST 
antigen was prepared according to standard procedure using L. peruviana 
[MHOMI PE8S1 LPOS2] prom atigotes (143); the MST response was read 48-
96hrs post-inoculation with an induration size > Smm being regarded as 
positive. 
Dog data set. When collecting human data during the base-line household 
surveys in 1994 [villages 901-909] and 1996 [villages 914-919], data were 
also collected on the household num ber of dogs from which the total 
num bers of dogs in a village and the village dog: hum an ratio was calculated 
[for reasons of convenience these dog data are referred to as 1994* data]. 
Data on 1997 to 1999 [i. e. 1997*] ACL infect ion in dogs and total household 
num ber of dogs were obtained from surveys carried out as previously 
described, with a positive dog being defined as a dog that was either positive 
by PCR or ELISA, or both [see Chapters 2 and 4]. However, because the 
1997* dog surveys were not carried out by house-to-house surveys, only 
households with dogs were included in the analyses using 1997* data; 
households from wh ich no dogs were sam pled had to be excluded from the 
analyses. 
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Data Analysis. Human An... infection was defined as at least one positive 
MST response during any of the surveys between 1996 and 1998. The 
epidem iological im pact of dogs was tested at two spatial levels, at the village 
and at the household level [i.e. after controlling for inter-village variation in 
ACL transm ission]. Both analyses were carried out by logistic regression in 
STATA 7, i.e. assuming binomial errors in the outcome proportion 
[individuals MST positive]. I n the village analyses the effect of the following 
variables was tested: [i) the num ber of dogs per house in 1994*; [ii] the 
rat io of dogs to hum ans in 1994*; [iii] the proport ion of households with a 
dog in 1994*; and [iv] the total village population of dogs in 1994*. These 
variables were tested both in univariate analyses and in com bination with an 
additional parameter, dog prevalence [based on 1997* surveys]. I nail 
models over-dispersion was controlled with Pearson's ,./. I n the household 
analyses, the effect of [i) presence of a dog in the house in 1994*; and [ii] 
the number of dogs in the house in 1994* was tested. These variables were 
included in models which were clustered by households and controlled for 
gender and age [grouped into four age classes: 1, ~4 years of age [yrs]; 2, 
~5 yrs; 3, ~6 yrs; 4, ~7 yrs; these groups were chosen as the proportion 
infected levels out at about 30% after 7yrs of age; Davies & Llanos-Cuentas, 
unpub/ishedJ, and inter-village variability in transmission rates [Le. clustering 
villages as categories]. I n addition, we tested the effect of the num ber of 
infected dogs in a household - but only for those households where dogs 
were sam pled in 1997*. For com pleteness, all analyses that were carried out 
are included in the Appendix of the chapter, with only the most significant 
findings being reported below. 
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5.3. Results. 
Between 1996 and 1998, 1916 people were tested by MST for ACL infection, 
437 of which tested positive at least once [Table 5.1.]. The mean village dog 
population size in 1994* was 57 dogs [range: 18-125], the mean village 
dog:human ratio was 0.34 [0.13-0.53], and 64% [326/510] surveyed 
houses owned a dog. Of surveyed dogs included in the analyses, 26% 
[251/953] were shown to have an ACL infection during 1997 to 1999 [Table 
5.1.] . 
Effect of village dog population size, dog ownership patterns, and 
dog ACL prevalence on inter-village differences in risk of ACL. The risk 
of ACL was not associated with either [i] dog populations in 1994* 
[OR=1.00, 95% C.I. 0.99-1.02, z=0.44, p=0.659]; [ii] dog:human ratios 
[OR=1.03, 95% C.I. 0.98-1.07, z=1.24, p=0.213]; or [iii] proportion of 
households owning a dog [OR=1.00, 95% C.I. 0.97-1.04, z=0.28, p=0.783]. 
A significant positive association was observed for risk of human ACL and 
village dog ACL prevalence [OR=1.04, 95% C.I. 1.01-1.08, z=2.28, 
p= 0.022], i.e. with every 10% increase in ACL canine village prevalence, 
there was a 4 % increase in human ACL prevalence. Controlling dog 
population size and dog ownership patterns for village dog prevalence 
param eters did not change the association between these param eters and 
risk of human ACL. Although there was no association between the average 
number of dogs per household and risk of ACL [OR= 1.51, 95% C.I. 0.68-
3.36, z=1.01, p=0.315], the association became significant when controlled 
for village dog ACL prevalence [OR=1.90, 95% C.I. 1.05-3.44, z=2.13, 
p= 0.033], i.e. with every additional unitary increase in the average number 
of dogs per household in a village there was a 90% [5-344%] [1994*] 
increase in the odds of a village inhabitant having a positive MST. 
Association between household variation in dog ow nership patterns 
and infection rates in dogs and humans at the household level after 
controlling for variability in village ACL transm ission rates. After 
controlling for inter-village variability in ACL transm ission rates, the risk of 
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An... was significantly greater in households owning at least one dog in 1994* 
as compared to households without a dog [OR 1.36, 95% C.I. 1.17-1.57, 
Z= 4.13, p< 0.001]. When treated as a continuous explanatory variable, the 
num ber of dogs per household was also significantly associated with risk of 
human disease in 1994* [OR 1.07,95% C.I. 1.02-1.12, z=2.75, p=0.006]. 
Thus in 1994*, within each village, with every additional dog per household 
there was a 7% [2-12%] increase in the odds of a household member having 
a positive MST response. There was no greater risk of ACL when households 
owned at least one [as com pared to none] [OR 0.87, 95% 0.56-1.35, z=-
0.64, p= 0.525] or two infected dogs [as com pared to one or less] [OR 1.23, 
95% C.1.0.70-2.16, z=0.71, p=0.475]. Neither was the number of infected 
dogs per household in a village associated with higher risk of human disease 
when used as a continuous explanatory variable [OR 0.94, 95% C.1. 0.75-
1.18, z=-O.52, p=O.606]. 
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Table 5.1. Human ?nd cani~e ~arameters of ACL in study villages 
used In the logistic regression analyses. 
Vii/age ACL prevalence No. dogs ACL prevalence 
[proportion MST 1994* Dog: dogs 1997-1999 
positiveJ human 
Ratioa 
Coz [908] 0.56 [68/121] 37 0.26 0.43 [49/114] 
Chinobamba [904] 0.46 [90/196] 122 0.53 0.33 [47/143] 
Chullay [907] 0.34 [33/98] 45 0.25 0.22 [5/23] 
Limapampa [906] 0.27 [28/103] 56 0.34 0.12 [8/66] 
Virroy [914] 0.27 [31/113] 18 0.13 0.43 [6/14] 
Conchumayo [902] 0.23 [39/170] 66 0.32 0.28 [33/120] 
Quechualoma [903] 0.21 [63/305] 125 0.26 0.23 [33/146] 
Parcoy [916] 0.18 [15/82] 19 0.20 0.37 [7/19] 
Atahuayon [917] 0.14 [13/89] 37 0.36 0.45 [5/11] 
Pomacucho [901] 0.12 [25/208] 69 0.24 0.24 [34/142] 
Cochachinche [915] 0.12 [11/91] 32 0.31 0.30 [6/20] 
Huancapallac [909] 0.11 [9/83] 54 0.24 0.22 [11/51] 
Vilcabamba [905] 0.06 [11/170] 89 0.31 0.08 [6n5] 
Mauca [918] 0.01 [1/86] 28 0.32 0.11 [1/9] 
Total 0.23 [43711916J 797 0.29 0.26 [2511953J 
NOTE. Human ACL prevalence was defined as described in Materials & Methods, i.e. as a 
positive Montenegro skin test [MST] response in at least one of the three follow-up surveys 
during 1996 to 1998. ACL prevalence in dogs was established as described in Chapters 2-
4. a based on 1994* dog data. 
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Table 5.2. Dog ownership patterns: number of dogs owned per 
household in 1994*and proportion MST positive. 
Household 
number of dogs 
0 
1 
2 
3 
4 
5 
6 
7 
Total 
Number of 
households 
184 
152 
106 
48 
16 
3 
1 
510 
ACL prevalence [proportion 
MST positive r S.E.J 
0.19 ± 0.02 [117/601] 
0.21 ± 0.02 [122/572] 
0.29 ± 0.02 [120/412] 
0.20 ± 0.03 [46/230] 
0.32 ± 0.05 [24/76] 
0.32 ± 0.11 [6/19] 
0.33 ± 0.19 [2/6] 
0.23rO.01 [43711916J 
Table 5.3. Dog ownership patterns: number of infected dogs owned per 
household [1997-1999] and proportion MST positive. 
Household number of Number of ACL prevalence [proportion 
infected dogs households MST positive r S.E.J 
0 407 0.21 ±0.01 [311/1471] 
1 75 0.23 ± 0.02 [73/319] 
2 19 0.44 ± 0.05 [39/81 ] 
3 4 0.59 ± 0.12 [10/17] 
4 3 0.23 ± 0.12 [3/13] 
5 2 0.13±0.12 [2/8] 
Total 510 0.23± 0.01 [43711916J 
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Figure 5.1. Changes in household number of dogs 
between 1994* and 1997 [n=174]. 
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Figure 5.2. The risk of human ACL due to dog 
abundance, ownership patterns and canine ACL infection. 
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NOTE. The relationship between cumulative MST prevalence and [a] the total number of dogs in 
the same study villages; [b] the ratio of dogs to humans in the same study villages; and [c] the 
cumulative ACL prevalence in dogs in the same study villages. 
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5.4. Discussion. 
Dog abundance, dog ownership patterns and dog prevalence and the 
risk of hum an ACL. To date case-control studies have been inconsistent in 
showing an association between dog ownership and risk of hum an disease. 
The reason why despite numerous studies on ACL infection rates in dogs 
such inform ation is scarce is because reliable data sets on canine and hum an 
data are rarely available for analysis [Part 1: Introduction]. Also, 
com parative data sets on infection rates of other potential [sylvatic] ACL 
reservoir hosts do not exist. This is the first study to demonstrate the 
epidem iological significance of geographical variability in dog population size 
[in relation to dog ownership patterns] as a risk for hum an ACL - a key 
prediction of the hypothesis that domestic dogs are reservoir hosts of ACL. At 
both the village [when controlled for dog ACL prevalence] and household 
level [when controlled for inter-village ACL transm ission] we show that the 
risk of human ACL increases with the number of dogs per household. 
Because the human and one of the dog data sets were from different years, 
cumulative ACL prevalence between 1996 and 1998 [as opposed to 1994 to 
1998] was chosen as an outcom e variable in an attem pt to link all three data 
sets. There are potentially a number of caveats in our analyses. First, dog 
ownership in itself could be a confounder, as dogs and humans could share a 
common ACL risk factor. However, to our knowledge, no behavioural 
difference between people owning or not owning dogs can be observed in 
Huanuco [e.g. dog owners might be m ore inclined to go hunting and thereby 
be at higher risk of ACL infection]. Second, we used cumulative MST 
positivity in all analyses. This was done in order to increase the sample size 
of the human data set and hence the power of the analyses; once infected, 
individuals remain MST positive for a long time due to the very low recovery 
rates (143). Third, ownership of infected dogs in 1997* was biased towards 
those households where owners were willing to have dogs sampled for ACL 
diagnosis. Although the human and dog data sets did not overlap completely 
[due to the tim ing of the different surveys], dog ownership did not vary 
dramatically over time as no change in dog number was recorded in 33% of 
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the households with dogs in 1994* and 1997. A change in one, two, three of 
four dogs between 1994 and 1997 was seen in 47%, 15%, 3% and 2% of 
households, respectively [Figure 5.1.]. Fourth, the number of regression 
analyses that were carried out will have increased the odds of finding a 
significant association between risk of human ACL and at least one of the dog 
variables. Nevertheless, bearing these caveats in mind, our analyses 
consistently show that village dog ownership patterns [in absolute terms] are 
associated with risk of human ACL both at the village [when controlled for 
ACL dog prevalence] and at the household level. The reason why no 
associations were found between dog abundance or dog: human ratio and 
increased risk of human ACL is probably due to other variables associated 
with ACL transm ission, e.g. altitude, hum idity and tem perature, factors that 
are known to influence sandfly ecology and, hence, transmission 
heterogeneity (146). Above findings can be com pared to observations made 
recently in a L. infantum endem ic area in I ran, where it was shown that child 
seropositivity increased significantly with village dog abundance [OR 1.01, 
95% C.I. 1.01-1.02] as well as with greater dog:human ratios [OR 10.9, 
95% C.1. 1.3-92] (211). 
Alternative domestic reservoir hosts of ACL. Considering that previous 
studies in Peru have shown relatively low L. [Vianniaj infection rates in 
sylvatic animal hosts [e.g. Didelphis albiventris and Phyllotis andinum] as 
com pared to dogs (322), the findings presented here suggest that the 
importance of sylvatic animals in the domestic transm ission cycle of ACL in 
Huanuco is probably negligible. So far the only domestic animals other than 
dogs to have been reported to be associated with a higher risk of ACL are: 
pigs in Argentina [OR 6.91, 95% C.I. 1.47-36.67] (520) and Costa Rica [OR 
2.1, 95% C.I. 1.1-4.3] (467). I n contrast, chicken [OR 1.43, 95% C.1. 0.94-
2.19], sheep [OR 1.51, 95% C.1. 0.94-2.42], goats [OR 1.20, 95% C.1. 0.73-
1.96] and cows [OR 1.79, 95% C.I. 0.90-3.55] were not associated with a 
greater risk of ACL (321). These results, however, are not sufficient enough 
to incrim inate pigs as ACL reservoir hosts, especially as no L. [Vianniaj 
infections in pigs have been reported in the literature. The association with 
human ACL risk is likely to stem from the effect that pigs might have on 
sandfly abundance and distribution in the peridomestic environment. 
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Ultimately, the relative importance of dogs in the L. [Viannia] t ransm ission 
cycle will depend on [i] the relative biting rates of sandfly vectors on different 
hosts including dogs; [ii] the susceptibility of dogs to Leishmania infection; 
and [iii] the infect iousness of infected dogs to sandfly vectors [Pa rt 1: 
Introduction]. As outlined previously, data describing either the sandfly 
biting rate or the infectiousness to sandfly vectors is scarce and is ham pered 
by a number of confounding variables [e.g. methods of sandfly collection to 
measure biting rates, exposure of sandlfies to either healthy skin or active 
lesion in xenodiagnosis experim ents] . Data com paring the relat ive 
susceptibility of dogs, humans or other reservoir hosts to L. [Viannia] 
infection does no exist. However, assum ing that there is no difference in [i] 
host susceptibility and [ii] sandfly host preference, the ratio of bites a sandfly 
takes on a dog and a human can be estimated by multiplying the ratio of dog 
and hum an incidence rates by the ratio of their respective population 
densities. As seen in Chapter 4, the incidence of ACL in dogs in Huanuco 
was estimated to be - O.290/year. The human ACL incidence in Huanuco is 
- O.029/year [Davies & Llanos-Cuentas, unpublished] and the dog:human 
ratio is 1:3.4 [Table 5.1]; hence, the estimated dog:human sandfly biting 
ratio is 2.8:1. 
Conclusion. Direct incrim inatory evidence that dogs are ACL reservoir host 
would come from a dog control trial, similar as the ones carried out for AVL 
(32, 171, 210). Were dogs reservoirs of ACL, dog control programmes should 
be effective in reducing not only canine incidence but human incidence as 
well. However, so far there is no evidence that targeting dogs with ACL is 
effective. Only one controlled intervention trial has been carried out to 
measure the epidemiological impact of dog control [treatment of infected 
dogs with 20mg/kg Glucantime vs no dogs treated] on human ACL. Although 
the reduction in human ACL prevalence was larger in the treatment area 
[from 24% to 4%] than in the control area [from 29% to 12%], the 
difference was not significant (504). The results presented here indicate that 
dog ownership and dog infection rates are associated with an increased risk 
of human disease in Huanuco, and appear to suggest that -at least in 
Huanuco- a controlled dog intervention trial could have a significant 
epidemiological impact on human disease [Chapter 4]. 
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Introduction 
As outlined in Chapter 1, L. infantum is the etiological agent of ZVL. L. 
infantum has been isolated from a range of mammalian hosts [e.g. D. 
albiventris and D. marsupialis, R. rattus, Acomys capirinus] , and can ids [e.g. 
Vulpes vulpes, V. pa llida , Cerdocyon thous] and domestic dogs, in particular, 
have been incrim inated as [peri-] dom est ic ZVL reservoir hosts. This 
incrim ination is based on the following observations. First, dogs are highly 
susceptible to L. infantum infection with high infection rates observed in dogs 
throughout the L. infantum endem ic range (220). Second, the distribution of 
canine and human ZVL overlap considerably, and identical L. infantum 
zym odem es have been isolated from dogs, m an and sandfly vectors (168, 
220, 285, 289). Third, both asymptomatic and symptomatic L. infantum-
infected dogs have been shown to be infectious to sandfly vectors (22, 125, 
224, 238, 239, 376, 540). Fourth, the risk of human ZVL infection has been 
shown to be significantly associated with dog ownership and abundance 
(211 ). 
Similar to the disease in humans [Chapter 1], canine visceral leishmaniasis 
tends to be a systemic disease with a broad spectrum of clinical signs such as 
skin ulcers, Iym phadenopathy, hepatoslpenom egaly, em aciation, 
conj unctivitis, onychogryphosis, epistaxis and alopecia (115, 201, 290, 513). 
In som e cases, additional signs may include polyarthtritis, throm bosis and 
intestinal bleeding. ZVL in dogs is also associated with a number of 
biochem ical changes in urine and serum, including proteinuria, 
hypergammaglobulemia, decreased packed cell volume and increased blood 
urea nitrogen (115, 201, 290, 353, 513). 
As for ZVL in murine experimental models, resistance to infection is 
associated with a Th1-type CD4+ T cell response with high levels of INFy, IL2 
and TNFa. Susceptibility of infection and progression of disease is associated 
with a Th2 response. As the im m une response to L. infantum in dogs is cell-
mediated, no serological markers to distinguish susceptible and resistant 
dogs exist. I ndeed, whereas som e authors have shown that different I gG 
110 
subclasses appear to be associated with either acute or chronic infections 
(108, 397, 441), others failed to observe such association (311 , 427, 428). 
Dog control. 
Thus, because domestic dogs are reservoir hosts of L. infantum, one of the 
approaches to reduce the Leishmania infection rates in sandfly vectors and to 
control human ZVL is by targeting dogs either through culling, treatment or 
vaccination. 
Dog cu lIing. The im pact of dog culling program m es on canine and hum an 
ZVL incidence has been doubted on both theoretical (176, 532) and practical 
(85, 188, 416, 508) grounds. In particular, despite culling an average 20 000 
out of 850 000 screened dogs per year since 1989, human ZVL incidence has 
increased steadily during the same period in Brazil (560). There are several 
problems associated with the culling strategy. First, a significant proportion 
of infected [and infectious] dogs are not culled, because the diagnostic tests 
used to screen dogs [e.g. I FAT or ELISA] are not 100% sensitive [e.g. the 
sensitivity of serology to detect infectious dogs after patency is 63-69%, 
(440)], and because of non-com pliance by dog owners [e.g. up to 13% of 
seropositive dogs are not culled as owners hide their dogs from culling 
personnel, (508)]. Second, positive dogs are detected many weeks after they 
have been infected due to the infrequency of surveys and because the time-
span between surveying, diagnosing and culling dogs is large [up to 120 
days] (85,188,416). Third, culled dogs are rapidly replaced with susceptible 
animals through birth and immigration (32, 85, 171, 188, 416). 
Results of two controlled intervention trials in Brazil are equivocal (32, 171). 
Thus, although temporary reductions in dog seroconversion rates [from 36% 
to 6% over the first two years] were observed when culling seropositive dogs 
at yearly intervals, no change in the cum u lative incidence of canine ZVL 
could be shown after five years (32). There was also an observed 25% 
reduction in the num ber of hum an ZVL cases incidence; however, this 
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reduction was not significant showing that ZVL transmission was not fully 
interrupted. The authors argued that this was likely to be due to the high 
immigration rates of dogs into the intervention area, which meant that only 
42-73% of the seropositive dog population was elim inated in any 
intervention year. Sim ilarly, a study by Dietze and colleagues (171) 
demonstrated that a blanket cull of the seropositive dogs at two 6-monthly 
intervals did not significantly reduce the ZVL seroconversion rate in either 
dogs [36% to 14% seronconversion rate in the intervention rate compared to 
52% to 11 % in the control area] or humans [33% to 54% and 36% to 54% 
in intervention and control areas, respectively]. 
Where there is som e anecdotal evidence that dog culling reduces canine 
and/or human ZVL incidence [e.g. China (234, 235, 312), Brazil (149, 336, 
402, 415) and Italy (223)], it is difficult to clearly demonstrate or quantify 
the efficacy of this specific measure, as the culling of infected dogs was part 
of an integrated control strategy including insecticide spraying of houses 
(149, 235, 336) and active case detection and treatment of human cases 
(149, 235, 336) or infected dogs (223). 
The failure of the epidem iological im pact of m ass-culling program m es of ZVL 
infected dogs on human ZVL incidence has led some authors to question the 
dogma that humans have no role in the ZVL transmission cycle. Most human 
ZVL infections tend to be asym ptom atic with num erous parasites in skin and 
blood, and, hence, are potent ially infect ious to the sandfly vector (40, 269, 
273). Thus, there have been calls to study the epidemiological role of 
hum ans played in the ZVL transm ission cycle in m ore detail. However, so far 
only hum an ZVL cases have been shown to be infectious to sandfly vectors 
(121). 
Treatm e nt of infected dogs. I n countries where ZVL is mainly a veterinary 
problem, such as Europe [where estimates suggest that up to seven million 
dogs are at risk of infection (220)] and United States [where there has been 
a recent, widely publicised outbreak in foxhounds in Pennsylvania (209)] 
culling of infected dogs is considered unacceptable and dogs are treated with 
antileishm anial drugs [e.g. pentavalent antim onials (165, 223, 339, 385, 
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406, 436, 460, 473, 514, 524, 543, 544), amphotericin B (302, 303, 405, 
545), am inosidine (406, 436, 559) or allopurinol (108, 165, 199, 318, 385, 
554, 555)]. Treatment of infected dogs is not a very practical control policy, 
not only because of the prohibitive cost involved [up to US$800/ dog with 
liposomal amphotericin B (302, 391)], but also because of the high relapse 
rates [up to 74% (514)] am ongst treated and clinically cured dogs. 
Moreover, a high proportion of clinically cured dogs rem ain parasitologically 
positive (302, 303, 339, 385, 460, 473, 514, 524) and infectious to the 
sandfly vector (22, 224, 376). There is also great concern that large-scale 
use of drugs for ZVL-infected dogs may enhance the emergence of drug-
resistant parasite strains. 
Dog vaccination. Several vaccine candidates have been promising in 
experimental animal models, phase 1 and phase 2 vaccine trials, only two 
were tested in phase 3 trials (221). Surprisingly, only two vaccine candidates 
have been evaluated in phase 3 trials. I n the first trial no protection in 
vaccinated dogs could be demonstrated; in fact, vaccinated were shown to 
be more susceptible to L. infantum infection than non-vaccinated dogs (175). 
I n a recent trial in Brazil, 92% protection was reported for dogs vaccinated 
with a fucose mannose ligand [FML]-based vaccine (136). However, the 
sample size [n= 117, 58 cases, 59 placebo controls] and trial protocol [e.g. 
no data were presented on the sensitivity and specificity of the diagnostic 
test used to differentiate incident clinical and asym ptom atic cases in the 
vaccine and placebo group] are not rigorous enough to support the data and 
conclusions. 
The next three chapters will discuss present issues regarding the control of 
canine ZVL control policies. First, a rapid im m unochrom atographic dipstick to 
detect ZVL infection was evaluated as a possible solution to the 
epidem iological consequences of the delay [i.e. the tim e between surveying, 
sam piing, diagnosing and culling dogs] in canine control im plem entation 
[Chapter 6]. Second, the potential usefulness of insecticide-impregnated 
dog collars was tested as an alternative canine leishmaniasis control 
113 
strategy, by protecting dogs from sandfly bites [Chapter 7] and from 
disease [Chapter 8]. 
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CHAPTER 6: 
Rapid detection of Leishmania infantum infection in dogs: a 
comparative study using an immunochromatographic 
dipstick test, ELISA and PCR. 
Abstract 
OJrrent ZVL control programmes in Brazil include the culling of L. 
infantum-infected reservoir dogs, a strategy which has failed to prevent 
a rise of canine and human ZVL cases over the past decade. One of the 
main reasons why this strategy has failed is because of a long delay 
between sample collection, sample analysis and control 
implementation. A rapid, sensitive and specific diagnostic tool would be 
highly desirable, as it would allow control interventions to be 
implemented in situ. We compared an immunochromatographic dipstick 
test to ELI SA and PCR for detecting L. infantum infections in dogs from 
a ZVL-endemic area in Brazil. The dipstick test was shown to have 61-
75% specificity and 72-77% sensitivity, compared to 100% specificity 
for both ELI SA and PCR and 71-88% and 51-64% sensitivity for BJ SA 
and PCR, respectively. Of the tested field samples, 92/175 [53%], 
65/175 [37%] and 47/175 [27%] were positive by dipstick, B...ISA and 
PCR, respectively. The positive and negative predictive values for 
tested dipstick were 58-77% and 75%, respectively. Sforts should be 
made to develop a more specific dipstick test for leishmaniasis 
diagnosis, as they may ultimately prove more cost-effective than 
currently used diagnostic tests, when used in mass-screening surveys. 
Richard Reithinger, Rupert Quinnell, Bruce Alexander and Clive R. 
Davies [2001] Rapid detection of Leishmania infantum infection in 
dogs: a comparative study using an immunochromatographic dipstick 
test, ELISA and PCR. J. Clin. Microbiol. 40, 2352-2356. 
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6.1. Introduction. 
As outlined in Part 2: I ntroduction, one of the reasons why dog culling 
program m es have failed is because of the long delay between sam pie 
collection, sample analysis and control implementation [i.e. culling of infected 
dogs]. This delay typically is 30 days long, but can be as long as 120 days, 
with infected dogs remaining infectious to sandfly vectors during this period, 
thereby transm itting ZVL to susceptible dogs and humans. I n a study in 
Brazil, it was shown that whereas a standard culling strategy im plem ented 
80 days post sample collection resulted in only a 9% decrease in dog 
seroprevalence, culling im plem ented 7 days post sam pie collection resulted 
in a 27% decrease in seroprevalence (85). Current diagnostic methods used 
for Leishmania mass-screening surveys [mainly ELISA, IFAT or DAT] lack 
sensitivity or specificity [Chapter 2], require technological expertise and 
specialised laboratory equipment, and can be labour-intensive and time-
consuming. Hence, a rapid, sensitive and specific diagnostic test would be 
extremely valuable in mass-screening surveys and intervention campaigns, 
as results could be read immediately and control measures could be 
implemented in situ. Implementation coverage rates would be improved [e.g. 
dog owners would have less opportunity to hide their dogs from culling 
personnel] and the control intervention would be more effective. 
Immunochromatographic dipstick tests for Leishmania diagnosis have 
recently been developed and are all based on recom binant K39 [rK39], a 
protein predom inant in L. infantum and L. donovan; tissue am astigotes (95). 
rK39 dipstick tests have shown to be quite sensitive [reported sensitivities: 
67-100% ] and very specific [reported specificities: 97-100% ] when tested on 
kala-azar patients (66, 274, 276, 481, 526, 594), with similar results to 
rK39-ELISA assays (38, 95, 293, 414, 438, 480, 494, 512, 592, 593). 
Although rK39- ELI SA assays have been used to detect ZVL infection in dogs 
(38, 414, 457, 494, 592), there are no published reports on the use of the 
rK39 dipstick to detect ZVL in dogs. 
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Here the sensitivity and specificity of a commercially available 
immunochromatographic rK39 dipstick test were compared to serological and 
molecular diagnostic tests [ELI SA and PCR] used in canine leishm aniasis 
diagnosis. Epidem iological and cont rol intervent ion im plications are 
discussed. 
6.2. Materials & Methods. 
Sampling. Blood sam pies [2-1 Om I] were taken from 148 dogs in the 
municipality of Capitao Eneas [16°30'S, 44°00'W], a L. infantum-endemic 
area in Minas Gerais, Brazil. 27 dogs were sam pled again after 5 months. 
Sam pies were taken by venepuncture and put into sterile, EDT A-coated 10m I 
polypropylene tubes, and processed 4-10hrs after collection. The blood was 
centrifuged at 800g for 20m in, the buffy coat layer and sera were separated 
and stored at -20 0 C. Dog age was estim ated by tooth wear and when 
interviewing dog owners. Mean dog age was 34 months [range: 2 to 180 
months], 57 of sampled dogs were female, 91 male. No L. [Viannia] spp. or 
T. cruz; transmission was reported in the area [Plate SE-G]. 
Polymerase chain reaction [peR]. DNA from buffy coat samples was 
extracted using the DNeasy® DNA extraction kit [Qiagen, UK] according to 
the manufacturer's protocol. All samples were amplified with L. donovani 
complex-specific AJS31 [5'-GGGGTTGGTGTAAAATAGGGCC-3'] and DBY [5'-
CCAGTTTCCCGCCCCGGAG-3'] prim ers according to previously published 
conditions (439). Am plificat ion products were analysed by electrophoresis on 
1.5% agarose gels in 1xTAE buffer. To evaluate sample degradation or PCR 
inhibition, sam pie DNA was also am plified for a canine housekeeping gene, 
acidic ribosom al phosphoprotein fragm ent, using P03 [5'-
GGAGAAGGGGGAGATGTT-3'] and P05 [5'- TCATTGTGGGAGCAGACA-3'] 
primers [Chapter 2]. When samples did not yield amplification with P03/P05 
primers, they were extracted again, until positive amplification was obtained. 
Each amplification cycle included negative [no DNA, DNA from uninfected 
dog] and posit ive [water-Iysates of reference strain cult u res] cont rols. PCR-
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grade H20 was used throughout. To avoid cross-contamination, separate 
areas were used for DNA extraction, FeR sample preparation and 
amplification. 
Hybridisation. Agarose gels were processed according to standard 
procedures, i.e. in denaturation and neutralisation buffer for 20m in each, 
Southern blotted onto a nylon m em brane [Boehringer Mannheim, 
Switzerland], and DNA was fixed by UV-crosslinking. Mem branes were 
prehybridised at 42° C and hybridised with a [y32p]-ATP-labelled B4RsaB [5'-
GACCTGAAACCCTGGGTCCTGGGCGT-3'] probe for 8-12hrs (439), then 
washed at 65°C for 2x15m in in 2xSSC/O.1 % SOS and in 0.1 xSSC/O.1 % SOS, 
before being exposed for autoradiography for 36hrs and 72hrs at -70°C. 
Enzyme-linked im m unosorbent antibody tests [ELI SA]. Log-phased L. 
donovani promastigotes [MHOM/ET/67/L82] were harvested at a 
concentration of ca. 2.5x109 cells/ml, centrifuged at 5000rpm, washed in PBS 
and frozen at -20°C. Cells were freeze/thawed and briefly sonicated. Antigen 
[105 prom astigotes/well] was added to polysterene m icrotitre plates 
[I m m unolon® 2, Therm 0 LabSystem s, UK] in 100f-.LI of carbonate coating 
buffer [pH9.6] and incubated overnight at 4°C. Plates were washed [x3] with 
PBS and blocked with 100f.1l1well 2% milk powder in coating buffer for two 
hours at 37°C. They then were washed [x3] with PBS, and serum samples 
were added at 1/100, 1/400 and 1/800 dilutions in 100f.11 incubation buffer 
[PBS/O.05% Tween20+ 2% m ilk powder], and again incubated for two hours 
at 37°C. After washing [x6] with PBS/O.05% Tween20, peroxidase-
conj ugated, affinity- purified rabbit anti-dog I gG [Sigm a, Poole, UK] was 
added at 1/1500 in 100f.11 incubation buffer, and plates were incubated for 
two hours at 37°C. Plates were washed [x6] with PBS/O.05% Tween20 
before 100f.11 of substrate solution [O-phenylenediamine dihydrochloride in 
phosphate-citrate buffer, pH5.5] was added. The reaction was stopped with 
50f.11 2M H2S04 and plates were read at 490nm in an ELISA plate reader. 
ELISA standardisation. The method used is sim ilar as to the one used in 
Chapter 2. Briefly, on each plate a positive control serum was titrated two-
fold from 1/20 to 1/327680. The positive control serum was assigned an 
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arbitrary number of units/ml, 81920/ml, which was defined as the reciprocal 
of the highest dilution at which absorbance was greater than the mean + 3 
s.d. of background [i.e. no antibody] wells. Absorbance was calculated as 
observed absorbance minus mean background absorbance. A standard line 
was fitted over the range 1/80 to 1/81920 to the positive control absorbance 
values using a log-Iogit transformation. Absorbances of the three test sera 
dilutions were expressed as antibody units/ml using the standard line, from 
which the test sample's geometric mean number of antibody units/ml was 
calculated. Where the dilution curve for any test serum was noticeably non-
parallel to the standard, test sera were repeated at dilutions of 1/100, 1/720 
and 1/4320. Sam pies were considered positive when their antibody level was 
greater than the arithmetic mean of antibody body units/ml + 3 s.d. of 
negative controls. 
Dipstick test. The dipstick test [Leishmania RAPYDTEST®, I ntersep, UK] 
was carried out according to the manufacturer's instructions. The dipsticks 
were briefly placed into 50111 of serum. After 5-8m in, a red control line and, if 
positive, a second line appeared on the test field. The test is based on a 
com bination of protein A colloidal gold conj ugate and rK39 Leishmania 
antigen to detect anti- Leishmania antibody in serum or plasma [Plate 5A]. 
Negative and positive controls. Three groups of uninfected dog sera were 
used as negative controls for all diagnostic tests. The sera cam e from [i] 
dogs of various ages and breeds which had attended a veterinary clinic in 
Lim a [Peru; n= 17]; [ii] mongrel dogs from Belem [Brazil; n= 12]; and [iii] 
dogs of various ages and breeds which had attended a veterinary clinic in 
Cam bridge [UK; n= 11]. The positive standard control serum as well as nine 
other high-titre positive control sera came from dogs with confirmed L. 
infantum infection [by either culture, m icroscopy or xenodiagnosis] from 
Maraj6, Brazil [see Chapter 2]. 
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6.3. Resu Its. 
Table 6.1. summarises the dipstick, ELISA and PeR results of field samples, 
negative and positive controls, and the frequency distribution of log units of 
anti- Leishmania antibody units/m I depending on dipstick or PCR positivity is 
represented in Figure 6.1.-6.3. The mean antibody levels for the three 
groups of negative controls were 2562 [s.d.= 558] [Lim a], 1099 [s.d.= 689] 
[Maraj6] and 1854 [s.d.=783] [Cambridge] units/ml. The mean antibody 
units of all negative controls was 1831 [s.d.=978] units/ml, hence the cut-off 
for positivity was 4765 units/ml [i.e. 3.68 log [antibody units/ml]]. The mean 
for positive control sera was 170237 [s.d.=97281] units/ml. 
None of the 40 negative control sam pies was positive by ELI SA or PCR 
[Table 6.1.], but 10 out of 40 negative control sera were positive using the 
dipstick test. Thus, specificity of PCR, ELI SA and dipstick was 100%, 100% 
and 75%, respectively. The 10 negative control dogs that were positive in 
the dipstick test cam e from Cam bridge [n= 4], Peru [n= 2] and Brazil [n= 4] 
[mean antibody units/ml=1851, s.d.=1230]. All 10 positive controls were 
positive by both ELI SA and dipstick [i.e. 100% sensitivity], while 8 of 10 
were positive by PCR. The proportion positive of the field sam pies with each 
diagnostic technique was 53% [92/175], 37% [65/175] and 27% [47/175] 
for dipstick, ELISA and peR, respectively. 
To estimate the sensitivity and specificity of each test in the field samples, 
the true num ber of infected dogs must be estim ated. Two approaches were 
used to estimate the number of infected and uninfected field dogs. In 
approach 1, we use the estim ates of 100% specificity for ELI SA and PCR 
from the control sam pies [i.e. all ELI SA and/or PCR positives are true 
positives], and assume that all ELI SA-/PCR- samples were true negatives 
[i.e. all 39 RAPYD+ but ELI SA-/PCR- sam pies were false positives]. Approach 
1 gives an estimated 74 positives and 101 negatives. In approach 2, we 
again use the estimated 100% specificity for ELI SA and PCR, but also the 
estimated 75% dipstick specificity. Thus, only 21 [62/3] of the 39 
RAPYD+/ELlSA-/PCR- sam pies are false positives, and 18 are true positives. 
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Approach 2 gives a total of 92 positives and 83 negatives. Table 6.2. 
summarises the sensitivity, specificity and positive and negative predictive 
values [PP\I and NPV, respectively] of each test using each approach. With 
approach 1, the sensitivity and specificity of the dipstick test were 72% and 
61 %, respectively; approach 2 increases the estimated sensitivity to 77% • 
The sensitivities of ELISA and peR were 88% and 64% using approach 1, and 
71% and 51% using approach 2 [Table 6.2.]. 
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Table 6.1. Comparative diagnosis of L. infantum in dog blood. 
Negative Controlsa Positive Controlsa Field Samples 
[n=40] [n=10] [n=175] 
RAPYD+ RAPYD- RAPYD+ RAPYD- RAPYD+ RAPYD-
ELlSA+/PCR+ 8 30 8 
ELlSA-/PCR+ 6 3 
ELlSA+/PCR- 2 17 10 
ELlSA-/PCR- 10 30 39 62 
NOTE. a PCR on positive and negative Maraj6 controls were carried out on sera, not buffy coat. 
Table 6.2. Sensitivity, specificity, negative and 
positive predictive values for used diagnostic tests. 
PCR ELISA RAPYDTEST 
Approach 1 2 1 2 1 2 
PPV 100% 100% 100% 100% 58% 77% 
[47/47] [47/47] [65/65] [65/65] [53/92] [71/92] 
NPV 79% 65% 92% 75% 75% 75% 
[101/128] [83/128] [101/110] [83/110] [62/83] [62/83] 
Sensitivity 64% 51% 88% 71% 72% 77% 
[47/74] [47/92] [65/74] [65/92] [53/74] [71/92] 
Specificity 100% 100% 100% 100% 61% 75% 
[101/101] [83/83] [101/101] [83/83] [62/101 ] [62/83] 
NOTE. See Text for different approaches used to estimate PPV, NPV, sensitivity and specificity 
of each diagnostic test; the different assumptions made for each approach are in italic. PPV, 
positive predictive value; NPV, negative predictive value. 
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Figure 6.1. Frequency distribution of log units/ml of anti-Leishmania 
antibody in the tested field samples. 
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6.4. Discussion. 
Mass-screening in epidem iological surveys: a choice of tests. This is 
the first study to use a dipstick test to detect Leishmania infection in dogs. 
Our study indicates that the RAPYDTEST has a com parable sensitivity to 
ELI SA, but that its specificity is very low [61-75%]. Thus, use of the dipstick 
tests would lead to a high proportion of dogs being misdiagnosed as false 
positives [up to 39 out of 92 positive field sam pies, Table 6.1.]. The reason 
for this is unknown, but it could include test cross-reactivity to some factor 
present in dog blood, as tested rK39 dipsticks were highly specific when 
tested on kala-azar patient blood. Previous studies using the rK39-ELlSA 
assay reported responsiveness to rK39 in 2/33 Chinese toxoplasmosis 
patients [though the authors reported that the two responsive patients may 
have had sub-clinical ZVL (512)], 2/61 Sudanese healthy endemic controls 
(593), 1/10 Turkish malaria patients (414), and 6/83 Turkish cutaneous 
leishm aniasis patients (414). The rK39 antigen is not known to cross-react to 
L. braziliensis or T. cruzi (38, 95, 163, 438). Also, rK39 responsiveness 
appears to be restricted to active kala-azar infections as opposed to 
asymptomatic, self-healing, cured or treatment-resistant patients (38, 293, 
512) or dogs (457, 494), though other studies failed to show such association 
(593,594). 
Five reported studies used a rK39-ELISA assay to detect Leishmania infection 
in dogs (38, 414, 457, 494, 592). The rK39- ELI SA was 100% sensitive in 90, 
parasitologically confirmed, high-antibody titre dogs in Brazil (38) and in 37 
parasitologically confirmed dogs in Venezuela [negative controls were not 
included in either study] (592). In a Turkish study 18/494 dogs were positive 
by rK39- ELI SA, sen sit ivity and specificity were reported to be 93% and 
100%, respectively (414); in a large epidemiological survey in Italy rK39-
ELI SA sensitivity and specificity were 97% and 99%, respectively (494). 
Finally, in a Moroccan study the rK39- ELI SA was 100% sensitive in detecting 
11 parasitologically confirm ed, clinically sym ptom atic dogs, but failed to 
detect ZVL infect ion in 9 parasitologically confirm ed, clin ically asym ptom atic 
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dogs (457). Variability in dipstick perform ance will depend on factors such as 
the type of diagnostic antigen and conjugate used. Previous experience on 
malaria dipstick tests show that these tests can be highly variable in terms of 
sensitivity and specificity (580). False positive rates for malaria dipsticks can 
be as high as 28%, which may for example be due to cross-reactivity to 
rheumatoid factor (297). 
Anum ber of PCR protocols to detect L. infantum have been developed and 
PCR has been shown to be a sensitive and highly specific technique for the 
detect ion of sym ptom atic or parasitologically proven infect ions [see also 
Chapter 2] (31,67,202,439,472,473,518). Evidence suggests that peR is 
less sensitive in detecting asymptomatic dogs (31, 439). The results 
presented here confirm this observation, as PCR only detected 79% of ELISA 
positive and 39% of dipstick positive field samples, with PCR positivity being 
associated with ELI SA antibody units [linear regression after arc-sine 
transformation of data, d.f.= 39, r= 0.84, p< 0.001]. The sensitivity and 
specificity of the PCR assay depend on several factors including PCR prim ers, 
DNA extraction protocol and source of biopsy material [Chapter 2] (294, 
296). The advantage of using blood [buffy coat] is that the sampling is less 
invasive than bone marrow, spleen or lymph node aspirates, and samples can 
be processed readily. On the other hand, parasite load in blood tends to be 
lower than in bone marrow, spleen or lymph node aspirates, and blood may 
contain a number of PCR inhibitors [e.g. heme] that may affect PCR assay 
sensitivity. 
Using a conservative cut-off [i.e. mean + 3 s.d.] (440), ELISA was 100% 
sensitive in detecting culture positive dogs and 84% sensitive to detect 
parasitologically confirm ed [PCR] field dogs. Interestingly, 4 out 9 PCR 
positive but ELI SA negative sam pies were from dogs that had recovered 
serologically by the time the second sam pies were taken. This demonstrates 
that the sensitivity of the diagnostic technique used can change with course 
of infection (439), and that these dogs appear to have developed an immune 
response controlling infection. The sensitivity and specificity of ELI SA depend 
on type of antigen used [e.g. parasite species, promastigotes or amastigotes] 
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and changes to the standard experimental protocol [e.g. incubation time or 
type of microtitre plates used]. 
Conclusion. Research into developing a more specific Leishmania dipstick 
test should be pursued, as the advantage of such a tool with respect to other 
diagnostic methods such as microscopy, ELISA or peR are many-fold. Using 
dipsticks, a vast num ber of sam pies can be processed quickly and with 
minimum effort. Compared to microscopy, ELISA or PCR, minimal 
technological expertise [i.e. training of personnel] and specialised laboratory 
equipment are required. Another advantage of dipstick tests is that patients 
[in this case, dog owners] can see the results for themselves, which should 
contribute to a better working relationship between local com m unities and 
people carrying out the surveys, and increase com pliance rates. 
Epidemiologically, the most important characteristic of a dipstick test is that it 
allows interventions to be im plem ented in situ. The outcom e should be to 
significantly reduce the mean duration of infectiousness of dogs that have 
becom e infected, thereby significantly enhancing the im pact of the 
intervention on the basic reproductive number, Ro. Immunochromatographic 
dipstick tests are com paratively expensive, but considering the above, a 
sensitive and specific dipstick test could prove a very cost-effective 
alternative to currently available diagnostic tests, especially when used in 
mass- screening surveys. 
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CHAPTER 7: 
A comparative trial of topical insecticide treatments to 
protect dogs from bites of sandfly vectors of leishmaniasis. 
Abstract 
We compared the susceptibility of sandfly vectors to four topical 
insecticide treatments applied to domestic dogs, a reservoir of 
human leishmaniasis. Dogs were exposed to sandflies pretreatment 
and at 1 week, 1 month, and 2 months posttreatment. Sandfly 
bloodfeeding and survival rate of both fed and unfed flies were 
significantly reduced by the permethrin, deltamethrin, and fenthion 
treatments, but diazinon had no effect. The survival of bloodfed 
sandflies was reduced by up to 86% with deltamethrin collars. The 
antifeeding effect suggests that deltamethrin collars may be 
recommended to dog owners to protect their pets from sandfly-
borne diseases. The combined effects on sandfly feeding and 
survival indicate that epidemiologic, community-based trials are 
warranted to test whether deltamethrin collars could reduce the 
incidence of canine and, hence, human leishmaniasis. 
Richard Reithinger, Ueslei Teodoro, and Clive R. Davies [2001] 
Topical Insecticide Treatments to Protect Dogs from Sandfly Vectors 
of Leishmaniasis. Emerg. Infect. Dis. 7, 486-490. 
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7.1. Introduction. 
The first evidence that topical insecticides could be used to control ZVL came 
from experim ental studies in China. After showing that deltam ethrin bath 
treatm ent reduced the bloodfeeding rate and survival rate of Phlebotomus 
chinensis sandflies exposed to an unnatural host [hamsters: (110)], it was 
found that the bloodfeeding rates of P. chinensis exposed to dogs for 8 hrs 
were significantly reduced from 62% to 4% by dipping dogs in 25ppm 
deltam ethrin, and none of the sandflies [unfed or fed] exposed to treated 
dogs survived (236). The effect persisted for up to 104 days. Field evidence 
for the im pact of topical insecticides com es from a com m unity-based trial in 
China, where ZVL transm ission was apparently interrupted following 2 years 
of treatm ent [two rounds per year] of all village dogs in 50ppm deltam ethrin 
baths (237). However, the trial results must be interpreted with caution, as 
no control villages were included in the study. 
I n contrast to insecticide lotions [Molina et al., unpublished], experimental 
trials in France have shown that the effects of deltam ethrin- impregnated 
collars on sandfly bloodfeeding and survival can persist for up to 8 months 
(287). Once collars had been applied for 2 weeks, blood-feeding consistently 
dropped by 90% and mortality rates increased by 51 % during the course of 
the experiment. This level of persistence was not fully achieved when similar 
trials were carried out in Spain (329), where the anti-feeding effect dropped 
significantly from> 90% during the first 4 months to 84% after 6 months, 
and the lethal effect dropped steadily from 76% after 2 weeks to 42% after 6 
months. Nevertheless, both trials demonstrate that, when using collars, the 
effects persist for much longer than when dogs are dipped in deltam ethrin. 
The potentially wide applicability of DMC collars for protecting dogs against 
sandflies has since been demonstrated by experimental trials with P. papatasi 
in Iran (247) and Lu. Longipalpis and Lu. migonei in Brazil (142). 
The work reported in this chapter directly compared the anti-feeding and 
lethal effects of deltamethrin-impregnated dog collars versus the effects of 
alternative topical insecticide applications. The study also increases the 
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number of sandfly species against which insecticide-impregnated dog collars 
have now been tested, and was the first such study to test their impact on a 
vector of ACL [Lu. intermedia] , which is known to feed on both humans and 
dogs (102). 
7.2. Materials & Methods 
Study Site and Protocol. All 17 dogs used in the experimental trial came 
from the Fazenda Palm ital, a large farm 40km from Maringa, Estado do 
Parana, Brazil [23° 40'S, 52°25'W]. Mongrel dogs were stationed individually 
inside cages [50cm width x 60cm height x 60cm depth] and were exposed 
overnight [±22.30-5.30hrs, i.e. for 7 hours] to an average 96 [range: 69-
121] wild-caught sandflies introduced through sleeves of closed net curtain 
tents [1 OOcm x 180cm x 130cm] [Plate 5 B]. Sandflies had been caught the 
sam e night by mouth aspirator inside open chicken pens at the Fazenda 
Marista [21.00-22.00hrs], a neighbouring farm. Previous studies have shown 
that> 85% of all collections made at the Fazenda Marista are Lu. intermedia 
[Teodoro et aI., unpublished data], which was confirm ed by microscopically 
identifying to species a subset of caught sandflies: of 200 unfed and 40 
bloodfed sandflies, 172 [86%] and 35 [88%] were identified as Lu. 
intermedia, respectively; the remainder being Lu. whitmani. Sandflies were 
collected from the tents the following morning using a mouth aspirator, 
placed into suspended gauze cubic cages, and maintained on sucrose- solution 
for a further 17hrs at 24-26° C and 90-95% RH. After a total of 24hrs, flies 
were sexed and scored as either dead or alive, and bloodfed or unfed. 
All dogs were exposed to sandflies prior to treatm ent [day 0] and again at 5-
12 days post treatm ent [dpt], 32-36dpt, and 58- 65dpt. For brevity, these 
time points are referred to in this paper as 1 week [1 w], 1 month [1 m] and 2 
months [2m]. Four treatments were compared: [i] 40mg/g deltamethrin-
im pregnated collars [OMC, Scalibor®, I ntervet International Gm bH, 
Wiesbaden, Germ any] [n= 5]; [ii] 15% diazinon- im pregnated collars [OZ, 
Canovel®, Pfizer, UK] [n= 3]; [iii] application of 1 m I O. 65g/ m I perm ethrin 
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topical lotion [PM, Pulvex®, Coopers Brasil Ltda, Sao Paulo, Brazil] [n= 3]; 
and [iv] application of 1 ml 15% fenthion topical lotion [F, Pulfim®, Bayer S.A. 
Brasil, Barueri, Brazil] [n= 3] [Plate 5 C]. The collars were attached around 
the neck of the dogs. The topical lotions were applied directly onto the skin 
after the dog's hair was separated at the nape of the neck. Three untreated 
dogs [negative controls, C] were exposed to sandflies at the sam e tim e 
points in order to adj ust for any background changes in sandfly feeding and 
survival rates over tim e. Changes in climatic conditions [tem perature and 
relative humidity] were measured at the start and end of each bioassay. 
Data Analysis. The effects of the different treatments [in relation to the 
negative control] at each time point were tested using General Linear Models 
(129) in the computer package STATA, i.e. by analyses of deviance, 
specifying bin om ial errors, of the effect of treatm ent on the log odds of 
sandfly bloodfeeding and mortality. Any significant overdispersion was 
corrected by re-scaling the model using the ratio of the residual deviance to 
residual degrees of freedom. Maxim al models incorporated the effects of dog 
age, dog size and climatic conditions along with treatment. The significance 
of each variable was tested by back-step analysis of deviance, i.e. by 
observing whether these variables explained a significant [P<O.05] proportion 
of the deviance remaining after their removal from the model. Variables were 
excluded from the models in order of least significance until only significant 
variables were retained in the minimum adequate model. 
7.3. Resu Its. 
An average of 49 [range: 19-86] fem ale and 22 [range: 2-47] male sandflies 
were recovered from the tents the following morning [i.e. a mean recovery 
rate of 74%]. The sex ratio was remarkably constant throughout the 
experiment, with no significant differences detected with time or treatment 
[median proportion of females recovered: 0.68; 25%-75% quartiles: 0.61 -
0.75]. Sandfly bloodfeeding and mortality rates were unaffected by dog age, 
dog size or climatic conditions throughout the trial. No dogs had visible side-
effects against the different treatments. 
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Table 7:1. ~xperimental do~ trial comparing effects of topical insecticide 
applications on the feedmg and survival rates of female sand flies. 
Dog TM Odpt 5-12dpt 32-36dpt 58-65dpt 
B U B U B U B U 
1 C 40 (1) 37 (3) 37 (0) 38 (6) 25 (0) 34 (4) 23 (1) 30 (4) 
2 C 43 (1) 34 (8) 28 (0) 27 (2) 26 (1) 39 (6) 25 (1) 33 (3) 
3 C 31 (1) 44 (5) 24 (2) 40 (7) 30 (0) 29 (2) 14 (3) 37 (8) 
4 DM 20 (1) 28 (2) 21 (2) 31 (10) 14 (3) 34 (14) 8 (1) 36 (11) 
5 DM 24 (0) 54 (4) 16 (1) 27 (5) 7 (3) 37 (8) ND§ ND § 
6 DM 47 (1) 39 (2) 9 (1) 53 (7) 8 (2) 37 (14) 5 (1) 43 (9) 
7 DM 26 (0) 28 (3) 3 (0) 20 (10) 4 (2) 31 (20) 4 (2) 34 (15) 
8 DM 25 (1) 34 (1) 14 (0) 26 (5) 6 (2) 26 (23) 5 (1) 23 (19) 
9 DZ 38 (0) 40 (5) 32 (0) 20 (3) 23 (1) 18 (6) ND¥ ND¥ 
10 DZ 26 (0) 38 (4) 36 (2) 8 (4) 29 (1) 27 (7) ND¥ ND¥ 
11 DZ 16 (0) 34 (5) 15 (1) 21 (2) 13 (0) 39 (6) 17 (0) 29 (4) 
12 PM 17 (0) 27 (6) 6 (2) 35 (7) 9 (1) 21 (4) 8 (1) 23 (8) 
13 PM 16 (1) 39 (3) 10 (1) 24 (11) 21 (1) 38 (19) 11 (0) 38 (11) 
14 PM 22 (0) 14 (3) 15 (1) 31 (9) 13 (2) 36 (10) 10 (1) 39 (9) 
15 F 22 (1) 47 (7) 15 (2) 15 (6) 6 (0) 17 (9) 9 (1) 28 (13) 
16 F 29 (1) 22 (8) 27 (1) 15 (13) 11 (4) 28 (19) 16 (0) 37 (7) 
17 F 10 (1) 21 (2) 16 (0) 44 (5) 4 (3) 15 (10) 8 (3) 33 (8) 
NOTE. Dead sand flies (after 24hrs) are in brackets. Abbreviations: S, bloodfed sand flies; C, 
control; DM, deltamethrin-impregnated dog collar; dpt, days post treatment; DZ, diazinon-
impregnated dog collar; F, fenthion topical lotion; PM, permethrin topical lotion; ND, not done; 
TM, treatment; U, unfed sand flies. §, dog 5 was killed by his owner; ¥, dog 9 and dog 10 moved. 
Sandfly bloodfeeding rate. In the absence of treatment, the average 
sandfly bloodfeeding rate was 42% [Table 7.1. and Figure 7.1.]. There was 
no significant difference between the bloodfeeding rate on negative control 
dogs and the rates on any of the four 'treatment groups' prior to treatment 
[P> 0.2 for all four com parisons]. Neither were there any significant 
differences in bloodfeeding rates on treated and untreated dogs at the first 
tim e point [i .e. 1 w], although there was som e suggestion of a reduction on 
the dogs treated with PM [P= 0.088] and DMC [P= 0.083]. Bloodfeeding rates 
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Table 7.2. Percentage reduction in sand fly 
bloodfeeding after application of topical insecticides. 
Reduction in sand fly bloodfeeding (%) [95% C.I.J 
5-12dpt 32-36dpt 58-65dpt 
OM 37.6 [5.3,68.0] 56.7 [38.7, 70.5] 68.5 [42.8, 77.6] 
OZ -37.0 [ -77. 1, 1 3.3] 1.4 [-23.1,24.7] 3.4 [-40.1,40.0] 
PM 44.1 [-7.2,76.2] 31.6 [7.8, 51.4] 49.2 [14.3, 61.6] 
F 4.2 [44.8, 48.3] 41.4 [13.3, 62.9] 43.1 [53.0, 56.0] 
NOTE. Abbreviations are as in Table 7.1. 
were significantly less on dogs treated with DMC, PM and F treatment [as 
com pared with untreated dogs] at both 1 m [P<O.001; P= 0.010; and 
P=O.005, respectively] and 2m [P<O.001; P=O.004; and P=O.018, 
respectively]. At both time points the reduction in bloodfeeding rate was 
greatest on DMC treated dogs [Table 7.2.], though the difference with PM 
and F treated dogs was not statistically significant. The greatest anti-feeding 
effect in all trials was detected on DMC-treated dogs after 2m, when 
bloodfeeding rates were reduced by 69% [95% CI: 43-78%]. A sim ilar 
pattern was demonstrated when bloodfeeding rates post-treatment were 
compared to bloodfeeding rates pre- treatment on the same dogs [rather than 
to bloodfeeding rates on control dogs at the sam e tim e points]. I n these 
analyses, a significant reduction in bloodfeeding was detected on DMC 
treated dogs at all three time points: at 1w [P=0.012], 1m [P<0.001] and 
2m [P<0.001]. In contrast, bloodfeeding rates only dropped significantly by 
1 m on FL treated dogs, and by 2m on PM treated dogs. No significant 
reduction in bloodfeeding was detected on DZ treated dogs at any time point, 
when compared to either negative control dogs or pre- treatment controls. 
Sandfly mortality. I n the absence of treatment, the average sandfly 
mortality (i.e. the proportion of sandflies dying during the first 24hrs post-
treatment) of unfed and bloodfed sandflies was 12% and 2%, respectively 
[Table 7.1, Figure 7.1.]. There was no significant difference between the 
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mortality of bloodfed sandflies on negative control dogs and the equivalent 
rates on any of the four 'treatment groups' prior to treatment [P>O.4 for all 
four com parisons]. I n com parison with untreated dogs, mortality of bloodfed 
flies was significantly increased at 1w by 11%, i.e. 5.7-fold [95% CI: 1.1-
20.5], as a result of PM treatment [P=O.037] , and at 1 m by 33%, i.e. 27-fold 
[4.4-66], by F treatm ent [P=O.001] and by 30%, i.e. 25-fold [4.2-63], by 
DMC treatm ent [P=O.001]. No significant treatm ent effects on the mortality 
of bloodfed sandflies were detected at 2m. 
Prior to treatment, there was no significant difference between the mortality 
of unfed sandflies on negative control dogs and the equivalent rates on three 
of the 'treatment groups' [P> 0.4 for all three comparisons], but the mortality 
of unfed sandflies on the group allocated with DMC treatment was 
significantly less [P= 0.020] than on the control group. The effect of this 
minor pre-treatm ent bias was to make it harder to detect any sign ificant 
increase in mortality as a result of DMC treatment. With this caveat, we were 
unable to detect any significant differences in the mortality of unfed sandflies 
at 1w. However, in comparison with untreated dogs, mortality of unfed 
sandflies was significantly increased by 41%, i.e. 4.1-fold [1.7-6.6], at 1m 
by DMC treatment [P=O.004] and by 58%, i.e. 5.4-fold [2.3-7.6], by F 
t reatm ent [P=O. 00 1]. Mortality of unfed sandflies at 2m was sign ificantly 
increased by 29%, i.e. 2.6-fold [1.02-4.7], by DMC treatment [P=O.046]. 
Finally, we analysed the com bined effects of treatm ent on bloodfeeding and 
the mortality of bloodfed flies, i.e. how treatment affected the proportion of 
females that both took a bloodmeal and survived 24hrs. As expected, the DZ 
collar had no effect at any time point. None of the treatments had a 
significant effect at 1 w [although the effects of DMC and PM were of 
borderline significance: P= 0.064 and P= 0.053, respectively]. At 1 m DMC 
[P< 0.001], PM [P= 0.003] and F [P< 0.001] all caused a significant reduction; 
but the effect of DMC was significantly greater than that of PM [P= 0.001]. A 
significant reduction was again detected at 2m for DMC [P< 0.001], PM 
[P= 0.008] and F [P= 0.015]; and the effect of DMC was significantly greater 
than that of both PM [P=0.019] and F [P=0.01]. 
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Figure 7.1. Comparison of various topical insecticide 
applications to protect dogs from sand fly bites. 
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7.4. Discussion. 
The effects of topical insecticides on sandfly blood-feeding. The 
observed reduction in Lu. intermedia bloodfeeding and increase in sandfly 
mortality supports the hypothesis that topical insecticides, including collars, 
could protect dogs against leishmaniasis. Bloodfeeding rates of sandflies were 
reduced from 1 m post-treatm ent not only on dogs with deltam ethrin collars 
[DMC], but also on dogs treated with topical lotions of perm ethrin [PM] and 
fenthion [F). No effect was detected for dogs with diazinon collars [DZ]. 
Although no significant difference between the anti-feeding effects of DMC, 
PM and F were detected, the reduction due to DMC was greater than that due 
to either PM or F at both 1 m and 2m post-treatment [Table 7.2.]. The failure 
to detect any significant effect on bloodfeeding 1 w post treatm ent is probably 
due to the time required for the lipophilic insecticides to spread in the dermal 
secretions over the dog's body (370); and the manufacturers currently 
recom m end that the DMC collar is put on approxim ately 2 weeks prior to an 
anticipated sandfly challenge. However, a significant 5-fold increase in 
mortality rates was detected for bloodfed sandflies on PM-treated dogs after 
1 w, suggesting that topical application of PM lotion can have a com paratively 
immediate effect. But this effect is short-lived as no lethal effect on bloodfeds 
was detected at 1 m or 2m post treatment, and no effect on unfeds was 
detected at any tim e points. I n contrast, topical F application showed greater 
persistence, significantly increasing mortality rates of both unfeds and 
bloodfeds at 1 m post treatm ent. The lethal effect of the DMC collar was the 
most persistent of all the treatm ents, with significant effects on bloodfeds 
after 1 m and on unfeds at both 1 m and 2m post-treatm ent. The failure to 
detect a significant im pact on bloodfeds after 2 months may be due to the 
relatively few bloodfeds at that time point [due to the high anti-feeding 
effect]. The DZ collar failed to cause any impact on mortality rate of either 
bloodfed or unfeds at any time- point. 
Com parisons of the results of our trial with those of sim ilar studies with DMC 
collars (142, 247, 287, 329) are difficu It, due to variation in experim ental 
protocol. For exam pie, we used wild-caught Lu. intermedia whereas Killick-
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Kendrick et al. (287) and Lucientes (329) used 7-15 day-old, colonised P. 
perniciosus, and David et al. used 7-15 day-old, colonised Lu. longipalpis and 
Lu. migonei (142). This may account for the relatively low lethal effect 
detected in our trial, as old and colonized flies tend to be more sensitive to 
low doses of insecticide. Secondly, whereas dogs were exposed to high 
sandfly densities [m ean 155 fem ale flies/ dog recovered after 2hrs] in the 
study by Killick-Kendrick et al. (287), our dogs were exposed to low fly 
densities [m ean 49 fem ale flies/ dog recovered after 7hrs]. The longer 
exposure tim e in our experim ents, which was chosen in order to increase 
sandfly bloodfeeding rates and contact time with the various treatments, may 
have contributed to the decreased sandfly recovery rates observed in our 
study [see below]. Thirdly, in contrast to all previously reported studies, we 
chose not to sedate the dogs, in order to make the trial conditions as 'natural' 
as possible. This provides a further reason for the slightly lower recovery 
rates of sandflies after exposure, as compared to previous studies. 
The potential protection against sandfly transm itted diseases afforded by 
collars to individual dogs depends solely on their anti-feeding effect. Although 
trials measuring im pact on dog infection rates are still required, the 
entomological results reported here strongly indicate that DMC collars may be 
recom m ended to dog owners wishing to protect their dogs from 
leishmaniasis. This could include dog owners travelling to leishmaniasis-
endemic countries, such as Southern Europe, as imported leishmaniasis cases 
of dogs with a travel history to Mediterranean leishmaniasis-endemic areas 
are increasingly com m on (219, 513). With the recent change in the UK 
quarantine laws, this is likely to be of increasing concern to British dog 
owners. 
The effects of topical insecticides on sandfly mortality. The putative 
epidemiological impact of DMC collars on leishmaniasis transmission will 
depend not only on reducing the num ber of sandflies feeding on dogs, but 
also on reducing the survival of those flies that do feed so that they are less 
likely to transm it Leishmania when taking a subsequent bloodm eal on a 
susceptible dog or human. Combining the effects on the bloodfeeding and 
mortality rates, we calculate that DMC collars reduced the number of 
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bloodfeds that survive 24hrs by an average of 91 % at 1 m post-treatment 
and by 81 % at 2m post-treatment. This was greater than the reductions of 
61% [ns] and 37% [P=0.010] for F treatment, and of 37% [P=0.001] and 
41 % [P= 0.019] for PM treatm ent, at 1 m and 2m respectively. Thus, there 
appears to be a clear advantage in terms of effectiveness in using DMC 
collars versus the two topical lotions. Another advantage of collars is that 
their presence on dogs, when following-up treated dogs during a control 
campaign, is proof that the insecticide is applied. Balancing these 
advantages, pour-on lotions are probably easier to use, and wear and tear is 
not a concern. Further studies are clearly needed to decide the optimal 
mechanism s of insecticide application and delivery [e. g. topical lotions, 
sprays, powders, dips, collars, or ear tags], before widespread 
implementation can be recommended. 
Conclusion. The entomological results reported here are sufficiently 
encouraging to warrant the undertaking of trials measuring the 
epidemiological impact of community-wide DMC collar implementation [see 
Chapter 8]. 
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CHAPTER 8: 
The use of insecticide-impregnated collars to control canine 
leishmaniasis: a matched cluster intervention trial in Brazil. 
Abstract 
We tested the effectiveness of deltamethrin-impregnated dog collars 
[OMC] to reduce the incidence of canine zoonotic visceral 
leishmaniasis [ZVL] in a community-based intervention trial in Brazil. 
After blood was taken from 441 dogs in two different 
neighbourhoods [01 and 02], OMC were attached to surveyed dogs 
in 01. Using PCR and/or ELISA ZVL infection was detected in 18.7% 
and 12.6% of dogs in 01 and 02, respectively. After five months 
dogs were surveyed and sampled again in both areas. Although ZVL 
incidence was 32% lower in collared as compared to uncollared 
dogs, the difference was not significant. However, OMC did reduce 
the odds of dogs increasing their anti-Leishmania antibody titre by 
50% [95% G.I. 29-87, p=0.01]. The effect of the community-wide 
application of OMC was compared to the currently practised dog 
culling control strategy using mathematical modelling; 
epidemiological implications are discussed. 
Richard Reithinger, Paul G. Coleman, Bruce Alexander, Edvar Vieira, 
Geraldo Assis, and Clive R Davies [2003] Are insecticide-impregnated 
dog collars a feasible alternative to dog culling as a strategy for 
controlling canine visceral leishmaniasis in Brazil? Int. J. Parasitol., in 
press. 
139 
8.1. Introduction. 
Dom estic dogs are established reservoir hosts of ZVL caused by L. infantum 
[Part 2: I ntroduction]. Hence, one of the approaches to reduce the 
incidence of hum an ZVL is to cull infected dogs. Critics have cast doubt on 
the im pact of such dog culling program m es on hum an and canine ZVL 
incidence on both theoretical (176) and practical grounds (85, 416), and 
because results of controlled intervention trials are equivocal (32, 171). 
Others remain adamant that culling is effective in reducing canine and human 
ZVL incidence (415). The costly treatm ent of ZVL infected dogs is not a 
feasible control strategy because treated and clinically cured dogs often 
relapse as they rem ain parasitolog ically posit ive and, hence, are infectious to 
the sandfly vector (452). Whilst waiting for an effective canine (221) or 
human (249) vaccine, alternative control strategies are paramount. 
As seen in Chapter 7, several experimental trials have demonstrated that 
topical insecticides, and deltam ethrin- im pregnated dog collars [DMC] in 
particular, can protect dogs from> 85% of sandfly bites for periods of up to 6 
months. The objective of this study was to test the effectiveness of DMC to 
control canine ZVL in a matched cluster intervention trial and to highlight 
possible constraints associated with a com m unity-wide im plem entation of a 
dog collar ZVL control strategy. 
8.2. Materials & Methods. 
Study site. The intervention trial was carried out in Capitao Eneas [16°30'S, 
440 00'W], a L. infantum-endem ic area in Minas Gerais State, Brazil [see 
Chapter 6]. Capitao Eneas is a small town of 9800 inabitants, located 72km 
from Montes Claros in an arid plain. Main economic activities are commerce 
and a local computer chip plant. Most people own chickens, pigs, and dogs. 
Houses tend to be surrounded by abundant vegetation [either garden or 
crops] [Map 2, Plate 5]. Transm ission of ZVL by the vector Lu. longipalpis 
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occurs throughout the year; there is no documented L. braziliensis or T. cruzi 
transmission in the area. 
Dog survey and diagnoses. In September 1999, a cohort of 441 dogs was 
su rveyed clinically, parasitologically and im m unologically in two different 
neighbourhoods [01 and 02, respectively] of Capitao Eneas [Box 2]; 01 and 
02 were 500m apart and selected at random. After blood sam pies [2-1 Oml] 
had been taken from all dogs, 40m g/ g OMC [Scalibor, I ntervet International, 
The Netherlands] were attached to all dogs above three months of age in 01 
[Plate 5 D], whereas dogs rem ained uncollared in 02. All dog owners were 
informed about the objective of the study and possible side-effects due to 
collar use; participation was voluntary. After five months, i.e. February 2000, 
dogs in both areas were re- surveyed and a second blood sample was taken in 
order to estimate effectiveness of OMC in reducing canine ZVL incidence. 
Collar loss and side effects were also recorded. All blood sam pies were 
processed as described Chapter 6. Briefly, for parasitological diagnosis, 
sam pies were screened by a PCR-hybridisation protocol using L. donovani 
complex-specific AJS31 [5'-GGGGTTGGTGTAAAATAGGGCC-3'] and OBY [5'-
CCAGTTTCCCGCCCCGGAG-3'] primers and a [y32p]-ATP-labelled B4RsaB [5'-
GACCTGAAACCCTGGGTCCTGGGCGT- 3'] probe. Sam pies were screened by 
ELISA for immunological diagnosis, with log-phased L. donovani 
prom astigotes [MHOM/ ET/67 / L82] as antigen [at a concentration of 105 
prom astigotes/ m icrotiter plate well] and peroxidase- conj ugated, affinity-
purified rabbit anti-dog I gG as antibody [at a concentration of 1/1500]. As 
shown in Chapter 6, using these protocols PCR and ELI SA had both 100% 
specificity and 53-64% and 74-88% sensitivity, respectively. 
Statistical analysis. To measure the epidemiological impact of OMC, chi-
squared tests were used to com pare the odds of dogs from 01 and 02 
getting infected. I n a second analysis, logistiC regression was used to 
compare these odds after controlling for pre-intervention prevalence in each 
locality [i.e. the proportion of dogs that are positive by either ELI SA or PCR, 
or both] and dog gender. Neither dog age nor loss of collar during the trial 
were shown to significantly affect the odds of infection in dogs after analyses 
and so these factors were excluded from the final regression model. The 
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outcome variables in all analyses were [i] positive by ELISA or PCR, or both, 
and [ii] increase in anti-Leishmania log antibody units [LAU]/ml [as a 
binomial variable]. All analyses were done in STATA 7. 
Mathematical modelling. The potential effectiveness of OMC as compared 
to cu rrent dog cu lIing program m es was sim ulated by using the vector- borne 
disease model of Ross- Macdonald (24). Total dogs and sandflies are divided 
into proportions that are uninfected and susceptible [Os and Fsl, latent [i.e. 
infected but not infectious] [Ol and Fd and infectious [0
1 
and FI]. Changes in 
the proportions of dogs and flies in each group through time are given by the 
following equations: 
Box 2. Flow diagram of model parameters 
[E1 ] dOL 
-- = 0sabmF, -OlO"-OlJ dt 
[E2] dOl ~=OlO"-OI p-O, J 
[E3] Os = 1 -Ol -0 1 
p 
~ abmFI (J 
Os ~ 
°L ~ °1 ~ ~ ~ 
0 0 0 
[E4] dFl 1 
- = acF sO, - ~ - - F f.1 dt l r I 
[ES] dFI 1 
- = Fl --FI f.1 dt r 
[E6] Fs = 1 -Fl -F, 
where 8 and J..l are the dog and sandfly mortality rates, respectively [note 
that the model assumes that both populations are constant, with 
instantaneous replacement of dead dogs and sandflies, and that mortality 
rates are independent of age and infection status], cr the rate at which latent 
dogs becom e infectious, p the rate at which infectious dogs recover from 
infection and, hence, infectiousness, a the sandfly biting rate on dogs, b the 
probability that an infectious sandfly transm its Leishmania when feeding on a 
susceptible host, c the probability that a sandfly becomes infected when 
feeding on a infectious dog, m the ratio of vectors to dogs, and 't the extrinsic 
incu bat ion period [i. e. tim e required for the developm ent of infect ive 
metacyclics in infected sandflies]. Using a series of difference equations 
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derived from E1-6, sim ulations were run at quarter day intervals until an 
equilibrium prevalence of infectious dogs was obtained. The effect of collaring 
or culling dogs at 180-day pulses was then sim ulated. I n additional 
sim ulations, the rates of collar coverage and collar loss were varied in order 
to test their effect on prevalence of infectious dogs. All sim ulations were 
carried out in Microsoft Excel. 
8.3. ReSUlts. 
Pre-intervention data. Of the 441 surveyed dogs, 267 were male [mean 
age ± standard error: 30.6 ± 1.7 months, range: 3-180 months] and 174 
female [28.2 ± 2.1 months, range: 2-168 months]. Results for both pre -and 
post- intervention surveys are represented in Table 8.1. Although the local 
Ministry of Health [MOH] had apparently killed all I FAT-seropositive dogs one 
month prior to our survey as part of their leishmaniasis control programme, 
baseline prevalences in 01 and 02 were very high, 18.7% [47/251] and 
12.6% [24/190], respectively [Yates-corrected, x2=2.54, p=O.11]. 
Post-intervention data. After five months, 136/251 [54%] and 97/190 
[51%] dogs were re-surveyed in 01 and 02, respectively; 44/251 [18%] and 
40/190 [21 %] dogs had died and 40/251 [16%] and 21/190 [11 %] dogs had 
em igrated from 01 and 02, respectively. 56/136 [41 %] dogs in 01 lost their 
collar during the study, of which 10/136 [7%] had reportedly experienced 
side-effects [skin irritation [n=5], loss of appetite and epitaxis [n=4] and 
trembling [n=1]], so that collars had to be removed. 
Using the diagnostic criteria set out in Chapter 6, an incident ZVL infection 
was defined as a dog that either converted by peR or ELI SA, or by both PCR 
and ELISA. The ZVL incidence in D1 was 13.5% [13/96] [95% C.1. 6.7; 20.4] 
and 21.4% [15/70] [95% C.I. 11.8; 31.0] in 02 [Table 8.1.], i.e. the odds 
ratio [OR] for a ZVL ELiSA/PCR conversion in 01 as compared to D2 was 0.63 
[95% C.I. 0.26; 1.51, Yates-corrected, x2=0.84, p=0.36]. A logistic 
regression analysis incorporating dog sex and pre-intervention ZVL 
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prevalence confirmed the trend [OR 0.62,95% C.I. 0.28; 1.39, p=0.24]. The 
mean change in LAU/ml in D1 dogs was -0.04 LAU/ml [95% C.I. -0.16 to 
0.08] compared to +0.10 LAU/ml [95% C.I. -0.04 to +0.24] in D2 dogs, the 
frequency distribution of which is represented in Figure 8.1. The proportion 
of dogs whose titre increased in 01 [55/136] was significantly less than in 02 
[55/97] [OR 0.52,95% C.I. 0.30; 0.91, Yates-corrected, X2=5.37, p=0.02]. 
Using multiple regression analysis adjusting for dog sex and pre-intervention 
ZVL prevalence it was estim ated that collars reduced the odds of dogs 
increasing their antibody titre by 50% [95% C.1. 0.29-0.87, p=0.01]. 
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I 
44 died 
40 emigrated 
31 lost to follow-up 
I 
Box 3. Study design of the intervention trial. 
August 1999 All infected dogs were culled as part of the Brazilian 
MOH leishmaniasis control campaign, and control and intervention 
areas for current trial were defined . 
• 
r September 1999 441 dogs included in the trial I 
I 
251 collared in 01 I I 190 un collared in 02 I 
40 died 
1..- 21 emigrated 32 lost to follow-up 
, 
March 2000 I I 
March 2000 
136 dogs at the end of the trial 97 dogs at the end of the trial 
To measure the epidemiological impact of collars on canine leishmaniasis 
incidence, ELISA and peR carried out on blood samples taken from 01 and 02 
dogs in September 1999 and in March 2000. 
I 
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Table 8.1. Pre-intervention and post-intervention infection prevalence. 
Treatment area [01}. 
1999 2000 
ELlSA+/PCR+ ELlSA+/PCR- ELlSA-/PCR+ ELlSA-/PCR- -1 Total 
ELlSA+/PCR+ 10 2 4 12 28 
ELlSA+/PCR- 5 1 2 7 15 
ELlSA-/PCR+ 1 2 1 4 
ELlSA-/PCR- 5 3 5 96 95 204 
-1 1 2 2 5 
Total 20 5 8 106 117 256 
Control area [02]. 
1999 2000 
ELlSA+/PCR+ ELlSA+/PCR- ELlSA-/PCR+ ELlSA-/PCR- -1 Total 
ELlSA+/PCR+ 2 3 9 14 
ELlSA+/PCR- 5 1 3 9 
ELlSA-/PCR+ 1 1 
ELlSA-/PCR- 6 4 5 70 81 166 
-1 1 14 3 18 
Total 13 4 6 89 96 208 
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Figure 8.1. Frequency distribution of changes in anti-L. infantum log antibody units/ml. 
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NOTE. 01 , inteNention area with collared dogs; 02, control area with uncollared dogs. 
Mathematical modelling. The total dog population was kept constant , i. e. 8 = 
~ = 0 .0025/ day [data from this study], and the other param eters used were 
cr = 0 .0048/ day (125) and p = 0.0036/ day [data from th is st udy] . Parasites 
take approximately seven days to mature in the sandfly gut [i .e. 'C =7] (176) , 
flies have a life expectancy of 8 days [i.e . 11 = 0 .125] (442) and bite dogs 
every four days (176). The other param eters describ ing sandfly population 
dynamics are unknown [i.e . band m] and were chosen so that equilibrium 
prevalence of infectious dogs was 31 %, which corresponds to a basic 
reproduction number Ro ::::: 10, similar to the Ro observed for canine ZVL in the 
field (177 , 440) . The effect of culling dogs on the prevalence of infectious 
dogs was simulated by assuming that at 180-day pulses , 64% of infected and 
infectious dogs are culled with a 60-day delay between sampling , diagnosis 
and culling (85) . Similarly, the effect of collaring dogs was simulated 
assum ing that collars are applied to 80% of all dogs at each 180-day pulse , 
t hat collars prot ect dogs from 80% of the sandfly bit es, and that t hey rem ain 
on dogs for a mean 167 days [i.e . the collar loss rate is 0.006/day, data from 
this study] . The comparison of collars compared to culling is represented in 
Figure 8.2 .A . using parameters as outl ined above. The impact of cove rage 
rat es on prevalence of infect ious dogs is represent ed in Fig u re 8 .2. B. , 
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whereas the impact of collar loss rates [collar longevity tested: 100,200 and 
300 days] on prevalence of infectious dogs is represented in Figure 8.2.C. 
Using given param eters in our model sim ulations, the equilibrium prevalence 
of infectious dogs was 31% [Figure 8.2.A.]. When dogs are collared at each 
180-day pulse, the prevalence of infectious dogs should drop by 64% 
because 80% of the dogs are protected from 80% of the sandfly bites due to 
the collars. Although the proportion of infective flies initially drops in the 
sim ulations due to the action of collars, prevalence of infectious dogs then 
increases between pulse intervals as the number of unprotected dogs 
increases due both to new- born dogs, and to latent and infectious dogs losing 
their collars [Figure 8.2.A.]. In contrast, assuming that 64% of all latent and 
infectious dogs are culled, prevalence of infectious dogs drops to 12% upon 
the first culling pulse. The prevalence then rapidly increases until the next 
culling pulse due to susceptible dogs becoming latent and infectious. Figure 
8.2.A. dem onst rates that collars have a bigger im pact on the prevalence of 
infectious dogs than culling. Sustained implementation of each method during 
6.5 years should lower the prevalence of infectious dogs to 4.6-12.9% 
[prevalence after and before last pulse] for collaring and to 8.4-17.4% 
[prevalence after and before last pulse] for culling. However, our sim ulations 
also show that the effectiveness of a com m unity-wide application of collars 
would be significantly affected by collar coverage and loss rates [Figure 
8.2.B. and 8.2.C.]. A 25% lower coverage rate at each pulse reduces by 
about half the epidem iological im pact on the prevalence of infectious dogs 
after 6.5 years of collaring. I ncreasing collar longevity by 100 days reduces 
by approxim ately 40% the prevalence of infectious dogs prior the last 
collaring pulse after 6.5 years of collaring. 
148 
A 
B 
C 
Figure 8.2. Epidemiological impact of insecticide-i mpregnated dog collars on 
zoonotic visceral leishmaniasis. 
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8.4. Discussion. 
Epidem iological im pact of DMC on canine ZVL in Capitao Eneas. 
Previous experim ental trials have shown that DMC reduce the biting rate of 
Lu. longipalpis [the ZVL vector in Capitao Eneas and most of Latin America] 
from 81 % to 100% for up to 35 weeks [see Chapter 7]. Based on these and 
similar observations by others, an intervention trial was carried out to 
measure the epidemiological impact of DMC on canine ZVL incidence. 
Although we observed a lower ZVL incidence in collared dogs than in 
uncollared dogs, the effect was not significant; possibly due to the low 
number of tested animals, the high rate of collar loss as compared to other 
studies [8% in Italy (342) and 10% in I ran (210)], the high num ber of 
animals with pre-patent infections during the baseline survey [see below], 
and the possibility that a number of dogs infected during the trial had yet to 
seroconvert by the end of the trial. However, we show that five months after 
collar application, the likelihood of dogs having higher LAU/m I was 
significantly decreased. The change in antibody titre can be seen as an 
approximation for infection, as a positive change in LAU/ml indicates that the 
dog has been exposed to Leishmania parasites. The discrepancy between the 
analyses of the two outcome measures may be because by taking into 
account all positive changes in antibody titre we are able to include new 
cases in the process of seroconverting [i.e. sam pies which otherwise are 
excluded from the relatively arbitrary ELlSA+ category in Table 8.1.] [see 
also Chapter 2]. This approach probably represents a more accurate 
estimate of the ZVL transm ission rate, because the duration of the trial was 
short [five months] and the number of incident infections may have been 
significantly underestimated due to the long [ca. 2 months] ZVL pre-patent 
period (177, 178,439,440). 
Mathematical modelling and implications for dog control. We compared 
the epidem iological im pact of collars and culling using a sim pie vector- borne 
disease model. Although we used conservative estim ates for the effect of 
collars [i.e. 80% coverage rate and 80% protective effect] and optim istic 
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estimates for the effect of culling [i.e. 64% of infected and infectious dogs 
are culled], the model exposes -despite recent contrary claim s (415)- the 
problems associated with the culling strategy. In endemic transmission areas, 
the remaining non-culled, infected and infectious dogs are sufficient to drive 
transm ission over tim e, with newly recruited susceptible dogs rapidly 
acquiring ZVL infection (32, 85,171,176,416,440). The effect of culling 
program m es will additionally be underm ined by the im migration of infected 
dogs into culling areas (85, 416). I t is probable that far m ore infected and 
infectious dogs than the 36% in our model are not culled because they 
rem ain undetected [in part due to the significant ZVL pre-patent period] or 
because owners refuse to have their dogs culled. Also, the diagnostic test 
used [I FAT on filterpaper eluate] to mass-screen dogs is not sensitive enough 
to detect all ZVL infected anim als: one study suggests that up to 65% of ZVL 
dogs are not detected by I FAT-based ZVL diagnosis (85). Moreover, culling 
strategies are ham pered by the long delay between dog sam piing, ZVL 
diagnosis and culling. This delay has been shown to be as high as gO-days 
[we used 60 days in our sim ulations] (85), with infected dogs rem aining 
infectious to sandfly vectors and driving ZVL transmission. These 
observations appear to be confirmed in our study site, as despite the culling 
of infected dogs by the local MOH one month prior to the intervention trial, 
pre- intervention prevalence in 01 and 02 was surprisingly high [m ean 
prevalence: 16%]. 
Our results can be com pared with results from another com m m unity-based 
intervention trial in Italy (342) where the epidem iological im pact of OMC on 
canine ZVL was tested during two consecutive transmission seasons. 
Although seroconversion rates in intervention and control villages were not 
different [2.7% and 5.4%, respectively] after the first transmission season, 
they were shown to be significantly different after the second transmission 
season [3.5% to 25.8%, respectively], with collars providing an estimated 
86% [95% C.1. 55; 96] protection to dogs. 
Whether topical insecticides such as OMC will be effective as leishm aniasis 
control tools will depend on several factors. Firstly, the strategy will be most 
effective in those endem ic areas where dom estic dogs are the main ZVL 
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reservoir and the epidem iological significance of wild reservoirs or stray dogs 
contributing to ZVL transmission is negligible. Secondly, our simulations show 
that in order to achieve a significant epidem iological im pact on ZVL 
transmission, high dog collar coverage rates are essential [Figure 8.2.C.]. 
This will not only require the rapid replacem ent of lost collars [Figure 
8.2.8.], but also the collaring of new dogs recruited into the population; 
where population turnover rates are high, maintaining high coverage rates 
will be a greater logistic challenge, which invariably applies to dog 
populations in tropical, ZVL-endemic countries. 
Conclusion. There is now increasing evidence that DMC not only protect 
dogs from sandfly bites, but also from ZVL. These findings are not only of 
interest to dog owners travelling with their dogs to ZVL-endemic countries, 
but are of potential public health importance: because dogs are ZVL 
reservoirs, the findings im ply that DMC could be effective in cont rolling 
human disease as well. Indeed, preliminary results from a trial in Iran 
indicate that collars significantly reduce the ZVL incidence in both dogs and 
children after one year of collar application (210). Ultim ately, the decision to 
replace the dog culling strategy with com m unity-wide application of DMC will 
depend on [i] the relative cost of the interventions (8); and [ii] the practical 
applicability of DMC in the field [e.g. the willingness of the com m unity to 
apply DMC and the efficiency with which they replace collars which have 
detached]. Clearly, the implementation of DMC on dogs is more likely to have 
the consent of the population at risk than the highly unpopular dog culling 
policy that continues to be practised in some ZVL-endemic countries. 
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PART 3 
CHAPTER 9 
01 SCUSSI ON & CONCLUSION 
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Dogs and their role as zoonotic reservoirs of human disease. It is now 
known that dogs have been part of hum an activities and households ever 
since the em ergence of hum an settlem ents 12 000 to 15 000 years ago 
(333). Today, dogs continue to occupy a major role in human societies. While 
dogs can significantly contribute to the well-being of people [e.g. either as a 
pet, play companion, guard or hunting dog], people can also suffer from 
detrim ental effects due to the contact with dogs, because of inj ury from dog 
bites and because dogs are reservoir host for a range of zoonosis. Over 50 
zoonotic diseases are associated with dom estic dogs [see for review Refs. 
(117, 333)], including infections caused by arthropods [e.g. skin ulcerations 
caused by the sand flea Tunga penetrans and the cat flea Ctenocephalides 
telis telis], cestodes [e.g. cystic echinococcosis caused by Echinococcus 
granulosus and alveolar echinococcosis caused by E. multilocularis, or 
diphyllobothriasis caused by the tapeworm Diphyllobothrium latum], 
nem atodes [e.g. visceral larva m igrans due to Toxocara canis, hookworm 
infections due to Ancylostoma spp. and Ucinaria spp.], trematodes [e.g. 
paragon om iasis caused by Paragonimus spp. Flukes], bacteria [e.g. 
pasteu rellosis caused by Pasteurella canis and salm onellosis caused by 
Salmonella spp.], and viruses [e. g. rabies]. Finally, dogs are also reservoir 
hosts of a range of intestinal [e.g. Entamoeba histolytica and Giardia spp.] 
and blood-borne protozoan parasites [e.g. Trypanosoma spp.], including 
Leishmania infantum, the aetiological agent of ZVL. 
Are domestic dogs reservoirs of human American cutaneous 
leishmaniasis? As discussed in Part 1: I ntroduction there is a growing 
belief that domestic dogs dogs may also act as reservoir hosts of human ACL, 
because [i] t ransm ission of ACL has becom e increasingly evident in the [peri-
]domestic environment; [ii] several studies have reported high ACL infection 
in dogs throughout the Latin American continent; [iii] parasites isolated 
sym patrically from ACL patients and dogs are indistinguishable; and [iv] 
som e studies have shown an association between ACL infection in dogs and 
risk of hum an ACL. However, this evidence to incrim inate dogs as ACL 
reservoirs is largely circumstantial, because the isolation and identification of 
parasites from both patients and dogs as well as the observed high ACL 
prevalence in dogs only suggests that humans and dogs are exposed to the 
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sandfly vector in the sam e way. Also, natural ACL infections have been 
detected in a range of sylvatic animals frequenting the domestic environment 
[e.g. opposums and rodents], and their potential role in the transm ission 
cycle of ACL has rarely been addressed. I n Part 1 of this thesis data are 
presented on a three-year, prospective study of ACL in dogs which was 
carried out to establish whether dogs could act as L. [Viannia] reservoir hosts 
in an area where dom estic transm ission of ACL to humans is apparently 
widesdpread. Though planned xenodiagnosis experim ents could not be 
carried out due to shortage of sandflies, several findings presented in 
Chapters 2-5 are strong enough to incrim inate dogs as reservoir hosts of 
[peri- ]domestic L. [Viannia] transmission in Huanuco, Peru. First, whereas 
the prevalence and incidence of clinical disease is low, the prevalence and 
incidence of L. [Viannia] infection in dogs is comparatively high. Second, the 
average duration of infection can be as long as the mean life expectancy of a 
dog. Third, L. [Viannia] parasites in dogs do not remain localised at the site 
of inoculation but are able to dissem inate to both viscera and mucosa. 
Fourth, the detection of L. [Viannia] parasites by PCR in the blood of a high 
proportion of both symptomatic and asymptomatic dogs suggests that 
infected dogs are potentially infectious to sandfly vectors. Fifth, after 
controlling for inter-village differences in transmission rates, household dog 
ownership was shown to be a significant risk factor for human ACL. This 
incrim inatory evidence is further strengthened because of the apparent 
absence or low abundance [e.g. opposum s] of alternative [sylvatic] reservoir 
hosts that would be able to maintain domestic L. [Viannia] transmission in 
Huanuco. Rodents are at a density that would be able to maintain domestic L. 
[Viannia] transmission over such a wide area and their role as ACL reservoir 
host should be investigated in future epidem iological studies. The results 
presented here show that were dogs the main ACL reservoir host, a dog 
control strategy in the study villages in Huanuco would be very feasible and 
effective, because the control effort to reduce Ro< 1 would be comparatively 
small. Such an intervention should also provide the ultimate proof in the 
incrim ination of dogs as ACL reservoir hosts, as -if such an intervention 
strategy were successful- it should have a significant epidem iologial im pact 
on human ACL transmission. 
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Are PCR-based diagnostic methods or immunochromatographic 
dipstick test useful for mass-screening of dogs in epidemiological 
studies or control program m es? Several studies have suggested that 
PCR-based methods for Leishmania diagnosis may provide the best gold 
standard for determ ining the presence and identity of leishm anial infections 
not only when diagnosing active cases, but also for monitoring parasitological 
cure of patients after chemotherapy and as a mass-screening tool to detect 
Leishmania infections in vertebrate hosts or sandfly vectors. Various PCR 
protocols have been reported for the detection of ACL-causing Leishmania in 
humans using either purified DNA [from cultured parasites or clinical 
specim ens, including lesion and scar biopsies or blood] and have consistently 
proven to be more sensitive than other diagnostic methods, including in vitro 
culture of biopsies, biopsy smears and hamster inoculation. In the work 
presented in Chapter 2 the utility of a PCR as a diagnostic mass-screening 
tool in epidem iological studies was evaluated. Specifically, the sensitivity and 
specificity of established PCR protocols on canine blood and bone marrow 
were com pared to an ELI SA for detecting L. [Vianniaj spp. infection in dogs. 
A PCR- based assay on blood is advantageous as sam pies can be obtained 
less invasively from the patient [human or dog] and are easy to process. 
Although a positive PCR-hybridisation was associated with a higher anti-
Leishmania antibody titre, the ELISA test was much more sensitive than PCR 
in detecting Leishmania infection in symptomatic and asymptomatic field 
dogs. We also show that the choice of biopsy material does not appear to be 
as critical as for studies using PCR to diagnose hum an ACL patients [skin 
snips, lesion aspirates], as the sensitivity of the PCR on GBL, BCS or BMS was 
not significantly different. Thus, PCR on blood alone does not appear to be 
the elusive 'gold standard' for diagnosing ACL infections in dogs [or humans] 
and to be used as a mass-screening tool in epidem iological and intervention 
studies. Unless a more sensitive PCR protocol [e.g. PCR-ELlSA] is developed 
to detect asymptomatic ACL infections, the use of PCR will be restricted to 
the diagnosis of active cases. The use of PCR on blood could, however, have 
an im portant epidem iological application in studies to monitor the clinical and 
chemotherapeutic follow-up of patients with ACL. Detection of disseminating 
Leishmania parasites in patient blood would indicate that they are at risk of 
developing mucocutaneous lesions, the treatm ent of which is more 
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complicated than the treatment of the single lesions characteristic of ACL. 
Also, PCR com bined with specific DNA probing and sequencing should help to 
identify and characterise those strains that are drug resistant and that cause 
the different clinical pathologies associated with ACL. 
As outlined in Part 2: I ntroduction, one of the reasons why dog culling 
prog ram m es have failed is because of the long delay between sam pie 
collection, sample analysis and control implementation [Le. culling of infected 
dogs]. This delay typically is 30 days long, but can be as long as 120 days, 
with infected dogs remaining infectious to sandfly vectors during this period, 
thereby transm itting ZVL to susceptible dogs and humans. Current diagnostic 
methods used for Leishmania mass-screening surveys [mainly ELISA, I FAT or 
OAT] lack sensitivity or specificity, require technological expertise and 
specialised laboratory equipment, and can be labour-intensive and time-
consuming. Hence, a rapid, sensitive and specific diagnostic test would be 
ext rem ely valuable in m ass-screening surveys and intervention cam paigns, 
as results could be read immediately and control measures could be 
implemented in situ. 1m plem entation coverage rates would be im proved [e.g. 
dog owners would have less opportunity to hide their dogs from culling 
personnel] and the control intervention would be more effective. I n Chapter 
6 the sen sit ivity and specificity of a com m ercially available 
immunochromatographic rK39 dipstick test were compared to the sensitivity 
and specificity of standard serological and molecular diagnostic tests [ELI SA 
and PCR] used in canine ZVL diagnosis. Although the dipstick test was 
com parable to ELI SA and PCR in term s of sensitivity, specificity was 
surprisingly low. This finding contradicts previous studies reporting high 
sensitivities and specificities of the rk39 dipstick when tested to detect ZVL 
infections in humans. The research into developing a more specific 
Leishmania dipstick test should be pursued, as the advantage of such a tool 
with respect to other diagnostic methods such as microscopy, ELI SA or PCR 
are m any-fold. Using dipsticks, a vast num ber of sam pies can be processed 
quickly and with minim um effort. Com pared to microscopy, ELI SA or PCR, 
minim al technological expertise and specialised laboratory equipm ent are 
required. Another advantage of dipstick tests is that patients [in this case, 
dog owners] can see the results for themselves, which should contribute to a 
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better working relationship between local com m unities and people carrying 
out the surveys, and increase com pliance rates. Epidem iologically, the most 
important characteristic of a dipstick test is that it allows interventions to be 
implemented in situ. The outcome should be to significantly reduce the mean 
duration of infectiousness of dogs that have become infected, thereby 
significantly enhancing the impact of the intervention on the basic 
reproductive number, Ro. Immunochromatographic dipstick tests are 
comparatively expensive, but considering the above, a sensitive and specific 
dipstick test could prove a very cost-effective alternative to currently 
available diagnostic tests, especially when used in mass-screening surveys. 
Can topical insecticides be used to control canine and human 
leishmaniasis? Domestic dogs are established reservoir hosts of ZVL caused 
by L. infantum [Part 2: I ntroduction]. Hence, one of the approaches to 
reduce the incidence of human ZVL is to cull infected dogs. Critics have cast 
doubt on the impact of such dog culling programmes on human and canine 
ZVL incidence on both theoretical and practical grounds, and because results 
of controlled intervention trials are equivocal. Others remain adamant that 
culling is effective in reducing canine and human ZVL incidence. The costly 
treatment of ZVL infected dogs is not a feasible control strategy because 
treated and clinically cured dogs often relapse as they remain 
parasitologically positive and, hence, are infectious to the sandfly vector. 
Whilst waiting for an effective canine or human vaccine, alternative control 
strategies are paramount. The findings of a comparative study testing topical 
insecticides and applications to protect dogs from sandfly bites were 
presented in Chapter 7. It was shown that whilst permethrin and fenthion 
pour-on lotions had a more immediate effect on sandfly biting rates and 
mortality, deltam ehtrin-im pregnated collars [DMC] had a m ore prolonged 
protective effect, with the survival rate of bloodfed sandflies reduced by up to 
86% after two months of deltamethrin collar application. 
I n the work described in Chapter 8 the effectiveness of DMC to control 
canine ZVL was tested in a matched cluster intervention trial. Possible 
constraints associated with a com m unity-wide im plem entation of a dog collar 
ZVL control strategy were also investigated using mathematical modelling. 
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Although ZVL incidence was 32% lower in collared as com pared to uncollared 
dogs after five months collar application, the difference was not significant. 
However, DMC did significantly reduce the odds of dogs increasing their anti-
Leishmania antibody titre. Whether topical insecticides such as DMC will be 
effective as leishmaniasis control tools will depend on several factors. Firstly, 
the strategy will be most effective in those endem ic areas where dom estic 
dogs are the main ZVL reservoir and the epidemiological significance of wild 
reservoirs or stray dogs contributing to ZVL transm ission is negligible. 
Secondly, in order to achieve a significant epidem iological im pact on ZVL 
transm ission, high dog collar coverage rates are essential. This will not only 
require the rapid replacement of lost collars, but also the collaring of new 
dogs recruited into the population; where population turnover rates are high, 
maintaining high coverage rates will be a greater logistic challenge, which 
invariably applies to dog populations in tropical, ZVL-endemic countries. 
Ultimately, the decision to replace the dog culling strategy with community-
wide application of DMC will depend on [i] the relative cost of the 
interventions; and [ii] the practical applicability of DMC in the field [e.g. the 
willingness of the community to apply DMC and the efficiency with which they 
replace collars which have detached]. Clearly, the im plem entation of DMC on 
dogs is more likely to have the consent of the population at risk than the 
highly unpopular dog culling policy that continues to be practised in some 
ZVL- endemic countries. 
Future recommendations. The objectives of this thesis were to [i] 
investigate whether dom estic dogs are im portant reservoir hosts of ACL; and 
[ii] to identify the shortcom ings of currently practiced dog control 
program m es and to evaluate whether topical insecticides could be used to 
control canine leishmaniasis. Based on the findings presented in this thesis, 
the following recommendation can be made: 
[1] Research into the developm ent of a sensitive and specific, rapid 
diagnostic test for leishmaniasis [e.g. dipstick test, or field-based PCR-ELlSA] 
should be pursued, as not only would this facilitate the im plem entation of 
epidem iological st udies, but also considerably im prove the effectiveness of 
implemented control strategies. 
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[2] Further epidem iological studies should be carried out in Huanuco in order 
to exclude that [peri-] dom estic an im als [e. g. rodents] other than dogs can 
maintain the domestic transmission of L. [Vianniaj to humans. 
[3] A dog control trial [e.g. using deltamethrin-impregnated dog collars] 
should be carried out in Huanuco, Peru, as data presented in this thesis 
suggests that such an intervention strategy could have a significant 
epidem iological im pact on ACL transm ission to hum ans. This also would 
provide the irrefutable proof to incriminate dogs as ACL reservoir hosts. 
[4] The dog culling programmes [such as the one carried out in Brazil] should 
be stopped as they have only a lim ited epidem iological im pact on the ZVL 
transm ission to hum ans due to several logistical and methodological 
problems associated with its implementation. 
[5] A dog control program m e using deltam ethrin- im pregnated dog collars 
should be im plem ented in [highly] endem ic ZVL areas in order to reduce the 
incidence of human disease, because data presented here showed that collars 
can protect dogs from both sandfly bites and exposure to L. infantum. Data 
from other collar intervention trials currently being carried out in Brazil and 
I ran should also show the effect of collar loss, collar coverage and collar field 
efficacy on the effectiveness of the collar intervention strategy. 
160 
REFERENCES 
161 
1. Abranches, P., G. Santos-Gomes, N. Rachamim, L. Campino, L. 
F. Schnur, and C. L. Jaffe 1991. An experimental model for canine 
visceral leishmaniasis. Parasite Immunol. 13:537-50. 
2. Aebischer, T., S. F. Moody, and E. Handman 1993. Persistence of 
virulent Leishmania major in m urine cutaneous leishm aniasis: a 
possible hazard for the host. Infect Immun. 61 :220-6. 
3. Aguilar, C. M., E. Fernandez, R. de Fernandez, and L. M. Deane 
1984. Study of an outbreak of cutaneous leishmaniasis in Venezuela. 
The role of domestic animals. Mem Inst Oswaldo Cruz. 79:181-95. 
4. Aguilar, C. M., and E. F. Rangel 1986. [Cutaneous leishmaniasis in a 
mule (Equus cabal/us x Equus asinus) in an endem ic area of the State 
of Rio de Janeiro]. Mem Inst Oswaldo Cruz. 81 :239-40. 
5. Aguilar, C. M., E. F. Rangel, L. Garcia, E. Fernandez, H. Momen, 
G. Grimaldi Filho, and Z. De Vargas 1990. Zoonotic cutaneous 
leishm aniasis due to Leishmania (Viannia) braziliensis associated with 
domestic animals in Venezuela and Brazil. Mem Inst Oswaldo Cruz. 
84:19-28. 
6. Aguilar, C. M., E. F. Rangel, G. Grimaldi Filho, and H. Momem 
1987. Human, canine and equine leishmaniasis caused by Leishmania 
braziliensis braziliensis in an endem ic area in the State of Rio de 
Janeiro. Mem Inst Oswaldo Cruz. 82:143. 
7. Akendengue, B., E. Ngou-Milama, A. Laurens, and R. 
Hocquemiller 1999. Recent advances in the fight against 
leishmaniasis with natural products. Parasite. 6:3-8. 
8. Akhavan, A. A. 1996. Analise de custo-efetividade do componente de 
leishmaniose no projeto de controle de doengas endemicas no nordeste 
do Brasil. Rev Patol Trop 25:203-52. 
9. Alcais, A., L. Abel, C. David, M. E. Torrez, P. Flandre, and J. P. 
Dedet 1997. Evidence for a major gene controlling susceptibility to 
tegum entary leishm aniasis in a recently exposed Bolivian population. 
Am J Hum Genet. 61 :968- 79. 
162 
10. 
11. 
12. 
Alexander, B. 1987. Dispersal of phlebotomine sand flies (Diptera: 
Psychodidae) in a Colom bian coffee plantation. J Med Entom 01. 
24:552-8. 
Alexa nder, B. 2000. Sam piing methods for phlebotom ine sandflies. 
Med Vet Entomol. 14:109-22. 
Alexander, B., H. Cadena, M. C. Usma, and C. A. Rojas 1995. 
Laboratory and field evaluations of a repellent soap containing diethyl 
toluam ide (DEET) and perm ethrin against phlebotom ine sand flies 
(Diptera: Psychodidae) in Valle del Cauca, Colombia. Am J Trop Med 
Hyg. 52: 169- 73. 
13. Alexander, B., C. Jaramillo, M. C. Usma, B. L. Quesada, H. 
Cadena, W. Roa, and B. L. Travi 1995. An attempt to control 
Phlebotom ine sand flies (Diptera: Psychodidae) by residual spraying 
with deltam ethrin in a Colom bian village. Mem I nst Oswaldo Cruz. 
90:421-4. 
14. Alexander, B., C. Lozano, D. C. Barker, S. H. McCann, and G. H. 
Adler 1998. Detection of Leishmania (Viannia) braziliensis complex in 
wild m am m als from Colom bian coffee plantations by PCR and DNA 
hybridization. Acta Trop. 69:41- 50. 
15. Alexander, B., M. C. Usma, H. Cadena, B. L. Quesada, Y. Solarte, 
W. Roa, J. Montoya, C. Jaram illo, and B. L. Travi 1995. 
Phlebotom ine sandflies associated with a focus of cutaneous 
leishmaniasis in Valle del Cauca, Colombia. Med Vet Entomol. 9:273-8. 
16. Alexander, B., M. C. Usma, H. Cadena, B. L. Quesada, Y. Solarte, 
W. Roa, and B. L. Travi 1995. Evaluation of deltamethrin-
im pregnated bednets and curtains against phlebotom ine sandflies in 
Valle del Cauca, Colombia. Med Vet Entomol. 9:279-83. 
17. Alexander, B., and D. G. Young 1992. Dispersal of phlebotomine 
sand flies (Diptera: Psychodidae) in a Colom bian focus of Leishmania 
(Viannia) braziliensis. Mem Inst Oswaldo Cruz. 87:397-403. 
18. Allen, J. E., and R. M. Ma ize Is 1997. Th 1-Th2: reliable paradigm or 
dangerous dogma? Immunol Today. 18:387-92. 
163 
19. Almeida, M. C., C. A. Cuba-Cuba, M. A. Moraes, and M. A. Miles 
1996. Dissem ination of Leishmania (Viannia) braziliensis. J Com p 
Pathol. 115:311-6. 
20. Alvar, J., C. Canavate, B. Gutierrez-Solar, M. Jimenez, F. 
Laguna, R. Lopez-Velez, R. Molina, and J. Moreno 1997. 
Leishmania and human immunodeficiency virus coinfection: the first 10 
years. Clin Microbiol Rev. 10:298-319. 
21. Alvar, J., B. Gutierrez-Solar, I. Pachon, E. Calbacho, M. Ramirez, 
R. Valles, J. L. Guillen, C. Canavate, and C. Amela 1996. AIDS and 
Leishmania infantum. New approaches for a new epidemiological 
problem. Clin Dermatol. 14:541-6. 
22. Alvar, J., R. Molina, M. San Andres, M. Tesouro, J. Nieto, M. 
Vitutia, F. Gonzalez, M. D. San Andres, J. Boggio, F. Rodriguez, 
and et al. 1994. Canine leishmaniasis: clinical, parasitological and 
entom ological follow- up after chem otherapy. Ann Trop Med Parasitol. 
88:371-8. 
23. Amela, C., I. Mendez, J. M. Torcal, G. Medina, I. Pachon, C. 
Canavate, and J. Alvar 1995. Epidemiology of canine leishmaniasis in 
the Madrid region, Spain Eur J Epidemiol. 11 :157-61. 
24. Anderson, R. M., and R. M. May 1992. Infectious Diseases of 
Humans. Oxford Science Publications, Oxford. 
25. Andrade, S. L., Confort, E. M, Toledo, L. M., and Romero, G. A. S. 
1999. Leishmaniose tegumentar americana em area de ocupacao 
recente na periferia da cidade de Manaus, Estado do Amazonas, Brasil 
-inquerito canino. Revista da Sociedade Brasileira de Medicina Tropical. 
32 {Supplement 1):253. 
26. Anstead, G. M., B. Chandrasekar, W. Zhao, J. Yang, L. E. Perez, 
and P. C. Melby 2001. Malnutrition alters the innate immune response 
and increases early visceralization following Leishmania donovani 
infection. Infect Immun. 69:4709-18. 
27. Aragort de Rossell, R., O. Rossell, R. de Jesus de Duran, and A. 
M. Rodriguez 1993. Thermotherapy v. antimonials: what happens 
164 
after the healing of cutaneous leishmaniasis lesions? Ann Trop Med 
Parasitol. 87:23- 30. 
28. Armijos, R. X., M. E. Chico, M. E. Cruz, R. H. Guderian, R. D. 
Kreutzer, J. D. Berman, M. D. Rogers, and M. Grogl 1990. Human 
cutaneous leishmaniasis in Ecuador: identification of parasites by 
enzyme electrophoresis. Am J Trop Med Hyg. 42:424-8. 
29. Armijos, R. X., M. M. Weigel, R. Izurieta, J. Racines, C. Zurita, 
W. Herrera, and M. Vega 1997. The epidemiology of cutaneous 
leishmaniasis in subtropical Ecuador. Trop Med Int Health. 2: 140- 52. 
30. Arraes, S. M. A. A., Zanzarini, P. D., and Rodrigues, M. 1999. 
Situation of dogs in endemic area of American tegumentar 
leishmaniasis. Mem6rias do Instituto Oswaldo Cruz. 94 (Supplement 
11):80. 
31. Ashford, D. A., M. Bozza, M. Freire, J. C. Miranda, I. Sherlock, C. 
Eulalio, U. Lopes, O. Fernandes, W. Degrave, R. H. Barker, Jr., 
and et al. 1995. Comparison of the polymerase chain reaction and 
serology for the detection of canine visceral leishmaniasis. Am J Trop 
Med Hyg. 53:251-5. 
32. Ashford, D. A., J. R. David, M. Freire, R. David, I. Sherlock, M. C. 
Eulalio, D. P. Sampaio, and R. Badaro 1998. Studies on control of 
visceral leishmaniasis: impact of dog control on canine and human 
visceral leishm aniasis in Jacobina, Bahia, Brazil. Am J Trop Med Hyg. 
59:53-7. 
33. Ashford, R. W. 1996. leishmaniasis reservoirs and their significance in 
control. Clin Dermatol. 14:523-32. 
34. Avila, H. A., J. B. Pereira, O. Thiemann, E. De Paiva, W. DeGrave, 
C. M. Morel, and L. Simpson 1993. Detection of Trypanosoma cruzi 
in blood specim ens of chronic chagasic patients by polym erase chain 
reaction am plification of kinetoplast m inicircle DNA: com parison with 
serology and xenodiagnosis. J Clin Microbiol. 31 :2421-6. 
35. Avila, H. A., D. S. Sigman, L. M. Cohen, R. C. Millikan, and L. 
Simpson 1991. Polym erase chain reaction am plification of 
165 
Trypanosoma cruzi kinetoplast m inicircle DNA isolated from whole 
blood Iysates: diagnosis of chronic Chagas' disease. Mol Biochem 
Parasitol. 48:211-21. 
36. Aviles, H., A. Belli, R. Armijos, F. P. Monroy, and E. Harris 1999. 
PCR detection and identification of Leishmania parasites in clinical 
specim ens in Ecuador: a com parison with classical diagnostic methods. 
J Parasitol. 85: 181-7. 
37. Badaro, R. 1988. Progress of research in visceral leishmaniasis in the 
endemic area of Jacobina-Bahia 1934-1989. Rev Soc Bras Med Trop. 
21:159-64. 
38. Badaro, R., D. Benson, M. C. Eulalio, M. Freire, S. Cunha, E. M. 
Netto, D. Pedral-Sampaio, C. Madureira, J. M. Burns, R. L. 
Houghton, J. R. David, and S. G. Reed 1996. rK39: a cloned antigen 
of Leishmania chagasi that predicts active visceral leishmaniasis. J 
Infect Dis. 173:758-61. 
39. Badaro, R., and W. D. Johnson, Jr. 1993. The role of interferon-
gam m a in the treatm ent of visceral and diffuse cutaneous 
leishmaniasis. J Infect Dis. 167 Suppl1 :813-7. 
40. Badaro, R., T. C. Jones, E. M. Carvalho, D. Sam paio, S. G. Reed, 
A. Barral, R. Teixeira, and W. D. Johnson, Jr. 1986. New 
perspectives on a subclinical form of visceral leishm aniasis. J Infect 
Dis. 154:1003-11. 
41. Badaro, R., T. C. Jones, R. Lorenco, B. J. Cerf, D. Sampaio, E. M. 
Carvalho, H. Rocha, R. Teixeira, and W. D. Johnson, Jr. 1986. A 
prospective study of visceral leishmaniasis in an endemic area of 
Brazil. J Infect Dis. 154:639-49. 
42. Bancroft, J. D. 1967. An introduction to histochemical technique. 
Butterworths, London. 
43. Banuls, A. L., R. Jonquieres, F. Guerrini, F. Le Pont, C. Barrera, 
I. Espinel, R. Guderian, R. Echeverria, and M. Tibayrenc 1999. 
Genetic analysis of Leishmania parasites in Ecuador: are Leishmania 
166 
(Viannia) panamensis and Leishmania (V.) Guyanensis distinct taxa? 
Am J Trop Med Hyg. 61 :838- 45. 
44. Banzet, S. 2000. [Epidem ics of cutaneous leishm aniasis in military 
personnel working in French GUiana] Med Trop (Mars). 60:297-302. 
45. Barbosa, E. G. 0., M. Marzochi, E. Almeida, and V. L. Silva 1990. 
Evaluation of skin test efficiency to the diagnosis of canine 
mucocutaneous leishm aniasis by Leishmania (Viannia) braziliensis. 
Mem Inst Oswaldo Cruz. 85 (Supplement 11):93. 
46. Barbosa, E. G. 0., M. Marzochi, N. F. Conceicao, C. M. M. Brito, 
and R. S. Pacheco 1998. N-methylglucamine antimonate (SbV+): 
intralesional canine tegumentary leishmaniasis therapy. Parasite 
5:175-80 
47. Barbosa, E. G. 0., M. Marzochi, N. F. Concei~ao, V. L. Silva, and 
P. C. T. Silva 1987. Canine epidemiological survey in an endemic area 
of American cutaneous leishmaniasis (Mesquita, Rio de Janeiro). Mem 
Inst Oswaldo Cruz. 82 (Supplement II): 164. 
48. Barbosa, G. M., M. C. Marzochi, C. L. Massard, G. P. Lima, and E. 
M. Confort 1999. [Epidem iological aspects of canine Am erican 
tegumentary leishmaniasis in the Municipality of Paraty, State of Rio de 
Janeiro, brazil]. Cad Saude Publica. 15:641-6. 
49. Barbosa-Santos, E. G., M. C. Marzochi, W. Urtado, F. Queiros, J. 
Chicarino, and R. S. Pacheco 1994. leishmaniasis disseminated by 
Leishmania braziliensis in a mare (Equus cabalus) im m unotherapy and 
chemotherapy assays. Mem Inst Oswaldo Cruz. 89:217-20. 
50. Barbosa-Santos, E. G. 0., Marzochi, M. C. A., Conceicao, N. F., 
Paranhos, M. A. S., Silva, V. L., and Souza, M. B. 1988. Inquerito 
epidem iol6gico canino e entom 016gico em area endem ica de 
leishmaniose cutanea no Rio de Janeiro (Pacuf-Jacarepagua). Revista 
da Sociedade Brasileira de Medicina Tropical. 21 (Supplem ent 
11):81-82. 
51. Barral, A., M. Barral-Netto, R. Almeida, A. R. de Jesus, G. 
Grimaldi Junior, E. M. Netto, I. Santos, O. Bacellar, and E. M. 
167 
Carvalho 1992. Lymphadenopathy associated with Leishmania 
braziliensis cutaneous infection. Am J Trop Med Hyg. 47:587-92. 
52. Barral, A., J. Guerreiro, G. Bomfim, D. Correia, M. Barral-Netto, 
and E. M. Carvalho 1995. Lymphadenopathy as the first sign of 
hum an cutaneous infection by Leishmania b razilien sis. Am J Trop Med 
Hyg.53:256-9. 
53. Barral, A., Pedral-Sampaio, D., Grimaldi Junior, G., Momen, H., 
McMahon-Pratt, D., Ribeiro de Jesus, A." and R. Almeida, 
Badaro, R., Barral-Netto, M., Carvalho, E. M., et al. 1991. 
leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis 
produces a wide spectrum of clinical disease. Am J Trop Med Hyg. 
44:536-46. 
54. Barral-Netto, M., and A. Barral 1994. Transforming growth factor-
beta in tegumentary leishmaniasis. Braz J Med Bioi Res. 27:1-9. 
55. Barral-Netto, M., A. Barral, C. E. Brownell, V. A. Skeiky, L. R. 
Ellingsw orth, D. R. Twardzik, and S. G. Reed 1992. Transform ing 
growth factor-beta in Leishmanial infection: a parasite escape 
mechanism. Science. 257:545-8. 
56. Barretto, A. C., C. Cuba Cuba, J. A. Vexenat, A. C. Rosa, P. D 
Marsden, and A. V. Magalhaes 1984. Caracteristicas epidemiologicas 
da leishm aniose tegum entar am ericana em una regiao endem ica do 
estado da Bahia. II Leishmaniose canina. Rev Soc Bras Med Trop 17: 
59-65. 
57. Barretto, A. C., C. A. Cuba, P. D. Marsden, J. A. Vexanat, and M. 
De Belder 1981. [Epidemiological features of cutaneous leishmaniasis 
am ericana in an endem ic region of the state of Bahia, Brazil. I. Hum an 
leishmaniasis]. Bol Oficina Sanit Panam. 90:415-24. 
58. Becker, S., and C. L. Jaffe Effect of protein kinase inhibitors on the 
growth, morphology, and infectivity of Leishmania promastigotes. 
59. Belkaid, V., S. Kamhawi, G. Modi, J. Valenzuela, N. Noben-
Trauth, E. Rowton, J. Ribeiro, and D. L. Sacks 1998. Development 
of a natural model of cutaneous leishmaniasis: powerful effects of 
168 
vector saliva and saliva preexposure on the long-term outcome of 
Leishmania major infection in the mouse ear derm is. J Exp Med. 
1 88: 1 941 - 53. 
60. Belkaid, Y., S. Mendez, R. Lira, N. Kadambi, G. Milon, and D. 
Sacks 2000. A natural model of Leishmania major infection reveals a 
prolonged "silent" phase of parasite amplification in the skin before the 
onset of lesion formation and immunity. J Immunol. 165:969-77. 
61. Belli, A., D. Garcia, X. Palacios, B. Rodriguez, S. Valle, E. Videa, 
E. Tinoco, F. Marin, and E. Harris 1999. Widespread atypical 
cutaneous leishmaniasis caused by Leishmania (L.) Chagasi in 
Nicaragua. Am J Trap Med Hyg. 61 :380-5. 
62. Belli, A., B. Rodriguez, H. Aviles, and E. Harris 1998. Simplified 
polymerase chain reaction detection of new world Leishmania in clinical 
specimens of cutaneous leishmaniasis. Am J Trap Med Hyg. 58: 102- 9. 
63. Berger, T. G., M. S. Meltzer, and C. N. Oster 1985. Lymph node 
involvement in leishmaniasis. J Am Acad Dermatol. 12:993-6. 
64. Berman, J. D. 1997. Human leishmaniasis: clinical, diagnostic, and 
chem otherapeutic developm ents in the last 10 years. Clin I nfect Dis. 
24:684- 703. 
65. Berman, J. 0.1996. Treatment of New World cutaneous and mucosal 
Leishmaniases. elin Dermatol. 14:519-22. 
66. Bern, C., S. N. Jha, A. B. Joshi, G. D. Thakur, and M. B. Bista 
2000. Use of the recombinant K39 dipstick test and the direct 
agglutination test in a setting endem ic for visceral leishmaniasis in 
Nepal. Am J Trap Med Hyg. 63:153-7. 
67. Berrahal, F., C. Mary, M. Roze, A. Berenger, K. Escoffier, D. 
Lamouroux, and S. Dunan 1996. Canine leishmaniasis: identification 
of asym ptom atic carriers by polym erase chain reaction and 
immunoblotting. Am J Trop Med Hyg. 55:273- 7. 
68. Bertho, A. L., M. A. Santiago, A. M. Da-Cruz, and S. G. Coutinho 
2000. Detection of early apoptosis and cell death in T CD4+ and CD8+ 
169 
cells from lesions of patients with localized cutaneous leishmaniasis. 
Braz J Med Bioi Res. 33:317-25. 
69. Bezerra, H. S., J. R. Viana, M. J. Texeira, C. S. Chaves, B. Bastos 
de Araujo, and J. H. Lima Filho 1996. [Evaluation of direct 
agglutination tests in the detection of Leishmania (Viannia) braziliensis 
in possible reservoirs of cutaneous Am erican leishm aniasis in the state 
of Ceara] Rev Soc Bras Med Trap. 29:181-4. 
70. Bezerra, H. S., and M. J. Teixeira 2001. Effect of Lutzomyia 
whitmani (Diptera: Psychodidae) salivary gland Iysates on Leishmania 
(Viannia) braziliensis infection in BALB/c mice. Mem Inst Oswaldo Cruz. 
96:349-51. 
71. Bezold, G., M. Lange, K. Gethoffer, H. Pillekamp, H. Reindl, C. 
Richter, G. Schonian, L. Weber, and R. U. Peter 2001. Competitive 
polym erase chain reaction used to diagnose cutaneous leishm aniasis in 
German soldiers infected during military exercises in French Guiana. 
Eur J Clin Microbial Infect Dis. 20:421-4. 
72. Blackwell, J. 1999. Tumour necrosis factor alpha and mucocutaneous 
leishmaniasis. Parasitol Today. 15:73-5. 
73. Blackwell, J. M. 1998. Genetics of host resistance and susceptibility 
to intram acrophage pathogens: a study of m ulticase fam ilies of 
tuberculosis, leprosy and leishm aniasis in north-eastern Brazil. I nt J 
Parasitol. 28:21-8. 
74. Blackwell, J. M. 1992. leishmaniasis epidemiology: all down to the 
DNA Parasitology. 104:S19-34. 
75. Blank, C., H. Fuchs, K. Rappersberger, M. Rollinghoff, and H. 
Moll 1993. Parasitism of epidermal Langerhans cells in experimental 
cutaneous leishm aniasis with Leishmania major. J I nfect Dis. 167:418-
25. 
76. Bogdan, C., and M. Rollinghoff 1998. The immune response to 
Leishmania: mechanisms of parasite control and evasion. Int J 
Parasitol. 28: 121- 34. 
170 
77. Bogdan, C., G. Schonian, A. L. Banuls, M. Hide, F. Pratlong, E. 
Lorenz, M. Rollinghoff, and R. Mertens 2001. Visceral leishmaniasis 
in a German child who had never entered a known endemic area: case 
report and review of the literature. Clin Infect Dis. 32:302-6. 
78. Bogdan, C., S. Stenger, M. Rollinghoff, and W. Solbach 1991. 
Cytokine interactions in experim ental cutaneous leishmaniasis. 
I nterleukin 4 synergizes with interferon-gam m a to activate murine 
macrophages for killing of Leishmania major amastigotes. Eur J 
Immunol. 21 :327-33. 
79. Bonfante-Garrido, R., E. Melendez, R. Torres, N. Morillo, C. 
Arredondo, and I. Urdaneta 1981. Enzootic equine cutaneous 
leishmaniasis in Venezuela. Trans R Soc Trop Med Hyg. 75:471. 
80. Bonfante-Garrido, R., N. Morillo, and R. Torres 1981. [Canine 
cutaneous leishmaniasis in Venezuela]. Bol Oficina Sanit Panam. 
91 :160-5. 
81. Borges, A. S., A. A. Machado, M. S. Ferreira, J. F. de Castro 
Figueiredo, G. F. Silva, S. Cimerman, H. A. Bacha, and M. C. 
Teixeira 1999. [Concurrent leishmaniasis and human 
immunodeficiency virus (HIV) infection: a study of four cases]. Rev 
Soc Bras Med Trop. 32:713- 9. 
82. Borges Filho GM, G. D., Michalick MSM, Mayrink W, Couto MOR, 
Rocha MOC 1994. Estudo eco-epidemiologico da leishmaniose 
tegum entar am ericana (L TA) no Bairro Sevilha, Ribeirao das Neves 
(regiao m etropolitana de Belo Horizonte): inform es prelim inares. Rev 
Soc Bras Med Trop. 27 (Supplement 11):247. 
83. Bosque, F., N. G. Saravia, L. Valderrama, and G. Milon 2000. 
Distinct innate and acquired im m une responses to Leishmania in 
putative susceptible and resistant hum an populations endem ically 
exposed to L. (Viannia) panamensis infection. Scand J Immunol. 
51 :533-41. 
84. Bowdre JH, C. J., Walker DH, Tart DE. 1981. American 
mucocutaneous leishmaniasis. Culture of a Leishmania species from 
peripheral blood leukocytes. Am J Clin Pathol. 75:435-438. 
171 
85. Braga, M. D., I. C. Coelho, M. M. Pompeu, T. G. Evans, I. T. 
MacAullife, M. J. Teixeira, and J. W. Lima 1998. [Control of canine 
visceral leishmaniasis: com parison of results from a rapid elim ination 
program of serum - reactive dogs using an im m unoenzym e assay and 
slower elim ination of serum - reactive dogs using filter paper elution 
indirect immunofluorescence]. Rev Soc Bras Med Trop. 31 :419- 24. 
86. Brandao Filho, S. , M. E. de Brito, C. A. Martins, I. B. Sommer, H. 
F. Valenca, F. A. Almeida, and J. Gomes. 1998. [American 
cutaneous leishmaniasis in a military training center located in Zona da 
Mata, Pernambuco, Brazil]. Rev Soc Bras Med Trop. 31 :575- 8. 
87. Brandao-Filho, S. P., D. Campbell-Lendrum, M. E. Brito, J. J. 
Shaw, and C. R. Davies 1999. Epidem iological surveys confirm an 
increasing burden of cutaneous leishmaniasis in north-east Brazil. 
Trans R Soc Trop Med Hyg. 93:488- 94. 
88. Brandao-Filho, S. P., F. G. de Carvalho, M. E. de Brito, F. 
Almeida, and L. A. Nascimento 1994. American cutaneous 
leishmaniasis in Pernambuco, Brazil: eco- epidemiological aspects in 
'Zona da Mata' region. Mem Inst Oswaldo Cruz. 89:445- 9. 
89. Brecelj, M., F. Pikelj, F. Gubensek, and G. Anderluh 2000. 
Polymerase chain reaction as a diagnostic tool for detecting 
Leishmania. Infection. 28:111-3. 
90. Britto, C., M. A. Cardoso, C. Ravel, A. Santoro, J. B. Pereira, J. R. 
Coura, C. M. Morel, and P. Wincker 1995. Trypanosoma cruzi: 
parasite detection and strain discrimination in chronic chagasic patients 
from northeastern Brazil using PCR am plification of kinetoplast DNA 
and nonradioactive hybridization. Exp Parasitol. 81 :462- 71. 
91. Britto, C., M. A. Cardoso, C. M. Vanni, A. Hasslocher-Moreno, S. 
S. Xavier, W. Oelemann, A. Santoro, C. Pirmez, C. M. Morel, and 
P. W incker 1995. Polym erase chain reaction detection of 
Trypanosoma cruzi in hum an blood sam pies as a tool for diagnosis and 
treatment evaluation. Parasitology. 110:241-7. 
92. Britto, C., M. A. Cardoso, P. Wincker, and C. M. Morel 1993. A 
sim pie protocol for the physical cleavage of Trypanosoma cruz; 
172 
kinetoplast DNA present in blood sam pies and its use in polym erase 
chain reaction (peR) -based diagnosis of chronic Chagas disease. Mem 
Inst Oswaldo Cruz. 88: 171- 2. 
93. Brumpt, E., and A. M. Pedroso 1913. Pesquisa epidemiologica sobre 
la leishmaniose americana das florestas no Estado do Sao Paulo 
(Brasil). An Paulistas Med Cir. 1 :97-132. 
94. Buescher, M. D., L. C. Rutledge, R. A. Wirtz, K. B. Glackin, and M. 
A. M ou ssa 1982. Laboratory tests of repellents against Lutzomyia 
/ongipa/pis (Diptera: Psychodidae).J Med Entomol. 19: 176- 80. 
95. Burns, J. M., Jr., W. G. Shreffler, O. R. Benson, H. W. Ghalib, R. 
Badaro, and S. G. Reed 1993. Molecular characterization of a 
kinesin-related antigen of Leishmania chagasi that detects specific 
antibody in African and American visceral leishmaniasis. Proc Natl Acad 
Sci USA. 90:775-9. 
96. Cabral, M., R. McNerney, S. Gomes, J. O'Grady, I. Frame, J. C. 
Sousa, M. A. Miles, and J. Alexander 1993. Demonstration of 
natural Leishmania infection in asymptomatic dogs in the absence of 
specific humoral immunity. Arch Inst Pasteur Tunis. 70:473-9. 
97. Cabral, M., J. O'Grady, and J. Alexander 1992. Demonstration of 
Leishmania specific cell mediated and hum oral im m unity in 
asymptomatic dogs. Parasite Immunol. 14:531- 9. 
98. Cabral, M., J. E. O'Grady, S. Gomes, J. C. Sousa, H. Thompson, 
and J. Alexander 1998. The immunology of canine leishmaniosis: 
strong evidence for a developing disease spectrum from asymptomatic 
dogs. Vet Parasitol. 76: 173- 80. 
99. Cabrera, G. P., V. O. Oa Silva, R. T. Oa Costa, A. B. Reis, W. 
Mayrink, O. Genaro, and C. B. Palatnik-de-Sousa 1999. The 
fucose-m annose ligand- ELI SA in the diagnosis and prognosis of canine 
visceral leishmaniasis in Brazil. Am J Trap Med Hyg. 61 :296-301. 
100. Calvopina, M. H., Guevara, A., Gomez, E. A., Guderian, R., 
M im ori, T., Hashiguchi, Y. 1997. A com parative study on 
conventional and PCR-based diagnosis of cutaneous leishmaniasis in 
173 
Ecuador., p. 69-73. In Y. Hashiguchi (ed.), Studies on the New World 
leishmaniasis and its transmission, with particular reference to 
Ecuador. Kyowa Printing, Kochi, Japan. 
101. Campbell-Lendrum, D. H., S. P. Brandao-Filho, P. D. Ready, and 
C. R. Davies 1999. Host and/or site loyalty of Lutzomyia whitmani 
(Diptera: Psychodidae) in Brazil. Med Vet Entomol. 13:209-11. 
102. Campbell-Lendrum, D. H., M. C. Pinto, S. P. Brandao-Filho, A. A. 
de Souza, P. D. Ready, and C. R. Davies 1999. Experimental 
com parison of anthropophily between geographically dispersed 
populations of Lutzomyia whitmani (Diptera: Psychodidae). Med Vet 
Entomol. 13:299-309. 
103. Carter, K. C., G. Gallagher, A. J. Baillie, and J. Alexander 1989. 
The induction of protective im m unity to Leishmania major in the 
BALB/c mouse by interleukin 4 treatment. Eur J Immunol. 19:779-82. 
104. Castro, E. A., Thomaz-Soccol, V., Gubert, I., Panday, A., 
Membrive, N., and Luz, E. 1999. Cutaneous leishmaniasis: 
seroepidem iological study of canine in Parana state, South of Brazil. 
Revista da Sociedade Brasileira de Medicina Tropical. 32 (Supplement 
II): 126. 
105. Castro- Sousa, F., M. Paranhos- Silva, I. Sherlock, M. S. Paixao, L. 
C. Pontes-de-Carvalho, and W. L. dos-Santos 2001. Dissociation 
between vasodilation and Leishmania infection-enhancing effects of 
sand fly saliva and maxadilan. Mem Inst Oswaldo Cruz. 96:997-9. 
106. Castro- Sousa, F., M. Paranhos- Silva, I. I. Sherlock, M. S. Paixao, 
L. C. Pontes-De-Carvalho, and W. L. Dos-Santos 2001. 
Dissociation between vasodilation and Leishmania infection-enhancing 
effects of sand fly saliva and maxadilan. Mem I nst Oswaldo Cruz. 
96:997-9. 
107. Caux, C., C. Dezutter- Dambuyant, D. Schmitt, and J. Banchereau 
1992. GM-CSF and TNF-alpha cooperate in the generation of dendritic 
Langerhans cells. Nature. 360:258- 61. 
174 
108. Cavaliero, T., P. Arnold, A. Mathis, T. Glaus, R. Hofmann-
Lehmann, and P. Deplazes 1999. Clinical, serologic, and 
parasitologic follow-up after long-term allopurinol therapy of dogs 
naturally infected with Leishmania infantum. J Vet Intern Med. 13:330-
4. 
109. Chakraborty, P., D. Ghosh, and M. K. Basu 2000. Macrophage 
protein kinase C: its role in modulating m em brane m icroviscosity and 
superoxide in Leishmanial infection. J Biochem (Tokyo). 127:185-90. 
110. Changfa, J., Guanghua, X., Yumei, H, Zhongwei, S. 1994. Studies 
on the effect of deltamethrin bath treatment of hamsters infected with 
Leishmania donovani for interrupting kala-azar transm ission. Chin J 
Parasitol Paras Dis. 12:300-2. 
111. Chaniotis, B. N., R. E. Parsons, H. J. Harlan, and M. A. Correa 
1982. A pilot study to control phlebotom ine sand flies (Diptera: 
Psychodidae) in a neotropical rain forest J Med Entomol. 19:1-5. 
112. Chiaramonte, M. G., F. M. Frank, G. M. Furer, N. J. Taranto, R. A. 
Margni, and E. l. Malchiodi 1999. Polymerase chain reaction reveals 
Trypanosoma cruzi infection suspected by serology in cutaneous and 
mucocutaneous leishmaniasis patients. Acta Trap. 72:295-308. 
113. Chiaramonte, M. G., N. W. Zwirner, S. l. Caropresi, V. Heredia, 
N. J. Taranto, and E. l. Malchiodi 1996. [Study of cases of 
leishmaniasis in the Province of Salta: evidences of mixed infection 
with Trypanosoma cruzi and Leishmania spp]. Medicina (B Aires). 
56:259-68. 
114. Christensen, H. A., and A. Herrer 1972. Detection of Leishmania 
braziliensis by xenodiagnosis. Trans R Soc Trop Med Hyg. 66:798- 9. 
115. Ciaramella, P., G. Oliva, R. D. Luna, l. Gradoni, R. Ambrosio, l. 
Cortese, A. Scalone, and A. Persechino 1997. A retrospective 
clinical study of canine leishmaniasis in 150 dogs naturally infected by 
Leishmania infantu. Vet Rec. 141 :539-43. 
116. Cogswell, F. B., C. E. Bantar, T. G. Hughes, Y. Gu, and M. T. 
Philipp 1996. Host DNA can interfere with detection of Borrelia 
175 
burgdorferi in skin biopsy specimens by PCR. J Clin Microbiol. 34:980-
2. 
117. Coleman, P. G. 2001. The epidemiology and control of domestic dog 
rabies. PhD Thesis. University of London. 
118. Colem an, R. E., L. L. Robert, L. W. Roberts, J. A. Glass, D. C. 
Seeley, A. Laughinghouse, P. V. Perkins, and R. A. Wirtz 1993. 
Laboratory evaluation of repellents against four anopheline mosquitoes 
(Diptera: Culicidae) and two phlebotomine sand flies (Diptera: 
Psychodidae). J Med Entomol. 30:499-502. 
119. Convit, J. 1996. leishm aniasis: 1m m unological and clinical aspects and 
vaccines in Venezuela Clin Dermatol. 14:479-87. 
120. Corredor, A., R. D. Kreutzer, R. B. Tesh, J. Boshell, M. T. Palau, 
E. Caceres, S. Duque, D. Pelaez, G. Rodriguez, S. Nichols, and et 
al. 1990. Distribution and etiology of leishm aniasis in Colom bia. Am J 
Trop Med Hyg. 42:206-14. 
121. Costa, C. H., R. B. Gomes, M. R. Silva, L. M. Garcez, P. K. Ramos, 
R. S. Santos, J. J. Shaw, J. R. David, and J. H. Maguire 2000. 
Competence of the human host as a reservoir for Leishmania chagasi. 
J Infect Dis. 182:997-1000. 
122. Costa, J. M., E. M. Netto, K. C. Vale, N. K. Osaki, M. S. Tada, and 
P. D. Marsden 1987. Spontaneous healing of cutaneous Leishmania 
braziliensis braziliensis ulcers. Trans R Soc Trop Med Hyg. 81 :606. 
123. Costa, J. M., Vale, K. C., Franca, F., Saldanha, A. C., da Silva, J. 
0., Lago, E. L., Marsden, P. D., Magalhaes, A. V., e Silva" and S. 
N. C. M., A., et al. 1990. [Spontaneous healing of leishmaniasis 
caused by Leishmania Viannia braziliensis in cutaneous lesions]. Rev 
Soc Bras Med Trop. 23:205- 8. 
124. Coura, J. R., B. Galvao-Castro, and G. Grimaldi Junior 1987. 
Dissem inated Am erican cutaneous leishm aniasis in a patient with 
AIDS. Mem Inst Oswaldo Cruz. 82:581-2. 
125. Courtenay, O. 1998. The epidemiology and control of canine 
leishmaniasis in Brazil. PhD Thesis. University of London. 
176 
126. Courtenay, 0., D. W. Macdonald, R. Lainson, J. J. Shaw, and C. 
Dye 1994. Epidemiology of canine leishmaniasis: a comparative 
serological study of dogs and foxes in Amazon Brazil. Parasitology. 
109:273-9. 
127. Coutinho, S. G., A. M. Da-Cruz, M. P. de Oliveira, S. C. Mendonca, 
A. l. Bertho, and P. De Luca 1996. C04+ and C08+ T cell immune 
responses of im m unocom petent and im m unocom prom ised (AI OS) 
patients with American tegumentary leishmaniasis. Mem Inst Oswaldo 
Cruz. 91 :381-4. 
128. Coutinho, S. G., M. P. Nunes, M. C. Marzochi, and N. Tramontano 
1985. A survey for Am erican cutaneous and visceral leishm aniasis 
among 1,342 dogs from areas in Rio de Janeiro (Brazil) where the 
human diseases occur. Mem Inst Oswaldo Cruz. 80:17-22. 
129. Crawley, M. J. 1993. GUM for Ecologists. Blackwell Science, Oxford. 
130. Croft, A. M., D. Baker, and M. J. von Bertele 2001. An evidence-
based vector control strategy for military deployments: the British 
Army experience. Med Trop (Mars). 61 :91-8. 
131. Croft, S. l. 2001. Monitoring drug resistance in leishmaniasis. Trop 
Med Int Health. 6:899-905. 
132. Cuba Cuba, C. A., P. D. Marsden, A. C. Barreto, I. Roitman, A. 
Vexenat, l. M. de Lima, and M. H. de Sa 1984. Identification of 
human stocks of Leishmania spp. isolated from patients with 
mucocutaneous leishm aniasis in Tres Bracos, Bahia, Brazil. Trans R 
Soc Trap Med Hyg. 78:708-10. 
133. Cuba Cuba, C. A., M. A. Miles, A. Vexenat, D. C. Barker, D. 
McMahon Pratt, J. Butcher, A. C. Barreto, and P. D. Marsden 
1985. A focus of mucocutaneous leishm aniasis in Tres Bracos, Bahia, 
Brazil: characterization and identification of Leishmania stocks isolated 
from man and dogs. Trans R Soc Trap Med Hyg. 79:500-507. 
134. Cupolillo, E., G. Grimaldi, Jr., and H. Momen 1994. A general 
classification of New World Leishmania using num erical 
zymotaxonomy. Am J Trop Med Hyg. 50:296-311. 
177 
135. da Costa, C. A., O. Genaro, M. de Lana, P. A. Magalhaes, M. Dias, 
M. S. Michalick, M. N. Melo, R. T. da Costa, N. M. Magalhaes-
Rocha, and W. Mayrink 1991. [Canine visceral leishmaniasis: 
evaluation of the serologic method used in epidem iologic studies]. Rev 
Soc Bras Med Trop. 24:21-5. 
136. da Silva, V. 0., G. P. Borja-Cabrera, N. N. Correia Pontes, E. P. 
de Souza, K. G. Luz, M. Palatnik, and C. B. Palatnik de Sousa 
2000. A phase III trial of efficacy of the FML-vaccine against canine 
kala- azar in an endem ic area of Brazil (Sao Goncalo do Am aranto, 
RN). Vaccine. 19:1082-92. 
137. Da-Cruz, A. M., F. Conceicao-Silva, A. L. Bertho, and S. G. 
Coutinho 1994. Leishmania-reactive C04+ and C08+ T cells 
associated with cure of human cutaneous leishmaniasis. Infect Immun. 
62:2614-8. 
138. Da-Cruz, A. M., D. V. Filgueiras, Z. Coutinho, W. Mayrink, G. 
Grimaldi, Jr., P. M. De Luca, S. C. Mendonca, and S. G. Coutinho 
1999. Atypical mucocutaneous leishmaniasis caused by Leishmania 
braziliensis in an acquired im m unodeficiency syndrom e patient: T-cell 
responses and rem ission of lesions associated with antigen 
immunotherapy. Mem Inst Oswaldo Cruz. 94:537-42. 
139. Da-Cruz, A. M., E. S. Machado, J. A. Menezes, M. S. Rutowitsch, 
and S. G. Coutinho 1992. Cellular and humoral immune responses of 
a patient with Am erican cutaneous leishm aniasis and AI OS. Trans R 
Soc Trop Med Hyg. 86:511-2. 
140. Da-Cruz, A. M., M. Mattos, M. P. Oliveira-Neto, Z. Coutinho, E. S. 
Machado, and S. G. Coutinho 2000. Cellular immune responses to 
Leishmania braziliensis in patients with AI OS-associated Am erican 
cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 94:569- 71. 
141. Da-Silva, S. A., S. S. Costa, and B. Rossi-Bergmann 1999. The 
anti-Leishmanial effect of Kalanchoe is mediated by nitric oxide 
intermediates Parasitology. 118:575- 82. 
142. David, J. R., L. M. Stamm, H. S. Bezerra, R. N. Souza, R. Killick-
Kendrick, and J. W. Lima 2001. Oeltamethrin-impregnated dog 
178 
collars have a potent anti-feeding and insecticidal effect on Lutzomyia 
/ongipa/pis and Lutzomyia migone.i Mem I nst Oswaldo Cruz. 96:839-
47. 
143. Davies, C. R., M. Fernandez, L. Paz, N. Roncal, and A. Llanos-
Cuentas 1993. Lutzomyia verrucarum can transmit Leishmania 
peruviana, the aetiological agent of Andean cutaneous leishmaniasis. 
Trans R Soc Trop Med Hyg. 87:603- 6. 
144. Davies, C. R., A. Llanos-Cuentas, J. Canales, E. Leon, E. Alvarez, 
J. Monge, E. Tolentino, Q. Gomero, S. Pyke, and C. Dye 1994. The 
fall and rise of Andean cutaneous leishm aniasis: transient im pact of 
the DDT campaign in Peru. Trans R Soc Trop Med Hyg. 88:389-93. 
145. Davies, C. R., E. A. Llanos-Cuentas, P. Campos, J. Monge, E. 
Leon, and J. Canales 2000. Spraying houses in the Peruvian Andes 
with lam bda-cyhalothrin protects residents against cutaneous 
leishmaniasis. Trans R Soc Trop Med Hyg. 94:631-6. 
146. Davies, C. R., E. A. Llanos-Cuentas, P. Campos, J. Monge, P. 
Villaseca, and C. Dye 1997. Cutaneous leishmaniasis in the Peruvian 
Andes: risk factors identified from a village cohort study. Am J Trop 
Med Hyg. 56:85-95. 
147. Davies, C. R., E. A. Llanos-Cuentas, S. D. Pyke, and C. Dye 1995. 
Cutaneous leishm aniasis in the Peruvian Andes: an epidem iological 
study of infection and immunity. Epidemiol Infect. 114:297-318. 
148. Davies, C. R., R. Reithinger, D. Campbell-Lendrum, D. 
Feliciangeli, R. Borges, and N. Rodriguez 2000. The epidem iology 
and control of leishmaniasis in Andean countries. Cad Saude Publica. 
16:925-50. 
149. de Alencar, J. E. 1961. Profilaxia do calazar no Ceara, Brasil. Rev Inst 
Med Trop Sao Paulo. 3: 175- 80. 
150. de Andrade, A. S., R. F. Gomes, O. Fernandes, and M. N. de Melo 
2001. Use of DNA-based diagnostic methods for human leishmaniasis 
in Minas Gerais, Brazil. Acta Trop. 78:261- 7. 
179 
151. De Barjac, H., I. Larget, and R. Killick-Kendrick 1981. [Toxicity of 
Bacillus thuringiensis var. israelensis serotype H14, for larvae of 
sandflies, the leishmaniasis vectors (author's transl)]. Bull Soc Pathol 
Exot Filiales. 74:485-9. 
152. de Bruijn, M. H., and D. C. Barker 1992. Diagnosis of New World 
leishm aniasis: specific detection of species of the Leishmania 
braziliensis com plex by am plification of kinetoplast DNA. Acta Trop. 
52:45-58. 
153. de Brujin, M. H., L. A. Labrada, A. J. Smyth, C. Santrich, and D. 
C. Barker 1993. A comparative study of diagnosis by the polymerase 
chain reaction and by current clinical methods using biopsies from 
Colom bian patients with suspected leishm aniasis. Trop Med Parasitol. 
44:201-7. 
154. de Carvalho, P. B., and E. I. Ferreira 2001. leishmaniasis 
phytotherapy. Nature's leadership against an ancient disease. 
Fitoterapia.72:599-618. 
155. De Lima JW, D. F., Cavalcante EM, Vasconcelos lAB, Bezerra SS, 
De Santana EW, Vasconcelos AW 1993. An outbreak of American 
cutaneous leishmaniasis among dogs and humans in Serra de Baturite, 
Ceara, Brazil. Mem Inst Oswaldo Cruz. 88 (Supplement 11):127. 
156. de Queiroz, R. G., I. Vasconcelos, A. W. Vasconcelos, F. A. 
Pessoa, R. N. de Sousa, and J. R. David 1994. Cutaneous 
leishmaniasis in Ceara state in northeastern Brazil: incrimination of 
Lutzom yia whitmani (Diptera: Psychodidae) as a vector of Leishmania 
braziliensis in baturite municipality. Am J Trop Med Hyg. 50:693-8. 
157. De Raadt, P. 1985. [Congenital trypanosomiasis and leishmaniasis]. 
Arch Fr Pediatr. 42 Suppl 2:925-7. 
158. de Rossell, R. A., R. J. de Duran, O. Rossell, and A. M. Rodriguez 
1992. Is leishmaniasis ever cured? Trans R Soc Trop Med Hyg. 86:251-
3. 
159. de Souza e Souza, I., R. D. Naiff, T. C. Guimaraes, M. F. Naiff, E. 
Cupolillo, W. A. Rodrigues, and A. P. Schettini 1998. American 
180 
cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis as an 
initial clinical presentation of human im m unodeficiency virus infection. 
J Eur Acad Dermatol Venereol. 10:214-7. 
160. Dedet, J. P., R. Melogno, F. Cardenas, L. Valda, C. David, V. 
Fernandez, M. E. Torrez, L. Dimier-David, P. Lyevre, and M. E. 
Villareal 1995. Rural cam paign to diagnose and treat mucocutaneous 
leishmaniasis in Bolivia. Bull World Health Organ. 73:339-45. 
161. Delgado, 0., M. Castes, A. C. White, Jr., and R. D. Kreutzer 1993. 
Leishmania colombiensis in Venezuela. Am J Trop Med Hyg. 48: 145-7. 
162. Delgado, 0., E. Cupolillo, R. Bonfante-Garrido, S. Silva, E. 
Belfort, G. Grimaldi Junior, and H. Momen 1997. Cutaneous 
leishmaniasis in Venezuela caused by infection with a new hybrid 
between Leishmania (Viannia) braziliensis and L. (V.) guyanensis. Mem 
Inst Oswaldo Cruz. 92:581-2. 
163. Delgado, 0., M. D. Feliciangeli, V. Coraspe, S. Silva, A. Perez, 
and J. Arias 2001. Value of a dipstick based on recom binant RK39 
antigen for differential diagnosis of American visceral leishmaniasis 
from other sym patric endem ic diseases in Venezuela. Parasite. 8:355-
7. 
164. Delgado, 0., P. Guevara, S. Silva, E. Belfort, and J. L. Ramirez 
1996. Follow-up of a human accidental infection by Leishmania 
(Viannia) braziliensis using conventional im m unologic techniques and 
polymerase chain reaction. Am J Trap Med Hyg. 55:267- 72. 
165. Denerolle, P., and G. Bourdoiseau 1999. Combination allopurinol 
and antimony treatment versus antimony alone and allopurinol alone 
in the treatm ent of canine leishm aniasis (96 cases). J Vet Intern Med. 
13:413-5. 
166. Deparis, X., J. P. Boutin, R. Michel, L. Galoisy-Guibal, J. B. 
Meynard, F. Pages, T. Matton, A. Spiegel, and D. Baudon 2001. 
[Disease vector control strategy in the French army]. Med Trop (Mars). 
61 :87-90. 
181 
167. Dereure, J., I. Espinel, C. Barrera, F. Guerrini, A. Martini, R. 
Echeverria, R. H. Guderian, and F. Le Pont 1994. [Leishmaniasis in 
Ecuador. 4. Natural infestation of the dog by Leishmania panamensis. ] 
Ann Soc Belg Med Trop. 74:29-33. 
168. Dereure, J., Pratlong, F., Dedet, J.-P. 1999. Geographical 
distribution and the identification of parasites causing canine 
leishmaniasis in the Mediterranean Basin., p. 18-25. In R. Killick-
Kendrick (ed.), Canine leishm aniasis: an update. Proceedings of the 
I nternational Canine leishm aniasis Forum Barcelona, Spain -1999. 
Hoechst Roussel Vet, Wiesbaden. 
169. Desjeux, P. 2001. The increase in risk factors for leishmaniasis 
worldwide. Trans R Soc Trop Med Hyg. 95:239-43. 
170. Dias, M., W. Mayrink, L. M. Deane, C. A. da Costa, P. A. 
Magalhaes, M. N. Melo, S. M. Batista, F. G. Araujo, M. V. Coelho, 
and P. Williams 1977. [Epidemiology of mucocutaneous leishmaniasis 
Am ericana. I. Study of reservoirs in an endem ic region of the State of 
Minas Gerais]. Rev Inst Med Trop Sao Paulo. 19:403-10. 
171. Dietze, R., G. B. Barros, L. Teixeira, J. Harris, K. Michelson, A. 
Falqueto, and R. Corey 1997. Effect of eliminating seropositive 
canines on the transmission of visceral leishmaniasis in Brazil. Clin 
Infect Dis. 25:1240-2. 
172. Dimier-David, L., C. David, M. Munoz, F. Vargas, R. Bustillos, L. 
Valda, and J. P. Dedet 1993. [Epidemiological, clinical and biological 
feat u res of mucocutaneous leishm an iasis in Bolivia after a 221 pat ient 
sample]. Bull Soc Pathol Exot. 86: 1 06-11. 
173. Dimier-David, L., C. David, P. Ravisse, R. Bustillos, S. Revollo, P. 
Lyevre, M. Munoz, F. Vargas, and J. P. Dedet 1991. Parasitological 
diagnosis of mucocutaneous leishmaniasis due to Leishmania b. 
braziliensis in Bolivia. Rev Soc Bras Med Trop. 24:231-4. 
174. Donnelly, K. B., H. C. Lima, and R. G. Titus 1998. Histologic 
characterization of experimental cutaneous leishmaniasis in mice 
infected with Leishmania braziliensis in the presence or absence of 
sand fly vector salivary gland lysate. J Parasitol. 84:97-103. 
182 
175. Dunan, S., D. Frommel, L. Monjour, B. W. Ogunkolade, A. Cruz, 
and M. Quilici 1989. Vaccination trial against canine visceral 
leish man iasis. Phocean Veterinary St udy Group on Visceral 
leishmaniasis. Parasite Immuno!. 11 :397-402. 
176. Dye, C. 1996. The logic of visceral leishmaniasis control. Am J Trop 
Med Hyg. 55:125-30. 
177. Dye, C., R. Killick-Kendrick, M. M. Vitutia, R. Walton, M. Killick-
Kendrick, A. E. Harith, M. W. Guy, M. C. Canavate, and G. 
Hasibeder 1992. Epidemiology of canine leishmaniasis: prevalence, 
incidence and basic reproduction num ber calculated from a cross-
sectional serological survey on the island of Gozo, Malta. Parasitology. 
105:35-41. 
178. Dye, C., E. Vidor, and J. Dereure 1993. Serological diagnosis of 
leishmaniasis: on detecting infection as well as disease. Epidem iol 
Infect. 110:647-56. 
179. Dye C, W. P. 1993. Malnutrition, age and the risk of parasitic disease: 
visceral leishmaniasis revisited. Proc R Soc B. 254:33- 39. 
180. Echevarria, J., Campos, P., Chang, J., Cuellar, L., Gotuzzo, E., 
Paz, L., Llanos-Cuentas, A. 1993. Mucocutaneous leishmaniasis and 
AIDS: case report. Trans R Soc Trop Med Hyg. 87:186. 
181. Elamin, A., and M. I. Orner 1992. Visceral leishmaniasis in a 6-week-
old infant: possible congenital transmission. Trop Doct. 22:133-5. 
182. Eltoum, I. A., E. E. Zijlstra, M. S. Ali, H. W. Ghalib, M. M. Satti, B. 
Eltoum, and A. M. el-Hassan 1992. Congenital kala-azar and 
leishmaniasis in the placenta. Am J Trop Med Hyg. 46:57-62. 
183. Enk, A. H., V. L. Angeloni, M. C. Udey, and S. I. Katz 1993. 
I nhibition of Langerhans cell antigen-presenting function by I L-1 o. A 
role for IL-1 0 in induction of tolerance. J Immunol. 151 :2390-8. 
184. Eresh, S., S. M. McCallum, and D. C. Barker 1994. Identification 
and diagnosis of Leishmania m exicana com plex isolates by polym erase 
chain reaction. Parasitology. 109:423- 33. 
183 
185. Escobar, M. A., F. Martinez, D. Scott Smith, and G. I. Palma 
1992. Am erican cutaneous and mucocutaneous leishm aniasis 
(tegumentary): a diagnostiC challenge. Trop Doct. 22:69- 78;63-4. 
186. Estani S, Gomez A, Salomon 00, and S. EL 1995. leishmaniasis en 
Salta, Argentina. Epidem iologia: III. Congreso Brasileiro, Salvador, 
Bahfa, Brazil. 
187. Esterre, P., J. P. Chippaux, J. F. Lefait, and J. P. Dedet 1986. 
[Evaluation of a cutaneous leishm aniasis control program in a forest 
village of French Guyana]. Bull World Health Organ. 64:559-65. 
188. Evans, T. G., I. A. Vasconcelos, J. W. Lima, J. M. Teixeira, I. T. 
McAullife, U. G. Lopes, R. D. Pearson, and A. W. Vasconcelos 
1990. Canine visceral leishmaniasis in northeast Brazil: assessment of 
serodiagnostic methods. Am J Trop Med Hyg. 42: 118-23. 
189. Falcao, A. L., A. R. Falcao, C. T. Pinto, C. M. Gontijo, and A. 
Falqueto 1991. Effect of deltamethrin spraying on the sandfly 
populations in a focus of Am erican cutaneous leishm aniasis. Mem I nst 
Oswaldo Cruz. 86:399-404. 
190. Falcoff, E., N. J. Taranto, C. E. Remondegui, J. P. Dedet, L. M. 
Canini, C. M. Ripoll, L. Dim ier-David, F. Vargas, L. A. Gimenez, J. 
G. Bernabo, and et al. 1994. Clinical healing of antimony-resistant 
cutaneous or mucocutaneous leishm aniasis following the com bined 
adm inistrat ion of interferon- gam m a and pentavalent antim on ial 
compounds. Trans R Soc Trap Med Hyg. 88:95-7. 
191. Falqueto, A., J. R. Coura, G. C. Barros, G. Grimaldi Filho, P. A. 
Sessa, V. R. Carias, A. C. de Jesus, and J. T. de Alencar 1986. 
[Participation of the dog in the cycle of transm ission of cutaneous 
leishmaniasis in the municipality of Viana, State of Espirito Santo, 
Brazil]. Mem Inst Oswaldo Cruz. 81 :155-63. 
192. Falqueto, A., P. A. Sessa, J. B. Varejao, G. C. Barros, H. Momen, 
and G. Grim aldi Junior 1991. Leishmaniasis due to Leishmania 
braziliensis in Espirito Santo State, Brazil. Further evidence on the role 
of dogs as a reservoir of infection for humans. Mem Inst Oswaldo Cruz. 
86:499- 500. 
184 
193. Falqueto, A., P. Sessa, and J. B. Varejao 1993. Eco-epidemiologic 
aspects of m ucocutenous leishmaniasis in Espfrito Santo: evidence of 
dom iciliary transm ission and the role of dom estic anim als. In Brandao-
Filho, S. P. (ed.), Research and Control of leishmaniasis in Brazil. 
Proceeding of a workshop held in Recife, Brazil, Fundagao Oswaldo 
Cruz - Centro de Pesquisas Aggeu Magalhaes. 
194. Falqueto, A., P. Sessa, and J. B. M. Varejao 1989. Consideragoes 
acerca de um surto epidem ico de leishm aniose tegum entar ocorrido 
em una vila no Estado do Espfrito Santo. Rev Soc Bras Med Trop. 22 
{Supplement 11):51-52. 
195. Falqueto, A., J. B. Varejao, and P. A. Sessa 1987. Cutaneous 
leishm aniasis in a horse (Equus cabal/us) from endem ic area in the 
state of Espirito Santo, Brazil. Mem Inst Oswaldo Cruz. 82:443. 
196. Falqueto, A., J. Varejao, and P. A. Sessa 1989. Estudo 
epidemiol6gico sobre a leishmaniose tegumentar em area endemica do 
Municipio de Alfonso Claudio, Estado do Espfrito Santo. Rev Soc Bras 
Med Trop. 22 {Supplement 11):51. 
197. Fernandes, 0., M. Bozza, J. M. Pascale, A. B. de Miranda, U. G. 
Lopes, and W. M. Degrave 1996. An oligonucleotide probe derived 
from kDNA minirepeats is specific for Leishmania (Viannia). Mem Inst 
Oswaldo Cruz. 91 :279- 84. 
198. Ferreira, E., S. Lucena, G. Fonseca, T. C. Barbosa, R. B. Aquino, 
J. S. Lam bert, and S. A. Nogueira 2001. Visceral leishmaniasis in a 
Brazilian child infected perinatally with hum an im m unodeficiency virus. 
Pediatr Infect Dis J. 20:224-6. 
199. Ferrer, L., M. J. Aisa, X. Roura, and M. Portus 1995. Serological 
diagnosis and treatment of canine leishmaniasis. Vet Rec. 136:514-6. 
200. Ferrer, L., R. M. Rabanal, M. Domingo, J. A. Ramos, and D. 
Fondevila 1988. I dentification of Leishmania donovani am astigotes in 
canine tissues by immunoperoxidase staining. Res Vet Sci. 44: 194- 6. 
201. Ferrer, L. E. 1999. Clinical aspects of canine leishmaniasis, p. 6-11. In 
R. Killick- Kendrick (ed.), Canine leishm aniasis: an update. Proceedings 
185 
of the I nternational Canine leishmaniasis Forum Barcelona, Spain _ 
1999. Hoechst Roussel Vet, Wiesbaden1. 
202. Fisa, R., C. Riera, M. Gallego, J. Manubens, and M. Portus 2001. 
Nested PCR for diagnosis of canine leishm aniosis in peripheral blood, 
lymph node and bone marrow aspirates. Vet Parasitol. 99: 1 05-11. 
203. Follador, I., C. Araujo, M. A. Cardoso, J. Tavares- Neto, A. Barral, 
J. C. Miranda, A. Bittencourt, and E. M. Carvalho 1999. [Outbreak 
of Am erican cutaneous leishmaniasis in Canoa, Santo Amaro, Bahia, 
Brazil]. Rev Soc Bras Med Trop. 32:497-503. 
204. Forattini OP, and Santos MR 1955. Novas observagaos em regioes 
endem icas de leishm aniose tegum entar am ericana nos Estados de Sao 
Paulo e Mato Grosso, Brasil. Rev elin Sao Paulo. 31: 13-20. 
205. Franke, E. D., A. Llanos-Cuentas, J. Echevarria, M. E. Cruz, P. 
Campos, A. A. Tovar, C. M. Lucas, and J. D. Berman 1994. Efficacy 
of 28-day and 40-day regim ens of sodium stibogluconate (Pentostam) 
in the treatment of mucosal leishmaniasis. Am J Trop Med Hyg. 51:77-
82. 
206. Franke, E. D., F. S. Wignall, M. E. Cruz, E. Rosales, A. A. Tovar, 
C. M. Lucas, A. Llanos-Cuentas, and J. D. Berman 1990. Efficacy 
and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann 
Intern Med. 113:934-40. 
207. Fu, G., G. Perona-Wright, and D. C. Barker 1998. Leishmania 
braziliensis: characterisation of a com plex specific subtelom eric repeat 
sequence and its use in the detection of parasites. Exp Parasitol. 
90:236-43. 
208. Garcia, N., K. Figarella, A. Mendoza-Leon, and A. Ponte-Sucre 
2000. Changes in the infectivity, pyruvate kinase activity, acid 
phosphatase activity and P-glycoprotein expression in glibenclam ide-
resistant Leishmania mexicana. Parasitol Res. 86:899-904. 
209. Gaskin, A. A., P. Schantz, J. Jackson, A. Birkenheuer, L. 
Tomlinson, M. Gramiccia, M. Levy, F. Steurer, E. Kollmar, B. C. 
Hegarty, A. Ahn, and E. B. Breitschwerdt 2002. Visceral 
186 
leishmaniasis in a New York foxhound kennel. J Vet Intern Med. 16:34-
44. 
210. Gavgani, A. S. M., Mohite, H., Davies, C. R. 2002. I m pact of 
insecticide im pregnated dog collars on incidence rate of zoonotic 
visceral leishm aniasis infection in children: matched com m un ity- based 
trial in Iran. The Lancet. in press. 
211. Gavgani, A. S. M., Mohite, H., Evans, D. A. , Edrissian, G. H., 
Mohebali, M, Davies, C. R. 2002. Oom estic dog ownership in I ran is 
a risk factor for human infection with Leishmania infantum. Am J Trop 
Med Hyg. in press. 
212. Genaro 0, C. M., Pinto FA, Dias M 1990. The course of the 
experimental infections by Leishmania (Viannia) braziliensis and 
Leishmania (Leishmania) amazonensis in dogs. Mem I nst Oswaldo 
Cruz. 85 (Supplement 11):27. 
213. Genaro, 0., P. Raso, C. A. da Costa, M. D. Carvalho, F. do 
Amaral, A. C. Botelho, P. Williams, M. Dias, and W. Mayrink 
1992. Montenegro skin tests in dogs experimentally infected with 
Leishmania (Viannia) braziliensis. Mem Inst Oswaldo Cruz. 87:163-4. 
214. Ghazanfari, T., Z. M. Hassan, M. Ebtekar, A. Ahmadiani, G. 
Naderi, and A. Azar 2000. Garlic induces a shift in cytokine pattern in 
Leishmania major- infected BALB/c mice Scand J Immunol. 52:491-5. 
215. Gomes, A., S. G. Coutinho, G. V. Paim, S. M. de Oliveira, E. A. 
Galati, M. P. Nunes, A. N. Capinzaiki, Y. I. Yamamoto, and P. 
Rotter 1990. [Ecological aspects of American tegumentary 
leishmaniasis: 8. Evaluation of the enzootic activity of Leishmania 
(Viannia) braziliensis, in forest and peridom iciliary environm ents of the 
Ribeira Valley region, Sao Paulo State, Brazil]. Rev I nst Med Trop Sao 
Paulo. 32: 1 05-15. 
216. Gontijo, C. M., E. S. da Silva, M. B. de Fuccio, M. C. de Sousa, R. 
S. Pacheco, E. S. Dias, J. D. Andrade Filho, R. P. Brazil, and M. N. 
Melo 2002. Epidem iological studies of an outbreak of cutaneous 
leishmaniasis in the Rio Jequitinhonha Valley, Minas Gerais, Brazil. Acta 
Trop. 81: 143- 50. 
187 
217. Gontijo CMF, S. E., Dias ES, Andrade Filho JD, Fuccio MB, Souza 
MCA, Borges SEM 1996. Cutaneous leishmaniasis in Arac;uai, Minas 
Gerais State, Brazil: serological survey of dogs and phlebotom ine 
fauna. Mem Inst Oswaldo Cruz. 91 (Supplement II): 153. 
218. Gordon RM, and Y. CJ 1922. Parasites in dogs and cats in Amazonas. 
Ann Trap Med Parasitol. 36:297-300. 
219. Gothe, R., I. Nolte, and W. Kraft 1997. [leishmaniasis in dogs in 
Germ any: epidem iological case analysis and alternatives to 
conventional causal therapy]. Tierarztl Prax. 25:68-73. 
220. Gradoni, L. 1999. Epizootiology of canine leishmaniasis in Southern 
Europe, p. 32-39. In R. Killick-Kendrick (ed.), Canine leishmaniasis: an 
update. Proceedings of the I nternational Canine leishmaniasis Forum 
Barcelona, Spain -1999. Hoechst Roussel Vet, Wiesbaden. 
221. Gradoni, L. 2001. An update on antileishmanial vaccine candidates 
and prospects for a canine Leishmania vaccine. Vet Parasitol. 100:87-
103. 
222. Gradoni, L., G. B. Gaeta, G. Pellizzer, A. Maisto, and A. Scalone 
1994. Mediterranean visceral leishmaniasis in pregnancy. Scand J 
Infect Dis. 26: 627-629. 
223. Gradoni, L., M. Gramiccia, F. Mancianti, and S. Pieri 1988. Studies 
on canine leishmaniasis control. 2. Effectiveness of control measures 
against canine leishmaniasis in the Isle of Elba, Italy. Trans R Soc Trop 
Med Hyg. 82:568- 71. 
224. Gradoni, L., M. Maroli, M. Gramiccia, and F. Mancianti 1987. 
Leishmania infantum infection rates in Phlebotom us perniciosus fed on 
naturally infected dogs under antimonial treatment. Med Vet Entomol. 
1 :339-42. 
225. Gratz, N. G. 1999. Em erging and resurging vector-borne diseases. 
Annu Rev Entomol. 44:51- 75. 
226. Grimaldi, G., Jr., J. R. David, and D. McMahon-Pratt 1987. 
Identification and distribution of New World Leishmania species 
188 
characterized by serodem e analysis using monoclonal antibodies. Am J 
Trop Med Hyg. 36:270-87. 
227. Grimaldi, G., Jr., and D. McMahon-Pratt 1991. Leishmaniasis and 
its etiologic agents in the New World: an overview. Prog Clin Parasito!. 
2:73-118. 
228. Grimaldi, G., Jr., H. Momen, R. D. Naiff, D. McMahon-Pratt, and 
T. V. Barrett 1991. Characterization and classification of Leishmanial 
parasites from humans, wild mammals, and sand flies in the Amazon 
region of Brazil. Am J Trop Med Hyg. 44:645-61. 
229. Grim aldi, G., Jr., and R. B. Tesh 1993. Leishmaniases of the New 
World: current concepts and implications for future research. Clin 
Microbiol Rev. 6:230-50. 
230. Grimaldi Junior, G., R. D. Kreutzer, Y. Hashiguchi, E. A. Gomez, 
T. Mimory, and R. B. Tesh 1992. Description of Leishmania 
equatorensis sp. n (Kinetoplast ida: Trypanosomatidae) , a new parasite 
infecting arboreal m am m als in Ecuador. Mem I nst Oswaldo Cruz. 
87:221-8. 
231. Grogl, M., R. K. Martin, A. M. Oduola, W. K. Milhous, and D. E. 
Kyle 1991. Characteristics of m ultidrug resistance in Plasmodium and 
Leishmania: detection of P-glycoprotein-like com ponents. Am J Trop 
Med Hyg. 45:98-111. 
232. Grogl, M., A. M. Oduola, L. D. Cordero, and D. E. Kyle 1989. 
Leishmania spp.: developm ent of pentostam-resistant clones in vitro 
by discontinuous drug exposure. Exp Parasitol. 69:78-90. 
233. Grogl, M., T. N. Thomason, and E. D. Franke 1992. Drug resistance 
in leishmaniasis: its implication in systemic chemotherapy of cutaneous 
and mucocutaneous disease. Am J Trop Med Hyg. 47:117-26. 
234. Gu an, L. R. 1991. Cu rrent status of kala-azar and vector cont rol in 
China. Bull World Health Organ. 69:595-601. 
235. Guan, L. R., and W. X. Shen 1991. Recent advances in visceral 
leishmaniasis in China. Southeast Asian J Trop Med Public Health. 
22:291-8. 
189 
236. Guanghua, X., Changfa, J., Xinzhong, C., Zyhongwei, S., Yumei, 
H. 1994. Oeltam ethrin bath of dom estic dog in the prevention of sand 
fly bite. Endemic Disease Bulletin. 9:32-4. 
237. Guanghua, X., Changfa, J., Yumei, H., Zyhongwei, S., Peize, X., 
Weikun, X, et al. 1995. Studies on the deltamethrin-medicated bath 
of domestic dogs for interrupting visceral leishmaniasis transmission. 
Chin J Parasitol Paras Dis. 13:178-81. 
238. Guarga, J. L., J. Lucientes, M. A. Peribanez, R. Molina, M. J. 
Gracia, and J. A. Castillo 2000. Experimental infection of 
Phlebotom us perniciosus and determ ination of the natural infection 
rates of Leishmania infantum in dogs. Acta Trop. 77:203- 7. 
239. Guarga, J. L., J. Moreno, J. Lucientes, M. J. Gracia, M. A. 
Peribanez, J. Alvar, and J. A. Castillo 2000. Canine leishmaniasis 
transm ission: higher infectivity amongst naturally infected dogs to 
sand flies is associated with lower proportions of T helper cells. Res Vet 
Sci. 69:249-53. 
240. Guderian, R. H., M. E. Chico, M. D. Rogers, K. M. Pattishall, M. 
Grogl, and J. D. Berman 1991. Placebo controlled treatment of 
Ecuadorian cutaneous leishmaniasis. Am J Trop Med Hyg. 45:92- 7. 
241. Guerra, H., E. Falconi, A. Llanos-Cuentas, and J. Chang 1993. 
[Research in tropical medicine and primary health care in Peru]. Salud 
Publica Mex. 35:477-86. 
242. Guerra, J. A., Paes, M.G., Dias, C.M.F, Castanheiras, A.C., de 
Andrade, M.B, Marcela, S., Ferreira Fe, N., de Andrade Fe, F., de 
Fe Guerra, M.V. 2000. Avaliacao dos reservatorios silvestres e 
domesticos para leishmaniose em bairro de implantacao antiga em 
Manaus, Amazonas. Rev Soc Bras Med Trop. 33 (Supplement 1):36. 
243. Guevara, L. A. and A. Paredes 1992. Immunoenzymatic method 
dot-ELI SA in the detection of potential reservoir host of leishmaniasis 
in Peruvian rural endemic areas. p. 326-329. In: Wiyeratne, P. (ed.) 
Leishm aniasis control strategies: a critical evaluation of IORC-
supported research. Proceedings of an international workshop. IORC 
Press, Ottawa. 
190 
244. Guevara, P., J. L. Ramirez, E. Rojas, J. V. Scorza, N. Gonzalez, 
and N. Anez 1993. Leishmania braziliensis in blood 30 years after 
cure. Lancet. 341: 1341. 
245. Guevara, P., E. Rojas, N. Gonzalez, J. V. Scorza, N. Anez, M. 
Valera, and J. L. Ramirez 1994. Presence of Leishmania braziliensis 
in blood sam pies from cured patients or at different stages of 
immunotherapy. Clin Diagn Lab Immunol. 1 :385- 9. 
246. Gutierrez, V., G. H. Salinas, G. Palma, L. B. Valderrama, C. V. 
Santrich, and N. G. Saravia 1991. Correlation between 
histopathology, im m une response, clinical presentation, and evolution 
in Leishmania braziliensis infection. Am J Trop Med Hyg. 45:281-9. 
247. Halbig, P., M. H. Hodjati, A. S. Mazloumi-Gavgani, H. Mohite, 
and C. R. Davies 2000. Further evidence that deltamethrin-
impregnated collars protect domestic dogs from sandfly bites. Med Vet 
Entomol. 14:223-6. 
248. Hall, L. R., and R. G. Titus 1995. Sand fly vector saliva selectively 
modulates macrophage functions that inhibit killing of Leishmania 
major and nitric oxide production. J Immunol. 155:3501-6. 
249. Handman, E. 2001. Leishmaniasis: current status of vaccine 
development. Clin Microbiol Rev. 14:229-43. 
250. Harada, M., Suguri, 5., Katakura, K., Eshita, V., Furuya, M., 
Gomez, E. A., Hashiguchi, V. 1997. Preliminary studies on diagnosis 
of cutaneous leishmaniasis using skin biopsy specimen by polymerase 
chain reaction., p. 74-81. In Y. Hashiguchi (ed.), Studies on the New 
World leishm aniasis and its transm ission, with particular reference to 
Ecuador. Kyowa Printing, Kochi, Japan. 
251. Harris, E., G. Kropp, A. Belli, B. Rodriguez, and N. Agabian 1998. 
Single-step multiplex PCR assay for characterization of New World 
Leishmania complexes. J Clin Microbiol. 36: 1989-95. 
252. Hashiguchi V, G. E., Mimori T, Furuya M, Flor T 1990. A further 
trial of Leishmania isolation from wild and domestic animals in 
Ecuador, p. 27-30. In H. Y (ed.), Studies on the New World 
191 
leishmaniasis and its transm ission, with particular reference to 
Ecuador. Kyowa Printing, Kochi, Japan. 
253. Hashiguchi, Y., E. A. Gomez, V. V. de Coronel, T. Mimori, M. 
Kawabata, M. Furuya, S. Nonaka, H. Takaoka, J. B. Alexander, A. 
M. Quizhpe, and et al. 1991. Andean leishmaniasis in Ecuador caused 
by infection with Leishmania mexicana and L. major·like parasites. Am 
J Trop Med Hyg. 44:205-17. 
254. Heinzel, F. P., M. D. Sadick, S. S. Mutha, and R. M. Locksley 
1991. Production of interferon gamma, interleukin 2, interleukin 4, and 
interleu kin 10 by CD4+ Iym phocytes in vivo du ring healing and 
progressive murine leishmaniasis. Proc Natl Acad Sci USA. 88:7011-
5. 
255. Hermeto, M. V., D. Vieira-Dias, O. Genaro, A. Rotondo-Silva, C. 
A. da Costa, V. P. Toledo, M. S. Michalick, P. Williams, and W. 
Mayrink 1994. Outbreak of cutaneous leishmaniasis in the Rio Doce 
Valley, Minas Gerais, Brazil. Mem Inst Oswaldo Cruz. 89:519-21. 
256. Hernandez, D., N. Rodriguez, C. Martinez, L. Garcia, and J. 
Convit 1993. Leishmania braziliensis causing visceral leishmaniasis in 
a patient with human immunodeficiency virus infection, identified with 
the aid of the polym erase chain reaction. Trans R Soc Trop Med Hyg. 
87:627-8. 
257. Hernandez, D. E., M. Oliver, C. Martinez, and G. Planas 1995. 
Visceral leishm aniasis with cutaneous and rectal dissem ination due to 
Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS) 
Int J Dermatol. 34:114-5. 
258. Hernandez-Montes, 0., A. Monroy-Ostria, S. McCann, and D. C. 
Barker 1998. I dentification of Mexican Leishmania species by analysis 
of PCR amplified DNA Acta Trop. 71 :139-53. 
259. Herrer A 1955. Simposium sobre leishmaniasis tegumentaria en el 
Peru. Consideraciones sobre el reservorio. Rev Viernes Med. 6:22-33. 
192 
260. Herrer A, B. G. 1951. Estudios sobre leishmaniasis tegumentaria en el 
Peru. I. I nfecci6n experim ental del perro con cepas de Leishmanias 
procedentes de casos de uta. Rev Med Exp (Lima). 8:12-23. 
261. Herrer, A., and H. A. Christensen 1980. Leishmania braziliensis in 
the Panamanian two-toed sloth, Choloepus hoffmanni. Am J Trop Med 
Hyg.29:1196-200. 
262. Herrer, A., and H. A. Christensen 1976. Natural cutaneous 
leishmaniasis among dogs in Panama. Am J Trop Med Hyg. 25:59-63. 
263. Herrer A., Hidalgo V., and Meneses O. 1980. Leishmaniasis 
tegumentaria e insecticidas en el Peru, reactivaci6n de la Uta 
(leishmaniasis tegumentaria). Rev Inst Med Trop Sao Paulo. 24:162-
167. 
264. Herrero MV, Rojas JC, Jimenez AE, Zeledon R, Pereira R, and 
Gutierrez H 1992. Phlebotom ine sandflies associated with human 
houses in an endem ic area for cutaneous leishm aniasis in Costa Rica., 
p. 229-241. leishm aniasis control strategies: a critical evaluation of 
IORC-supported research. Proceedings of an international workshop. 
IORC Press, Ottowa. 
265. Herwaldt, B. L. 1999. Leishmaniasis. Lancet. 354: 1191- 9. 
266. Herwaldt, B. L., B. A. Arana, and T. R. Navin 1992. The natural 
history of cutaneous leishmaniasis in Guatemala. J Infect Dis. 
165:518-27. 
267. Ho, J. L., S. H. He, M. J. Rios, and E. A. Wick 1992. Interleukin-4 
inhibits human macrophage activation by tumor necrosis factor, 
granulocyte-monocyte colony-stim ulating factor, and interleukin- 3 for 
antileishmanial activity and oxidative burst capacity. J Infect Dis. 
165:344-51. 
268. Holaday, B. J. 2000. Role of CD8+ T cells in endogenous interleukin-
10 secretion associated with visceral leishm aniasis. Mem I nst Oswaldo 
Cruz. 95:217-20. 
269. Holaday, B. J., M. M. Pompeu, T. Evans, D. N. Braga, M. J. 
Texeira, Q. Sousa Ade, M. D. Sadick, A. W. Vasconcelos, J. S. 
193 
Abrams, R. D. Pearson, and et al. 1993. Correlates of Leishmania-
specific im m unity in the clinical spectrum of infection with Leishmania 
chagasi. J Infect Dis. 167:411-7. 
270. Holaday, B. J., M. M. Pompeu, S. Jeronimo, M. J. Texeira, A. 
Sousa Ade, A. W. Vasconcelos, R. D. Pearson, J. S. Abrams, and 
R. M. Locksley 1993. Potential role for interleukin-10 in the 
im m unosuppression associated with kala azar. J Clin Invest. 92:2626-
32. 
271. Hom mel, M., C. L. Jaffe, B. Travi, and G. Milon 1995. Experimental 
models for leishmaniasis and for testing anti-Ieishmanial vaccines. Ann 
Trop Med Parasitol. 89 Suppl 1 :55- 73. 
272. Horta, F. T., C. M. Antunes Uchoa, C. M. Barrientos Serra, R. 
Duarte, C. M. Magalhaes, R. M. Silva, F. Teophilo, L. P. Figliuolo, 
and M. F. Madeira 1998. [Serological and epidem iological features of 
canine American tegumentary Leishmaniasis from Marica, Rio de 
Janeiro, Brazil]. Rev Soc Bras Med Trop. 34:563- 8. 
273. Ibrahim, M. E., B. Lambson, A. O. Yousif, N. S. Deifalla, D. A. 
Alnaiem, A. Ismail, H. Yousif, H. W. Ghalib, E. A. Khalil, A. 
Kadaro, D. C. Barker, and A. M. EI Hassan 1999. Kala-azar in a 
high transmission focus: an ethnic and geographic dimension. Am J 
Trap Med Hyg. 61 :941-4. 
274. Iqbal, J., P. R. Hira, G. Saroj, R. Philip, F. AI-Ali, P. J. Madda, and 
A. Sher 2002. Imported visceral leishmaniasis: diagnostic dilemmas 
and comparative analysis of three assays. J Clin Microbial. 40:475-9. 
275. Iversson, L. B., M. E. Camargo, A. Villanova, M. L. Reichmann, E. 
A. Andrade, and J. E. Tolezano 1983. [Serological survey for 
research on visceral leishmaniasis in an urban dog population of the 
municipality of Sao Paulo, Brazil (1979-1982)]. Rev I nst Med Trop Sao 
Paulo. 25:310-7. 
276. Jelinek, T., S. Eichenlaub, and T. Loscher 1999. Sensitivity and 
specificity of a rapid im m unochrom atographic test for diagnosis of 
visceral leishmaniasis. Eur J Clin Microbial Infect Dis. 18:669-70. 
194 
277. Johnson, R. N., D. G. Young, J. F. Butler, and H. Bogaert-Diaz 
1992. Possible determ ination of the vector and reservoir of 
leishmaniasis in the Dom inican Republic. Am J Trop Med Hyg. 46:282-
7. 
278. Junqueira, A. C., E. Chiari, and P. Wincker 1996. Comparison of 
the polymerase chain reaction with two classical parasitological 
methods for the diagnosis of Chagas disease in an endem ic region of 
north- eastern Brazil. Trans R Soc Trop Med Hyg. 90: 129- 32. 
279. Kahl, L. P., J. E. Byram, J. R. David, S. A. Comerford, and F. Von 
Lichtenberg 1991. Leishmania (Viannia) braziliensis: com parat ive 
pathology of golden hamsters infected with isolates from cutaneous 
and mucosal lesions of patients residing in Tres Bracos, Bahia, Brazil. 
Am J Trop Med Hyg. 44:218-32. 
280. Kane, M. M., and D. M. Mosser 2001. The role of IL-10 in promoting 
disease progression in leishmaniasis. J Immunol. 166:1141-7. 
281. Kar, K. 1995. Serodiagnosis of leishmaniasis. Crit Rev Microbiol. 
21 :123-152. 
282. Katz, 0., J. N. Waitumbi, R. Zer, and A. Warburg 2000. Adenosine, 
AMP, and protein phosphatase activity in sandfly saliva. Am J Trop Med 
Hyg.62:145-50. 
283. Kayser, 0., H. Kolodziej, and A. F. Kiderlen 2001. 
1m m unom odulatory principles of Pelargonium sidoides. Phytother Res. 
15:122-6. 
284. Kelly, D. W., Z. Mustafa, and C. Dye 1997. Differential application of 
lambda-cyhalothrin to control the sandfly Lutzomyia longipalpis. Med 
Vet EntomoI.11:13-24. 
285. Killick-Kendrick, R. 1999. The biology and control of phlebotomine 
sand flies. Clin Dermatol. 17:279- 89. 
286. Killick-Kendrick, R. 1981. Transmission of leishmaniasis by the bite 
of phlebotomine sandflies: possible mechanisms. Trans R Soc Trop Med 
Hyg. 75: 152-4. 
195 
287. Killick-Kendrick, R., M. Killick-Kendrick, C. Focheux, J. Dereure, 
M. P. Puech, and M. C. Cadiergues 1997. Protection of dogs from 
bites of phlebotom ine sandflies by deltam ethrin collars for control of 
canine leishmaniasis. Med Vet Entomol. 11: 1 05-11. 
288. Killick- Kendrick, R., M. Killick- Kendrick, E. Pinelli, G. Del Real, R. 
Molina, M. M. Vitutia, M. C. Canavate, and J. Nieto 1994. A 
laboratory model of canine leishmaniasis: the inoculation of dogs with 
Leishmania infantum prom astigotes from m idguts of experim entally 
infected phlebotomine sandflies. Parasite. 1 :311-8. 
289. Killick-Kendrick, R., Killick-Kendrick, M. 1999. Biology of sand fly 
vectors of Mediterranean canine leishmaniasis, p. 26-31. In R. Killick-
Kendrick (ed.), Canine leishm aniasis: an update. Proceedings of the 
I nternational Can ine leishm an iasis Foru m Barcelona, Spain -1999. 
Hoechst Roussel Vet, Wiesbaden. 
290. Koutinas, A. F., Z. S. Polizopoulou, M. N. Saridom ichelakis, D. 
Argyriadis, A. Fytianou, and K. G. Plevraki 1999. Clinical 
considerations on canine visceral leishmaniasis in Greece: a 
retrospective study of 158 cases (1989-1996). JAm Anim Hosp Assoc. 
35:376-83. 
291. Krause, G., and A. Kroeger 1994. Topical treatment of American 
cutaneous leishmaniasis with paramomycin and methylbenzethonium 
chloride: a clinical study under field conditions in Ecuador. Trans R Soc 
Trop Med Hyg. 88:92-4. 
292. Kreutzer, R. D., N. Souraty, and M. E. Semko 1987. Biochemical 
identities and differences among Leishmania species and subspecies. 
Am J Trap Med Hyg. 36:22- 32. 
293. Kumar, R., K. Pai, K. Pathak, and S. Sundar 2001. Enzyme-linked 
im m unosorbent assay for recom binant K39 antigen in diagnosis and 
prognosis of I ndian visceral leishm an iasis. Clin Diagn Lab 1m m unol. 
8:1220-4. 
294. Lachaud, L., E. Chabbert, P. Dubessay, J. Reynes, J. Lamothe, 
and P. Bastien 2001. Comparison of various sample preparation 
196 
295. 
methods for PeR diagnosis of visceral leishm aniasis using peripheral 
blood. J Clin Microbial. 39:613-7. 
Lachaud, L., J. Dereure, E. Chabbert, J. Reynes, J. M. 
Mauboussin, E. Oziol, J. P. Dedet, and P. Bastien 2000. Optimized 
peR using patient blood sam pies for diagnosis and follow- up of visceral 
leishmaniasis, with special reference to AI OS patients. J Clin Microbiol. 
38:236-40. 
296. Lachaud, L., S. Marchergui-Hammami, E. Chabbert, J. Dereure, 
J. P. Dedet, and P. Bastien 2002. Comparison of six PeR methods 
using peripheral blood for detection of canine visceral leishmaniasis. J 
Clin Microbial. 40:210-5. 
297. Laferi, H., K. Kandel, and H. Pichler 1997. False positive dipstick 
test for malaria. N Engl J Med. 337: 1635- 6. 
298. Lainson, R. 1983. The American Leishmaniases: some observations 
on their ecology and epidem iology. Trans R Soc Trop Med Hyg. 
77:569-96. 
299. Lainson, R., J. J. Shaw, and Z. C. Lins 1969. leishmaniasis in Brazil. 
IV. The fox, Cerdocyon thous (L) as a reservoir of Leishmania donovani 
in Para state, Brazil. Trans R Soc Trop Med Hyg. 63:741-5. 
300. Lainson, R., J. J. Shaw, and M. Povoa 1981. The importance of 
edentates (sloths and anteaters) as primary reservoirs of Leishmania 
braziliensis guyanensis, causat ive agent of "pianbois" in north Brazil. 
Trans R Soc Trop Med Hyg. 75:611-2. 
301. Lainson, R., J. J. Shaw, F. T. Silveira, A. A. de Souza, R. R. 
Braga, and E. A. Ishikawa 1994. The dermal leishmaniases of Brazil, 
with special reference to the eco- epidem iology of the disease in 
Amazonia. Mem Inst Oswaldo Cruz. 89:435-43. 
302. La m othe, J. 2001. Activity of am photericin B in lipid em ulsion in the 
initial treatment of canine leishmaniasis. J Small Anim Pract. 42:170-5. 
303. Lamothe, J. 1999. Treatment of canine leishmaniasis from A 
(Amphotericin B) to Z (Zyloric), p. 12-17. In R. Killick-Kendrick (ed.), 
Canine leishmaniasis: an update. Proceedings of the International 
197 
Canine leishmaniasis Forum Barcelona, Spain -1999. Hoechst Roussel 
Vet, Wiesbaden. 
304. Lanzaro, G. C., B. Alexander, J. P. Mutebi, J. Montoya-Lerma, 
and A. Warburg 1998. Genetic variation among natural and 
laboratory colony populations of Lutzomyia longipalpis (Lutz & Neiva, 
1912)( Diptera: Psychodidae) from Colom bia. Mem I nst Oswaldo Cruz. 
93:65-9. 
305. Lanzaro, G. C., A. H. Lopes, J. M. Ribeiro, C. B. Shoemaker, A. 
Warburg, M. Soares, and R. G. Titus 1999. Variation in the salivary 
peptide, maxadilan, from species in the Lutzomyia longipalpis complex. 
Insect Mol BioI. 8:267-75. 
306. Lara, M. L., Z. Layrisse, J. V. Scorza, E. Garcia, Z. Stoikow, J. 
Granados, and W. Bias 1991. Immunogenetics of human American 
cutaneous leishm aniasis. Study of HLA haplotypes in 24 fam ilies from 
Venezuela. Hum Immunol. 30: 129- 35. 
307. Ie Fichoux, Y., J. F. Quaranta, J. P. Aufeuvre, A. Lelievre, P. 
Marty, I. Suffia, D. Rousseau, and J. Kubar 1999. Occurrence of 
Leishmania infantum parasitem ia in asym ptom atic blood donors living 
in an area of endem icity in southern France. J Clin Microbiol. 37: 1953-
7. 
308. Le Pont, F., and P. Desjeux 1986. leishmaniasis in Bolivia. II. The 
involvement of Psychodopygus yucumensis and Psychodopygus 
lIanosmartinsi in the selvatic transm ission cycle of Leishmania 
braziliensis braziliensis in a lowland subandean region. Mem I nst 
Oswaldo Cruz. 81 :311-8. 
309. Le Pont, F., S. Mollinedo, J. Mouchet, and P. Oesjeux 1989. 
[Ieishm aniasis in Bolivia. I V. The dog in the cycles of leishm aniasis in 
Bolivia]. Mem Inst Oswaldo Cruz. 84:417-21. 
310. Le Pont, F., J. M. Padilla, P. Desjeux, A. Richard, and J. Mouchet 
1989. [ I m pact of t he spraying of deltam ethrin in a focus of 
leishmaniasis in Bolivia]. Ann Soc Bel9 Med Trap. 69:223-32. 
198 
311. Leandro, C., G. M. Santos-Gomes L Camp·lno P R S 
' . , . omao, . 
Cortes, N. Rolao, S. Gomes-Pereira, M. J. Rica Capela, and P. 
Abranches 2001. Cell mediated im m unity and specific I gG1 and I gG2 
antibody response in natural and experimental canine leishmaniosis. 
Vet Immunol Immunopathol. 79:273-84. 
312. Leng, Y. J. 1982. A review of kala-azar in China from 1949 to 1959. 
Trans R Soc Trop Med Hyg. 76:531-7. 
313. Lerner, E. A., J. M. Ribeiro, R. J. Nelson, and M. R. Lerner 1991. 
I solation of maxadilan, a potent vasodilatory peptide from the salivary 
glands of the sand fly Lutzom yia longipalpis. J Bioi Chem. 266: 11234-
6. 
314. Lerner, E. A., and C. B. Shoemaker 1992. Maxadilan. Cloning and 
functional expression of the gene encoding this potent vasodilator 
peptide. J Bioi Chem. 267:1062-6. 
315. Levine, N. 1992. Cutaneous leishm aniasis treated with controlled 
localized heating. Arch Dermatol. 128:759-61. 
316. Lezama-Davila, C. M., and G. Gallagher 1995. CD4+, CD8+ and 
CD4- CD8- T cell-subsets can confer protection against Leishmania m. 
mexicana infection. Mem Inst Oswaldo Cruz. 90:51-8. 
317. Lima, H. C., and R. G. Titus 1996. Effects of sand fly vector saliva on 
developm ent of cutaneous lesions and the im m une response to 
Leishmania braziliensis in BALB/c mice. Infect Immun. 64:5442-5. 
318. Liste, F., and M. Gascon 1995. Allopurinol in the treatment of canine 
visceral leishmaniasis. Vet Rec. 137:23-4. 
319. Llanos Cuentas, E. A., C. C. Cuba, A. C. Barreto, and P. D. 
Marsden 1984. Clinical characteristics of human Leishmania 
braziliensis braziliensis infections. Trans R Soc Trop Med Hyg. 78:845-
6. 
320 LI C t A J Echevarria, M. Cruz, A. La Rosa, P. . anos- uen as, ., . 
Campos, M. Campos, E. Franke, J. Berman, F. Modabber, and J. 
Marr 1997. Efficacy of sodium stibogluconate alone and in combination 
199 
wit h allopu rinol for t reatm ent of mucocutaneous leishm aniasis. Clin 
Infect Dis. 25:677-84. 
321. Llanos-Cuentas, E. 1993. Risk factors associated with the 
transm ission of Andean cutaneous leishmaniasis. PhD. University of 
London. 
322. Llanos-Cuentas, E. A., N. Roncal, P. Villaseca, L. Paz, E. 
Ogusuku, J. E. Perez, A. Caceres, and C. R. Davies 1999. Natural 
infections of Leishmania peruviana in animals in the Peruvian Andes. 
Trans R Soc Trop Med Hyg. 93:15-20. 
323. Loeffler, J., H. Hebart, R. Bialek, L. Hagmeyer, D. Schmidt, F. P. 
Serey, M. Hartmann, J. Eucker, and H. Einsele 1999. 
Contam inations occurring in fungal PCR assays. J Clin Microbiol. 
37:1200-2. 
324. Loke, Y. W. 1982. Transm ission of parasites across the placenta. Adv 
Parasitol. 21 : 155-228. 
325. Lonardoni, M. V., U. Teodoro, S. M. Arraes, T. G. Silveira, D. A. 
Bertolini, E. A. Ishikawa, and J. J. Shaw 1993. [Canine 
leishm aniasis in Parana state, southern Brazil]. Rev Saude Publica. 
27:378-9. 
326. Lopes, U. G., H. Momen, G. Grimaldi, Jr., M. C. Marzochi, R. S. 
Pacheco, and C. M. Morel 1984. Schizodeme and zymodeme 
characterization of Leishmania in the investigation of foci of visceral 
and cutaneous leishmaniasis. J Parasitol. 70:89-98. 
327. Lopez, M., R. I nga, M. Cangalaya, J. Echevarria, A. Llanos-
Cuentas, C. Orrego, and J. Arevalo 1993. Diagnosis of Leishmania 
using the polym erase chain reaction: a sim plified procedure for field 
work. Am J Trop Med Hyg. 49:348-56. 
328. Lopez, M., R. I nga, N. Cueva, E. Alvarez, and J. Arevalo 1993. 
PCR: a tool for diagnosis of American tegumentary leishmaniasis in a 
health post of rural endem ic areas. Arch I nst Pasteur Tunis. 70:499-
504. 
200 
329. Lucientes, J. 1999. Laboratory observations on the protection of dogs 
from the bites of Phlebotomus perniciosus with Scalibor 
ProtectorBands: prelim inary results., p. 92-95. In R. Killick-Kendrick 
(ed.), Canine leishm aniasis: an update. Proceedings of the 
I nternational Canine leishm aniasis Forum Barcelona, Spain -1999. 
Hoechst Roussel Vet, Wiesbaden. 
330. Lucumi, A., Robledo, S., Gama, V., Saravia, N. G. 1998. Sensitivity 
of Leishmania Viannia panamensis to pentavalent antim ony is 
correlated with the formation of cleavable DNA-protein complexes. 
Antimicrob Agents Chemother. 42: 1990- 5. 
331. Ludewig, B., D. Graf, H. R. Gelderblom, Y. Becker, R. A. Kroczek, 
and G. Pauli 1995. Spontaneous apoptosis of dendritic cells is 
efficiently inhibited by TRAP (CD40-ligand) and TNF- alpha, but strongly 
enhanced by interleukin- 10. Eur J Immunol. 25: 1943-50. 
332. Machado, E. S., M. Braga, A. M. Da Cruz, S. G. Coutinho, A. R. 
Vieira, M. S. Rutowitsch, T. Cuzzi-Maya, G. Grimaldi junior, and 
J. A. Menezes 1992. Disseminated American muco-cutaneous 
leish m an iasis caused by Leishmania braziliensis braziliensis in a patient 
with AIDS: a case report. Mem Inst Oswaldo Cruz. 87:487-92. 
333. MacPherson, C. N. L., Meslin. F. X., Wandeler, A. I. 2000. Dogs, 
Zoonoses and Public Health. CABI Publishing, Wallington. 
334. Madeira, M., C. M. Serra, C. M. Uchoa, R. Duarte, D. A. Cruz, and 
C. Perdom 0 2000. [Canine leishm aniasis: a serological survey of 310 
dogs in Itaipu, Rio de Janeiro, Brazil]. Cad Saude Publica. 16:568. 
335. Madeira, M. F., Uchoa, C. M. A., Duarte, R., Magalhaes, C. M., 
Macedo, R. S., Teophilo, F. A. 0., Sigliuolo, L. P., Horta, F. T., 
and Serra, C. M. 2000. Leishmaniose tegumentar canina em Marica -
Rio de Janeiro: aspectos sorol6gicos e epidem iol6gicos. Revista da 
Sociedade Brasileira de Medicina Tropical. 33 (supplemento I) :44-
45. 
336. Magalhaes, P. A., W. Mayrink, C. A. da Costa, M. N. Melo, M. 
Dias, S. M. Batista, M. S. Michalick, and P. Williams 1980. [Kala-
201 
azar in the Rio Doce, Minas Gerais area. Results of prophylactic 
measures]. Rev Inst Med Trop Sao Paulo. 22:197-202. 
337. Magalhaes-Rocha NM, M. N., Dias M, Michalick MSM, Da Costa 
CA, Mayrink W, Williams P 1989. Characterisation of Leishmania 
st rains isolated from dogs in an endem ic area of Minas Gerais State, 
Brazil. Mem Inst Oswaldo Cruz. 84 (Supplement 11):41. 
338. Magill, A. J. 1995. Epidem iology of the leishmaniases. Dermatol Clin. 
13:505-23. 
339. Mancianti, F., M. Gramiccia, L. Gradoni, and S. Pieri 1988. Studies 
on canine leishmaniasis control. 1. Evolution of infection of different 
clinical forms of canine leishmaniasis following antimonial treatment. 
Trans R Soc Trop Med Hyg. 82:566- 7. 
340. Manoel, E. R. 2000. Surto de leishmaniose tegumentar americana no 
Municfpio de Cum ari, Estado de Goias. Revista da Sociedade Brasileira 
de Medicina Tropical. 33 (Supplemento 1):283. 
341. Marco, J. D., A. M. Padilla, P. Diosque, M. M. Fernandez, E. L. 
Malchiodi, and M. A. Basombrio 2001. Force of infection and 
evolution of lesions of canine tegumentary leishmaniasis in 
northwestern Argentina. Mem Inst Oswaldo Cruz. 96:649-52. 
342. Maroli, M., V. Mizzon, C. Siragusa, A. D'Oorazi, and L. Gradoni 
2001. Evidence for an impact on the incidence of canine leishmaniasis 
by the mass use of deltamethrin-impregnated dog collars in southern 
Italy. Med Vet Entomol. 15:358-63. 
343. Marquez, J. C. , unpublished data. 
344. Marsden, P. D. 1994. Mucosal leishmaniasis due to Leishmania 
(Viannia) braziliensis in Tres Bracos, Bahia-Brazil. Rev Soc Bras Med 
Trop. 27:93-101. 
M d P D 1986. Mucosal leishmaniasis ("espundia" Escomel, 345. ars en, . . 
1911). Trans R Soc Trop Med Hyg. 80:859- 76. 
346. Marsden, P. D., H. A. Lessa, M. R. Oliveira, G. A. Romero, J. G. 
Marotti, R. N. Sampaio, A. Barral, E. M. Carvalho, C. C. Cuba, A. 
202 
v. Magalhaes, and V. O. Macedo 1998. Clinical observations of 
unresponsive mucosal leishmaniasis. Am J Trop Med Hyg. 59:543-5. 
347. Marsden, P. D., R. N. Sam paio, E. M. Carvalho, J. P. Veiga, J. L. 
Costa, and E. A. L1anos-Cuentas 1985. High continuous antimony 
therapy in two patients with unresponsive mucosal leishmaniasis. Am J 
Trop Med Hyg. 34:710-3. 
348. Marsden, P. D., M. S. Tada, A. C. Barreto, and C. C. Cuba 1984. 
Spontaneous healing of Leishmania braziliensis braziliensis skin ulcers. 
Trans R Soc Trop Med Hyg. 78:561-2. 
349. Martinez, J. E., Alba, L. Arias, M. A. Escobar, and N. G. Saravia 
1992. Haemoculture of Leishmania (Viannia) braziliensis from two 
cases of mucosal leishm aniasis: re- exam inat ion of haem atogenous 
dissemination. Trans R Soc Trop Med Hyg. 86:392-4. 
350. Martinez, N. I. 1969. [Results of experimental innoculations in dogs 
with strains of Leishmania from cases of espundia]. Hospital (Rio J). 
75: 1705-18. 
351. Martinez N I 1969. Resultados de las inoculaciones experimentales en 
el perro con cepas de Leishmania procedentes de casos de espundia 0 
Hospital (Lima). 75: 1705-1716. 
352. Martinez-Moreno, A., M. S. Martinez-Cruz, A. Blanco, and S. 
Hernandez-Rodriguez 1993. Immunological and histological study of 
T- and B-Iym phocyte activity in canine visceral leishm aniosis. Vet 
Parasito!. 51 :49-59. 
3 M · MAT Moreno F. J. Martinez-Moreno, I. 35. artlnez- oreno, .,. , 
Acosta, and S. Hernandez 1995. Humoral and cell-mediated 
im m unity in natural and experim ental canine leishm aniasis. Vet 
Immunol Immunopatho!. 48:209-20. 
M C V A . It B Faugere, and A. J. Dessein 1999. Control 354. ary,.,. urlau , . 
of Leishmania infantum infection is associated with CD8( +) and 
gamma interferon- and interleukin-5-producing CD4( +) antigen-
specific T cells. Infect Immun. 67:5559-66. 
203 
355. Marzochi, M. C., and E. G. Barbosa-Santos 1988. Evaluation of a 
skin test on the canine mucocutaneous leishmaniasis diagnosis. Mem 
Inst Oswaldo Cruz. 83:391-2. 
356. Mathis, A., and P. Deplazes 1995. PCR and in vitro cultivation for 
detection of Leishmania spp. in diagnostic samples from humans and 
dogs. J Clin Microbial. 33: 1145- 9. 
357. Matsumoto, T., Y. Hashiguchi, E. A. Gomez, M. H. Calvopina, S. 
Nonaka, H. Saya, and T. Mimori 1999. Comparison of PCR results 
using scrape/ exudate, syringe-sucked fluid and biopsy sam pies for 
diagnosis of cutaneous leishm aniasis in Ecuador. Trans R Soc Trop Med 
Hyg. 93:606-7. 
358. Mattos, M., A. Caiza, O. Fernandes, A. J. Goncalves, C. Pirmez, C. 
S. Souza, and M. P. Oliveira-Neto 1998. American cutaneous 
leishmaniasis associated with HIV infection: report of four cases. J Eur 
Acad Dermatol Venereal. 10:218-25. 
359. Mayrink, W., P. A. Magalhaes, M. N. Melo, M. Dias, C. A. da 
Costa, M. S. Michalick, and P. Williams 1981. Canine cutaneous 
leishmaniasis in Manaus, Amazonas State, Brazil. Trans R Soc Trop 
Med Hyg. 75:757. 
360. Mayrink, W., P. Williams, M. V. Coelho, M. Dias, A. V. Martins, P. 
A. Magalhaes, C. A. Da Costa, A. R. Falcao, M. N. Melo, and A. L. 
Falcao 1979. Epidem iology of dermal leishmaniasis in the Rio Doce 
Valley, State of Minas Gerais, Brazil. Ann Trop Med Parasito/. 73:123-
37. 
361. Maywald, P. G., M. I. Machado, J. M. Costa-Cruz, and M. 
Goncalves- Pires 1996. [Canine cutaneous and visceral leishm aniasis 
and Chagas' disease from counties in the Triangulo Mineiro and Alto 
Paranaiba regions, Minas Gerais State, Brazil]. Cad Saude Publica. 
12:321-328. 
362. Mazza, S. 1926. Existencia de la leishmaniose cutanea en el perro en 
la Republica Argentina. Bol Inst Clin Quir (Buenos Aires). 2: 147-148. 
204 
363. Mazza, S. 1927. Leishmaniose cutanea en el caballo y nueva 
observaci6n de la m ism a en el perro. Bol I nst Clin Quir (Buenos Aires). 
3:462-464. 
364. Mbow, M. L., J. A. Bleyenberg, L. R. Hall, and R. G. Titus 1998. 
Phlebotomus papatasi sand fly salivary gland lysate down-regulates a 
Th1, but up-regulates a Th2, response in mice infected with 
Leishmania major. J Immuno!. 161 :5571- 7. 
365. Meinecke, C. K., J. Schottelius, L. Oskam, and B. Fleischer 1999. 
Congenital transm ission of visceral leishmaniasis (Kala Azar) from an 
asymptomatic mother to her child Pediatrics. 104:e65. 
366. Melby, P. C. 1991. Experimental leishmaniasis in humans: review Rev 
Infect Dis. 13: 1009-17. 
367. Mendes Da Cruz DA, D. R., Marzochi MCA 1997. Comparative 
serologic survey of sera and bloodspot eluates samples in the diagnosis 
of canine American tegumentary leishmaniasis. Mem Inst Oswaldo 
Cruz. 92 (Supplement 11):269. 
368. Mendez, M., and R. Bosch 1995. [Fever, anemia and 
decompensation of liver disease in a 9-year-old child with congenital 
immunodeficiency] .Med Clin (Barc). 105:549-56. 
369. Migone LE 1913. La buba du Paraguay, leishmaniose americaine. Bull 
Soc Pathol Exot. 6:210-218. 
370. Miller, T. A., Salgado, V. L. 1985. The mode of action of pyrethroids 
on insects. Taylor & Francis, London. 
371. Mimori, T., J. Sasaki, M. Nakata, E. A. Gomez, H. Uezato, S. 
Nonaka, Y. Hashiguchi, M. Furuya, and H. Saya 1998. Rapid 
identification of Leishmania species from formalin-fixed biopsy samples 
by polym orphism -specific polym erase chain reaction. Gene. 210: 179-
86. 
372. Mimori T, S. R., Gomez EA, Hashiguchi Y 1992. A 
f . ·n an area for Andean seroepidem iological survey 0 canines I 
leishmaniasis in Ecuador, p. 45-58. In H. Y (ed.), Studies on the New 
205 
World leishmaniasis and its transm ission, with particular reference to 
Ecuador. Kyowa Printing, Kochi, Japan. 
373. Mittal, V., S. Sehgal, T. P. Yadav, and V. K. Singh 1987. Congenital 
transmission of kala-azar. J Commun Dis. 19:184-5. 
374. Modabber, F. 1989. Experiences with vaccines against cutaneous 
leishmaniasis: of men and mice. Parasitology. 98:S49-60. 
375. Modabber, F. 1995. Vaccines against leishmaniasis. Ann Trop Med 
Parasitol. 89 Suppl 1 :83- 8. 
376. Molina, R., C. Amela, J. Nieto, M. San-Andres, F. Gonzalez, J. A. 
Castillo, J. Lucientes, and J. Alvar 1994. I nfectivity of dogs 
naturally infected with Leishmania infantum to colonized Phlebotomus 
perniciosus. Trans R Soc Trap Med Hyg. 88:491-3. 
377. Moll, H. 1993. Epidermal Langerhans cells are critical for 
immunoregulation of cutaneous leishmaniasis. Immunol Today. 
14:383-7. 
378. Molyneux, D. H. 1998. Vector-borne parasitic diseases--an overview 
of recent changes. Int J Parasitol. 28:927-34. 
379. Montoya, Y., C. Leon, M. Talledo, O. Nolasco, C. Padilla, U. 
Munoz-Najar, and D. C. Barker 1997. Recombinant antigens for 
specific and sensitive serodiagnosis of Latin Am erican tegum entary 
leishmaniasis. Trans R Soc Trap Med Hyg. 91 :674-6. 
380. Montoya-Lerma, J., and R. P. Lane 1996. Factors affecting host 
preference of Lutzom yia evansi (Diptera: Psychodidae), a vector of 
visceral leishmaniasis in Colombia. Bull Entomol Res. 86:43-50. 
381. Morais, N.A 2000. Leishmaniose tegumentar americana no Estado de 
Goias. Rev Soc Bras Med Trap. 33 (Supplement 1):282-283. 
382. Morales A, Corredor A, Caceres E, I bagos AL, and Rodriguez C 
1981. Aislam iento de tres cepas de Leishmania a partir de Lu. trapidoi 
en Colombia. Biomedica (Bogota). 1: 198-207. 
383. Morgado, M. G., C. Barcellos, F. Pin a Mde, and F. I. Bastos 2000. 
Hum an im m unodeficiency virus/ acquired im m unodeficiency syndrom e 
206 
384. 
and tropical diseases: a Brazilian perspective. Mem I nst Oswaldo Cruz. 
95:145-51. 
Mori M, D. C., Terabe M, Katakura K, Nonaka S, Gomez EA, 
Hashiguchi V, Matsumoto V 1994. Serological survey of the 
domestic dogs in leishmaniasis-endemic areas of Ecuador, p. 64-70. In 
H. Y (ed.), Studies on the New World leishmaniasis and its 
t ransm ission, wit h part icular reference to Ecuador. Kyowa Printing, 
Koch i, Japan. 
385. Moritz, A., S. Steuber, and M. Greiner 1998. Clinical follow-up 
examination after treatment of canine leishmaniasis. Tokai J Exp Clin 
Med. 23:279- 83. 
386. Morris, R. V., C. B. Shoemaker, J. R. David, G. C. Lanzaro, and R. 
G. Titus 2001. Sandfly maxadilan exacerbates infection with 
Leishmania major and vaccinating against it protects against L. major 
infection. J Immunol. 167:5226-30. 
387. Morrison, A. C., C. Ferro, A. Morales, R. B. Tesh, and M. L. 
Wilson 1993. Dispersal of the sand fly Lutzomyia longipalpis (Diptera: 
Psychodidae) at an endem ic focus of visceral leishm aniasis in 
Colombia. J Med Entomol. 30:427-35. 
388. Morrison, A. C., C. Ferro, and R. B. Tesh 1993. Host preferences of 
the sand fly Lutzomyia longipalpis at an endemic focus of American 
visceral leishmaniasis in Colombia. Am J Trop Med Hyg. 49:68- 75. 
389. Mouchet, J., F. Le Pont, R. Leon, R. Echeverria, and R. H. 
Guderian 1994. [Leishmaniasis in Ecuador. 5. leishmaniasis and 
anthropization on the Pacific coast]. Ann Soc 8elg Med Trop. 74:35-41. 
390. Muller, I., Kropf, P., Louis, J. A., Milon, G. 1994. Expansion of 
gam ma interferon-producing CD8+ T cells following secondary 
infection of mice immune to Leishmania major. Infect Immun. 
62:2575-81. 
391 M H W 2000. Treatment of visceral leishmaniasis (kala-azar): . urray, . . 
a decade of progress and fut u re approaches. I nt J I nfect Dis. 4: 158-
177. 
207 
392. 
393. 
Nabors, G. S., and J. P. Farrell 1995. Activity of pentostam (sodium 
stibogluconate) against cutaneous leishmaniasis in mice treated with 
neutralizing anti-interferon-gamma antibody. Am J Trop Med Hyg. 
53:55-60. 
Nacher, M., B. Carme, D. Sainte Marie, P. Couppie, E. Clyti, P. 
Guibert, and R. Pradinaud 2001. Seasonal fluctuations of incubation , 
healing delays, and clinical presentation of cutaneous leishmaniasis in 
French Guiana. J Parasitol. 87: 1495- 8. 
394. Naiff RD, N. M., Barrett TV, DE Queiroz RG, 1996. New records of 
cutaneous leishmaniasis in dogs in Manaus, Amazonas State, Brazil. 
Mem Inst Oswaldo Cruz. 91 (Supplement II): 154. 
395. Navin, T. R., B. A. Arana, F. E. Arana, A. M. de Merida, A. L. 
Castillo, and J. L. Pozuelos 1990. Placebo-controlled clinical trial of 
meglumine antimonate (glucantime) vs. localized controlled heat in the 
treatm ent of cutaneous leishm aniasis in Guatem ala. Am J Trop Med 
Hyg. 42:43- 50. 
396. Nery-Guimaraes, F. 1955. Estudo de um foco de leishmaniose muco-
cutanea na Baixada Flum inense (Estado do Rio de Janeiro). Mem I nst 
Oswaldo Cruz 53: 1-11. 
397. Nieto, C. G., M. Garcia-Alonso, J. M. Requena, C. Miron, M. Soto, 
C. Alonso, and I. Navarrete 1999. Analysis of the humoral immune 
response against total and recom binant antigens of Leishmania 
infantum: correlation with disease progression in canine experimental 
leishmaniasis. Vet Immunollmmunopathol. 67:117-30. 
398. Nogueira-Castanon, M. C., C. A. Pereira, and T. Furtado 1996. 
Unusual association of American cutaneous leishmaniasis and acquired 
immunodeficiency syndrome. Int J Dermatol. 35:295- 7. 
399. Nohara SJ, P. C., Leito R, Verissimo E, Pacheco RS, Conceicao 
N F, Barbosa-Santos EG 1994. Canine epidem iological survey on 
human cutaneous leishmaniasis, outbreak in Bra<;anan da Serra District 
(Rio Bonito Municipality, Rio de Janeiro State, Brazil). Am J Trop Med 
Hyg. 51 (Supplement):170. 
208 
400. Nolde r, D. 1998. Molecu lar diversity in the Leishmania subgenus 
Viannia. PhD. University of London. 
401. Nonata, R., Sampaio, R., Tauil, P., and Da Cunha, N. F. 2000. 
Investigacao epidemiol6gica da autoctonia da leishmaniose tegumentar 
am ericana no Dist rito Federal - aspectos no hom em e no cao. Revista 
da Sociedade Brasileira de Medicina Tropical. 33 (Supplem ento 
1):51. 
402. Nunes, M. P., J. M. Jackson, R. W. Carvalho, N. J. Furtado, and S. 
G. Coutinho 1991. Serological survey for canine cutaneous and 
visceral leishmaniasis in areas at risk for transmission in Rio de Janeiro 
where prophylactic measures had been adopted. Mem I nst Oswaldo 
Cruz. 86:411-7. 
403. Nyakundi, P. M., R. Muigai, J. B. Were, C. N. Oster, G. S. Gachihi, 
and G. Kirigi 1988. Congenital visceral leishmaniasis: case report. 
Trans R Soc Trop Med Hyg. 82:564. 
404. Ogusuku, E., J. E. Perez, L. Paz, E. Nieto, J. Monje, and H. 
Guerra 1994. I dentification of bloodm eal sources of Lutzomyia spp. in 
Peru. Ann Trop Med Parasitol. 88:329- 35. 
405. Oliva, G., L. Gradoni, P. Ciaramella, R. De Luna, L. Cortese, S. 
Orsini, R. N. Davidson, and A. Persechino 1995. Activity of 
liposom al am photericin B (Am Bisom e) in dogs nat u rally infected with 
Leishmania infantum. J Antimicrob Chemother. 36: 1 013- 9. 
406. Oliva, G., L. Gradoni, L. Cortese, S. Orsini, P. Ciaramella, A. 
Scalone, R. de Luna, and A. Persechino 1998. Comparative efficacy 
of m eglum ine antim oniate and am inosidine sulphate, alone or in 
combination, in canine leishmaniasis. Ann Trop Med Parasitol. 92:165-
71. 
407. Oliveira Filho, A. M., and M. T. Melo 1994. The chemical control of 
vectors of leishmaniasis. Mem Inst Oswaldo Cruz. 89:461-2. 
408. Oliveira Filho, A. M., and M. T. Melo 1994. Vectors control 
importance on leishmaniasis transmission. Mem Inst Oswaldo Cruz. 
89:451-6. 
209 
409. Oliveira-Neto, M. P., C. Pirmez, E. Rangel, A. Schubach, and G. 
Grim aldi Junior 1988. An outbreak of A m erican cutaneous 
leishm aniasis (Leishmania braziliensis braziliensis) in a periurban area 
of Rio de Janeiro city, Brazil: clinical and epidem iological studies. Mem 
Inst Oswaldo Cruz. 83:427-35. 
410. Olivier, M., K. G. Baimbridge, and N. E. Reiner 1992. Stimulus-
response coupling in monocytes infected with Leishmania. Attenuation 
of calcium transients is related to defective agonist- induced 
accumulation of inositol phosphates. J Immunol. 148: 1188- 96. 
411. Osorio, L. E., C. M. Castillo, and M. T. Ochoa 1998. Mucosal 
leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: 
clinical characteristics. Am J Trap Med Hyg. 59:49-52. 
412. Osorio, L. E., R. Palacios, M. E. Chica, and M. T. Ochoa 1998. 
Treatment of cutaneous leishmaniasis in Colombia with dapsone. 
Lancet. 351 :498- 9. 
413. Ouellette, M., D. Legare, and B. Papadopoulou 2001. Multidrug 
resistance and ABC transporters in parasitic protozoa. J Mol Microbiol 
Biotechnol. 3:201- 6. 
414. Ozensoy, S., Y. Ozbel, N. Turgay, M. Z. Alkan, K. Gul, A. Gilman-
Sachs, K. P. Chang, S. G. Reed, and M. A. Ozcel 1998. 
Serodiagnosis and epidem iology of visceral leishm aniasis in Turkey. 
Am J Trap Med Hyg. 59:363- 9. 
415. Palatnik-de-Sousa, C. B., W. R. dos Santos, J. C. Franca-Silva, R. 
T. da Costa, A. B. Reis, M. Palatnik, W. Mayrink, and O. Genaro 
2001. I m pact of canine control on the epidem iology of canine and 
human visceral leishmaniasis in Brazil. Am J Trap Med Hyg. 65:510-7. 
416. Paranhos-Silva, M., E. G. Nascimento, M. C. Melro, G. G. Oliveira, 
W. L. dos Santos, L. C. Pontes-de-Carvalho, and A. J. Oliveira-
dos-Santos 1998. Cohort study on canine emigration and Leishmania 
infection in an endem ic area for Am erican visceral leishmaniasis. 
Implications for the disease control. Acta Trap. 69:75-83. 
210 
417. Passos, V. M., A. C. Andrade, E. S. Silva, E. M. Figueiredo, and A. 
L. Falcao 1996. [A canine survey in a recent focus of cutaneous 
leishmaniasis in the city of Sabara, the metropolitan area of Belo 
Horizonte]. Rev Soc Bras Med Trop. 29:323-9. 
418. Passos, V. M., A. L. Falcao, M. C. Marzochi, C. M. Gontijo, E. S. 
Dias, E. G. Barbosa-Santos, H. L. Guerra, and N. Katz 1993. 
Epidem iological aspects of Am erican cutaneous leishm aniasis in a 
periurban area of the metropolitan region of Belo Horizonte, Minas 
Gerais, Brazil. Mem Inst Oswaldo Cruz. 88: 1 03-1 o. 
419. Passos, V. M., E. B. Lasmar, C. M. Gontijo, O. Fernandes, and W. 
Degrave 1996. Natural infection of a domestic cat (Felis domesticus) 
with Leishmania (Viannia) in the metropolitan region of Belo Horizonte, 
State of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz. 91: 19- 20. 
420. Passos VMA, F. 0., Andrade AC, Gontijo CMF, Degrave W, 1995. 
Detecgao e tipagem de Leishmania da regiao metropolitana de Belo 
Horizonte atraves da reagao de polim erizagao em cadeia e da 
hibridizagao com sondas moleculares. Rev Soc Bras Med Trop. 28 
(Supplement II): 136. 
421. Payne, D. A., M. Vander Straten, D. Carrasco, and S. K. Tyring 
2001. Molecular diagnosis of skin-associated infectious agents. Arch 
Dermatol. 137:1497-502. 
422. Pearson RD, and Sousa A 1996. Clinical spectrum of leishmaniasis. 
Clin Infect Dis. 22:1-13. 
423. Pearson, R. D., and A. Q. Sousa 1996. Clinical spectrum of 
leishmaniasis. Clin Infect Dis. 22:1-13. 
424. Pedroso AM 1923. I nfecgao do cao pela leishmania tropical. Rev Med 
(Sao Paulo). 7:42-45. 
AM 1913 Leishmaniose local do cao An Paulistas Med Cir. 425. Pedroso . 
1 :33-39. 
426. Perich, M. J., A. L. Hoch, N. Rizzo, and E. D. Rowton 1995. 
I nsecticide barrier spraying for the control of sand fly vectors of 
211 
427. 
cutaneous leishmaniasis in rural Guatemala. Am J Trop Med Hyg. 
52:485-8. 
Pinelli, E., R. Killick- Kendrick, J. Wagenaar, W. Bernadina, G. del 
Real, and J. Ruitenberg 1994. Cellular and humoral immune 
responses in dogs experimentally and naturally infected with 
Leishmania infantum. Infect Immun. 62:229-35. 
428. Pinelli, E., Rutten, V. P. M. G., RUitenberg, E. J. 1999. Cellular 
immune responses in canine visceral leishmaniasis, p. 60-65. In R. 
Killick-Kendrick (ed.), Canine leishmaniasis: an update. Proceedings of 
the I nternational Canine leishm aniasis Forum Barcelona, Spain -1999. 
Hoechst Roussel Vet, Wiesbaden. 
429. Pinelli, E., S. Y. van der Kaaij, R. Siappendel, C. Fragio, E. J. 
Ruitenberg, W. Bernadina, and V. P. Rutten 1999. Detection of 
canine cytokine gene expression by reverse transcription- polymerase 
chain reaction. Vet Immunollmmunopathol. 69:121-6. 
430. Pinero, J., E. Martinez, R. Pacheco, Z. Aragon, F. De Armas, A. 
Del Castillo, and B. Valladares 1999. PCR-ELISA for diagnosis of 
mucocutaneous leishmaniasis. Acta Trop. 73:21-9. 
431. Pirm ez, C. 1992. 1m m unopathology of Am erican cutaneous 
leishmaniasis. Mem Inst Oswaldo Cruz. 87:105-9. 
432. Pirmez, C., S. G. Coutinho, M. C. Marzochi, M. P. Nunes, and G. 
Grim aldi, Jr. 1988. Canine American cutaneous leishmaniasis: a 
clinical and im m unological study in dogs naturally infected with 
Leishmania braziliensis braziliensis in an endem ic area of Rio de 
Janeiro, Brazil. Am J Trop Med Hyg. 38:52-8. 
433. Pirmez, C., V. da Silva Trajano, M. Paes-Oliveira Neto, A. M. da-
Cruz, S. C. Goncalves-da-Costa, M. Catanho, W. Degrave, and O. 
Fernandes 1999. Use of PCR in diagnosis of human american 
tegum entary leishm aniasis in Rio de Janeiro, Brazil. J Clin Microbiol. 
37:1819-23. 
212 
434. Pirmez, C., M. C. Marzochi, and S. G. Coutinho 1989. Experimental 
canine mucocutaneous leishmaniasis (Leishmania braziliensis 
braziJiensis). Mem Inst Oswaldo Cruz. 83: 145-51. 
435. Pirmez, C., M. Yamamura, K. Uyemura, M. Paes-Oliveira, F. 
Conceicao-Silva, and R. L. Modlin 1993. Cytokine patterns in the 
pathogenesis of human leishmaniasis. J Clin Invest. 91: 1390-5. 
436. Poli, A., S. Sozzi, G. Guidi, P. Bandinelli, and F. Mancianti 1997. 
Comparison of aminosidine (paromomycin) and sodium stibogluconate 
for treatment of canine leishmaniasis. Vet Parasitol. 71 :263- 71. 
437. Pozio, E., L. Gradoni, S. Bettini, and M. Gramiccia 1981. 
Leishm aniasis in Tuscany (I taly): VI. Canine leishm aniasis in the focus 
of Monte Argentario (Grosseto). Acta Trop. 38:383-93. 
438. Qu, J. Q., L. Zhong, M. Masoom-Yasinzai, M. Abdur-Rab, H. S. 
Aksu, S. G. Reed, K. P. Chang, and A. Gilman-Sachs 1994. 
Serodiagnosis of Asian leishm aniasis with a recom bin ant antigen from 
the repetitive domain of a Leishmania kinesin. Trans R Soc Trop Med 
Hyg. 88:543- 5. 
439. Quinnell, R. J., O. Courtenay, S. Davidson, L. Garcez, B. 
Lambson, P. Ramos, J. J. Shaw, M. A. Shaw, and C. Dye 2001. 
Detection of Leishmania in fan tum by PCR, serology and cellular 
im m une response in a cohort study of Brazilian dogs. Parasitology. 
122:253-61. 
440. Quinnell, R. J., O. Courtenay, L. Garcez, and C. Dye 1997. The 
epidem iology of canine leishm aniasis: transm ission rates estim ated 
from a cohort study in Amazonian Brazil. Parasitology. 115:143-56. 
441. Quinnell, R. J., O. Courtenay, M. A. Shaw, M. J. Day, L. M. 
Garcez, C. Dye, and P. M. Kaye 2001. Tissue cytokine responses in 
canine visceral leishmaniasis. J Infect Dis. 183:1421-4. 
442. Quinnell, R. J., and C. Dye 1994. Correlates of the peridomestic 
L . long,'palp,'s (DI'ptera: Psychodidae) in abundance of utzomy,a 
Amazonian Brazil. Med Vet Entomol. 8:219-24. 
213 
443. Quinnell, R. J., C. Dye and J J Shaw 1992 H t f 
' .. . os pre erences of 
the phlebotom ine sandfly Lutzomyia longipalpis in Amazonian Brazil. 
Med Vet Entomol. 6:195-200. 
444. Qureshi, A. A., A. Asahina, M. Ohnuma, M. Tajima, R. D. 
Granstein, and E. A. Lerner 1996. Immunomodulatory properties of 
m axadilan, the vasodilator peptide from sand fly salivary gland 
extracts. Am J Trop Med Hyg. 54:665-71. 
445. Rab, M. A., M. T. Mahmood, D. Bux, M. Hassan, and K. Hassan 
1991. Visceral leishmaniasis in a six month old child: is congenital 
transmission of disease possible? J Pak Med Assoc. 41: 191- 3. 
446. Ram irez, J. L., and P. Guevara 1997. Persistent infections by 
Leishmania (Viannia) braziliensis. Mem Inst Oswaldo Cruz. 92:333- 8. 
447. Ram irez, J. R., S. Agudelo, C. M uskus, J. F. Alzate, C. Berberich, 
D. Barker, and I. D. Velez 2000. Diagnosis of cutaneous 
leishmaniasis in Colom bia: the sampling site within lesions influences 
the sensitivity of parasitologic diagnosis. J Clin Microbiol. 38:3768- 73. 
448. Ramos-Santos, C., O. Hernandez-Montes, G. Sanchez-Tejeda, 
and A. Monroy-Ostria 2000. Visceral leishmaniosis caused by 
Leishmania (L.) mexicana in a Mexican patient with human 
immunodeficiency virus infection. Mem Inst Oswaldo Cruz. 95:733- 7. 
449. Rangel, E. F., N. A. de Souza, E. D. Wermelinger, and A. F. 
Barbosa 1984. [Natural infection of Lutzomyia intermedia Lutz & 
Neiva, 1912, in an endemic area of visceral leishmaniasis of Rio de 
Janeiro]. Mem Inst Oswaldo Cruz. 79:395-6. 
450. Ready, P. D., J. R. Arias, and R. A. Freitas 1985. A pilot study to 
control Lutzomyia umbratilis (Diptera: Psychodidae), the major vector 
of Leishmania braziliensis guyanensis, in a peri-urban rainforest of 
Manaus, Amazonas State, Brazil. Mem Inst Oswaldo Cruz. 80:27-36. 
451. Reale, S., L. Maxia, F. Vitale, N. S. Glorioso, S. Caracappa, and G. 
Vesco 1999. Detection of Leishmania in fan tum in dogs by PCR with 
lymph node aspirates and blood. J Clin Microbiol. 37:2931-5. 
452. Reithinger, R. 1999. Control of leishmaniasis. Vet Rec. 144:735. 
214 
453. Reithinger, R., and C. R. Davies 1999. Is the domestic dog (Canis 
fam iliaris) a reservoir host of Am erican cutaneous leishm aniasis? A 
critical review of the current evidence. Am J Trop Med Hyg. 61 :530-41. 
454. Reithinger, R., C. R. Davies, H. Cadena, and B. Alexander 1997. 
Evaluation of the fungus Beauveria bassiana as a potential biological 
control agent against phlebotom ine sand flies in Colom bian coffee 
plantations. J Invertebr Pathol. 70: 131-5. 
455. Revollo, S. , unpublished data. 
456. Rey, J. A., B. L. Travi, A. Z. Valencia, and N. G. Saravia 1990. 
I nfectivity of the subspecies of the Leishmania braziliensis com plex in 
vivo and in vitro. Am J Trop Med Hyg. 43:623-31. 
457. Rhalem, A., H. Sahibi, N. Guessous-Idrissi, S. Lasri, A. Natami, 
M. Riyad, and B. Berrag 1999. Immune response against Leishmania 
antigens in dogs naturally and experimentally infected with Leishmania 
infantum. Vet Parasitol. 81: 173- 84. 
458. Ribeiro, J. M., A. Vachereau, G. B. Modi, and R. B. Tesh 1989. A 
novel vasodilatory peptide from the salivary glands of the sand fly 
Lutzomyia longipalpis. Science. 243:212-4. 
459. Ribeiro-de-Jesus, A., R. P. Almeida, H. Lessa, O. Bacellar, and E. 
M. Carvalho 1998. Cytokine profile and pathology in human 
leishmaniasis. Braz J Med Bioi Res. 31: 143- 8. 
460. Riera, C., J. E. Valladares, M. Gallego, M. J. Aisa, S. Castillejo, R. 
Fisa, N. Ribas, J. Carrio, J. Alberola, and M. Arboix 1999. 
Serological and parasitological follow- up in dogs experim entally 
infected with Leishmania infantum and treated with meglumine 
antimoniate Vet Parasitol. 84:33-47. 
461. Rocha, P. N., R. P. Almeida, O. Bacellar, A. R. de Jesus, D. C. 
Filho, A. C. Filho, A. Barral, R. L. Coffman, and E. M. Carvalho 
1999. Down-regulation of Th1 type of response in early human 
American cutaneous leishmaniasis. J Infect Dis. 180: 1731-4. 
462. Rocha, R. A., R. N. Sampaio, M. Guerra, A. Magalhaes, C. C. 
Cuba, A. C. Barreto, and P. D. Marsden 1980. Apparent Glucantime 
215 
463. 
464. 
failure in five patients with m uc t ocu aneous leishmaniasis. J Trop Med 
Hyg.83:131-9. 
Rodgers, M. R., S. J. Popper, and D. F. Wirth 1990. Amplification of 
kinetoplast DNA as a tool in the detection and diagnosis of Leishmania. 
Exp Parasito!. 71 :267- 75. 
Rodrigues V. L. C. C., P. Goldenberg, O. L. I. Souza, M. L. F. 
Condino, and E. E. B. Galati 1999. Prevalencia da leishmaniose 
americana a partir de sinais clfnicos em caes do Municfpio de Ilhabela, 
Estado de Sao Paulo, Brasil. Rev Soc Bras Med Trop 32 (supplem ent 
II): 10-11. 
465. Rodriguez, N., B. Guzman, A. Rodas, H. Takiff, B. R. Bloom, and 
J. Convit 1994. Diagnosis of cutaneous leishmaniasis and species 
discrim ination of parasites by PCR and hybridization. J Clin Microbiol. 
32:2246-52. 
466. Rojas, E., and J. V. Scorza 1990. [Xenodiagnosis using Lutzomyia 
youngi in Venezuelan cases of cutaneous leishmaniasis due to 
Leishmania brazi/iensis]. Mem Inst Oswaldo Cruz. 84:29-34. 
467. Rojas, J. C, A. Munoz., M. V. Herrero, A. Dobies, and R. Zeledon 
R 1994. Risk factors for dom iciliary and peridom iciliary transm ission of 
cutaneous leishmaniasis in Costa Rica. Am J Trop Med Hyg. 51 
(Supplement I): 104. 
468. Romana, C., L. Najera, M. Conejos, and J. W. Abalos 1949. 
Leishmaniosis tegumentaria en perros de Tucuman. II. Foco domestico 
de leishmaniosis. An Inst Med Region. 2 :283-292. 
469. Romero, G. A., M. V. Guerra, M. G. Paes, E. Cupolillo, C. Bentin 
Toaldo, V. O. Macedo, and O. Fernandes 2001. Sensitivity of the 
polymerase chain reaction for the diagnosis of cutaneous leishmaniasis 
due to Leishmania (Viannia) guyanensis Acta Trop. 79:225- 9. 
470. Rosa, A. C., C. C. Cuba, A. Vexenat, A. C. Barreto,' and P. D. 
Marsden 1988. Predom inance of Leishmania braziliensis braziliensis in 
the regions of Tres Bracos and Corte de Pedra, Bahia, Brazil. Trans R 
Soc Trop Med Hyg. 82:409-410. 
216 
471. Rosatelli, J. B., C. S. Souza, F. A. Soares, N. T. Foss, and A. M. 
Roselino 1998. Generalized c t I u aneous eishmaniasis in acquired 
im m unodeficiency syndrom e. J Eur Acad Derm atol Venereol. 10:229-
32. 
472. Roura, X., D. Fondevila, A. Sanchez, and L. Ferrer 1999. Detection 
of Leishmania infect ion in paraffin- em bedded skin biopsies of dogs 
using polymerase chain reaction. J Vet Diagn Invest. 11 :385-7. 
473. Roura, X., A. Sanchez, and L. Ferrer 1999. Diagnosis of canine 
leishmaniasis by a polymerase chain reaction technique. Vet Rec. 
144:262-4. 
474. Russell, M. E., D. H. Adams, L. R. Wyner, Y. Yamashita, N. J. 
Halnon, and M. J. Karnovsky 1993. Early and perSistent induction of 
monocyte chemoattractant protein 1 in rat cardiac allografts. Proc. Natl 
Acad Sci USA. 90: 6086-90. 
475. Saenz, R. E., H. Paz, and J. D. Berman 1990. Efficacy of 
ketoconazole against Leishmania braziliensis panamensis cutaneous 
leishmaniasis. Am J Med. 89:147-55. 
476. Sa 10m on 0 D, Sosa Esta n i S, Gom ez A, and S. EL 1992. Sandflies 
associated with a tegumentary leishmaniasis focus in Salta, Argentina. 
Mem Inst Oswaldo Cruz. 87 (Supplement 1I):S223. 
477. Salomon, O. D., M. Bogado De Pascual, M. L. Molinari, and V. 
Verri 2001. Study of a cutaneous leishmaniasis outbreak in General 
Vedia, Province of Chaco, 1996. Rev I nst Med Trop Sao Paulo. 43:99-
104. 
478. Salom on, O. D., B. L. Travi, and E. L. Segura 1995. Note on 
sandflies associated with a tegum entary leishmaniasis focus in Salta, 
Argentina, 1988. Rev Inst Med Trop Sao Paulo. 37:91-2. 
479. Salomon, O. D., M. Zaidenberg, R. Burgos, V. I. Heredia, and S. 
L. Caropresi 2001. American cutaneous leishmaniasis outbreak, 
Tartagal city, province of Salta, Argentina, 1993. Rev I nst Med Trop 
Sao Paulo. 43:105-8. 
217 
480. Salotra, P., G. Sreenivas A A Nasim B V S bb R' 
, " '" u a aJu, and V. 
Ramesh 2002. Evaluation of Enzyme- Linked Immunosorbent Assay for 
Diagnosis of Post- Kala-Azar Derm al leishmaniasis with Crude or 
Recombinant k39 Antigen. Clin Diagn Lab Immunol. 9:370-3. 
481. Salotra, P., G. Sreenivas, V. Ram esh, and S. Sundar 2001. A 
sim pie and sen sit ive t est for field diagnosis of post kala-azar derm al 
leishmaniasis. Br J Dermatol. 145:630-2. 
482. Sam brook, J., Fritsch, E. F., Maniatis, T. 1989. Molecular cloning a 
laboratory manual. Cold Spring Harbour Laboratory Press, New York. 
483. Sampaio, R. N., J. H. Sampaio, and P. D. Marsden 1985. 
Pentavalent ant im on ial treatm ent in mucosal leishm an iasis. Lancet. 
1 :1097. 
484. Sam uelson, J., E. Lerner, R. Tesh, and R. Titus 1991. A mouse 
model of Leishmania braziliensis braziliensis infection produced by 
coinjection with sand fly saliva. J Exp Med. 173:49-54. 
485. Sanchez-Tejeda, G., N. Rodriguez, C. I. Parra, O. Hernandez-
Montes, D. C. Barker, and A. Monroy-Ostria 2001. Cutaneous 
leishmaniasis caused by members of Leishmania braziliensis complex 
in Nayarit, State of Mexico. Mem Inst Oswaldo Cruz. 96:15-9. 
486. Santos, G. P. L., Beta, C. A. F., Batista, J. V., Marzochi, M. C. A., 
Souza, M. B., Gomes, G. S., Santos, E. G. 0., Contort, E. M., 
Santos, G. P. L., Dias, A. S., Ponte, C. S., and Wanzeller, F. 2000. 
Estudo preliminar da populacao canina na leishmaniose tegumentar 
americana (LTA) no Municfpio de Oriximina, Estado do Para. Revista da 
Sociedade Brasileira de Medicina Tropical. 33 (su pple m ento I): 27-
28. 
487. Santos GPL, P. C., Maspero RC, Espindola CB, Silva VL, Santos 
EGOB, Marzochi MCA, Andrade MV, Conceicao NF, Silva AF, 
Almeida DC, Leite RF 1994. Leishmaniose tegumentar americana 
(LTA) no Municfpio de Paracambi, Estado do Rio de Janeiro. III. 
Inquerito canino. Rev Bras Med Trap. 27 (Supplement 11):35. 
218 
488. Santrich, C., I. Segura A L Arias and N G S . 
, .. , .. aravla 1990. 
Mucosal disease caused by Leishmania braziliensis guyanensis. Am J 
Trop Med Hyg. 42:51-5. 
489. Saravia, N. G., A. F. Holguin, D. McMahon-Pratt, and A. 
D'Alessandro 1985. Mucocutaneous leishm aniasis in Colom bia: 
Leishmania braziliensis su bspecies diversity. Am J Trop Med Hyg. 
34:714-20. 
490. Saravia, N. G., I. Segura, A. F. Holguin, C. Santrich, L. 
Valderrama, and C. Ocampo 1998. Epidemiologic, genetic, and 
clinical associations among phenotypically distinct populations of 
Leishmania (Viannia) in Colombia. Am J Trop Med Hyg. 59:86- 94. 
491. Saravia, N. G., L. Valderrama, M. Labrada, A. F. Holguin, C. 
Navas, G. Palma, and K. A. Weigle 1989. The relationship of 
Leishmania braziliensis subspecies and im m une response to disease 
expression in New World leishmaniasis. J Infect Dis. 159:725- 35. 
492. Saravia, N. G., K. Weigle, I. Segura, S. H. Giannini, R. Pacheco, 
L. A. Labrada, and A. Goncalves 1990. Recurrent lesions in human 
Leishmania braziliensis infection-- reactivation or reinfection? Lancet. 
336:398- 402. 
493. Savani, E. S., E. A. Galati, M. C. Camargo, S. R. D'Auria, J. T. 
Damaceno, and S. A. Balduino 1999. [Serological survey for 
Am erican cutaneous leishm aniasis in stray dogs in the S. Paulo State, 
Brazil]. Rev Saude Publica. 33:629-31. 
494. Scalone, A., R. De Luna, G. Oliva, L. Baldi, G. Satta, G. Vesco, W. 
Mignone, C. Turilli, R. R. Mondesire, D. Simpson, A. R. 
Donoghue, G. R. Frank, and L. Gradoni 2002. Evaluation of the 
Leishmania recom binant K39 antigen as a diagnostic marker for canine 
leishmaniasis and validation of a standardized enzyme- linked 
immunosorbent assay. Vet Parasitol. 104:275- 85. 
495. Scharton-Kersten, T., L. C. Afonso, M. Wysocka, G. Trinchieri, 
and P. Scott 1995. IL-12 is required for natural killer cell activation 
T helper 1 cell developm ent in experim ental and subsequent 
leishmaniasis. J Immunol. 154:5320- 30. 
219 
496. Scharton-Kersten, T., and P. Scott 1995. The role of the innate 
im m une response in Th 1 cell developm ent following Leishmania major 
infection. J Leukoc BioI. 57:515-22. 
497. Schreck, C. E., D. L. Kline, B. N. Chaniotis, N. Wilkinson, T. P. 
McGovern, and D. E. Weidhaas 1982. Evaluation of personal 
protection methods against ph lebotom ine sand flies including vectors 
of leishmaniasis in Panama. Am J Trop Med Hyg. 31 :1046-53. 
498. Schubach, A., F. Haddad, M. P. Oliveira-Neto, W. Degrave, C. 
Pirmez, G. Grimaldi, Jr., and O. Fernandes 1998. Detection of 
Leishmania DNA by polymerase chain reaction in scars of treated 
human patients. J Infect Dis. 178:911-4. 
499. Schubach, A., M. C. Marzochi, T. Cuzzi-Maya, A. V. Oliveira, M. L. 
Araujo, A. L. Oliveira, R. S. Pacheco, H. Momen, F. Conceicao-
Silva, S. G. Coutinho, and K. B. Marzochi 1998. Cutaneous scars in 
Am erican tegum entary leishm aniasis patients: a site of Leishmania 
(Viannia) braziliensis persistence and viability eleven years after 
antimonial therapy and clinical cure. Am J Trop Med Hyg. 58:824- 7. 
500. Schubach, A., Oliveira-Neto, M. P., Paranhos, M. A. S., Souza, M. 
501. 
B., and Conceicao, N. F. 1988. Estudios iniciais de um foco de 
leishm aniose tegum entar em zona rural do Estado do Rio de Janeiro. 
Revista da Sociedade Brasileira de Medicina Tropical. 21 (Supplement 
11):82-83. 
Scorza JV, Marquez M, and Marquez JC 1984. Hallazgo de 
Lutzomyia townsendi naturalmente infectada con Leishmania 
braziliensis en el area suburbana de Truj illo, Venezuela. Bol Dir 
Malariol Saneamiento Ambiental. 24:21- 28. 
502. Scorza, J. V., S. Rezzano, and J. Cesar Marquez 1984. [Didelphis 
marsupialis: principal reservoir of Leishmania spp. in the city of 
Trujillo, Venezuela]. Rev Cubana Med Trop. 36: 194-200. 
503. Scott, P., B. Hondowicz, A. Eaton, and T. Scharton-Kersten 1996. 
The role of I L-12 in regulation of T helper cell subsets in vivo. Lessons 
from experimental cutaneous leishmaniasis. Ann N Y Acad Sci. 
795:250-6. 
220 
504. Sessa PA, Falqueto A, and Varejao JBM 1994. Tentativa de 
controle da leishmaniose tegum entar am ericana por m eio do 
tratam ento dos caes doentes. Cad Saude Publ (Rio de Janeiro). 
10:457-463. 
505. Sharma, R., L. Bahl, A. Goel, A. Upadhaya, S. L. Kaushik, R. L. 
Sharma, and A. Gupta 1996. Congenital kala-azar: a case report. J 
Commun Dis. 28:59- 61. 
506. Shaw, M. A., C. R. Davies, E. A. Llanos-Cuentas, and A. Collins 
1995. Human genetic susceptibility and infection with Leishmania 
peruvian. a Am J Hum Genet. 57:1159-68. 
507. Silva, E. S., C. M. Gontijo, C. Pirmez, O. Fernandes, and R. P. 
Brazil 2001. Short report: detection of Leishmania DNA by polymerase 
chain reaction on blood sam pies from dogs with visceral leishm aniasis. 
Am J Trop Med Hyg. 65:896- 8. 
508. Silva, J. C., Vieira, E.P., Rabelo, L.S.S., Costa, R.T., Franca-Silva, 
J.C., Mayrink, W., Genaro, O. 2000. Epidemiologia e controle da 
leishmaniose visceral no Estado de Minas Gerais, Brasil. Rev Soc Bras 
Med Trop. 33 (Supplement 1):32-33. 
509. Silveira, F. T., R. Lainson, J. J. Shaw, and R. Ribeiro 1984. 
[Cutaneous leishmaniasis in Amazonia. Report of the 1st human case 
of mixed infect ion, determ ined by 2 different Leishmania species: 
Leishmania brasiliensis and Leishmania m exicana amazonensis]. Rev 
Inst Med Trop Sao Paulo. 26:272-5. 
510. Silveira, T. G., U. Teodoro, M. V. Lonardoni, M. J. Toledo, D. A. 
Bertolini, S. M. Arraes, and D. Vedovello Filho 1996. [SerologiC 
survey of dogs in an endem ic area of tegumentary leishmaniasis in 
Parana State, southern Brazil]. Cad Saude Publica. 12:89-93. 
511. Singh, B. 1997. Molecular methods for diagnosis and epidem iological 
studies of parasitic infections. Int J Parasitol. 27: 1135-45. 
512. Singh, S., A. Gilman-Sachs, K. P. Chang, and S. G. Reed 1995. 
Diagnostic and prognostiC value of K39 recom binant antigen in Indian 
leishmaniasis. J Parasitol. 81 :1000-3. 
221 
513. Siappendel, R. J. 1988. Canine leishmaniasis. A review based on 95 
cases in The Netherlands. Vet Q. 10: 1-16. 
514. Siappendel, R. J., and E. Teske 1997. The effect of intravenous or 
subcutaneous adm inistration of m eglum ine antim onate (Glucantim e) in 
dogs with leishmaniasis. A randomized clinical trial. Vet Q. 19:10-3. 
515. Smith, H. R., M. P. Connor, T. W. Beer, and R. E. Ashton 1998. 
The use of polymerase chain reaction in New World cutaneous 
leishmaniasis. Br J Dermatol. 139:539-40. 
516. Soares, M. B., R. G. Titus, C. B. Shoemaker, J. R. David, and M. 
Bozza 1998. The vasoactive peptide m axadilan from sand fly saliva 
inhibits TNF- alpha and induces IL-6 by mouse macrophages through 
interaction with the pituitary adenylate cyclase-activating polypeptide 
(PACAP) receptor. J Immunol. 160: 1811-6. 
517. Solano-Gallego, L., J. Llull, G. Ramos, C. Riera, M. Arboix, J. 
Alberola, and L. Ferrer 2000. The I bizian hound presents a 
predom inantly cellular im m une response against natural Leishmania 
infection. Vet Parasitol. 90:37-45. 
518. Solano-Gallego, L., P. Morell, M. Arboix, J. Alberola, and L. 
Ferrer 2001. Prevalence of Leishmania infantum infection in dogs 
living in an area of canine leishm aniasis endem icity using PCR on 
several tissues and serology. J Clin Microbiol. 39:560-3. 
519. Solbach, W., and T. Laskay 2000. The host response to Leishmania 
infection. Adv Immunol. 74:275-317. 
520. Sosa-Estani, S., E. L. Segura, A. Gomez, O. D. Salom n, M. 
521. 
Peralta, V. Coutada, and L. M. Ruiz 2001. [Cutaneous leishmaniasis 
in Northern Argentina: identification of risk factors in a case-cohort 
study of three municipalities in Salta]. Rev Soc Bras Med Trop. 
34:511- 7. 
Soto, J., P. Buffet, M. Grogl, and J. Berman 1994. Successful 
treatment of Colombian cutaneous leishmaniasis with four injections of 
pentamidine. Am J Trop Med Hyg. 50:107-11. 
222 
522. 
523. 
Soto, J., M. Grogl, J. Berman, and P. Olliaro 1994. Limited efficacy 
of inj ectable am inosidine as single-agent th f C . erapy or olom blan 
cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 88:695-8. 
Soto, J., F. Medina, N. Dember, and J. Berman 1995. Efficacy of 
permethrin-impregnated uniforms in the prevention of malaria and 
leishmaniasis in Colombian soldiers. Clin Infect Dis. 21 :599-602. 
524. Steuber, S., A. Moritz, I. Schirrmann, and M. Greiner 1998. PeR 
follow- up exam ination after t reatm ent of canine leishm aniosis (Cal). 
Tokai J Exp Clin Med. 23:285-92. 
525. Sundar, S. 2001. Drug resistance in Indian visceral leishmaniasis. 
Trop Med Int Health. 6:849-54. 
526. Sundar, S., S. G. Reed, V. P. Singh, P. C. Kumar, and H. W. 
Murray 1998. Rapid accurate field diagnosis of I ndian visceral 
leishmaniasis. Lancet. 351 :563-5. 
527. Tafuri, W. L., P. Raso, M. V. Hermeto, D. Vieira-Dias, and W. 
Mayrink 1993. [Com parative histopathologic study of the skin test in 
dogs from an endem ic area of tegum entary leishmaniasis, using 2 
antigens: Leishvacin and P10.000G]. Rev Soc Bras Med Trop. 26: 11-4. 
528. Tapia, F. J., G. Caceres-Dittmar, and M. A. Sanchez 1994. 
Inadequate epidermal homing leads to tissue damage in human 
cutaneous leishmaniasis. Immunol Today. 15:160-5. 
529. Tapia, F. J., G. Caceres-Dittmar, M. A. Sanchez, A. E. Fernandez, 
and J. Convit 1993. The cutaneous lesion in American leishmaniasis: 
leukocyte subsets, cellular interaction and cytokine production. Bioi 
Res. 26:239-47. 
530. Telleria, J., M. F. Bosseno, T. Tarifa, R. Buitrago, E. Martinez, M. 
Torrez, F. Le Pont, and S. F. Breniere 1999. Putative reservoirs of 
Leishmania amazonensis in a sub-andean focus of Bolivia identified by 
kDNA- polymerase chain reaction. Mem Inst Oswaldo Cruz. 94:5-6. 
531. Teodoro, U., J. B. Kuhl, D. R. Santos, and E. S. Santos 1999. 
[Impact of environm ental changes on sand fly ecology in southern 
Brazil]. Cad Saude Publica. 15:901-6. 
223 
532. Tesh, R. B. 1995. Control of zoonotic visceral leishmaniasis: is it time 
to change strategies? Am J Trop Med Hyg. 52:287-92. 
533. Theodos, C. M., J. M. Ribeiro, and R. G. Titus 1991. Analysis of 
enhancing effect of sand fly saliva on Leishmania infection in mice. 
Infect Immun. 59: 1592- 8. 
534. Titus, R. G., I. Muller, P. Kimsey, A. Cerny, R. Behin, R. M. 
Zinkernagel, and J. A. Louis 1991. Exacerbation of experimental 
m urine cutaneous leishmaniasis with CD4+ Leishmania major-specific 
T cell lines or clones which secrete interferon-gamma and mediate 
parasite- specific delayed-type hypersensitivity. Eur Jim m uno!. 
21 :559-67. 
535. Titus, R. G., and J. M. Ribeiro 1988. Salivary gland Iysates from the 
sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science. 
239: 1306- 8. 
536. Tolezano, J. E., unpublished data. 
537. Tolezano JE, T. H., Araujo MFL, Bisugo MC, Cunha EA, Elias CR, 
Larosa R 1997. Epidemiology of American cutaneous leishmaniasis 
(ACL) in the State of Sao Paulo, use of particulated antigen of 
Leishmania (Viannia) braziliensis in canine inquiries in different 
endemic areas. Mem Inst Oswaldo Cruz. 92 (Supplement II): 119. 
538. Trajano J., unpublished. 
539. Travi, B. L., Y. Osorio, and N. G. Saravia 1996. The inflammatory 
response promotes cutaneous metastasis in hamsters infected with 
Leishmania (Viannia) panamensis. J Parasito!. 82:454-7. 
540. Travi, B. L., C. J. Tabares, H. Cadena, C. Ferro, and V. Osorio 
2001. Canine visceral leishmaniasis in Colombia: relationship between 
clinical and parasitologic status and infectivity for sand flies. Am J Trop 
Med Hyg. 64: 119- 24. 
G F S th and S M. Beverley 2001. Is 541. Turco, S. J., . . pa , . 
I vl'rulence factor? A surprising diversity between lipophosphog ycan a 
Leishmania species. Trends Parasito!. 17:223- 6. 
224 
542. Uezato, H., K. Hagiwara, A. Hosokawa M M 
, . aruno, S. Nonaka 
M. Oshiro, M. Furuya, E. A. Gomez, and Y. Hashiguchi 1998. ~ 
prelim inary study aim ed at the detection of Leishmania parasites in 
subjects with cutaneous leishmaniasis uSI'ng polym erase chain 
reaction. J Dermatol. 25:290-8. 
543. Valladares, J. E., J. Alberola, M. Esteban, and M. Arboix 1996. 
Disposition of antimony after the administration of N-methylglucamine 
antimoniate to dogs. Vet Rec. 138:181-3. 
544. Valladares, J. E., C. Riera, J. Alberola, M. Gallego, M. Portus, C. 
Cristofol, C. Fra nquelo, and M. Arboix 1998. Pharm acokinetics of 
m eglum ine antim oniate after adm inistration of a multiple dose in dogs 
experim entally infected with Leishmania infantum. Vet Parasitol. 
75:33-40. 
545. Valladares, J. E., C. Riera, P. Gonzalez-Ensenyat, A. Diez-
Cascon, G. Ramos, L. Solano-Gallego, M. Gallego, M. Portus, M. 
Arboix, and J. Alberola 2001. Long term improvement in the 
treatm ent of canine leishmaniosis using an antimony liposomal 
formulation. Vet Parasitol. 97:15-21. 
546. van Eys, G. J., G. J. Schoone, G. S. Ligthart, J. J. Laarman, and 
W. J. Terpstra 1987. Detection of Leishmania parasites by DNA in situ 
hybridization with non- radioactive probes. Parasitol Res. 73: 199- 202. 
547. Vannia, C. G., de Lima Takami, H., da Cunha, N.F., Sampaio, 
R.N.R., Tauil, P. 2000. Investigacao epidemiologica da autoctonia da 
leishmaniose tegumentar americana no Distrito Federal - aspectos no 
homen e no cao. Rev Soc Bras Med Trop. 33 (supplemento 11):98. 
548. Vasconcelos, I. A., A. W. Vasconcelos, N. M. Fe Filho, R. G. 
Queiroz, E. W. Santana, M. Bozza, S. M. Sallenave, C. Valim, J. R. 
David, and U. G. Lopes 1994. The identity of Leishmania isolated 
from sand flies and vertebrate hosts in a major focus of cutaneous 
leishmaniasis in Baturite, northeastern Brazil. Am J Trop Med Hyg. 
50:158-64. 
549. Vasconcelos, I. A., A. W. Vasconcelos, H. Momen, G. Grimaldi, 
Jr., and J. E. Alencar 1988. Epidemiological studies on American 
225 
550. 
leish m an iasis in Ceara State Brazil Mole I h '. 
, . cu ar c aracterlzatlon of the 
Leishmania isolates. Ann Trop Med Parasitol. 82:547-54. 
Vasconcelos lAB, V. A., Grimaldi G, Momen H, Alencar JE 1986. 
Epidem iological studies of Am erican visceral le'lsh '" C ' manlasls In eara 
State, Brazil. XV. Further characterisation of stocks of Leishmania sp. 
isolated from dogs and humans within ancient and recent foci of the 
disease. Mem Inst Oswaldo Cruz. 81 (Supplement 11):176. 
551. Vasconcelos lAB, V. A., Lopes UG, Junior ANMS, Abreu RMR, 
Lima JWO, Alencar JE 1987. Reservoir hosts of Leishmania 
braziliensis braziliensis in a peculiar and coastal-sited focus of 
cutaneous leishm aniasis in Ceara State, Brazil. Mem I nst Oswaldo 
Cruz. 82 (Supplement 11):200. 
552. Vazquez, M. L., A. Kroeger, R. Lipowsky, and A. Alzate 1991. 
[Popular conceptions regarding cutaneous leishmaniasis in Colombia 
and their applicability in control program s]. Bol Oficina Sanit Panam. 
110:402-12. 
553. Vercammen, F., D. Berkvens, D. Le Ray, D. Jacquet, and T. 
Vervoort 1997. Development of a slide ELISA for canine leishmaniasis 
and comparison with four serological tests. Vet Rec. 141 :328-30. 
554. Vercam men, F., and R. De Deken 1995. Treatment of canine 
visceral leishmaniasis with allopurinol. Vet Rec. 137:252. 
555. Vercam men, F., and R. DeDeken 1996. Antibody kinetics during 
allopurinol treatment in canine leishmaniasis. Vet Rec. 139:264. 
556. Vexenat, A., J. M. Santana, and A. R. Teixeira 1996. Cross-
reactivity of antibodies in human infections by the kinetoplastid 
protozoa Trypanosoma cruzi, Leishmania chagasi and Leishmania 
(Viannia) braziliensis. Rev Inst Med Trop Sao Paulo. 38:177-85. 
557. Vexenat, J. A., A. C. Barretto, and A. Rosa 1986. [Experimental 
infection of Lutzomyia whitmani in dogs infected with Leishmania 
braziliensis braziliensis]. Mem Inst Oswaldo Cruz. 81 :125-6. 
558. Vexenat, J. A., J. A. Fonseca de Castro, R. Cavalcante, M. R. da 
Silva, W. H. Batista, J. H. Campos, F. C. Pereira, J. P. Tavares. 
226 
and M. A. Miles 1993. Prelim inary observations on the diagnosis and 
transm issibility of canine visceral leishmaniasis in Teresina 
, n. e. Brazil. 
Arch Inst Pasteur Tunis. 70:467-72. 
559. Vexenat, J. A., P. l. Olliaro, J. A. Fonseca de Castro, R. 
Cavalcante, J. H. Furtado Campos, J. P. Tavares, and M. A. Miles 
1998. Clinical recovery and limited cure in canine visceral leishmaniasis 
treated with aminosidine (paromomycin). Am J Trop Med Hyg. 58:448-
53. 
560. Vieira, J. B., and G. E. Coelho 1998. [Visceral leishmaniasis or kala-
azar: the epidemiological and control aspects]. Rev Soc Bras Med Trop. 
31 Suppl 2:85- 92. 
561. Villaseca, P., A. Llanos-Cuentas, E. Perez, and C. R. Davies 1993. 
A com parative field study of the relative im portance of Lutzomyia 
peruensis and Lutzom yia verrucarum as vectors of cutaneous 
leishmaniasis in the Peruvian Andes. Am J Trop Med Hyg. 49:260-9. 
562. Waitumbi, J., and A. Warburg 1998. Phlebotomus papatasi saliva 
inhibits protein phosphatase activity and nitric oxide production by 
murine macrophages. Infect Immun. 66:1534-7. 
563. Walsh, J. F., D. H. Molyneux, and M. H. Birley 1993. Deforestation: 
effects on vector- borne disease. Parasitology. 106:855-75. 
564. Walsh, P. S., D. A. Metzger, and R. Higuchi 1991. Chelex 100 as a 
medium for simple extraction of DNA for PCR-based typing from 
forensic material Biotechniques. 10:506-13. 
565. Walton, B. C. 1987. American cutaneous and mucocutaneous 
leishmaniasis., p. 637-664. In W. Peters, and R. Killick-Kendrick (eds), 
The leishmaniasis in Biology and Medicine. Academic Press, London. 
I B C l. V. Chinel, and O. Eguia y Eguia 1973. Onset of 566. Wa ton, . ., 
espundia after many years of occult 
braziJiensis Am J Trop Med Hyg. 22:696-8. 
infection with Leishmania 
567. W a rbu rg, A. 1991. Entom opathogens of phlebotom ine sand flies: 
laboratory experim ents and natural infections. J I nvertebr Pathol. 
58:189-202. 
227 
568. 
569. 
Warburg, A., E. Saraiva G. C. Lanzaro R G T't 
' , . . I us, and F. Neva 
1994. Saliva of Lutzomyia longipalpis sibling species differs in its 
com position and capacity to enhance leishm aniasis Philos Trans R Soc 
Lond B Bioi Sci. 345:223- 30. 
Weigel, M. M., R. X. Armijos, C. Zurita, J. Racines, A. Reddy, and 
J. Mosquera 1995. Nutritional status and cutaneous leishmaniasis in 
rural Ecuadorian children. J Trop Pediatr. 41 :22- 8. 
570. Weigle, K., and N. G. Saravia 1996. Natural history, clinical 
evolution, and the host-parasite interaction in New World cutaneous 
leishmaniasis. elin Dermatol. 14:433-50. 
571. Weigle, K. A., M. de Davalos, P. Heredia, R. Molineros, N. G. 
Saravia, and A. D'Alessandro 1987. Diagnosis of cutaneous and 
mucocutaneous leishm aniasis in Colom bia: a com parison of seven 
methods. Am J Trap Med Hyg. 36:489-96. 
572. Weigle, K. A., L. A. Labrada, C. Lozano, C. Santrich, and D. C. 
Barker 2002. PCR- Based Diagnosis of Acute and Chronic Cutaneous 
leish m an iasis Caused by Leishmania (Viannia). J Clin Microbio\. 
40:601-6. 
573. Weigle, K. A., C. Santrich, F. Martinez, L. Valderrama, and N. G. 
Saravia 1993. Epidemiology of cutaneous leishmaniasis in Colombia: a 
longitudinal study of the natural history, prevalence, and incidence of 
infection and clinical manifestations. J Infect Dis. 168:699-708. 
574. WHO 2001. World Health Report. Mental Health: New Understanding, 
New Hope. World Health Organisation. 
575. Wijeyaratne, P. M., L. K. Arsenault, and C. J. Murphy 1994. 
Endem ic disease and developm ent: the leishmaniases. Acta Trop. 
56:349-64. 
576. W illia m 5, B. G., and C. Dye 1997. I nfectious disease persistence 
when transmission varies seasonally. Math Biosci. 145:77-88. 
577. Wilson, H. R., B. S. Dieckmann, and G. E. Childs 1979. Leishmania 
braziliensis and Leishmania m exicana: experim ental cutaneous 
infections in golden hamsters. Exp Parasito\. 47:270-83. 
228 
578. Wincker, P., C. Britto, J. B. Pereira, M. A. Cardoso 
, w. 
Oe Ie man n, and C. M. M ore I 1994. Use of a sim plified polym erase 
chain reaction procedure to detect Trypanosoma cruzi in blood samples 
from chronic chagasic patients in a rural endemic area. Am J Trop Med 
Hyg. 51 :771- 7. 
579. Wincker, P., J. Telleria, M. F. Bosseno, M. A. Cardoso, P. 
Marques, N. Yaksic, C. Aznar, P. Liegeard, M. Hontebeyrie, F. 
Noireau, C. M. Morel, and S. F. Breniere 1997. PCR- based diagnosis 
for Chagas' disease in Bolivian children living in an active transm ission 
area: com parison with conventional serological and parasitological 
diagnosis. Parasitology. 114:367- 73. 
580. Wongsrichanalai, C. 2001. Rapid diagnostic techniques for malaria 
control. Trends Parasitol. 17:307- 9. 
581. Wong-Un, J. A. 1998. [Community-based control of infectious 
diseases: reflecting on the collective health practices of Andean 
Peruvian peasants]. Cad Saude Publica. 14:91-100. 
582. Woolhouse, M. E., C. Dye, J. F. Etard, T. Smith, J. D. Charlwood, 
G. P. Garnett, P. Hagan, J. L. Hii, P. D. Ndhlovu, R. J. Quinnell, C. 
H. Watts, S. K. Chandiwana, and R. M. Anderson 1997. 
Heterogeneities in the transm ission of infectious agents: im plications 
for the design of control programs. Proc Natl Acad Sci USA. 94:338-
42. 
583. Wortmann, G. W., N. E. Aronson, R. S. Miller, D. Blazes, and C. 
N. Oster 2000. Cutaneous leishm aniasis following local traum a: a 
clinical pearl. Clin Infect Dis. 31: 199- 201. 
584. Yadav, T. P., H. Gupta, U. Satteya, R. Kumar, and V. Mittal 1989. 
Congenital kala-azar. Ann Trop Med Parasitol. 83:535-7. 
585. Yadon, Z. E. 1996. Risk factors for American cutaneous leishmaniasis 
in Santiago del Estero, Argentina. PhD. University of London. 
586. Y h ·da ELF M Correa S. A. Marques, H. o. Stolf, N. L. os I , . ., .. , 
Dillon, H. Mom en, and G. Grim a Idi, Jr. 1990. Human, canine and 
equine (Equus cabal/us) leishmaniasis due to Leishmania braziliensis 
229 
587. 
(= L. braziliensis braziliensis) in the south- west region of Sao Paulo 
State, Brazil. Mem Inst Oswaldo Cruz. 85: 133-4. 
Zaffaroni, E., L. Rubaudo, P. Lanfranchi, and W. Mignone 1999. 
Epidemiological patterns of canine leishmaniasis [correction of 
leishmaniosis] in Western Liguria (Italy). Vet Parasitol. 81: 11- 9. 
588. Zeledon R 1985. leishmaniasis in North America, Central America and 
the Carribean Islands, p. 313-351. In B. R. Chang KP (ed.), 
leishmaniasis, vol. 1. Elsevier, Amsterdam. 
589. Zeledon, R., and M. Alfaro 1973. Letter: Isolation of Leishmania 
braziliensis from a Costa Rican sandfly and its possible use as a human 
vaccine. Trans R Soc Trop Med Hyg. 1973;67(3):416-7.67:416-7. 
590. Zeledon, R., E. Blanco, and E. De Monge 1969. Comparative 
experimental infections with Costa Rican strains of Leishmania 
braziliensis Vianna, 1911. Acta Trop. 26:136-55. 
591. Zeledon, R., C. Ponce, and D. E. Ponce 1977. Finding of Leishmania 
hertigi in the Costa Rican porcupine. J Parasitol. 63:924-5. 
592. Zerpa, 0., M. Ulrich, E. Negron, N. Rodriguez, M. Centeno, V. 
Rodriguez, R. M. Barrios, D. Belizario, S. Reed, and J. Convit 
2000. Canine visceral leishmaniasis on Margarita Island (Nueva 
Esparta, Venezuela). Trans R Soc Trop Med Hyg. 94:484-7. 
593. Zijlstra, E. E., N. S. Daifalla, P. A. Kager, E. A. Khalil, A. M. EI-
Hassan, S. G. Reed, and H. W. Ghalib 1998. rK39 enzyme-linked 
im m unosorbent assay for diagnosis of Leishmania donovani infection. 
elin Diagn Lab Immunol. 5:717-20. 
594 Z ··I tEE V Nur P. DesJ·eux, E. A. Khalil, A. M. EI-Hassan, . IJ S ra, . .,. , 
and J. Groen 2001. Diagnosing visceral leishmaniasis with the 
recom binant K39 strip test: experience from the Sudan. Trop Med I nt 
Health. 6: 1 08-13. 
M E Villarroel, N. Rodriguez, M. D. Feliciangeli, M. Zulueta, A. ., . 
Mazzarri, O. Reyes, V. Rodriguez, M. Centeno, R. M. Barrios, and 
M. Ulrich 1999. Epidemiologic aspects of American visceral 
595. 
230 
leishmaniasis in an endemic focus in Eastern Venezuela Am J Trop Med 
Hyg. 61 :945-50. 
231 
Plate 1. American cutaneous leishmanasis in Huanuco, Peru : clinical 
characteristics of L braziliensis and L peruviana infection. 
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Plate 1 Legend: A B 
C D 
E F 
G H I 
Plate 1 A. Localised cutaneous leishmaniasis: facial ulcer in a child a 
common disease manifestation in Huanuco. It highlights the impa~t of ACL on the local 
community: children often know about ACL, why and how it is transmitted because most 
of them have suffered from the disease and consequent course of treatment during their 
childhood. 
Plate 1 B. Localised cutaneous leishmaniasis: involvement of extremities. Lesions tend 
to appear on body sites which are exposed to the bites of sandfly vectors, i.e. the face, 
arms and lower legs. Of note is the typical appearance of the lesion, a large ulcer with 
raised borders, characteristics that are typical of L. braziliensis lesions. 
Plate 1C. Localised cutaneous leishmaniasis: reactivation. Of note is the depigmented 
area around the active lesion, characteristic of L. braziliensis scars. 
Plate 1 D. Localised cutaneous leishmaniasis: verrucous lesion. Verrucous lesions are 
extremely rare and can often be mistaken to be of other aetiology than Leishmania. 
Plate 1 E. Localised cutaneous leishmaniasis: scar. As in Plate 1 C, this lesion is 
characteristic of L. braziliensis infection, because of the depigmented area in the centre 
of the scar. 
Plate 1 F. Mucocutaneous leishmaniasis: palate and nose involvement. This is a non-
ulcerative mucosal lesion of the hard and soft palate. This particular patient was aphonic, 
as the infection had severely compromised vocal cords. 
Plate 1 G. Mucocutaneous leishmaniasis: palate involvement. This is a non-ulcerative 
mucosal lesion of the hard and soft palate. It is an exophytic plaque rich in granulation 
tissue; eventually erosion of the palate may result in bleeding. 
Plate 1 H. Differential diagnosis: maleolar ulcers. The crusted ulcers of venous aetiology 
on or around the ankles are commonly mistaken for LCL. 
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Plate 2. American cutaneous leishmanasis in Huanuco, Peru : cl inical 
characteristics of L. braziliensis and L. peruviana infection . 
/' 
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Plate 2 Legend: c 
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Plate 2A. localised cutaneous leishmaniasis This child has lCl d L . 
Though there are no published reports of Mc"l caused by L P . ue 't' peruvlana. 
MCl b t··t· . eruvlana, I may cause y con InUI y when lesions are close to the mucosae. 
Plate .2B. l~calised cutaneo~s leishmaniasis. localised cutaneous leishmaniasis: facial 
ulcer In a Child, a common d.lsease. manifestation in Huanuco. It highlights the impact of 
ACl o~ the local community: children often know about ACl, why and how it is 
transmitted because most of them have suffered from the disease and consequent 
course of treatment during their childhood. 
P~ate 2C. M~cocutaneous leishmaniasis: facial destruction. This adult has active MCl 
~I~h d~structlve polypoid lesions on the left ala nasae, scarring of the nose and upper lip 
infiltration. 
Plate 20. Mucocutaneous leishmaniasis: palate involvement. This is a non-ulcerative 
~ucosal lesion of the .hard and soft palate. It is an exophytic plaque rich in granulation 
tissue; eventually erosion of the palate may result in bleeding. 
Plate 2E. localised cutaneous leishmaniasis: cutaneous lesion due to Leishmania 
(Viannia) spp. 
Plate 2F. Cutaneous lesion due to Leishmania (Viannia) spp. Note, that in this case the 
patient used battery acid to cure the lesion, which makes differential diagnosis of ACl 
difficult. 
Plate 2G. Mucocutaneous leishmaniasis. Metastatic lesions usually begins within the 
deep nasal mucosa. There is heavy cellular infiltration around the small blood vessels, 
proliferation of the vascular endothelial cells, progressive necrosis and fibrosis, erosion 
of the nasal septum, liquefaction of the cartilage. As a result, the inflammation spreads to 
the surface of the skin causing superficial necrosis, desquamation of the surface 
epithelium and ulceration. In some cases the inflammation can also spread to the eye. 
Plate 2H. Mucocutaneous leishmaniasis: facial destruction due to cure after progressive 
disease. This particular patient [908/2/9] suffered from MCl for> 10 years and underwent 
three courses of antimonial therapy. The picture displays one of the facets of ACl: 
because the lesions tend not to be painful, patients do not seek treatment in local health 
posts, with progressive MCl causing severe facial destruction which ultimately may be 
fatal due to bacterial contamination. Patients suffering from progressive MCl also can 
suffer from severe stigmatisation and may face the exclusion of the community. 
Plate 21. Differential diagnosis: malignant neoplasm of the skin. This adult has a 
squamous cell carcinoma, with aggressive exophytic growth on cheek and upper neck. 
Skin cancers are often misdiagnosed as lCL. 
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Plate 3. American cutaneous leishmaniasis in Huanuco, Peru : 
field sites and community participation . 
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Plate 3A. Topography of the stu_dY site. A typical view of one of the field sites showing 
the dry slopes ?f the Huanuquenan valleys where both L. braziliensis and L. peruviana 
are endemic. Pictured: Conchumayo [902]. 
Plate 38. Topography of the stu_dY site. A typical view of one of the field sites showing 
the dry slopes of the Huanuquenan valleys where both L. braziliensis and L. peruviana 
are endemic. Of n~te are t~e dry mountain slopes and the fertile valley around the creek, 
where potatos, maize, manioc and wheat are grown. Pictured: Conchumayo [902]. 
Plate 3C. Topography of the study site. A typical view of one of the study villages. Of 
note are the dry mountain slopes and the fertile valley around the creek, where potatos, 
maize, manioc and wheat are grown. Pictured: Quechualoma [903]. 
Plate 3D. Seasonality of the study site: after the rainy season, the normally dry Andean 
valleys become green and lush. 
Plate 3E. Study site. Study villages are at high altitude (2000-3500m) in the Andes and 
tended to have between 150-650 inhabitants. Each village tends to have a main square 
with adjacent church and school. 
Plate 3F. Sandfly vector habitat. Many houses in the study sites have animal shelters 
close to the house, which provide optimal conditions for sandflies regarding temperature, 
humidity, and an abundance of blood meal sources. This animal shelter was next to the 
house of 'Tarzan' [908/97/27] (see Plate 4E). 
Plate 3G. Project logistics: community participation and involvement. Prior to the start of 
the surveys, reunions were organised in each village to outline the study's purpose, 
objectives and implementation. Pictured: meeting the adults on the village square in Coz 
[908]. 
Plate 3H. Project logistics: community partiCipation and involvement in epidemiologi~al 
surveys. During 1994 and 1998 an epidemiologi~al survey on human ACL was ~arned 
out by the Universidad Peruana Cayetano Heredia and the London School of ~y.glene & 
Tropical Medicine (Chapter 5). People in study villages were fol~owed-up ~llnically. at 
three-month intervals during this period, with yearly Montenegro skin tests being applied 
(pictured: Juan Canales Espinoza applying MST in Coz). 
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Plate 4. American cutaneous leishmaniasis in Canis familiaris . 
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Plate 4 Legend: 
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Plate .4A. S~~pling of dogs during the house-to-house surveys in study sites. Dogs were 
examined. clinically f?r scar~ and ulcers indicative of ACL. After blood sampling dogs 
were vaccinated against rabies (Chapter 2). ' 
Plate 4B. Sampli~g of the canine population in study sites. Of a subset of sampled dogs 
bone marrow aspirates were taken for diagnostic purposes (Chapter 2). 
Plate 4C. American cutaneous leishmaniasis in Canis familiaris. Clinical characteristics 
of ACL in dogs include small cutaneous ulcers or scars, which tend to be found at sites 
ex~osed to sandfly vectors, i.e. nose and ears. Dog: 902/97/30 aka 'Oso'; had an active 
lesion between 1997 and 1998, was PCR-/ELlSA+[6.1 LAU/ml] in 1997, 
PCR+/ELlSA+[7.2 LAU/ml] in 1998 and ELlSA+, and PCR+/ELlSA+ [6.3 LAU/ml] in 
1999. 
Plate 40. American cutaneous leishmaniasis in Canis familiaris. As the dog in Plate 4C, 
the dog pictured has an ulceration on the snout. Additionally is suffers from severe 
conjunctivitis ('lunettes') around the eyes, a common clinical sign for zoonotic visceral 
leishmaniasis. Dog: 904/98/17 aka 'Alicia', had an active lesion in 1998, PCR-
IELlSA+[5.5] in 1998. 
Plate 4E. American cutaneous leishmaniasis in Canis familiaris. As the dogs in Plate 
4C-0, the dog pictured has an ulceration on the snout. Additionally is suffers from severe 
conjunctivitis (,lunettes') around the eyes, a common clinical sign for zoonotic visceral 
leishmaniasis. Dog: 908/97/27 aka 'Tarzan', active lesions on the snout, around the 
eyes, and in the ear (not shown); PCR+/ELlSA+ [5.1], culture positive 
[CAN/PE/94/LC56] . 
Plate 4F. Clinical characteristics of ACL in Canis familiaris. Same dog as in Plate 4F, 
close-up of the lesion on the snout. 
Plate 4G. American cutaneous leishmaniasis in Canis familiaris. Advanced 
mucocutaneous leishmaniasis in a dog, where -similar to ACL in man- disease has led 
to the necrosis of the snout and partial collapse of the septum. Dog: 903/97/71 aka 
'Marquesa', had an active lesion between 1997 and 1998, PCR-/ELlSA+ [5.7LAU/ml] in 
1998). 
Plate 4H. American cutaneous leishmaniasis in Canis familiar!s. Advanced 
mucocutaneous leishmaniasis in a dog, where -similar to ACL in man- dlse~s.e has. led 
to the necrosis of the snout and partial collaps~ of t~e septum. Other cll~lc~1 slgn~ 
included emaciation, onychogryphosis, dry and bnttle hair. Dog: 92.1/97~1 aka Pnncesa, 
ELlSA+[5.5] PCR and histology detected parasites in blood, conJunctiva, lymph node, 
lung and ovary biopsies (Chapter 3). 
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Plate 5. peR as mass-s~reening tool to detect Leishmania (Viannia) 
Infection in dog blood 
M 2 3 4 5 6 7 8 9 10 11 12 13 
B 
M 2 3 4 5 6 7 8 9 10 11 12 13 
Plate SA. Sensitivity titration assay (STA) . As outlined in Chapter 2, an STA was set up to 
determine which DNA extraction protocol and DNA primers to use for PCR-hybridisation analysis 
of field samples. DNA was extracted from samples using four different extraction protocols, 
amplified using four different PCR primer pairs, Southern blotted and hybridised to a specific 
radioactive probe. Samples were amplified with B1 /2 PCR primers (A) and hybridised to a B3 
probe (B) (Box 1). Lane 1, no-DNA negative control; M, X174 base pair marker; Lanes 2-6, 
phenol/chloroform-extracted samples; Lane 7, no-L. braziliensis phenol/chloroform-extracted 
negative control ; Lanes 8-12; DNeasy-extracted samples; Lane 13, no-L. braziliensis DNeasy-
extracted negative control. 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
1 M 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
Plate 5B. P03/POS PCR amplification of guanidine blood lysate fi eld samples to eva luate sample 
degradation or PCR inhibition. Arrow indicates the 469bp amplification product (Box 1). M, X174 
base pair marker; Lanes 1-18, field samples . 
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Plate 5. peR as mass-screening tool to detect Leishmania (Viannia) 
infection in dog blood (guanidine blood lysate, GBl) 
12M 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
12M 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
Plate 5C. B 112 amplification of guanidine blood Iysates (A) and hybridisation to B3 probe (B) 
(Box1). Lane 1, no DNA guanidine blood lysate negative control ; Lane 2, dog DNA guanidine 
lysate negative control; M, X174 base pair marker; Lane 3, L. braziliensis positive control 
(MHOM/BR/75/M2903), Lanes 4-17, field samples. Though not visible by gel electrophoresis, 
750bp B 112 amplification products are detected by hybridisation for samples 7, 8 and 11-15. 
M 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 
B 
<: 
M 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 
Plate 50. B1 /2 amplification of guanidine blood Iysates (A) and hybridisation to B3 probe (B) 
(Box1) . M, 1 kilo base pair ladder; Lane 2, dog DNA guanidine lysate negative control ; Lane 3, L. 
braziliensis positive control (MHOM/BR/75/M2903) , Lanes 4-19, field samples. 750bp B 1/2 
amplification products from samples 16 and 17 were visible by gel electrophoresis and hybridised 
to the B3 probe. 
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Plate 5. PCR as mass-screening tool to detect Leishmania (Viannia) 
infection in dog blood (buffy coat, BCS) 
1 M2 3 4 5 6 7 8 9 10111213141516171819 
1 M 2 3 4 567 8910111213141516171819 
Plate SE. B1/2 amplification of buffy coat samples (A) and hybridisation to B3 probe (B) (Box1). 
Lane 1, no-DNA buffy coat negative control; M, X174 base pair marker; Lanes 2-19, field 
samples; Lane 20, dog DNA negative control ; Lanes 21 -36, field samples ; Lanes 37-38, L. 
braziliensis positive control (MHOM/BR/75/M2903) . 750bp B1 /2 amplification products from 
samples 7,8, 11-13 and 29 were hybridisation positive. Broken arrows indicate non-specific bands 
seen on the gel , which prevented classification of samples into gel electrophoresis or 
hybridisation positive or negative (see Chapter 2 for details) . 
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Plate 5. peR as mass-screening tool to detect Leishmania (Viannia) 
infection in dog bone marrow (BMS). 
1 M 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
::! B 
-~ 
• 
-if l- ~ ~ 
• • • 
1 M 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
Plate SF. B1/2 amplification of bone marrow samples (A) and hybridisation to B3 probe (8) 
(Box1). Lane 1, dog DNA bone marrow negative control; M, X174 base pair marker; Lanes 2-14, 
field samples; Lanes 15-17, L. braziliensis positive control (MHOM/BR/75/M2903). 750bp B1/2 
amplification products from samples 2,4 and 9 were hybridisation positive. Broken arrows indicate 
non-specific bands seen on the gel, which prevented classification of samples into gel 
electrophoresis or hybridisation positive or negative (see Chapter 2 for details). 
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Plate 6. Topical insecticides to control canine zoonotic visceral leishman ias is: 
experimental and matched cluster intervention trial. 
--------------------
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Plate 6 Legend: I~A I~ 
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P.lat~ 6A. Diagnosis of canine zoonotic visceral leishmaniasis. Immunochromatographic 
dipsticks were compared to peR and ELISA in detecting ZVL infection in dogs (Chapter 
6). 
Plate 68. Experimental trial to test the efficacy of topical insecticides in protecting dogs 
from sandfly bites. Caged dogs were exposed to wild-caught sandflies ovemight. After 7-
8 hrs, sandflies were retrieved from the tents and scored as either dead or live bloodfed 
or unfed (Chapter 7). ' 
Plate 6C. Experimental trial: Fazenda Palmital. Topical insecticides used in the trial 
included deltamethrin and diazinon-impregnated dog collars as well as permethrin and 
fenthion pour-on lotions (Chapter 7). 
Plate 60. Matched cluster intervention trial: Capitao Eneas. Dog with 40mg/g 
deltamethrin-impregnated dog collar (Chapter 8). 
Plate 6E. Matched cluster intervention trial: Capitao Eneas. Capitao Eneas has been a 
focus for urban ZVL for a number of years and canine culling campaigns are carried out 
every 1-2 years; area shown: D1 (Chapter 8). 
Plate 6F. Matched cluster intervention trial: Capitao Eneas. Capitao Eneas has been a 
focus for ZVL for a number of years and canine culling campaigns are carried out every 
1-2 years; area shown: D2. Note the proximity of houses to crops and vegetation, ideal 
resting and breeding places for Lutzomyia /ongipa/pis vectors (Chapter 8). 
Plate 6G. Matched cluster intervention trial: Capitao Eneas. House-to-house visits and 
sampling of dog population (Chapter 8). 
Plate 6H. Matched cluster intervention trial: Capitao Eneas. Fundac;ao Nacional de 
Saude staff helping with the intervention trial (Chapter 8). 
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